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Abstract 
A community-based case-control study was carried out in South London, to investigate the 
determinants of herpes zoster in adults without underlying immunosuppression. Incident 
zoster cases were identified from general practices. Two controls were selected per case, 
matched by age, sex, and practice. Participants were interviewed to determine exogenous 
contacts with varicella and with children as proxies for varicella contacts; ethnicity, country 
of birth and age at varicella; micronutrient Intake and intake of fruit and vegetables; 
ultraviolet radiation (UVR) exposure in childhood and in the last year, and stressful events. 
Odds ratios were estimated using conditional logistic regression. 
Data from 244 cases and 485 controls were analysed. On multi variable analysis, contacts 
with children significantly protected against zoster - most heavily exposed individuals were 
at one fifth the risk ofunexposed individuals, and this appeared to be mediated by increased 
exposure to varicella cases. Childhood UVR exposure was associated with a strongly 
increased risk of zoster. Individuals eating fresh fruit less than once a week were at a six-
fold risk of zoster compared to those with highest intakes, and individuals aged >60 years 
with a high combined micronutrient intake were protected against zoster. Individuals 
experiencing an incident stressful event in the last two months were at more than twice the 
risk of zoster, and stressful events in the last year were associated with increased risk 
amongst elderly individuals. The protective effect of Afro-Caribbean ethnicity was mostly 
explained by increased child contacts and high fresh fruit intake. 
This study identified new risk factors for zoster. Those factors that were restricted to older 
individuals may also be determinants of immunosenescence. The findings suggest that 
widespread varicella vaccination ,of children could lead to increased incidence of adult 
zoster by decreasing exogenous varicella exposures. Other implications for future research 
and for public health policy are discussed. 
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1: INTRODUCTION 
Herpes zoster (shingles) occurs as a result of reactivation of varicella zoster virus (VZV) which 
has remained dormant since primary infection associated with varicella (chickenpox). Zoster 
occurs frequently in ageing populations, with an estimated lifetime risk of 23-30% amongst 
individuals living in the United Kingdom.1,2 It causes significant acute morbidity, including 
dermatomal pain, vesicular rash and altered sensation. The commonest sequela is postherpetic 
neuralgia (pain lasting longer than one month after rash onset), which may follow zoster in 
approximately 50% of individuals aged over 60 years, and which can persist for years.3,4 It has 
been estimated that zoster results in a total of 19,966 quality-adjusted life years lost annually in 
England and Wales, and costs health care providers more than £47.6 million per year.5 
Oral antiviral therapies can be given to individuals with zoster in an attempt to limit acute pain 
and reduce the risk of post-herpetic neuralgia. There is evidence that antivirals have some 
effect if given within 72 hours of rash onset.6-8 However, many patients present too late to 
benefit from early therapy, and the frequent occurrence of prodromal pain in zoster indicates 
that neuronal damage often occurs before rash develops. Given the common occurrence of 
PHN and difficulties in its treatment, strategies to reduce the incidence of zoster are needed. 
This would be facilitated if there were a good understanding of the determinants of VZV 
reactivation. 
, 
Latent VZV virus is thought to reactivate as a result of declining specific cell-mediated 
immunity.9-12 It follows that individuals with diminished cell-mediated immunity due to 
immunosuppressive conditions or therapies are at higher risk of zoster. \3-15 However, these 
individuals only constitute 1-11% of zoster cases in population-based studies,4,16-22 and the 
determinants ofVZV reactivation in people without underlying immunosuppression are largely 
unknown. One of the few established risk factors is age - the risk of zoster increases markedly 
in elderly individuals.4,23 This may be due to the generalised loss of cell-mediated immunity 
which occurs as part of the ageing process, or to waning of VZV -specific immunity over 
time. Little is known about the determinants of either generalised or VZV -specific immune 
decay. 
Research is therefore needed to elucidate risk factors for VZV reactivation as zoster. As well 
as informing strategies to prevent zoster, this research could provide information on two 
additional issues: 
15 
1. A vaccine is available against varicella, and its introduction has been considered by many 
countries.24 A critical issue for any proposed varicella vaccination programme is whether 
continued exposure to cases of varicella protects individuals with latent infection from 
zoster, by exogenous boosting of VZV -specific immunity. If this were the case, 
widespread introduction of varicella vaccination could lead to an increase in the incidence 
of zoster. Research findings on the effect of exposure to varicella on the risk of zoster 
would allow modification of existing mathematical models which represent the 
transmission of varicella in an age structured population, including equations describing 
the incidence of herpes zoster,zS,26 These models can be used to explore the potential 
impact of introducing varicella vaccination in the UK and elsewhere, and to inform 
estimates of the cost effectiveness of vaccination. S 
2. The public health importance of diseases of the elderly is increasing in the United 
Kingdom as the population ages. Studies are needed to investigate extrinsic factors that 
contribute to the increasing incidence of disease with age, including increased 
susceptibility to infections. The generalised loss of cell-mediated immunity with age 
underlies this increasing morbidity. If reactivation of VZV as zoster in older individuals is 
a marker of generalised immune senescence, investigation of risk factors for zoster may 
also provide insight into the determinants of the generalised decline in immunity in the 
elderly. 
This thesis is a report of an investigation into the determinants of zoster in individuals with no 
known underlying immunosuppression. In Chapter 2, the literature on zoster is summarised -
this includes the biology and natural history of VZV infection, and existing descriptive and 
analytical epidemiological studies of zoster. The rest of the thesis describes a community-
based matched case-control study o(risk factors for zoster that was carried out in an urban 
United Kingdom population. Cases were adults with recently diagnosed zoster presenting to 
general practices in 1997-98. For each case, two controls (with no history of zoster) were 
selected, individually matched by age, sex, and practice. Participants were interviewed at 
home, using a standardised questionnaire. Information was sought on 1) factors that might 
protect against zoster by boosting specific immunity, 2) possible determinants of 
generalised loss of cell-mediated immunity and 3) other factors that might affect risk of 
zoster. Chapter 3 provides details of the methods used, including the study objectives, the 
study setting, recruitment of cases and controls, data collection and management, and the 
overall analytical strategy. Two groups of data required complex data transformation, and 
this is discussed in Chapter 4. The descriptive results are presented in Chapter 5. Chapter 6 
contains the analyses of risk factors for zoster, and is divided into sections - the first five of 
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these describe analyses of the five main subgroups of data, each with details of the specific 
hypotheses tested, analytical strategies used, results of univariable and multivariable 
analyses, and discussion of the findings. The final section reports the findings from a 
combined model, which contained selected variables from the five sub-models. In Chapter 
7, the main findings are summarised, the strengths and potential weaknesses of the study are 
analysed, and the implications for future research and public health practice are discussed. 
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2. LITERATURE REVIEW 
2.1 BIOLOGY AND NATURAL HISTORY OF HERPES ZOSTER 
Varicella zoster virus (VZV) is an alpha-herpes virus with a double-stranded DNA genome of 
approximately 125,000 base pairs?7 Primary infection is manifested as varicella (chickenpox), 
following which the virus establishes latency in do~sal root ganglia, residing predominantly in 
neurones.
28
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30 Reactivation of latent virus, often many decades after primary infection, results 
in herpes zoster (shingles). Control of the virus in the latent form is thought to be maintained 
by specific cell-mediated immunity. Evidence for this includes: 1) increasing risk of zoster and 
declining VZV-specific cell-mediated responses (reduced lymphoproliferation and delayed 
type hypersensitivity reactions) both occur with age;4,9,10,23 2) immunocompetent individuals at 
the onset of zoster have low VZV -specific cell-mediated responses compared to non-zoster 
controls, I 1,12 and 3) - individuals with diminished cell-mediated immunity due to 
immunosuppressive conditions experience zoster more frequently compared to 
immunocompetent individuals. 13-15 In contrast to the low cell-mediated responses, high levels 
ofVZV-specific antibody are present at onset ofzoster.31 ,32 
Reactivation in a single ganglion is thought to result in replication of the virus, which travels 
down sensory neural axons to the skin supplied by the dorsal roOt.33 The resulting 
erythematous rash of zoster therefore has a dermatomal unilateral distribution. The rash is 
typically limited to a single dermatome, but eruptions in the adjacent or in a separate 
dermatome have been described.34 The extent of rash within the dermatome varies; a large 
proportion of the dermatome is often involved but less extensive rash can occur, and very 
rarely there may be no rash visible (zoster sine herpete).35-37 The rash is initially 
maculopapular before developing into characteristic vesicles followed after about a week by 
crusts, although occasionally the papules persist without vesicle formation.38 The rash is 
usually accompanied (and often preceded) by dermatomal pain and/or paresthesia.35 
Specific cell-mediated immunity increases after zoster.12 Second attacks of zoster are 
uncommon in the immunocompetent, but were reported in 0.8-5% of individuals in 
population-based studies with follow-up of 9-30 years.4,21,34 Hope-Simpson extrapolated from 
his own data to estimate that amongst one thousand individuals who lived to the age of 85 
years, approximately half would experience a single episode of zoster, ten individuals would 
experience a second episode, and one individual would experience a third episode.34 However, 
recurrent zoster occurs more commonly in the immunosuppressed.39 
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The major sequela of zoster is chronic pain (post herpetic neuralgia, or PHN), which is 
commonly defined as pain lasting at least one month after rash onset.35 This occurs 
increasingly with age and may be experienced by approximately 50% of individuals over the 
age of60 years.4,35 The mechanism for PHN is unclear, but is thought to involve virus-induced 
inflammation and death of neurones.40 Uncommon neurological complications of zoster 
include contralateral hemiparesis, myelitis, motor neuropathies, cranial nerve palsies and 
encephalitis.37 Zoster of the ophthalmic branch of.the trigeminal nerve can result in corneal 
scarring or secondary panophthalmitis.4,41 In immunosuppressed individuals, widely 
disseminated rash with visceral involvement may occur.42 
Once established, PHN can persist for years.4 Oral antiviral therapies are often given during 
the acute phase of zoster in an attempt to reduce the incidence ofPHN. Randomised controlled 
trials have demonstrated that prompt administration of antivirals may reduce acute pain, limit 
the extent of rash and hasten rash healing, but may only have limited efficacy against PHN.6-8 
Prodromal pain is often reported in zoster, and this suggests that neuronal damage occurs early 
in many people, even before they develop rash. In addition, patients often present more than 
72 hours after rash onset, at which time oral antivirals are less effective. Therefore, zoster-
associated morbidity may be better avoided by trying to prevent reactivation of VZV, rather 
than by treating manifestations of reactivated infection. 
2.2 DIAGNOSIS OF HERPES ZOSTER 
The differential diagnosis of clinical zoster includes herpes simplex virus (HSV) infection, 
impetigo, and contact dermatitis. The major consideration in adults is to exclude HSV 
infection. The characteristic dermatomal distribution and accompanying pain usually identifies 
individuals with zoster. Other clinical differences between zoster and HSV infection include: 
4,34,43 
Frequency of recurrence: second episodes of zoster are uncommon, whereas HSV 
recurrences are frequent, usually occurring in the same site; 
Site of rash: zoster commonly occurs within the thoracic or lumbar dermatomes or in the 
distribution of the ophthalmic branch of the trigeminal nerve, whereas HSV infection most 
frequently arises as a small patch of rash on the buttocks or perioral area; 
Pain: zoster is usually accompanied by acute pain, and often results in PHN. Simplex 
infection is typically accompanied by a sensation of burning, tingling or itching, and does 
not lead to PHN. 
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In a few cases it may not be possible to distinguish zoster from HSV infection by clinical 
criteria alone. This is because zoster can occasionally present as a single patch of rash and 
HSV can present with a zosteriform rash. In one study, vesicular fluid swabs were analysed 
for 110 individuals with vesicular eruptions presenting to a dermatology department.36 All 65 
individuals clinically diagnosed as zoster had their diagnoses confirmed by the laboratory tests, 
but nine (20%) of 45 patients who were clinically diagnosed as having HSV infection were 
found to have zoster. Eight of the nine 'HSV' patients had small patches of rash on the 
extremities or trigeminal dermatomes, and three had no pain. However, within two days the 
area of rash increased in four patients, developing a more typical zoster presentation. In a 
second study, 47 of 111 patients referred to a general hospital with clinical zoster underwent 
laboratory investigations.44 Of these, six (13%) were found to have HSV infection .. All six 
had a 'dermatomal distribution' of rash, and 4/6 reported pain. It is unclear why only 47/111 
patients underwent laboratory testing, and other researchers have suggested that some of these 
patients may have had atypical HSV infection due to undetected immunosuppression - the 
hospital was situated in an inner-city area with high prevalence of HN infection.45,46 
Nevertheless, this study demonstrates that HSV can mimic zoster clinically. 
As indicated above, laboratory methods can be used to distinguish zoster from other infections. 
Live VZV can be isolated from vesicle fluid for a limited period, but the sensitivity of 
diagnosis based on viral culture is low, ranging from 26_64%.47 Polymerase chain reaction 
(peR) allows sensitive (-100%) and specific detection of VZV -specific nucleic acids in 
vesicle fluid by amplifying conserved sequences of the viral genome.48,49 The technique has 
also been used successfully to detect VZV DNA in crusted lesions.49,5o 
2.3 EPIDEMIOLOGY OF HERPES ZOSTER 
Zoster is not a nationally notifiable disease in developed or developing countries, and there are 
limited surveillance data available. Some sentinel systems and studies in general practices 
have provided population-based descriptive data. Although zoster is thought to result from a 
loss of VZV-specific cell-mediated immunity, little is known about why this happens in 
individuals without underlying immunosuppression. The relatively few analytical 
epidemiological studies of zoster are described below. 
2.3.1 Methods of identifying studies 
Published articles on the descriptive and analytical epidemiology of zoster were identified by 
searching two electronic databases - Medline and Embase. No language restrictions were used. 
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Articles published up to mid-1998 were retrieved by searching for herpes zoster as a thesaurus 
term, with any of the following subheadings: 'epidemiology', 'aetiology', 'transmission', 
'trends', 'statistics and numerical data'. Review articles on zoster were also identified, using a 
separate search. From mid-1998 onwards, monthly searches of the two databases were 
conducted, looking at all articles that indexed herpes zoster as a thesaurus term (all 
subheadings) or included 'zoster' as a free text term. Books on herpes viruses were identified 
by searching the databases of the London School of Hygiene and the British Library. 
Reference lists of all retrieved articles were examined, to identifY publications and thesaurus 
terms not captured by the search strategy. 
In addition to published articles, two major sources of information on the incidence of zoster in 
England and Wales were examined: 
1. Morbidity Statistics in General Practice (MSGP) studies: these national studies of 
morbidity seen in general practice are run collaboratively by the Royal College of General 
Practitioners (RCGP) and the (then) Office of Population Censuses and Surveys (OPCS). 
Four studies have taken place - in 1955-56 (with 106 participating general practices), 
1971-72 ( 43 practices), 1981-82 ( 48 practices) and 1991-92 (60 practices, providing for 
502,493 patients).23,51-53 For each study, participating practices provided details of every 
consultation within the study period, so that age- and sex-specific consultation rates for a 
wide range of diseases could be calculated. For the third and fourth study, new and 'first 
ever' episodes were reported separately, and thus incidence of specific conditions 
(including zoster) were available. 
2. The Royal College of General Practitioners (RCGP) Weekly Returns Service: this service 
was established in 1967. Up to 91 participating practices have reported all episodes of 
illness by age and sex each week to the RCGP Research Unit, representing a popUlation of 
more than 600,000 individuals.54 Again, analysis by diagnosis provides data on incidence 
of specific conditions. Some of the Weekly Returns practices have also participated in the 
MSGP studies. 
2.3.2 Descriptive epidemiology of zoster 
Twenty-five reports that included population-based descriptive data on zoster were identified 
. using the search strategy described above. Of these, five had no denominator information,55-59 
and two contained descriptive data entirely duplicated elsewhere.5,60 The 18 reports which 
provided information on zoster incidence, together with data from the RCGP Weekly Returns 
Service and the MRSP surveys, are summarised in Table 2.1 (overleaf). These comprised six 
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Table 2.1: Population-based studies of zoster incidence 
Country""f Date Po(!ulation Case ascertainment Diagnosis Cases {n~ Incidence Comments 
USA4 1945-59 Inhabitants of Rochester, Database of diagnoses from OPD, Clinical case definition 590 1.251l03py Rise in age-adjusted incidence 
Minnesota (census data) hospitals, housecalls, nursing homes applied to medical records from (1945-49) ~ (1955-59): 
41% in men, 28% in women 
No evidence of seasonality 
USA17 1%0-81 Child (0-19yrs) inhabitants of Database of diagnoses from OPD, Individual clinicians - 173 0.421103py 
Rochester, Minnesota hospitals, housecalls, nursing homes, questionable cases included 
(census data) death certificates, autopsies if culture positive 
USA 22 1983-92 Family practice in Somersworth, Records of all cases SingleGP 124 3.3/103/yr No practice denominator: assumed 
New Hampshire 113 town serviced by practice 
No evidence of seasonality 
USA61 1989-90 Cohort of3206 independently Interview: zoster in last 3yrs Self-reported 69 7.1I103/yr Lifetime zoster: 
living individuals in N.Carolina - urban 72% vs. rural 66% 
>64yold - black 26% vs. white 58% 
USA16 1990-92 250,204 members of Harvard Diagnoses from computerised medical Individual clinicians 1075 2.15/103 py No trend in incidence over 2yrs 
Community Health Plan: records and claims files: emergency 
depts, ambulatory settings, hospitals, 
telephone consultations 
Canada2 1979-97 Individuals living in province of Physician billing claims NIR NIR 0-4y: O.61103py . No evidence of seasonality 
Manitoba 5-14y: 1.21103py 
15-44: 1.9/1<Ypy 
45-64: 4.2/103 py 
65+y: 8.1I103py 
Scotland2O 1947-48 Individuals attending GPs (15- Notified by GPs or hospital doctors NIR 184 21103/yr Incidence calculated assuming 
20% of all practices) or hospitals practices saw 15-20% of all cases 
in Edinburgh No evidence of seasonality 
No assoc. with: population density 
or household crowding/conditions 
Scotland1S 1948-55 General practice in Hawick: c.2400 Records of all cases NIR 81 4.81103/yr No difference in rural/suburban 
individuals (213 suburban, 113 rural) incidence 
Scotland 19 1972-73 8 general practices in Glasgow - Notified by GPs a) Individual GPs 87 a) 2.4/103/yr 
c.36000 individuals b) Paired sera b) 2.211 03/yr 
(key to abbreviations overleaf) (continued overleaf) 
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Table 2.1 (continued): Population-based studies of zoster incidence 
Countryrel Date Po~ulation Case ascertainment 
Scotland21 1955-85 General practice in Dumfriesshire Records of all cases 
1850 patients 
England34,71 1947-62 General practice in Cirencester Records of all cases 
c.3500 patients 
England! 1981-82 48 general practices Reporting of all diagnoses 
Wales53 332,270 patients (MSGP3) 
England! 1991-92 60 general practices (88% urban) Reporting of all diagnoses in face-to-
Wales23 502,493 patients (MSGP4) face contacts 
England! 1967-89 Up to 91 general practices Weekly returns of all diagnoses 
Wales62 161729-239984 patients (RCGP) 
England! 1994- Up to 85 general practices Weekly returns of all diagnoses 
Wales63 2001 >570,000 patients (RCGP) 
Gennany64 1992-93 Ansbach, Gennany All cases seen by GPs, dennatologists, 
population c 40,000 paediatricians 
France65 1997-98 4635 GPs & 513 dennatologists Notified by GPs 
throughout France 
France66 1998 744 GPs Postal survey of GPs -,cases seen in 
(mostly urban) previous yr 
Itall7 1995 71 GPs throughout Italy Retrospective reporting by GPs: 
98,508 patients> 15y old all cases seen in previous year 
Iceland68,69 1990-95 62 general practices Notified by GPs + searches of 
(58% urban) computerised records 
Netherlands70 1994-99 22 general practices in 6 areas Searches of computerised records 
c.49,000 patients 
Diagnosis Cases {n} 
NIR 151 
NIR 192 
Individual GPs NIR 
Individual GPs NIR 
Individual GPs NIR 
Individual GPs NIR 
Individual clinicians 152 
Individual clinicians 8103 
Individual GPs 605 
Individual GPs 408 
Individual GPs: researchers 457 
excluded if clinical history 
~ 'unlikely to be zoster' 
Individual GPs 837 
Incidence 
2.6/103/yr 
3.4/103/yr 
3.71103py 
4.5/103py 
Comments 
Increased incidence 1969-1982 
Higher incidence May-Sept 
Higher incidence in 
summer+autumn 
3.21103/yr No evidence of seasonality 
3.81103/yrb No evidence of seasonality 
2.211 03/yr No evidence of seasonality 
4.8/103 
3.2/103 
4. 111 03/yr 
2.0/103py 
3.41103/yr 
54% response rate by GPs 
No evidence of seasonality 
Incidence=1.6/103/yr in 2nd study 
of childrenladolescents69 
Incidence standardised to Europe 
standard popl = 3.61103/yr 
OPD = outpatient departments. NIR = not recorded; py=person years; MSGP = Morbidity statistics from general practice; RCGP = Royal College of General Practitioners 
a Recalculated from data presented (reported as 3.7/103 /yr) 
b See Figure 2.1 for annual incidences 
studies from North America,2,4,16,17,22,61 nine from the United Kingdom (including two MSGP 
reports and two Weekly Returns summaries),18-21,23,34,53,62,63 and seven reports from elsewhere 
in Europe including two analyses from the same study in Iceland.64-70 In studies that included 
both younger and older individuals, overall incidences ranged from 1.3 - 4.8/103/year or per 
103 person years. Within all these populations, there was a steep rise in zoster incidence with 
age; for example, in the 1991-92 MSGP Study, incidence ranged from 1.0/103 person years (in 
patients aged 0-4 years) to 13.01103 person years (in patients aged 85 years or older).23 The two 
studies that were restricted to children and to children/adolescents reported low incidences, of 
0.42 and 1.6/103/year respectively, and the single study of elderly individuals (aged 65-104 
years) reported an incidence of7.1I103/year. 17,61,69 
S d· d 11 d'ffi . "d b 16182134 Oth orne stu les reporte no overa I erence m zoster mCI ence y sex. ' , , ers reported 
an excess of zoster incidence in females, but this may simply have reflected a larger proportion 
of women in the older (higher risk) age groupS.4,22,23,53,62 In the large US (Rochester) study, 
there was no significant overall difference in incidence between the sexes after adjusting for 
age, but a significantly lower incidence amongst females compared to males aged 35-44 years.4 
In the 1991-92 MSGP study, age-specific incidence was higher amongst females aged 45-64 
years (7.1 vs. 5.1I103py) and 65-74 years (12.2 vs. 9.01103py), but less marked in other age 
groups - the statistical significance of these differences was not reported, and there may have 
been residual confounding within the age bands. In the Iceland study, age-standardised 
incidence of zoster amongst the 60+ years age group was higher amongst women (5.6 vs. 
3.6/103 py).68 Only one study reported zoster incidence by ethnicity - the risk was significantly 
lower amongst elderly individuals of black ethnicity compared to white ethnicity after eight 
years offollow-up (1.4% versus 3.4%, p<0.001).61 
Seasonality of zoster incidence was not found m most of the population-based 
studies.2,4,20,22,56,57,62,64,68 However one Scottish and one English study reported higher 
incidence of zoster in summer and autumn.21 ,71 Clinic-based studies have also reported 
seasonality of zoster incidence, amongst physiotherapy patients in England (increased 
incidence in summer), dennatology patients in Sweden (summer), dennatology patients in the 
Netherlands (summer/autumn), emergency department attenders in Italy (summer), and renal 
transplant recipients in the Netherlands (summer).72-76 Similarly, higher zoster incidence was 
found in the wanner, drier months amongst dennatology patients in Indonesia.74 Caution is 
needed in interpreting the results from clinic-based data, as case ascertainment may be 
incomplete, especially during the colder months. 
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Some of the variation between studies in zoster incidence may result from differences in 
methodology or in the age structure of the populations, or secular changes. In the Rochester 
study, there was a 41 % age-adjusted rise in males and a 28% rise in females in 1955-59 
compared with 1945-494 The 1990-92 study of a similar US population showed a 64% rise in 
zoster incidence compared to the Rochester study, after standardising for age to the same 1970 
US white population.16 The proportion of individuals documented as having cancer were 
similar in the two studies (6.4% vs. 6%), although 4.5% of individuals in the later study were 
also known to be human immunodeficiency virus (HN) positive and the proportion of 
individuals on immunosuppressive therapies was not reported. It is also possible that the later 
study had more complete ascertainment of cases, as a result of free access to health care. In the 
UK, increase in overall zoster incidence was not found in the aggregated data of the first 23 
years reporting by the RCGP Weekly Returns Service, or from the last eight years of available 
data (Figure 2.1).63 However, the RCGP reported a slight increase in the number of cases in 
1998 amongst those aged ~65 years compared to the previous ten-year average.62,77 In the 
MSGP studies, there was an increase in zoster incidence from 3.7/103/year (MSGP3) to 4.5/103 
py (MSGP4). This increased incidence was also seen for each of the individual age groups 25-
44 years, 45-64 years and 65-74 years (older ages were grouped differently, so could not be 
compared). Comparisons with earlier MSGP data are limited, as the first two studies did not 
document new episodes of disease separately, but included prevalent cases consulting in the 
study year which arose in previous years.52,78 Nevertheless, there was an increase in these 
'patient consulting rates' (prevalent cases and new cases) in successive MSGP studies, from 
3.511000 in 1955/5678 to 4.9/1000 person-years in 1991192.23 
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Figure 2.1: Annual Incidence of herpes zoster (per 1000) 
In England & Wales (RCGP data) 
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2.3.3 Determinants of zoster 
IfVZV infection is maintained in the latent state by specific cell-mediated immunity, it follows 
that factors that predispose to loss of immunity may increase the risk of zoster. This may be 
loss of VZV immunity alone, or generalised diminution in cell-mediated immune responses. 
Both of these scenarios are discussed below. 
2.3.3.1 Loss of specific immunity to VZV 
Ageing: as described above, the risk of zoster increases sharply with age. Specific cell-
mediated immunity to VZV is decreased in elderly individuals, as measured by specific skin 
test and by examining viral-specific cytotoxic T lymphocytes.9,JO,31,79 This may be due to the 
waning of specific immunity with increasing time from primary infection, or may be part of 
the generalised decay in ceIl-mediated immunity that occurs with age (discussed in Section 
2.3.3.2, below). 
Age at primary infection: if zoster results from waning of specific immunity, then individuals 
who acquire varicella later in life may be at decreased risk of zoster. No studies were 
identified that specifically examined this hypothesis, but it has been suggested as an 
explanation for the finding that on multi variable analysis in one study, elderly individuals of 
black ethnicity were at approximately one third the risk of zoster compared to those of white 
ethnicity (RR=0.35, 95%CI=0.24-0.51).8o,81 The average age at infection for varicella differs 
in temperate and tropical regions. It is typically a disease of childhood in temperate countries, 
with approximately 90% of children immune by the age often years.82-85 However, in some 
tropical countries the average age at infection may be delayed to adolescence or adulthood, as 
has been demonstrated by serosurveys of residents or immigrants from the Caribbean, 
Southern India, Sri Lanka, and parts of South East Asia and Central America.86-93 However, 
some tropical populations appear to have early onset of varicella, as shown in studies of 
Northern Australians, urban Brazilian children, rural Bolivians, Calcutta slum residents and 
Japanese children.94-98 Hypotheses for delayed age at varicella include inactivation of virus 
and reduced transmission in hot, humid conditions, reduced mixing patterns in tropical rural 
areas, cross-immunity between HSV and VZV and competition with other viruses.86,92,97,99,loo 
In contrast to late age at varicella, acquisition of varicella in infancy or in utero may increase 
the risk of zoster. Guess et al demonstrated that children who acquired varicella in the first 
year of life were at nearly three times the risk of zoster in childhood or adolescence (RR=2.8, 
95%CI= 1.6-4. 7).17 In a study of 849 children, Baba et al reported nine cases of zoster, all of 
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whom acquired varicella in the first year of life. 101 Zoster incidence was significantly higher in 
the children who developed varicella before two months of age compared to those who were 
infected between 2-11 months. Enders et al reported that 1011291 infants born to mothers who 
had varicella during pregnancy developed zoster during infancy or early childhood; maternal 
varicella between 13-24 weeks and 25-36 weeks of pregnancy were associated with childhood 
zoster risks of 0.8% and 1.7% respectively.102 It is possible that the immature immune system 
of the infant or foetus is less able to establish and maintain viral latency. 
Exogenous boosting of specific immunity: Hope-Simpson hypothesised that exogenous 
exposure to infectious cases of varicella or zoster might boost specific immunity and 
therefore decrease the risk of zoster in latently infected individuals.34 Mothers of children 
with varicella experience VZV cell-mediated immune boosting, and the significantly lower 
zoster incidence amongst women aged 35-44 years in the Rochester study could reflect 
increased contacts with children (and therefore with varicella).4,103 If regular contact with 
varicella decreases the risk of zoster, the following might be expected: 
1. Seasonality of zoster is inversely correlated with seasonality of varicella: the lack of 
seasonality in zoster incidence in most population-based studies does not support this 
hypothesis. However, the handful of studies described in Section 2.3.2 that reported higher 
incidence of zoster cases in the summer months (when varicella is at its lowest) do support 
the theory of a protective effect of varicella. A further clinic-based study from Japan 
reported that monthly and annual incidence of zoster showed an inverse relationship with 
varicella incidence, although this did not reach statistical significance. 104 It is possible that 
the average duration of immune boosting following varicella contacts may be long relative 
to the yearly epidemic time scale of varicella, in which case simple inverse correlations 
may not be seen. Garnett and Grenfell attempted to clarify the relationship between 
varicella and zoster incidence using time series analysis of RCGP data. 105 There was no 
association between the two diseases at the weekly level, suggesting that varicella 
incidence had no immediate effect on zoster incidence. However at the annual level, an 
increase in varicella incidence among children under five years old was accompanied by a 
significant decrease in zoster incidence among individuals aged 15-44 years. This suggests 
that increased varicella among young children could exert a protective effect against zoster 
in the young adults exposed to them. 
2. Zoster incidence is decreased in areas of high population mixing: in two GP-based 
studies, there was no association between zoster incidence and rural/suburban residence or 
population densitylhousehold crowding. 18,2o In the US study of elderly individuals, 
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lifetime zoster was not associated with urban residence on multivariable analysis 
(OR=1.01, 95% CI=O.80-1.26).61 However, none of these studies provided information on 
mixing patterns with children, who are the sub-population most likely to have varicella. 
3. Zoster incidence is low amongst individuals with occupational contacts with varicella: 
Two studies have investigated this hypothesis. Responses to a US postal questionnaire by 
1109 paediatricians, 1984 dermatologists and 462 psychiatrists showed that 
paediatricians had most contacts with VZV-infected patients and were significantly less 
likely to have developed zoster, but the results may have been influenced by the <40% 
response rate.106 Similarly, 34 (9.1%) of 352 Japanese paediatricians and family 
practitioners who responded to a questionnaire reported a history of zoster, and this was 
estimated to be 50-87% lower than the age-specific incidences in the general population.107 
There is little other analYtical epidemiological information on the association between 
zoster and varicella contacts. A study of 511 leukaemic children vaccinated against VZV 
showed that subsequent household exposure to varicella and further doses of vaccine were 
both highly protective against zoster. lOS However it is unclear whether exogenous exposure 
protects against zoster in immunocompetent adults. 
2.3.3.2 Generalised loss of cell-mediated immunity 
The failure to maintain VZV latency may also occur because of a generalised diminution in 
cell-mediated immunity. This may occur under the following conditions: 
Immunosuppressive conditions/therapies: individuals with diminished cell-mediated immunity 
due to pre~existing cancers, autoimmllne disorders, HN infection and other conditions 
necessitating immunosuppressive therapies are at higher risk of zoster, with incidences ranging 
from 25.0 - 91.5/103 person_years. 13-15,109-119 Immunosuppressed individuals constituted 1-11% 
of cases in population-based studies.4,16-22 In studies of young African populations, zoster has 
a 85-95% positive predictive value for underlying HN infection.120-124 In contrast, incident 
zoster may not be a good indicator of occult cancer. In the Rochester study, subsequent 
incidence of cancer was not significantly higher amongst individuals with zoster after 9389 
person years of follow up compared to local residents without zoster (RR=1.1, 95% CI=O.9-
1.3).125 Similarly, Schmader et al reported that in a cohort study of elderly individuals, those 
with a history of cancer were not at increased risk of zoster after eight years of follow up 
(adjusted RR= 1.03, 95%CI=0.58-1.80), although individuals who self-reported their health as 
'excellent' were at half the risk of subsequent zoster (adjusted RR=O.51, 95%CI=O.27-0.95).sO 
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Ageing: the increasing risk of zoster in the elderly may reflect the generalised decay in cell 
mediated immunity which occurs as part of the ageing process. 126-13l Immunosenescence is a 
likely contributor to the increased susceptibility to infections, malignancies and autoimmune 
disorders in the elderly.132 However, the age at onset and degree of cell-mediated immune 
impairment associated with ageing varies widely, and some older individuals have immune 
responses similar to those of much younger individuals. 133,134 If zoster occurs as a result of 
immunosenescence, then investigation of risk factors for zoster may shed light on the 
determinants of loss of immune function with age. 
Psychological stress: stress affects a number of neuroendocrine functions and this can result in 
cell-mediated immune suppression.135 Both acute and chronic stress events may be associated 
with immune dysfunction. For example, individuals in two studies who were suffering acute 
stress from bereavement had a significant reduction in T-cell function one to two months after 
bereavement compared to non-bereaved controls or pre-bereavement function,136,137 and a non-
significant reduction for up to fourteen months. 137 Students experiencing acute stress prior to 
examinations have been shown to have impaired lymphoproliferation to mitogens or 
CD4+/CD8+ T-cell ratios.138,139 Carers of chronically ill patients have lower proliferative 
responses to mitogens and lower humoral and cell-mediated immune responses to vaccination 
compared to non-caregivers. 140,141 Irwin et al demonstrated that 11 adults with major 
depression had lower VZV -specific cellular immunity compared to age/sex matched controls 
without depression. 142 In contrast to the above findings, short-term stress can sometimes 
. 
result in enhanced cell-mediated immune responses. 143,144 It is likely that the effect of stress 
on the immune system depends on the severity and duration of the stress, and on 
individuals' defence and coping mechanisms. 145,146 
Stress also may increase susceptibility fo infectious disease, including reactivation of latent 
herpes virus infections.147-152 Two studies have investigated the effect of stress on risk of 
zoster. In the first, 101 elderly individuals with recent zoster and 101 age-matched controls 
were asked about stressful life events in the year preceding zoster onset in the cases, and 
whether they perceived these events as negative. 153 Cases experienced a significantly higher 
number of events in the six months before rash compared to controls (mean 2.64 vs. 1.82 
events, p=O.008). In the two months before rash, there were no significant differences in the 
overall number of events but cases were significantly more likely to have experienced 
negatively-perceived events (OR=2.60, 95%CI=1.13-6.27). However, these differences could 
have been due to recall bias. A second study of the same elderly population recorded 167 cases 
of zoster amongst 2568 individuals after eight years of follow up.so Negatively-perceived life 
events were weakly associated with risk of zoster on multivariable analysis (RR=1.38, 
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95%CI=0.96-1.97, p=0.078), but social support variables (such as presence of a confidant) 
were not associated with zoster risk. An incidental finding in this study was that cigarette 
smoking was associated with significant protection against zoster (adjusted RR=0.47, 
95%CI=0.25-0.89). 
Chemical exposures: certain pesticides, volatile organic substances (e.g. toluene, benzene) and 
metals such as arsenic and mercury can suppress cell-mediated immunity. Early reports 
mentioned arsenic as a risk factor for zoster.34,74,154 A cross-sectional study of 900 individuals 
aged between 18-40 years who lived within 2.5 miles of pesticide dump sites (repositories for 
organochlorines, volatile solvents and metals) in Aberdeen (North Carolina) found that they 
were twice as likely to report a history of zoster at telephone interview compared to individuals 
from neighbouring communities (multivariable RR=2.1, 95%CI=1.0-4.3).155 However, the 
temporal sequence of residence in the area and zoster was not ascertained. Older individuals 
in the study were not at increased risk of zoster, and the authors suggested that they may have 
had lower exposure levels to the chemicals, due to fewer outdoor recreational activities than 
younger individuals. 
2.3.3.3 Other determinants of zoster 
Mechanical trauma: this was associated with the development of zoster in 1-5% of cases in 
population based studies.4,19,34 Recent surgery and/or radiotherapy to the affected dermatome 
was also reported in 1.7% of cases in the Rochester study.4 Juel-Jensen suggested that local 
trauma preceded the onset of zoster in 38% of his series of 100 cases.156 However none of 
these studies employed controls for the history of trauma, which may be common in elderly 
populations. 
VZV contacts precipitating zoster: a few authors of case reports20,157-164 and small clusters of 
zoster13,109,165-168 have suggested that zoster-zoster or varicella-zoster transmission may 
occur. None of these studies used control subjects to estimate the population exposure to 
varicella or zoster, or carried out molecular analyses to determine the similarity of viral 
strains in the cases. Most zoster cases in clusters were immunosuppressed, and some cases 
with atypical presentations may have had second episodes of varicella rather than zoster. 13 
In one cluster of seven employees who developed zoster over a three-month period, three of 
the seven cases had bilateral lesions, which is rare in zoster. 166 However, four of the cases 
had measurable VZV -specific IgM, compared with none of the 22 employees who did not 
develop zoster. The only (unpublished) study which has carried out molecular analyses 
found that each of the five patients involved was infected with a different viral strain. 165 
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Genetic susceptibility: a recent study demonstrated that a significantly higher proportion (53%) 
of 60 immunocompetent patients with zoster carried the AT A haplotype at the promoter region 
of the interleukin-IO (IL-IO) gene, compared to 152 (38%) of 400 blood donors.169 It is 
unclear whether this haplotype is associated with diminished or enhanced IL-IO production 
capacity. 170,171 High circulating IL-I0 levels could increase the risk of VZV reactivation by 
down-regulating cytokines of the T-helper cell-l (TH1) subset, as discussed in Section 2.3.4.1, 
below. Also, ifpolymorphisms in the IL-IO gene are associated with general susceptibility to a 
range of infections or other immune-mediated disorders (in addition to VZV reactivation), then 
voluntary blood donors (who are essentially healthy) may not have been a suitable control 
group. 
2.3.4 Other putative risk factors for zoster 
As outlined in Section 2.3:3.2, older individuals are at increased risk of zoster, but little is 
known about the determinants of immunosenescence. Two exposures that cause diminution in 
cell-mediated immune functioning, and which might be risk factors for age-related immune 
decay (and therefore zoster) are ultraviolet radiation (UVR) and insufficient dietary 
micronutrient intake. These putative risk factors are discussed below. 
2.3.4.1 Ultraviolet radiation exposure 
Sunlight comprises both UVB (wavelength: 280-320nm) and UV A (wavelength: 320-
400nm).172 Absorption of UVR by proteins and nucleic acids in the epidermis is mostly 
restricted to shorter UVR wavelengths, and so most of the health effects of UVR result from 
UVB exposure. Stratospheric ozone partially absorbs UVB and prevents it from reaching the 
Earth's surface.172 It follows that the recent reduction in the atmospheric ozone layer together 
with changes in human sun-seeking behaviour has resulted in increased exposure to UVB. 
Acute UVR exposure has been widely shown to diminish cell-mediated immune responses 
both locally (at the exposed site) and systemically (at non-exposed sites). 173 The mechanisms 
involved have not been fully elucidated, but are thought to include the following steps. Firstly, 
UVR is absorbed into photoreceptor molecules in keratinocytes. The main photoreceptors are 
thought to be DNA and urocanic acid. Following UVR exposure, pyrimidine dimers are 
formed in keratinocyte DNA and trans-urocanic acid is photoisomerised to the cis-isomer, and 
both these events have been implicated in immunosuppression.174-176 Damaged keratinocytes 
1) produce PGE2 and IL-l 0, which decrease antigen presentation, increase IL-4 production and 
down-regulate THI cytokine production, resulting in local and systemic suppression of cell-
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mediated immunity,I77,178 and 2) up-regulate IL-l/3 and tumour necrosis factor-a (TNF-a), 
causing migration of Langerhans cells from the epidermis. 179,180 UVR-damaged Langerhans 
cells migrate to draining lymph nodes, where their impaired antigen-presenting function results 
in diminished proliferation of THI cells.181-183 Langerhans cells are replaced in the epidermis 
by other antigen-presenting cells (macrophages), which preferentially activate suppressor-
inducer T lymphocytes, and thus contribute to immune suppression.184-186 
Studies of UVR and cell-mediated immune responses: Studies of the effects of UVR on human 
populations often measure UVR exposure in terms of the minimal erythemal dose (MED). 
This can be defined as the minimum dose of UVR needed to produce a just perceptible 
erythema in unacclimatised skin 24 hours after exposure.187 The amount of UVR exposure 
needed to produce one MED varies between individuals, but estimates for 'average' MED 
have been made - for example, approximately 20 minutes exposure to sunlight at latitude 400 at 
midday in June will result in "one MED.188 
Studies of the effect of UVB exposure (alone or combined with UV A exposure) on cell-
mediated immune responses in humans are summarised in Table 2.2 (overleaf).185,189-209 Most 
enrolled small numbers of (often young) individuals. Of the three studies of acute exposure to 
varying doses of natural sunlight, two reported immunosuppression in terms of lower levels of 
circulating CD4+ (T helper) cells, increased levels of CD8+ cells, and (in one study) increased 
suppressor T-cell activity.189,190 Both studies were of individuals with previously low UVR 
exposures. The third study reported immunostimulation in the form of increased natural killer 
(NK) cell counts following summer holiday UVR exposure, but participants may have had 
higher baseline UVR exposures. 191 
Other studies in Table 2.2 used artificial lIght sources, either UV AIUVB lamps that simulated 
sunlight exposure, pure UVB lamps, or predominantly UV A-emitting lamps that simulated 
solarium exposure. Most studies that applied ~ 1 MED dose of UVR demonstrated local 
suppression of cell-mediated immunity lasting from a few hours to a few weeks, with impaired 
responses to contact allergensl92-200 or to pathogen antigens l95,201 applied to the irradiated site, 
and increased local suppressor T-cell responses. 185 Systemic effects were also reported, 
including decreased responses to antigens or allergens applied to non-irradiated 
sites,197,200,202,203 a drop in numbers of circulating T-cells, CD4+ T-helper cell subsets or NK 
cells,192,198,202,204 and increased numbers of circulating CD8+ cells or T-suppressor cell 
activity. 198,204 In the seven studies that looked at acute low-dose UVR exposures «1 
MED/day), local immunosuppression was seen in four studies,193,197,199,205 and systemic 
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Table 2.2: Studies of the effects of acute ultraviolet B radiation exposure (with/without ultraviolet A radiation) on cell-mediated immunity in human populations 
STUDY POPULATION I EXPOSURE ~ __ ._ .... _._.. v_I1_ ... 1 RESULTS IN IRRADIATED GROUP 
Kanarioul91 
Baadsgaard 185 
Cestari201 
Di Nuzz0209 
KellyI93,200 
Morrisonl92 
Kalimol94 
Rasanenl95 
Sunlight: sununer holiday 
exposure in Greece for ±3wks 
Sunlamp (UVBIUV A): 
single 4MED dose to forearm 
UVBIUV A: buttock exposure 
to 2MED every 4d for 20 days 
Sunlamp (UVBIUV A): lower back 
exposures to I, 2 & 4 MED 
Xenon arc (UVBIUV A): buttock 
exposure to 0.25, 0.5, 1,2 or 3 MED 
Sunlamp (UVB): single whole-
body exposure to 1.5 or 3 MED 
Sunlamp (UVB) single dose to 
forearm: strong erythema (n=9), 
mild erythema (2), no reaction (2) 
UVB bulbs: single dose to 
abdominal skin (2-4 MED) 
12 individuals~ holiday 
median age: 21y (l0-45y) 
Volunteers 
29 lepromin+ve contacts 
ofleprosy patients (lS-62y) 
5 volunteers 
mean age: 27.Sy(IS-47y) 
77 volunteers 
10 fair-skinned volunteers 
mean age: 26y (22-40y) 
13 patients with contact 
allergies 
mean age: 49y (23-S2y) 
II dermatology patients 
mean age: 3Sy (2S-52y) 
NID = not done; nJs = not significant; hr=hours; d = days; w = weeks 
Pre-holiday levels :5:1w 
Non-irradiated skin 3d 
Non-irradiated skin 7d 
Non-irradiated skin 7d 
16 volunteers 3w 
Pre-irradiation levels 72hr 
Non-irradiated skin 4d 
a) Non-irradiated skin 0-7d 
b) IS dermatology controls 
NID 
t Ts responses 
,1.DTH to lepromin 
,1. %CD4 + cells in granulomas 
1-2d: ,1. cm+ 
7d: ,1. CDS+; t CD4+ 
,1.DNCB reactionsl93 
skin types IIlI: ,1. at all UV doses 
skin types lIIIlV: ,1. at ::dMED 
3 MED: ,1. response to PHA 
1.5 MED: change nls 
,1. DTH to 19 out of25 
contact allergens 
,1. LP to PPD, HSV-I, ConA 
(Function restored in 3-7d) 
UVR = ultraviolet radiation (UV A or UVB); MED = minimal erythemal dose; skin type I1II=sun sensitive, tans poorly; skin type IIIIIV=sun tolerant, tans easily 
DNCB = dinitrochlorobenzene; DPCP = diphenylcyclopropenone; ConA = concanavalinA; PWM = pokeweed mitogen; PHA = phytohaemagglutinin; 
PPD = purified protein derivative; Ni = nickel; HBV = hepatitis B virus; HBsAg=hepatitis B surface antigen; HSV = herpes simplex virus; ag= antigen(s) 
CD3+ = pan-T cells; CD4+ = helper T -cells; CDS+ = cytotoxic / suppressor T -cells; T, = suppressor T -cells; NK=natural killer cells 
Systemic responses 
,1. T cells ,1. CD4+ t CDS+ 
Slight,1.NK t Ts activity 
,1.CD4+: CDS+ 
Changes to CD3+, CD4+, CDS+ nls 
tNK 
NID 
NID 
NID 
,1. DPCP response in unexposed skin 
in 10112200 
3 MED: ,1. T -cells (normal by 72h) 
1.5 MED: change nls 
NID 
NID 
(contd. overleaf) 
Table 2.2 (continued): Studies of the effects of acute ultraviolet B radiation with/without ultraviolet A radiation on ceO-mediated immunity in human populations 
STUDY POPULATION I EXPOSURE RESULTS IN IRRADIATED GROUP 
Studynf 
UV exposure I dose Irradiated Group Non-irradiated Follow Local responses Systemic responses 
com arison u 
Miura203 Lightbox (UVB): 90% body 6 individuals with latent a) Pre-irradiation levels 9-17d NID ~LP to HSV + PHA (lasted ~9d) 
exposure to IMED HSV infection (34-57y) b) I HSV infected control 
Yoshikawa 196 UVB: buttock exposure to 12 skin cancer patients 6 healthy volunteers Od DNCB response in 100% controls, NID 
1.44mJ/cm2/day for 4d 34 healthy volunteers 60% healthy (UV), 8% cancer (UV) 
SIeijffers202 Cabinet (UVB): ± whole body 97 volunteers receiving HBV 94 non UVB-exposed 60d ~ DPCP response in unexposed skin 
exposure to lMED/day for 5d vaccination HBV vaccinees ~NK activity 
before vaccination (age: 19-52y) LP to PHA, PWM, HBsAg unaffected 
COOper197 Sunlamp (UVB): buttock exposure 42 white volunteers 22 controls 0-2d ~DNCB reactions in all UV groups 4MED: ~ DPCP responses 
0.75MED or 2MED daily for 4d, (dose-response) (other groups nls) 
or single dose of 4MED 
Hersey04 Solarium (mostly UV A): whole- 22 volunteers a) Pre-irradiation levels 3w I ~ DTH (Multitest) - nls ~ T cells; ~ NK activity (normal by 3w) 
body exposure 30minlday for 12d 11122 wore sunscreen b)12 controls: sunscreen DNCB response unaffected II 'sunscreen': t%CD8+, ~CD4+:CD8+ 
(± IMED/day) 
Hersey198 Solarium (mostly UV A): whole- 18 untanned volunteers a) Pre-irradiation levels 2w I ~ DNCB response at 2 days ~ lymphocytes (remained ~ at 2w) 
body exposure 30minlday for 12d mean age: 30.5y± lOy b) 13 age matched controls ~ CD4\ t CD8+; t Ts activity at 2d 
+ NK activity at 2wks 
Sjovall205 Sunlamp (UVB): ± whole body 9 patients with Ni allergies a) Prior responses Od I,j..DTHtONi ,j.. DTH to Ni in unexposed skin 
exposure to <IMED 4x1w for 3w mean age: 34 y (22-44y) b) Non-irradiated skin 
Damianl99 Sunlamps to > I site on back. 54 volunteers with Non-irradiated skin up to I Max,j.. DTHto Ni at2d(~ for3w) DTH to Ni in adjacent skin 
a) UVB+UV A or b) UVB, for 2d-4w Ni allergies 4w Effect ofUV AIUVB> UVB only unaffected 
Mean dose = 0.6 MED/day mean ages: 26-34y 
Gilmou~o8 Cabinet (UVB): ?whole body 17 psoriasis patients a) Pre-irradiation levels 4w NID Slight ,j.. CD8+, CD4+ - nls 
exposure to <IMED 3x1w for 4-6wk mean age: 37.5y (±3.ly) b) 15 psoriasis patients No change in LP to HSV, ConA 
Matsuoka207 Chamber (UVB): whole body 20 women: 10 white, Pre-irradiation levels 9hr NID CD3+ & CD8+ unchanged 
exposure to single dose of <IMED 10 black (age: 21-59) Whites:t CD4+ , Blacks: t NK activity 
McGrath206 Sunlamp (60% UVB): total body 15 white volunteers Pre-irradiation levels 2d NID 0.5 MED: ,j..% CD8+, tCD4+: CD8+ 
exposure to 0.5 MED, lMED Id later + I MED: levels normalised 
\.;J 
Abbreviations: see previous page 
~ 
immunosuppression in one study.20S However, two studies reported transiently increased 
immune responses,206,207 and one study reported no change in T-cell subsets or 
lymphoproliferation to pathogen or mitogen antigens.208 
The finding that not all individuals experience diminished responses to contact allergens 
following UVR exposure has led to the hypothesis that individuals may be 'resistant' or 
'susceptible' to the immunosuppressive effects of acute UVR. 196,210 There is conflicting 
evidence that susceptibility is mediated by skin type (tendency to bum, ability to tan, and/or 
skin colour).193,207,211 .. 2\3 When responses are stratified by UVR dose, it appears that 
individuals who are sun-tolerant and tan easily may be resistant to the immunosuppressive 
effects of low-dose (~IMED) UVR,193,207,212 but that individuals of all skin types may be 
susceptible to higher UVR doses. 193,200,211,212 
Little is known about the effects of chronic UVR exposure on cell-mediated immunity. In 
animals, decreases in DTH reactions were reversed after 20 UVR exposures, suggesting 
adaptation, although suppression of tumour rejection was maintained.214 In humans, 
chronically UVR-exposed skin has fewer Langerhans cells and reduced sensitivity to contact 
allergens compared with non-exposed skin.215,216 A study of skin cancer patients reported that 
those with high UVR exposure in the previous 18 months had lower ratios of CD4+:CD8+ T 
cells compared with patients with low exposure levels.217 In contrast, in two cohorts of HIV-
positive men there was no significant correlation between !JVR exposure since becoming HIV 
infected (up to ten years previously or in the last two years) and the rate of CD4+ T-cell 
decline.2I8,219 However, measurement of past UVR exposure in one of the cohorts was 
imprecise, being based on answers to simple questions such as outdoor occupation, beach 
vacations and outdoor hobbies, and in the second cohort only a small number of participants 
(n=73) completed the questionnaire. 
Effects of UVR on infections: In animals, UVR exposure decreases the immune response to a 
variety of infectious agents, including HSV, Leishmania, Candida, Trichinella, Schistosoma, 
Listeria and Mycobacterium Sp.220-226 It also promotes HIV gene expression,227 and increases 
pathogen load or lesion severity in experimentally infected animals.22o,224-226,228,229 Researchers 
have attempted to use these data to make risk assessments of the effect of UVR on 
susceptibility to and severity of infections in humans, taking into account differences between 
animals and humans in sensitivity to UVR-mediated immunosuppression. For example, it has 
been estimated from animal models that 92 minutes of UVR exposure received over seven 
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days at noon in July at 40<N may suppress cell-mediated immune responses to Listeria 
monocytogenes in humans by 50%.76 
The effect of UVR on infections in humans has not been extensively studied. As outlined in 
Table 2.2, acute UVR exposure can diminish cell-mediated responses to pathogen 
antigens,195,201,203 although this was not demonstrated in all studies.202 Variation in responses to 
vaccination by latitude has also been demonstrated. !'or example, the efficacy of Bacillus 
Calmette-Guerin (BCG) vaccine against tuberculosis is greater at sites further from the 
Equator, where ambient UVR exposure is lower.23o However, this may be due to factors other 
than UVR exposure. Another approach is to measure seasonality in responses to vaccination. 
In one study, Dutch students vaccinated against hepatitis B virus had lower mean antibody 
titres after the first vaccine dose if they were vaccinated in the summer, although there was no 
significant difference in titres by season of vaccination after the third dose?6 Secular trends 
can also be investigated. A pilot project was instigated in Chile to investigate the effect of 
increased UVR exposure due to thinning of the ozone layer.231 Review of ophthalmologic and 
dermatologic records did not reveal any increase in consultations for skin infections during 
periods of ozone depletion, although the annual ambient UVB exposure during these times 
only increased by 1 %. 
Two recent studies have attempted to relate personal UVR exposure to susceptibility to 
infections. Amongst a cohort of children aged one year, exposure to UVR in the previous six 
weeks was ascertained by questionnaire.76,232 On multivariable analysis, children with low 
recent UVR exposure had a significantly higher incidence of symptoms suggesting upper 
respiratory tract infection. The authors suggested that this unexpected finding might be 
because children with low UVR exposure were more heavily exposed to respiratory pathogens 
in indoor settings. However, a slight increased incidence of symptoms was also found for 
children who had been sunburned. In a second cohort of renal transplant patients there was no 
overall correlation between cumulative lifetime UVR exposure (ascertained by questionnaire) 
and frequency of infections. 76,233 
Exposure to UVR has also been shown to increase reactivation of latent infections. Herpes 
simplex infection can be reactivated in humans following UVR exposure of 3-6 MED,z34-237 
Descriptive studies (summarised earlier in this Chapter) that have reported increased incidence 
of zoster in summer support the hypothesis that short-term UVR exposure may increase the 
risk of zoster. However, the effect of UVR exposure on reactivation of VZV has not been 
studied directly. 
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2.3.4.2 Micronutrient intake 
The cells of the immune system are dependent on micronutrients for their functional integrity. 
For example, vitamin A is needed for lymphocyte proliferation, in addition having a major role 
in humoral and innate immune responses.238,239 Vitamin B6 is involved in the synthesis and 
metabolism of nucleic acids and proteins (and so is important for lymphocyte proliferation), 
and also has a role in the production of thymulin, a hormone that induces T-cell maturation in 
the thymus and regulates T-cell function.240 Vitamin C prevents DNA damage in lymphocytes 
by limiting free radical formation, decreases T cell death, and up-regulates natural killer cell 
activity,z41,242 Vitamin E is also an antioxidant, protects the cell membranes of immune cells 
from damage, enhances T-cell function by inhibiting PGE2 production by macrophages, and 
facilitates lymphocyte maturation and proliferation via IL-2 production.243 Folic acid is a 
coenzyme for DNA synthesis in immune cells, and thus influences lymphocyte production and 
proliferation.244 Zinc is an essential cofactor for more than 300 enzymes and hormones 
involved in cellular function (including thymulin), and is involved in bone marrow T-cell 
precursor formation and production of THI cytokines.24s-247 Iron plays a key role in 
lymphocyte maturation, differentiation and proliferation.248 Multiple deficiencies of these 
nutrients occur increasingly with age, particularly in institutionalised individuals,z49-2s4 
Micronutrient deficiencies in the elderly are associated with diminished cell-mediated 
immunity (demonstrated by lower percentages of CD4+ T -cells, impaired lymphocyte 
proliferation and reduced DTH responses to skin test antigens), and increased susceptibility to 
infections,zss-262 The heterogeneity in cell-mediated immune decline in the elderly may 
therefore be partly explained by differences in micronutrient intake. 
Placebo-controlled randomised controlled trials have been instigated to investigate whether 
supplementation with single or multiple micronutrients improves cell-mediated immune 
functioning in the elderly (Table 2.3, overleaf).2S9,263-272 Many of these trials enrolled small 
numbers of participants. Increases in some immune parameters were reported amongst 
supplemented individuals in most studies, but these increases were not always significantly 
higher than increases in the placebo group. Of the four trials that used multivitamin/mineral 
preparations, three (all of which supplemented individuals for 12 months) reported significant 
increases in some or all of the cell-mediated immune parameters studied compared to 
individuals receiving placebo,269,27o,272 but one (which supplemented individuals for ten weeks) 
found no difference between groups in T-cell, T-cell subset or NK cell counts, or in 
lymphocyte function. 271 Differences in findings may have been due to variation in the duration 
and dosage of micronutrient intake and in the baseline nutritional and immune status of the 
participants. The remaining studies used single or simple combinations of micronutrients. The 
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Table 2.3: Placebo-controlled randomised controlled trials of the effect of micronutrient supplements on cell-mediated immune parameters in elderly populations 
Effects on cell-mediated immune parameters 
Stud~ Study population Micronutrient intervention Daily dose Duration (supplemented vs. placebo) 
Bogden263 103 independently living healthy individuals Zinc+ multivitamin/mineral Zinc: 15mg or lOOmg 3m No significant differences in DTH (Multitest) or LP 
aged 60-89y (placebo: multivitamin/mineral) 
Bogden264 
Kennes265 
Meydani266 
Meydani267 
Pallasf68 
Fortes269 
63 independently living healthy individuals 
aged 60-89)'" 
20 healthy individuals 
aged>70y 
32 healthy individuals 
aged ~5y 
78 independently living healthy individuals 
aged~5y 
157 independently living healthy individuals 
aged 65-80y 
118 individuals living in a home 
(mostly self-caring), aged ~5y 
penn259 28 elderly long-stay patients with strokes 
(mean ages 83.5y & 83.9y) 
Bogden270 56 independently living healthy individuals 
aged 59-85y 
Boardlef11 31 nuns living in residential home 
aged 65-89y 
Chandra272 86 independently living elderly individuals 
aged>65y 
Pike269 35 healthy independently living individuals 
aged 61-79y 
Zinc+ multivitamin/mineral 
(placebo: multivitamin/mineral) 
VitC 
VitE 
VitE 
.YitE 
3 intervention groups: 
1) Vit A; 2) Zinc; 3) VitA+Zinc 
Vit A+Vit C+Vit E 
Multivitamins/minerals 
(22 micronutrients) 
Multivitamins/minerals 
(22 micronutrients) 
Multivitamins/minerals 
(18 micronutrients) 
Multivitamins/minerals 
(16 micronutrients) 
Zinc: 15mg or l00mg 
500mg injection 
800iu 
6Omg, 200mg or 800mg 
50mg or lOOmg 
Vit A: 800llg 
Zinc sulphate:25mg 
Vit A: 8000iu; Vit C: l00mg 
VitE: 50mg 
20-450%RDA 
20-450"10 RDA 
USA RDA, except ~-carotene & Vit E 
(=4x upper quartile) 
Vit A: 800RE; Vit B6: 3.65mg; Vit C: 
9Omg; Vit E: 45mg; Folic acid: OAmg; 
Iron: 27mg; Zinc: 22.5mg 
12m 
1m 
30d 
4m 
6m 
3m 
28d 
12m 
lOw 
12m 
12m 
.J..DTH (Multitest) - especially l00mg group 
tNK cells; 
No significant differences in LP 
i~~} Unclear if significantly> placebo 
tDTH (Multitest); tIL-2 
tLP to ConA (not PHA or SAC) 
tDTH (Multitest) - significant for 200mg 
No difference in T cells 
tDTH (Multitest) in lOOmg group (near-significant) 
tIL-2 (non-significant) 
Zn groupsa: t%CD4+ cells, tTc cells 
Vit A groupSb: .J..%CD4+ cells, .J..CD3+ cells 
All groups: no difference in LP 
tT cells; t%CD,r CellS} Unclear if significantly 
t%CD4+:CD8+ tLP > placebo 
tDTH (Multitest) 
No difference in CD3+, CD44, CD8+ or NK cells 
No difference in LP 
IT cells, t%CD4+ cells, tLP 
tIL-2, tNK cells; no difference in CD8+ cells 
IT cells, tCD8+ cells tNK cells 
No difference in LP at 12m; .J.. LP at 9m 
t =significant increase in supplemented vs placebo .J-=significant decrease or significantly less change in supplement vs placebo; ConA = concanavalinA; PHA = phytohaemagglutinin; SAC=Staph. aureus Cowan I 
CD4+ = helper T -cells; CDS+ = cytotoxic I suppressor T -cells; DTI:I = delayed type hypersensitivity; NK=natural killer (cells); LP=lymphocyte proliferation; RDA = recommended daily allowance 
• ZnlZn+VitA compared to VitA/placebo byitAlVitA+Zn compared to Znlplacebo C Unclear whether the same individuals as in26J 
vitamin C supplementation trial reported significantly increased DTH responses and 
lymphocyte function in the supplemented group compared to baseline function, but it was 
unclear whether this increase was significantly greater than the responses amongst controls.265 
The four studies of vitamin E supplementation (used singly or in combination with vitamins A 
and C) reported significantly increased DTH responses amongst the supplemented group (in 
three studies), increased T cell subsets (in one study) and increased lymphocyte proliferation to 
one mitogen (in one study).259,266-268 Ofthe three trials ~fzinc supplementation, one found that 
T cell subsets were increased in the zinc group, but that lymphocyte proliferation was not 
significantly enhanced?69 This study additionally randomised some individuals to vitamin A, 
and found that these individuals experienced a reduction in T cell subsets. The other two zinc 
studies supplemented all individuals with a multivitamin/mineral tablet, and reported that DTH 
was either not significantly increased or (for individuals receiving high doses of zinc) was 
significantly less than in the placebo groUp.263,264 Consideration needs to be given to the effect 
of overnutrition with microiiutrients, as excess intakes of zinc, vitamin E and iron may all have 
an adverse effect on cell-mediated immunity.273-275 
Only one of the trials summarised in Table 2.3 investigated whether micronutrient 
supplementation reduced susceptibility to infection. Chandra et at found that elderly 
individuals receiving multivitamin/mineral supplements were significantly less likely to have 
episodes of (physician/laboratory diagnosed) infectious illness during the study compared to 
individuals receiving placebo (a mean of 23 vs. 48 da~s per ye~r).272 Other randomised 
controlled trials of micronutrient supplementation in the elderly have been designed primarily 
to investigate infections as an endpoint. Giridon et at randomised 81 elderly individuals living 
in a geriatric centre to daily doses of either 1) vitamins (j3-carotene: 6mg; vitamin C: 12Omg, 
vitamin E: 15mg); 2) minerals (zinc: 20mg; selenium: lOO/-Lg); 3) both vitamins and minerals, 
or 4) placebo.276 After two years, individ"iIals who received 2) or 3) (minerals or minerals with 
vitamins) had significantly fewer urogenital or respiratory infections compared to the placebo 
group, but this was not found for those receiving vitamins alone. In contrast, Chavance et at 
found no significant difference in the incidence of self-reported infections amongst 218 healthy 
independently living elderly individuals given daily multivitamin/mineral supplements 
(containing 21 nutrients) for four months.277 Similarly, Murphy et al reported the same 
number of antibiotic-treated infections amongst two groups of nursing-home residents given a 
single dose of vitamin A, either 200,OOOiu (n=53) or lOOOiu (n=56).278 Differences in findings 
may again have been due to the populations studied, dosage and type of micronutrients 
administered, duration of follow-up and outcome definition and measurement. No study has 
examined the effect of micronutrient intake on risk of zoster. 
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2.4 CONCLUSIONS 
There is limited information on risk factors for zoster amongst individuals without underlying 
immunosuppression, other than the increased risk associated with ageing. In addition, little is 
known about the determinants of the diminution of cell-mediated immunity with age. In this 
Chapter, existing data have been summarised, and two putative determinants for 
immunosenescence (and therefore for zoster) have ~een suggested - UVR exposure and 
micronutrient intake. The rest of this document reports on the community-based study that 
was undertaken to investigate risk factors for zoster in individuals without underlying 
immunosuppression. In the next Chapter, the main objectives and the methods of the study are 
described. 
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3. RESEARCH METHODS 
3.1 STUDY OBJECTIVES 
The primary objectives of the study were to: 
1. Investigate whether exogenous exposure to cases of varicella or zoster in the last ten years 
protects against development of zoster. 
2. Evaluate the interrelationship between the effects of ethnicity, country of residence in 
childhood and age at varicella on risk of zoster. 
3. Estimate the effect of micronutrient intake (specifically intake of vitamins A, C, E and B6 
and of folic acid, iron and zinc) in the last year on the risk of developing zoster. 
4. Estimate the role of exposure to ultraviolet radiation (UVR) in childhood and in the last 
year on the risk of zoster. 
The secondary objectives of the study were to: 
1. Evaluate the effect of psychological stress in the last year on the risk of zoster 
2. Investigate whether recent mechanical trauma affects the risk of zoster. 
3.2 STUDY DESIGN 
The study was conducted in two stages. Firstly, a surveillance system was set up to identify 
incident cases of zoster in the community. Secondly, a matched case-control study was 
designed to determine any association between risk of zoster and the exposures listed above. 
This design offered an efficient approach to examining the numerous exposures of interest. A 
hospital-based case-control study may have been logistically simpler to carry out, but in the 
United Kingdom individuals with zoster referred to hospitals are highly selected (mostly those 
with disseminated rashes or ophthalmic involvement). Therefore, exposures in these cases 
might not be representative of all cases in the community, and it may have been difficult to 
identify an appropriate control group. A cohort study design could also have been chosen, but 
this would have been considerably more time-consuming and expensive, given that the 
incidence of zoster is typically 2-411000 person-years. 
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3.3 STUDY SETTING 
The study was based in South London in the boroughs of Lambeth, Lewisham and Southwark, 
an area of approximately 35 square miles (Figure 3.1). The three boroughs comprise 76 
mostly inner-city wards, with an estimated total resident population in mid-1998 of 745,300, of 
which 63% were aged 16-59 years of age, and 15% were aged 60 years or older.279 The three 
boroughs are relatively deprived - Southwark is ranked 9th most deprived district in England, 
Lambeth 21 st and Lewisham 30th (out of 364 districts), using the Overall Index of Multiple 
Deprivation 2000,zso However, there is heterogeneity within boroughs. For example, 22 of the 
25 wards in Southwark are included amongst the top 25% most deprived wards in England, but 
one ward is only the 618 pt most deprived ward out of 8414 English wards. The boroughs are 
ethnically diverse, with 26% of residents of non-white ethnicity.281 The choice of study area 
therefore facilitated investigation of the effects of ethnicity and country of birth on the risk of 
zoster. 
Figure 3.1: The study setting within Greater London. 
3.4 SAMPLE SIZE CALCULATION 
Sample SIze calculations were derived from standard equations for matched case control 
studies, adjusted for choosing two controls per case.282 Taking an odds ratio of 2.0, a = 0.05 
(2-sided), and f3 = 0.2, the number of cases and controls needed were calculated for a range of 
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prevalences of exposure in the control group (Po): 
a) Po = 10%: 203 cases and 406 controls. 
b) Po = 15%: 149 cases and 298 controls 
c) Po = 20%: 125 cases and 250 controls 
(+20%)1 ~ 244 cases and 488 controls 
(+20%)1 ~ 179 cases and 358 controls 
(+20%)1 ~ 150 cases and 300 controls 
I Increase in sample size needed to accommodate multi variable analyses 
These calculations assume p to be a binary exposure. However, analyses were planned using 
quantiles of exposure for some of the exposures of interest. The slight increase in sample size 
needed to accommodate quantiles is offset by the power gained from using statistical tests-for-
trend rather than tests for heterogeneity, and by basing quantiles on the distribution of these 
exposures in controls (discussed in Section 3.10.3, below). Taking all the above into 
consideration, it was decided that a sample size of 244 cases and 488 controls would be sought. 
It was estimated that a combined practice population of 200,000 registered patients would 
be needed to recruit sufficient cases and controls within 18 months. This calculation was 
based on the necessity for the Principal Investigator to carry out all the recruitment, 
interviews and practice liaison, and on the following assumptions 
Available cases/year (n) 
1. Practice population of 200,000, with zoster incidence of,2.5/103/yr 500 
2. 60% of cases ascertained within 8 weeks of onset of rash 300 
3. 80% of reported cases eligible for the case-control study 240 
4. 85% of eligible cases consent to take part in the study 204 
5. 80% of participating cases classified as confirmed or 'probable'· 163 cases/yr 
~ 244 cases in 18 months 
* Defined in Section 3.7, below 
3.5 PRACTICE RECRUITMENT 
A list of general practices in the three boroughs was obtained from the Family Health Services 
Authority. All 42 practices comprising three or more general practitioners (GPs) were sent a 
letter in June 1997, outlining the study and asking them if they would like to participate. The 
Principal Investigator (PI) followed up the letters by telephoning the senior partner of each 
practice to ascertain interest, and then visited each interested practice to discuss the study 
further with practice staff. 
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Twenty-two of the 42 general practices agreed to take part, as did two smaller practices (each 
comprising two GPs) that were linked to one of the larger practices. Of these 24 practices, 22 
were recruited into the study - one large practice was not enrolled because they appeared 
insufficiently organised to report cases consistently, and the other practice agreed to participate 
after a sufficient number of practices were enrolled. Participating practices comprised a total 
practice population of 198,997 permanently registered patients, with 15.8% aged 60 years or 
older. The sites of participating and non-participating practices are indicated in Figure 3.2. 
Fil!ure 3.2: Sites of participating and non-participating practices within 
Lambeth, Southwark and Lewisham 
3.6 CASE SURVEILLANCE 
o Practice participated 
• Practice agreed but did not participate 
*Practice refused to participate 
Twenty of the 22 participating practices actively reported incident cases of zoster as they arose 
to the PI, using a dedicated telephone/fax number. Standardised reporting forms were used. 
These included information on the date of consultation, the reporting GP, and the patient' s 
name, sex, date of birth and contact details (see Appendix 1). Two practices reported cases 
weekly, after consulting fully computerised consultation records. Hand-searching of paper 
records of deputising service billings was also carried out in two practices. A study liaison 
person (usually the practice manager) was identified for each practice, and the PI maintained 
regular telephone contact with him/her to discuss the practice's ongoing contribution to the 
study and to sort out any problems. The study liaison person regularly reminded practice staff 
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about the need to report zoster cases. Additional reminders included the following: 
1. Study posters and computer stickers were placed and maintained in all consulting rooms as 
visual reminders to GPs and practice nurses (see Appendix 2); 
2. The PI visited all practices regularly; 
3. The PI wrote a monthly study newsletter about the study's progress, and sent multiple 
copies to each practice (see Appendix 3); 
4. Flyers about the study were provided for locum information packs. 
Posters were also put up in practice waiting rooms, informing patients that the study was taking 
place. 
3.7 CASE AND CONTROL DEFINITIONS I EXCLUSION CRITERA 
3.7.1 Case definition 
Cases were defined as adults with incident zoster (less than eight weeks from rash onset at 
interview) and with no known underlying immunosuppressive conditions (outlined in Section 
3.7.3, below). All cases reported to the PI were diagnosed by their GP as having zoster. Viral 
confirmation of cases was obtained wherever possible by polymerase chain reaction (PCR) 
analyses of vesicle fluid obtained at interview by the PI (detailed in Section 3.9.3) However, it 
was not possible to obtain vesicle fluid from all cases at interview, due to delays in reporting or 
interviewing cases or to the presence of maculopapular rashes in a few cases. In these 
situations, standardised clinical criteria were used to assign unconfirmed cases to one of three 
categories: 
1. Probable cases had a unilateral vesicular or maculopapular rash with a dermatomal 
distribution where a) rash covered more than one quarter of the dermatome, or b) rash 
was less extensive but pain or dysthesia covered more than one quarter of the 
dermatome, or c) rash and pain were less extensive, but pain lasted at least one month 
after rash onset. Individuals with a history of a similar dermatomal rash at any site 
within the last ten years were excluded from the 'probable' category 
2. Possible cases had a unilateral vesicular or maculopapular rash with a dermatomal 
distribution where the rash covered one quarter or less of the dermatome, with either no 
pain or with localised pain lasting less than one month. 
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3. Unlikely cases either had a rash with a non-dennatomal distribution, or had a history of a 
similar dennatomal rash at any site in the last ten years. 
Individuals without vesicle samples who had 'unlikely' zoster presentations were excluded by 
the PI at interview. Classification of other clinical cases into 'probable' or 'possible' was 
carried out by the PI at the end of the fieldwork, without referring to individuals' exposure 
histories. 
3.7.2 Control definition 
Controls were defined as adults with no history of zoster who were registered with the same 
practice that notified the case. Use of self-reporting of a lack of zoster is considered reliable, 
because the distinctive rash and pain of zoster are memorable. Schmader et al investigated 
accuracy of self-report of zoster among elderly individuals living independently in the 
community, by comparing responses with physician records and a zoster verification 
questionnaire.283 Compared to physician reports, none of the 63 individuals who denied 
previous zoster were false negatives, and one of 31 individuals (3.2%) reporting a previous 
history of zoster were false positive. Using the verification questionnaire as the gold standard, 
the sensitivity of self-report was 95% (40/42) and the specificity was 98% (80/82). 
Two controls were selected for each case, individually matched to the case on age, sex and 
general practice. Age is a known risk factor and sex a potential risk factor for zoster, and 
both variables were likely to confound many of the associations of interest in this study. 
Matching by practice may have diminished socioeconomic differences between cases and 
controls, and reduced the effect of ascert.!\inment bias. 
3.7.3 Exclusion criteria 
Exclusion criteria for both cases and controls included: 
1. Individuals under the age of 16 years 
2. Individuals with underlying suppression of cell-mediated immunity. These included a) 
individuals with HIV infection, b) malignancies considered active in the previous five 
years, c) autoimmune and other disorders known to be associated with altered cell-
mediated immunity (for example, systemic lupus erythematosus or sarcoidosis), and d) 
immunosuppressive therapies administered in the last six months (such as oral steroids, 
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cytotoxic drugs used to treat malignancies and cytotoxic immunosuppressants given to 
transplant recipients or to individuals with autoimmune disorders). 
3. Individuals of sub-Saharan African ethnicity. Africans comprise approximately 6% of the 
popUlation in the study area, and are at higher risk of undiagnosed HN infection compared 
to other residents?81,2S4 As discussed in the Chapter 2, zoster has an estimated 85-95% 
positive predictive value for HN infection in certain sub-Saharan African populations. 
Therefore Africans with zoster may have been -more likely to have undiagnosed or 
undisclosed HN infection. 
4. Individuals unable to answer questions at interview due to physical or mental impairment, 
without an available proxy interviewee. 
5. Individuals temporarily registered with the practice - these individuals were likely to differ 
from permanently registered patients with respect to the exposures of interest. 
Cases were also excluded if: 
1. Vesicle samples were negative for VZV on PCR analysis but positive for herpes simplex 
virus (see Section 3.9.3, below) 
2. Cases were categorised as 'unlikely' using clinical criteria, and vesicle samples were not 
available or were negative for both VZV and HSV 
3. Cases were ascertained more than eight weeks after rash onset 
Controls were also excluded ifthey reported a previous history of zoster. 
3.8 RECRUITMENT OF CASES AND CONTROLS 
3.8.1 Case recruitment 
The PI sent each zoster case over the age of 16 years an introductory letter and an information 
leaflet about the study (see Appendix 4 and Appendix 5). This was followed up by contacting 
cases by telephone or by visiting them (if no telephone number was available), to see if they 
were eligible for the study and were willing to participate. The PI agreed with willing and 
eligible cases a suitable time to visit them at home to carry out the interview. 
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3.8.2 Control ascertainment and enrolment 
After interviewing each case, the PI visited the notifying practice to ascertain matched controls. 
Twelve individuals ofthe same sex and with the nearest dates of birth to the case were initially 
identified by computer searches of the age-sex register, and the two individuals with the closest 
dates of birth were sent an information leaflet and a letter about the study, signed by their 
general practitioner or by the PI (see Appendix 6). The PI then contacted these controls by 
telephone and/or in person to ascertain whether they were eligible for the study and willing to 
participate. If contact was not made at the initial attempt, further contacts were attempted on at 
least three different occasions at different times of the day or evening (including one weekend 
visit) over a period of more than a week. Neighbours were also asked whether they knew of 
the individual's whereabouts, so that subsequent calls could be planned and individuals who 
were away on holiday could be included in the study. If controls were ineligible or refused to 
participate, individuals with the next nearest date of birth on the age-sex register were 
approached. Further attempts were also made at this stage to contact individuals who the PI 
had not been able to contact earlier. This process continued until two eligible controls were 
recruited. 
3.9 DATA COLLECTION 
The fieldwork lasted for sixteen months, from September 1997 to December 1998 inclusive. 
Cases and controls who agreed to participate were visited by the PI at a pre-arranged time, 
usually in their own homes. If a participant cancelled or failed to appear at the meeting, at 
least four further attempts were made to arrange a second meeting. 
The visit comprised: 
a fuller discussion about the study 
final checking of eligibility 
obtaining written informed consent for participation 
administration of a standardised questionnaire 
anthropometric measurement 
collection of a vesicle fluid sample from cases for PCR analysis. 
48 
3.9.1 The questionnaire 
The questionnaire was designed to confinn eligibility for the study, to obtain clinical 
infonnation about zoster in order to categorise cases without vesicle samples, and to elicit data 
on the exposures of interest and possible confounders. A copy ofthe final questionnaire can be 
found in Appendix 7. It was developed after considering the methods and questions used in a 
number of previous questionnaires, was piloted in August 1997 by interviewing ten individuals 
living in South London (4 males, 6 females) aged 46-84 years, and amended slightly before use 
in the main study. 
The questions and methods used are summarised below. 
General/medical history: questions were asked about date of birth, housing tenure and car 
access, and recent medical nistory, treatments and procedures 
Details of zoster: all participants were asked about past episodes of zoster, and cases were 
asked about pain, rash and other symptoms during the current zoster episode. 
Residence and job calendars: infonnation was sought on dates of residence for each place of 
residence in the participant's lifetime. Job history from the age of 14 years was also obtained, 
with the number of days worked per week. These data fonned the basis for later questions 
about ultraviolet radiation (UVR) exposure and occupational contacts with children or ill 
individuals (discussed below), and provided infonnation on country of childhood. The 
calendars were initially sent to cases and controls with the invitation letter, to self-complete 
before the main interview if they so wished. Within the first three months ofthe main study, it 
became clear that participants preferred 10 complete the calendars at interview, and this was 
carried out for the remainder of the study. 
Ethnicity and history of chickenpox: ethnicity was self-defined. Participants were asked 
whether they remembered having chickenpox, and if so at what age. 
Contacts with cases of varicella or zoster, and occupational/social contacts with children: 
questions were asked about contacts with cases of varicella or zoster in the last 10 years, and 
lifetime occupational contacts with ill individuals. However, varicella is infectious before 
rash onset and some contacts may have been unrecognised.285 As varicella is mostly 
acquired before the age of ten years in the United Kingdom,82 additional data were sought 
on contacts with children aged 1-10 years as surrogates for exogenous varicella exposures. 
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Questions were asked about social contacts with children in the last ten years, including 1) 
specific children living in the household, 2) specific children not living in the household, 
such as grandchildren and neighbours, or 3) a range of different children in groups with 
changing membership, such as at school playgrounds or parties. The job calendar was used 
to identify lifetime occupational contacts with children. 
Past UVR exposure: the objectives of this thesis wer~ to examine the effects of childhood 
and recent UVR exposures on the risk of zoster. Childhood exposure was chosen to 
examine the hypothesis that high levels of UVR exposure in early life might 'programme' 
the immune system to respond less robustly to subsequent challenges. However, data were 
collected for lifetime UVR exposures, for analysis at a later date. What follows is a brief 
description of the UVR data that were collected for the present analyses. 
The job and residence calendars were used to ask about the number of hours spent outdoors 
between 9am and 5pm in summer and in winter for childhood (age 7-8 years) and in the last 
year, and these data were then converted into UVR exposure using data on latitude and cloud 
cover for each geographical location (detailed in Chapter 4). The questions were based on the 
questionnaire developed by Kricker et ai, which has been widely used in studies of skin 
cancer.286 Questions about past UVR exposure are difficult to validate formally, but lifetime 
UVR exposure ascertained from the questionnaire has been shown to correlate with degree of 
benign cutaneous sun damage, and to be predictive for risk of basal cell carcinoma.287 Kricker 
demonstrated that use of residence and job calendars maximised participants' recall by relating 
each question about time outdoors to where they were living and working at that time. In this 
study, individuals were asked about how long they spent outdoors between 9am-5pm in 
childhood and in the last year on: 
work (or school) days: 'work' was defined as the occupation that took up the major 
part of the week, and included periods of retirement, full-time childcare, 
unemployment and (for childhood) school-days. Additional questions were asked to 
help participants recall outdoor exposure on school-days, including a) whether the 
participant walked to and from school, and how long this took, b) how long breaks 
were in the day and for lunch, c) what time school finished, and d) whether the 
participant went out to play after getting home from school. 
non-work days: these comprised the days when not 'working' or going to school. For 
exposure in childhood, separate questions were asked about non-school days 
(weekends) and school holidays. A separate question was asked about time spent 
outdoors sunbathing in adulthood. 
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summer and winter holidays: information was collected on both time spent outdoors 
and duration of holidays. For holidays in the last year, the dates of the holiday were 
sought, in order to obtain a more accurate estimate of recent UVR exposure. 
Data were also sought on use of hats and protective clothing on work days, non-work days 
and holidays, propensity to bum and ability to tan, history of severe sunburns, and non-
sunlight UVR exposures (use of sunbeds, and' occupational and therapeutic UVR 
exposures). 
Average micronutrient intake in the previous year and in the two months before rash onset was 
assessed using a food frequency questionnaire (FFQ) and questions about consumption of 
dietary supplements. Food frequency questionnaires typically comprise two or three 
components: what foods are eaten, how often they are eaten, and (sometimes) information on 
the portion size consumed, all over a specified period.288 These data can then be converted to 
micronutrient intake, using food composition tables. The advantages of FFQs are that firstly, 
they are easy to administer and are well accepted by participants. Secondly, they allow 
estimation of average (as opposed to short-term) intake. Thirdly, they seek information on 
food intake before disease onset. Alternative methods used to assess micronutrient intake 
include measurement of serum micronutrient levels, recall of all dietary items eaten in the last 
24 hours, and keeping weighed records of all food items consumed for a specified number of 
days. These methods have disadvantages when used in' case-control studies. For example, 
they all measure intake after disease onset (which may be unrepresentative of previous intake), 
and single biochemical measurements of some micronutrients and 24-hour recall may correlate 
poorly with average micronutrient intake because there can be substantial within-person 
variation in intake.289,29o 
The FFQ used in this study was a modification of Willett's FFQ, which was first developed 
for use in a cohort of over 10,000 US nurses.291 ,292 The original questionnaire comprised a 
list of foods of nutritional interest that were commonly eaten by US individuals. There were 
frequency options for each food (ranging from less than once a month to more than six times a 
day) and a semiquantitative approach was used - questions referred to standard portion sizes 
such as a slice of bread, a tablespoon of cream or a 'medium serving' of meat. Collection of 
more detailed individual portion size data may add little useful information because a) 
individuals often find it difficult to estimate how much they eat of foods that do not come in 
easily-defined units (leading to increased interview time and possibly decreased 
compliance),293,294 b) there may be considerable within-person variation in portion size,295 and 
51 
c) variations in micronutrient intake between individuals of the same sex and similar age may 
be largely determined by frequency of consumption?96-298 The questionnaire was validated on 
a sample of 194 nurses, by comparing micronutrient intakes in the last year estimated from the 
FFQ with intakes estimated from multiple weighed diet records taken over the same period.291 
Correlations ranged from 0.36 (for vitamin A intake without supplements) to 0.75 (for vitamin 
C intake with supplements). Subsequent validations against biochemical indicators reported 
correlation coefficients of 0.30-0.63 for micronutrients?90 
Willett's questionnaire has been modified for use in a variety of populations, and has been 
extensively validated?99-308 A UK version was developed as part of a multi-centre 
European cohort study of cancer and nutrition.309 This questionnaire used the same 
frequency categories as Willett et ai, but the food list was changed to allow for differences 
in diet between US and UK populations and to obtain accurate information on milk 
consumption and types of breakfast cereal and fat used.304,310 It has been validated on more 
than one occasion, with correlation coefficients for a variety of micronutrient intakes of 
0.43-0.59 compared to estimates from weighed records, coefficients of 0.44-0.45 compared 
to plasma vitamin C levels, and a coefficient of 0.13 compared to plasma measurement of 
p_carotene.304,307,308 A study of the reproducibility of the FFQ for micronutrient intakes 
reported correlation coefficients in the range of 0.47-0.78 for men and 0.59-0.85 for 
women.
308 The questionnaire underwent a slight further modification for use in a UK study 
of micronutrient intake in the elderly, to allow for seaso~al fruit and vegetable consumption 
(Prof. A Fletcher, personal communication). 
The present study used the modified UK questionnaire (used in the study of the elderly), 
which included a standard food list of 139 food items. An open-ended section was added 
for recording foods not listed on the form, to ensure that foods commonly eaten by different 
cultural groups were included. For each food item, nine frequency options and 
semiquantitative portion size information was sought, as with the Willett questionnaire. 
Changes in the frequency of consumption over the last year for any food and seasonal 
consumption of specific foods were noted. Questions about dietary supplements included the 
brand of supplement, dose and frequency of consumption. The PI studied the FFQ training 
manual that was developed for interviewers in the UK study of the elderly, and discussed 
the questionnaire with one of the trainers before administering it in the present study. 
Alcohol and cigarette consumption in the last year: both these factors may also affect cell-
mediated immune function, and so could confound some of the exposures of interest.311 -314 
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Questions about units of alcohol consumption were embedded in the food frequency 
questionnaire. Participants were also asked whether they were current, ex- or non-smokers, 
and about cigarette consumption in the last year. 
Stressful events: questions about major stressful events in the last year were adapted from the 
questionnaire used by Schmader et al in their study of the effect of stressful events on zoster, 153 
which was itself developed from the Geriatric Scale of Recent Life Events.315 As the 
questionnaire for the present study was lengthy, twelve main questions about stress were 
used, together with an open question about whether participants had experienced any other 
stressful event in the last year. All participants were asked about recent bereavements, major 
illnesses amongst family or friends, divorce or separation, difficulty with family members, 
moving house, problems with neighbours, serious financial worries, and difficulties at work 
(for those still working). Questions from the original questionnaire that were omitted 
included: 
multiple questions about the same topic (for example, seven separate questions 
about work) 
less common events (such as going to jail) that were likely to be reported in 
response to the open question by all individuals who experienced them 
events that were least likely to be stressful - for example, an improved financial 
situation. 
Physical trauma: questions were asked about injuries in the last six months. Information 
about surgical and other invasive procedures was obtained from the medical history (discussed 
above). 
3.9.2 Vesicle fluid samples 
Wherever possible, a swab of vesicle fluid was obtained by the PI from each case. The 
specimen was collected on a sterile cotton-tipped applicator, which was then broken off into a 
container of sterile saline and sent by post to Dr Judith Breuer (Department of Microbiology, 
the London Hospital). In some instances where vesicle fluid was not obtainable a crust sample 
was taken instead. Viral confirmation was carried out by amplifying viral DNA using 
polymerase chain reaction (peR). Samples were initially tested using single-round peR for 
the Pstl site within gene 38 of the viral genome. Negative samples were retested in three 
ways, 1) using the Taqman system (which can detect very low copy numbers) with primers 
amplifying the Pstl site within gene 38,316 2) using nested peR with primers amplifying gene 
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29 and 3) using nested PCR with primers amplifying gene 63. Samples that remained negative 
for VZV on all tests were stored, together with PCR-positive samples from cases with atypical 
clinical features. These samples were later tested for herpes simplex virus (HSV) DNA, using 
PCR with primers that could detect HSVI and HSV2 simultaneously. 
3.9.3 Anthropometric indices 
Single body measurements can be combined to provide information on nutritional status. For 
example, body mass index (BMI) is a measure of under- or over-nutrition in adults that 
standardises weight for height (BMI = weight (kg)lheight(mi). However, difficulties in 
standing or spinal curvature can complicate height measurement in elderly populations. 
Alternatives to height such as demispan (the distance of the outstretched arm from the sternal 
notch to the finger roots) can be used. Indices that standardise weight for demispan comprise 
demiquet (weight(kg)/demi-span(mi) in men, and mindex (weight(kg)/demi-span(m» in 
women. All these indices are influenced by food intake, energy expenditure and past or 
present health. 
Three anthropometric measures were taken at interview: 1) height to the nearest O.lcm, using a 
Microtoise height measure, 2) weight to the nearest O.lkg, using Soehnle electronic scales, and 
3) two demispan measurements to the nearest 0.1 cm using a metal retractable demispan tape, 
to obtain a mean demispan value. The PI attended a training session for taking anthropometric 
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measures set up for the UK study of the elderly, before embarking on measurements for the 
present study. 
3.10 DATA MANAGEMENT 
Data were manually checked by the PI after interview. They were then coded and double 
entered into multiple databases. After the data were validated, they were transformed, reduced 
to individual-level data, cleaned and categorised before data analysis. 
3.10.1 Data coding 
.Where possible, variables were pre-coded on the questionnaire. Coding schemes were 
developed for other variables, and used by the PI to code responses. Data on residences and 
holiday destinations were coded by latitude, hemisphere and mean percentage cloud cover. 
Latitude was determined by looking up each place of residence or holiday in a comprehensive 
world atlas.317 The mean percentage cloud cover data for warmer and cooler half-years and for 
three-month periods were obtained from maps of climatological data.318 Frequency of food 
consumption in the two months before rash onset (as opposed to consumption in the last year) 
was recoded using the seasonal infonnation and other changes in diet noted on the FFQ. 
3.10.2 Data entry 
Data entry templates were created in Epi-Info 6,319 using a hierarchical file structure. The main 
(primary level) database contained a single record for each individual. This held person-level 
data, such as clinical details of zoster and other current illness, history of sunburn, frequency of 
holidays, smoking and socioeconomic variables. The main database was linked to ten 
secondary- or tertiary-level databases, each of which contained multiple records per individual 
for repeated variables such as child contacts, residences, jobs and holidays. The relationship 
between the databases is summarised in Figure 3.3. The secondary and tertiary databases 
opened automatically froni the main database at certain stages of data entry if there were data 
on repeated variables for that individual, so that all the data on the questionnaire could be 
entered sequentially. The PI then double-entered the data, using interactive checking for legal 
values and ranges, and validated the entries using the EpiInfo Validate programme. 
Figure 3.3: Relational database structure used for data entry 
1 ° level database 2° level databases 3° level databases 
(One record per individual) .... ~~-- (Multipl~ records per individual) ----+ 
Main database I Residences I ~ ~ 
r-----------, 
Past holidays Leisure activities in last 20y 
-I Recent holidays 
1 Diet in last 12m & last 2m 1 
1 Child contacts in last lOy 1 
1 VZ:V contacts in last lOy 1 
1 Stress events in last 12m 1 
1 Physical trauma in last 6m 1 
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3.10.3 Data transformation, reduction, cleaning and categorisation 
Datasets were transferred into Stata v.6.0.320 New variables on the duration, level or number of 
exposures were created - for example, the level of UVR exposure and the number of child 
contacts in the last year were calculated from the original data by combining data within and 
between databases. These new variables were then summed or otherwise summarised to 
obtain individual-level data. Details of variables that were generated are given in Chapter 6. 
Contradictory responses were identified using consistency checks on original and derived 
variables. The distribution of each exposure variable was examined separately for cases and 
controls, using histograms and point plots. Outliers were checked against the original 
questionnaire, and any errors were corrected before data analysis. Programming errors were 
checked by manually calculating values of derived variables for a sample of data, and 
comparing the results to those obtained by programming. 
Most quantitative variables were categorised into quintiles of exposure, based on the 
distribution of the variable amongst controls. Where there were large numbers of individuals 
with no exposure, this was included as a separate category. Using the exposure distribution in 
controls resulted in increased power to detect significant effects for each exposure level 
compared to the use of pre-defined cutpoints, and reflected the exposure distribution in the 
underlying (age- and sex-matched) population. Other variables were grouped by generating 
categories considered relatively homogenous with respect to risk of zoster, and studying 
frequencies to ensure that wherever possible there were sufficient numbers of individuals in 
each category. 
3.11 DATA ANALYSIS 
Data analyses in this thesis are confined to the datasets of 'confirmed' and 'probable' cases 
and their matched controls (excluding matched sets with 'possible' cases). This decision 
was taken in order to exclude as far as possible unconfirmed 'zoster' cases that in reality 
had HSV infection. Exclusion of HSV cases was particularly important for the analyses of 
the effect of recent UVR exposure on risk of zoster, because UVR is a known risk factor for 
HSV reactivation. Therefore, inclusion of HSV cases might result in an overestimate of the 
effect of UVR on zoster. In addition, inclusion of HSV cases could lead to an 
underestimate of the effect of exposures that were not associated with risk of HSV 
infection. 
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The analysis was carried out in stages. For each group of related variables, descriptive 
analyses were followed by univariable analyses for the exposures of interest, and then 
multivariable analyses were undertaken. A final model was created by combining the 
results from the group-level analyses. 
3.11.1 Descriptive analyses 
Reporting of zoster cases by individual general practices over time and the numbers of 
confirmed, probable, possible and unlikely zoster cases ascertained were described. The 
age and sex distribution of cases was summarised, as were clinical features of zoster 
including rash, pain, antiviral use and previous zoster episodes. 
3.11.2 Univariable analyses 
As explained above, the dataset for these analyses was restricted to cases with confirmed or 
probable zoster, and their matched controls. Odds ratios were estimated for exposure and 
confounding variables using conditional logistic regression in Stata v.6.0, with zoster as the 
outcome variable. The baseline variable was usually taken as the lowest quintile of exposure 
or the group considered at lowest risk of zoster. The statistical significance of associations 
between exposure variables and risk of zoster was determined using likelihood ratio tests of 
heterogeneity and of trend, and 95% confidence intervals were determined using Wald tests. 
Univariable analyses identified variables for initial inclusion in multi variable models, based on 
their degree of association with zoster (discussed below). 
3.11.3 Multivariable analyses 
A large number of exposure variables were potentially associated with risk of zoster. 
Therefore, separate models were initially set up for five groups of risk factors: 
1. Child contacts and contacts with cases of varicella or zoster 
2. Ethnicity, country of childhood and age at varicella 
3. UVR exposures, history of sun bum, and protective behaviours (e.g. wearing a hat) 
4. Dietary exposures 
5. Stress events and recent illness 
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For each model, variables associated with zoster on univariable analysis to the level of 
p~0.2 were included. Two main modelling strategies were used. For some models, 
exposures strongly associated with risk of zoster were added first, followed by exposures 
more weakly associated with zoster. For other models, a conceptual framework was used to 
explore the interrelationship of exposures thought to lie at different points on the same 
causal pathway. In these models, variables were categorised according to their proximity to 
risk of zoster and were added in tum to the model, s~arting with distal variables and ending 
with proximal variables. The modelling strategies for individual models are discussed in 
more detail in Chapter 6. For all models, variables were kept in the model at each stage if 
they remained significantly associated with risk of zoster (p~0.1), or if they confounded any 
of the other variables of interest. A variable was considered a confounder if it changed any 
of the effect estimates of interest by ~1O%,32\ with no marked increase in standard errors (~ 
20%). Variables excluded at earlier stages of the analysis were added again to later models, 
to assess whether they became significantly associated with zoster in the presence of other 
variables. Effect modification of exposure variables by age was investigated in each model, 
to identify possible determinants of immunosenescence. For these analyses, the study 
population was split into two groups - 'younger' «60 years) and 'older' (~60 years) 
individuals. This cut-off was chosen because it resulted in groups of roughly equal size, 
and because limited data from published research has shown that individuals aged greater 
than 60 years have lower levels of cell-mediated immunity compared to younger individuals 
(Chapter 2, Section 2.3.3.2). A final model was then set up, combining the findings of the 
five individual models. In this way, the independent effects of all variables on the risk of 
zoster were estimated. 
3.12 ETHICAL ISSUES 
Ethical approval for the study was granted by the Ethics Committees of the London School of 
Hygiene and Tropical Medicine, and by the four local research ethics committees in the area. 
If cases refused to allow the GP even to give their name to the PI, the practice reported only 
their date of birth and sex. Written information on the study was provided to all eligible cases 
and controls with the initial letter, and the PI discussed the study with potential participants and 
answered their questions. Written consent was obtained before administration of the 
. questionnaire. Identification of controls was based on their proximity to cases in age, their sex 
and general practice, and medical records were not used by the PI to determine past history of 
zoster. 
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Participant confidentiality was ensured by identifying participants by numerical codes. 
Patients' names and addresses were not used on the questionnaire or on computerised 
databases, and access to all patient data was restricted to the study investigators. 
3.13 SOURCES OF FUNDING 
The PI obtained a studentship award from the Medical Research Council, from September 
1996 - August 1999. The Research Foundation for Microbial Diseases in Osaka also donated 
£40,000 towards the research. This provided a salary for the principal investigator for the 
fourth year of research, and contributed towards outstanding study expenses. 
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4. TRANSFORMING DATA ON HOURS SPENT OUTDOORS AND FOOD INTAKE 
Chapter 3 included a general overview of the transformation of exposure variables. Specific 
descriptions of derived variables are given in Chapter 6. However, detailed analyses were 
needed before hours spent outdoors could be transformed into ultraviolet radiation (UVR) 
levels, and before usual food intake could be transformed into micronutrient intake. This 
Chapter comprises a summary ofthese analyses. 
4.1 TRANSFORMING UVR DATA 
The amount of UVR reaching the ground at any specific location depends on a number of 
factors, including latitude, season, altitude, time of day, amount of cloud cover and 
stratospheric ozone levels.172 Therefore, differences between individuals in personal UVR 
exposure are due to three""main components: 1) differences in ambient UVR levels at their 
residences and holiday destinations over their lifetime, 2) differences in the amount of time 
they spent outdoors at each of these locations at various times of the year, and 3) whether they 
used protective measures against UVR exposure, such as hats or protective clothing. 
Data were collected at interview on the time spent outdoors at various residences and holiday 
destinations, and on the use of protective measures. Before this information could be 
converted into personal UVR exposure levels, it was necessary to convert the data on 
geographic locations into seasonal levels of ambient UVR. 
4.1.1 Calculating ambient UVR levels for residences and holiday destinations 
Direct measurement of UVR levels at the Earth's surface are made with instruments such as 
broadband meters, scanning spectoradiometers or satellite-based instruments.322 Networks of 
recording stations have been set up, but equipment is expensive and requires detailed 
calibration. An alternative approach is to use a computer model to estimate ambient UVR 
levels at specific locations at different times of the year and day. 323 One of the best known 
models was developed by Green et ai, who used data on latitude, ozone layer thickness, season 
and time of day to calculate UVR levels in the Northern Hemisphere.324-326 This model has 
been adapted by a number of other researchers, and has been validated by comparing UVR 
values derived from the model with direct measurements of UVR at the Earth's surface.323,327 
Diffey and Elwood expanded the model to produce tables of ambient UVR levels (expressed in 
MED) under clear sky conditions.328 The table gives UVR levels for each month at every 10° 
latitude from 60<N to 600S, from sunrise until different times ofthe day. 
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For this study, the level of UVR from 9am to 5am at each toO latitude were obtained from 
Diffey and Elwood's tables, for warmer and cooler half years and for each month of the year. 
Northern and Southern hemisphere data were modelled separately to estimate UVR levels for 
intermediate latitudes in each hemisphere. Quadratic, cubic or quartic equations were fitted in 
tum to the data, and likelihood ratio tests were used to determine which equation gave the best 
fit. An example is given in Figure 4.1 (overleaf), where the quartic equation offered the best 
fit for Northern Hemisphere latitude data for January. The resulting equations were used to 
estimate UVR exposure between 9am and 5pm for every residence and holiday destination 
under clear sky conditions at different times ofthe year. 
The above estimates took no account of the effect of cloud cover. Seasonal data on mean 
percentage cloud cover for each location were obtained from maps of climatological data.318 
The level of ambient UVR in each location was adjusted by multiplying clear sky UVR levels 
by a 'cloudiness factor', calculated as follows: 328 
Cloudiness factor = 1 - (0.005 xC) (where C = percentage cloud cover) 
4.1.2 Converting questionnaire data into UVR levels 
Data on ambient UVR levels at residence and holiday locations were combined with 
questionnaire data on time spent outdoors, to obtain personal UVR exposure in childhood and 
in the last year. Firstly, daily non-holiday UVR exposure was calculated by multiplying the 
proportion of time spent outdoors between 9am and 5pm on a work (or school) day or a non-
work day by the ambient UVR levels for the residence. For example, using the equations 
described above it was estimated that one hour spent outdoors between 9am and 5pm in the 
warmer months in London would result in a sub-erythemal UVR dose of 0.84 MED. 
Secondly, data on daily UVR doses on work- and non-work days were combined to obtain 
weekly non-holiday UVR exposure, for warmer and for cooler half-years. Similar calculations 
were carried out to estimate total holiday UVR exposure in childhood. It was possible to 
obtain a more precise estimate of holiday UVR exposure in the last year, because information 
was collected at interview on the month in which these holidays were taken. Therefore, recent 
holiday exposure was calculated using ambient UVR levels for the specific month at the 
holiday destination. Similarly, non-holiday UVR exposure in the month before rash onset was 
calculated using ambient UVR levels for that month at the individual's residence. 
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Figure 4.1: Fitting of quadratic, cubic or quartic equations to UVR levels by latitude 
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After personal levels of UVR exposure had been calculated, data were categorised into 
quintiles of exposure, based on the exposure distribution amongst controls. No adjustment was 
made at this stage for the use of protective measures against UVR, such as hat-wearing. These 
measures were later added as separate variables in the analysis, to assess any protective effect 
against zoster. The analysis ofUVR exposures is described in Chapter 6. 
4.2 TRANSFORMING FOOD INTAKE DATA 
Three types of information were needed to transform food frequency questionnaire (FFQ) data 
into micronutrient intake: 
1. Thefrequency with which various foods were consumed: this was collected at interview. 
2. The average portion size of these foods: portion size information was easily obtainable for 
items that were eaten-as 'units', such as slices of bread or pieces of fruit.329 However, 
questions were asked about 'medium portions' of other foods. The average size of a 
medium portion was likely to vary by age and sex, and was not immediately available 
from standard sources. 
3. The micronutrient content of a standard amount (for example, 100g) of each food: food 
composition tables list information on the micronutrient content of FFQ food items. In 
this study, data were sought from the latest edition and supplements of the standard UK 
tables, McCance and Widdowson's The Composition' of Foods. 330-340 Highly characterised 
FFQ food items such as fresh bananas or semi-skimmed milk were easily identified in 
McCance and Widdowson (M&W) listings. However, other FFQ items fell into broader 
categories (such as beef or lamb), for which there were multiple M&W items. For 
example, McCance and Widdowsol} lists 91 food items that could be included under beef, 
specifying types of meat (mince, stewing steak, sirloin etc) and methods of cooking (fried, 
grilled, roasted etc).334 It was necessary to identify the M&W food that best represented 
each of the broadly characterised FFQ items. 
Data on the commonest foods eaten within FFQ-defined categories and the age- and sex-
specific portion sizes of these foods were identified by analysing two large datasets of the 
dietary habits of English adults, the National Diet and Nutritional Surveys (NDNS). The 
objectives of the analysis were: 
1. To identify the commonest food eaten within each broadly characterised FFQ food, for 
men and for women of defined age groups and ethnicities 
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2. To obtain the median portion size for each food item identified from (1) above, by age, 
sex and ethnicity 
4.2.1 The National Diet and Nutritional Surveys 
The NDNS Programme has carried out two dietary surveys of adults, 1) a survey of 2197 
individuals aged 16-64 years in 1986-87,341 and 2). a survey of 1687 individuals aged 65 
years or older in 1994-95.342 In both surveys, participants weighed and recorded all foods 
and beverages consumed in 1) a seven-day or 2) a four-day period. Approximately 5000 
and 3000 highly characterised food items were recorded, and these were later coded using 
an NDNS coding system. The primary data are available from the Data Archive of Essex 
University. 343,344 
4.2.2 Preliminary data management of NDNS datasets 
Demographic and food consumption data were merged to obtain 630,213 coded and 
weighed food items consumed by 3884 individuals of known age, sex and ethnicity. Forty-
two datasets were then created by dividing participants by sex, age (16-24 years, 25-34 
years, 35-49 years, 50-64 years, 65-74 years, 75-84 years and 85+ years), and ethnicity 
(defined byNDNS interviewers as 'White', 'Asian' or 'Coloured'). 
Some individuals had multiple records of the same food item, because they had eaten this 
food on two or more occasions during the survey period. This led to two potential 
problems: 
1. Some NDNS foods could be ident!fied as the most common foods eaten within specific 
FFQ categories not because they were eaten by a wide range of individuals, but because a 
few individuals ate these foods repeatedly. 
2. Average portion sizes for foods eaten on multiple occasions in the NDNS survey were 
affected by both within-person and between-person variation. These had different 
detenninants - within-person variation in portion size partially arose from eating second 
helpings and leftovers of the same foods, whereas between-person variation arose 
mainly from differences amongst individuals in habitual portion sizes. 
To minimise these problems, mean portion sizes of foods were calculated for each individual. 
This ensured that specific foods were only counted once per person. 
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4.2.3 Identifying the commonest foods eaten for each FFQ category 
Every food eaten by an NDNS participant was assigned to one of the present study's FFQ 
food categories, so that each FFQ food comprised a set of NDNS foods (with up to 175 
NDNS foods per FFQ category). If the NDNS food was a composite dish not listed on the 
FFQ, the component foods were assigned to different FFQ food categories, reflecting the 
original data collection. For example, the NDNS fo?d bolognaise sauce might be assigned 
separately to the FFQ foods beef, onions, tinned tomatoes etc. The commonest NDNS food 
within each FFQ food category was then identified for each age/sexlethnicity group. 
However, individual NDNS foods were very finely categorised and mostly occurred with 
low frequency within FFQ categories. Therefore, the commonest NDNS food was 
identified using a two-stage process: 
1. The commonest subtype of food was first identified - for example, in some age/sex 
groups varieties of minced beefwere more commonly consumed than varieties of roast 
beef or stewed beef 
2. The commonest variety of that subtype was identified - in some groups, the 
commonest variety of minced beef consumed was 'minced beef, stewed, fat skimmed'. 
In some FFQ food categories, all NDNS foods remained at low frequency even after 
grouping foods into subtypes. In these cases, the com~onest NDNS food was identified by 
combining datasets of individuals of the same sex and adjoining age groups. Limited 
NDNS data on foods eaten by individuals of non-White ethnicity were supplemented by 
information collected during interview. 
4.2.4 Compiling a nutrient databank -
The next stage in the analysis was to set up a nutrient databank, containing information on the 
micronutrient and energy content of 100g of each food identified for an FFQ category. For 
most foods, this was achieved by identifying the food in McCance and Widdowson databases 
accessed using Integrated Dietary Analysis (IDA) Sofiware,345 and exporting the food 
composition data. For a minority of foods, there was no M&W listing. In these cases, data on 
,the nutrient content were obtained from the following sources: 
1. NDNS nutrient databank: this was originally compiled for the NDNS survey of 
individuals aged 65 years and above.342 If the food was listed in the NDNS databank, 
food composition data were exported to the study nutrient databank. 
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2. Manufacturer's data: if foods were not listed in either the NDNS nutrient databank or 
the M& W listings, food composition data were obtained directly from the manufacturer 
or from information printed on the packaging. This information was then added 
manually to the nutrient database. 
Data were also collected in the FFQ on the consumption of 222 different vitamin and mineral 
supplements. The micronutrient content per dose o~ these supplements was obtained from 
manufacturers and added to the database. 
4.2.5 Assigning portion sizes to questionnaire data 
Average portion sizes were then sought for each identified food item. Median portion sizes 
(in grams) were determined for the foods by sex, age group and ethnicity, using the NDNS 
datasets. For FFQ items that were eaten as units (such as slices of bread), standard portion 
sizes were obtained using the IDA Software, which includes a database of Ministry of 
Agriculture, Fisheries and Food portion size data.329 
If the NDNS food was an ingredient of a composite dish, the portion size was calculated by 
multiplying the median portion size of the composite dish by the proportion of the total weight 
made up by that ingredient. The latter value was obtained from standard NDNS or M&W 
recipes. 
4.2.6 Conversion of questionnaire data to micronutrient levels 
Once micronutrient content and portion size had been determined for each food, the food 
records were converted into daily micronutrient intake for each individual. This was carried 
out in three stages: 
1. The frequency of consumption of each food was converted to daily frequency. Where 
responses encompassed a range of frequencies, the middle value was taken - for 
example, a frequency of 2-4 times a week was recoded to 0.429 (3/7) times a day. 
Frequencies of less than once a month were recoded as 'none'. Frequencies of more 
than six times a day were recoded as seven times a day, after scrutinising information 
obtained at interview. 
2. Daily micronutrient intakes of each food record were calculated as daily frequency 
multiplied firstly by micronutrient content per 100g, and then by portion size (expressed 
as a proportion of 100g). Similar calculations were used to obtain the daily 
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micronutrient content per dose of vitamin and mineral supplements. 
3. The micronutrient intakes from individual food records were summed to obtain daily 
intakes for each individual of total energy intake (in kilojoules) and the seven 
micronutrients of interest. 
4.2.7 Adjusting for total energy intake 
The analysis described above provided estimates of the absolute daily intakes of the seven 
micronutrients. However, before these could be used in further analyses, the effect of variation 
in total energy intake had to be removed. Total energy intake varies between individuals due 
to differences in three main factors: 346 
1. Body size: this determines the amount of energy needed for resting metabolic activity; 
2. Physical activity: there is a strong positive relationship between physical activity and total 
energy intake. This is probably the major determinant of between-person variation in 
energy intake. 
3. Metabolic efficiency: metabolically efficient individuals need less energy to maintain their 
body size and physical activities compared to metabolically inefficient individuals. 
Almost all nutrients tend to be positively correlated, with energy intake; in this study, 
correlation coefficients ranged from 0.262 (retinol equivalents) to 0.817 (zinc) amongst 
controls for food intake in the last year. It follows that individuals with high energy intake had 
high absolute intakes of micronutrients. However, most nutrients are metabolised roughly in 
proportion to total energy intake - larger, physically active and metabolically inefficient 
individuals tend to have a higher micronutrient requirement compared to small, less active 
individuals.346 Therefore, it was necessary to separate the variation in micronutrient intake 
resulting from differences in dietary composition from the variation due to differences in body 
size, physical activity and metabolic efficiency. Information on body size is easily obtainable, 
but data on physical activity and metabolic efficiency are more difficult to measure. As an 
alternative, total energy intake was used as a proxy for the three variables. 
Adjustment for total energy intake was made using Willett's residual model.346 Firstly, data 
for micronutrient intake and total energy intake were log-transformed, as they were positively 
skewed. A simple linear regression model was then set up for each micronutrient amongst 
controls, with absolute (log-transformed) micronutrient intake as the outcome variable and 
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(log-transfonned) total energy intake as the explanatory variable. The residuals from the 
regression model were calculated for all participants (Figure 4.2). These residuals represented 
individual variation in micronutrient intake due to dietary composition, separated from the 
variation due to differences in total energy intake. 
Individuals were categorised into quintiles of exposure for each energy-adjusted micronutrient, 
according to the distribution of each variable amongst controls. The values of residuals 
provided little sense of the nutrient intake of the diet. The data were transfonned into less 
abstract nutrient levels by adding a constant - the (log) predicted micronutrient value for the 
mean energy intake amongst controls (see Figure 4.2). This was added to each residual value, 
and then the antilog was taken. 
Further analyses of micronutrient data are described in Chapter 6. 
m 
Log total energy intake -
Figure 4.2: Energy-adjusted micronutrient intake 
(adapted from Willett)346 
r = residual for an individual 
m = mean energy intake 
p = predicted log micronutrient value for an 
individual with mean energy intake 
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5. DESCRIPTIVE RESULTS 
5.1 CASE REPORTING 
A total of 436 cases were ascertained between 1 September 1997 and 31 October 1998. 
Reporting by the 22 general practices over time is summarised in Table 5.1 (overleaf). The 
highest numbers of cases were ascertained from. the two fully computerised practices 
(practice nos. 13 and 17) that carried out weekly computer searches for zoster diagnoses. 
There was no clear pattern in the number of cases reported over time - lowest numbers were 
reported in the first month of the study, and in January and August 1998. 
Of the 436 cases, 421 were actively reported by practices a median two days (range: 0-162 
days) after the day of consultation, with 351 (83%) cases reported within a week of 
consultation. Fifteen other cases were ascertained a median of 64 days (range: 21-139) after 
consultation, by searching partially computerised practice records. 
5.2 ENROLMENT, CATEGORISATION AND CLINICAL FEATURES OF CASES 
Of the 436 cases, 139 were categorised as ineligible based on infonuation given by the GP 
or ascertained by the PI after contacting patients. Forty-six of these cases were less than 16 
years old, 37 were immunosuppressed or had a recent history of cancer, 18 were African, 11 
were temporarily registered, 4 were incapable of answering questions and 23 were 
ascertained more than eight weeks after rash onset. Of the remaining 297 patients, 16 
(5.4%) were not enrolled due to refusal (12 patients), or being away from London or 
repeatedly unavailable for more than eight weeks (4 patients). The eligibility of these cases 
was not ascertained. 
The remaining 281 cases were contacted after a median of one (range: 1-12) attempt. 
Samples were taken from 104 individuals at interview, of which 94 were VZV-DNA 
positive. The clinical data and VZV-DNA results were used to categorise individuals as 
confinued (92), 'probable' (152), 'possible' (18) or 'unlikely' (19) cases (as defined in the 
previous Chapter, Section 3.7.1). The distribution of PCR results in each case category is 
. summarised in Table 5.2 (overleaf) and discussed further below. 
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Table 5.1: Reporting of zoster cases by practice and by month of consultation 
Practice 
1 
Practice 
sizeb 
8532 
2,8,lla 22337 
3 
4 
5 
6 
7 
9 
10 
12 
13 
14 
15 
16 
17 
18,19" 
20 
21 
7500 
7388 
5656 
10465 
9934 
9510 
5922 
15078 
13891 
9405 
9199 
7350 
16314 
11899 
6945 
11884 
22 9788 
TOTAL 198,887 
Sept 
1997 
3 
1 
2 
2C 
2 
2C 
3 
2 
4 
2C 
23 
Oct 
1997 
1 
6 
1 
2 
l C 
1 
1 
4 
4 
1 
2 
3 
2 
2 
4 
36 
Nov 
1997 
2 
2 
2C 
1 
4C 
6 
2 
4 
4 
1 
29 
Dec 
1997 
1 
2 
4 
1 
l C 
1 
1 
3C 
1 
2 
1 
3C 
1 
3 
1 
1 
27 
Jan 
1998 
1 
3 
1 
1 
3 
1 
1 
2 
3 
3 
2 
22 
Feb 
1998 
3 
4 
1 
4 
2 
1 
2 
1 
2 
3 
28 
Mar 
1998 
3 
4 
2 
1 
3 
2 
2 
6 
5 
5 
2 
1 
3 
39 
Apr 
1998 
1 
4 
2 
4 
1 
2 
9 
4C 
1 
3 
3 
36 
May 
1998 
2 
3 
3 
3 
5 
2 
1 
4 
3 
30 
Jun 
1998 
4 
1 
1 
3 
1 
2 
3 
8 
2C 
2 
2 
2 
2 
35 
~ a Linked practices b Number of permanently registered patients on 01.09.97 C Includes one or more case ascertained retrospectively 
Jul 
1998 
1 
9 
1 
3 
6 
3 
2 
4 
2 
5 
2 
6 
1 
45 
Aug 
1998 
1 
2 
1 
3 
1 
2 
2 
1 
5 
2 
2 
1 
23 
Sept 
1998 
1 
1 
2 
2 
1 
3 
3 
5 
2 
2 
2 
1 
1 
4 
1 
32 
Oct 
1998 
3 
3 
2 
2 
2C 
6 
3 
2 
5 
1 
31 
TOTAL 
15 
36 
18 
14 
8 
26 
17 
11 
25 
31 
59 
31 
12 
19 
41 
16 
8 
32 
17 
436 
-l 
-
Table 5.2: Distribution of PCR results by zoster case category 
PCRRESULTS Confirmed 
VZV+ve 92 
VZV-ve 
No sample 
TOTAL 92 
" See text 
Table 5.3: Distribution of rash and pain in eqroUed cases (n=262) 
RASH EXTENT 
PCR-confirmed cases (n=92) 
PAIN ~3/4 1/2 1/3 ~1/4 ~3/4 
CASE CATEGORY 
Probable Possible 
2 4 
150 14 
152 18 
RASH EXTENT 
'Probable' cases (n=152) 
1/2 1/3 ~1/4 
Unlikely 
2" 
4 
13 
19 
~3/4 
RASH EXTENT 
'Possible' cases (n=18) 
1/2 1/3 ~1/4 
EXTENT dermatome dermatome dermatome dermatome dermatome dermatome dermatome dermatome dermatome dermatome dermatome dermatome 
~3/4 dermatome 59 3 3 4 85 13 5 7 
1/2 dermatome 11 3 1 11 14 5 3 
1/3 dermatome 1 2 1 1 2" 
~1/4 dermatome 13 
Itching or 4 1 3 
dysthesia only 
No pain 3 2 
No information 
TOTAL 74 8 4 6 100 30 12 10 18 
" Both cases had pain lasting> 4 weeks after rash onset 
The nineteen 'unlikely' cases were excluded from the study. These comprised 12 
individuals with 1-24 previous episodes of similar rash in the last 10 years, two cases with 
rashes that recurred at the same site over the course of the study, four individuals with 
bilateral, non-dermatomal rashes, and one patient with a non-dermatomal backache without 
rash. Of the six samples taken from 'unlikely' cases, four were negative for VZV-DNA 
(Table 5.2). One VZV-DNA positive sample came from a patient with a widely distributed 
bilateral centripedal rash and with no history of va~cella. This patient was diagnosed as 
having varicella. The second positive sample came from a man with no history of varicella 
who had a bilateral, highly crusting non-dermatomal rash covering a wide area the face and 
neck, which occurred three weeks after his grandchildren developed similar rashes. This 
case was considered highly unlikely to be zoster, and was diagnosed as either varicella or 
impetigo (with a contaminated laboratory sample). All six 'unlikely' samples were negative 
for HSV-DNA when tested at the London Hospital. However, one 'unlikely' case with a 
rash with ophthalmic distribution and a history of thoracic 'zoster' seven years previously 
had a sample taken by her local hospital that tested positive for HSV-DNA. 
The 262 confirmed, probable and possible cases were enrolled in the study. These cases were 
seen by their GPs a median 3 days (range: -5 to 37 days) days after rash onset, and by the PI a 
median 9 days (range: 0 to 52 days) days after rash onset. In half (1311262) the patients the 
rashes occurred on the right side of the body. The commonest dermatomes affected were 
thoracic (57.2%), followed by lumbar (14.9%), cranial ,(11.8%), cervical (11.1%) and sacral 
(4.2%). Two (0.8%) patients had rash at two sites, both with extensive dermatomal rashes in 
the thoracic region and an additional small patch of rash in the sacral region. 
The extent of rash and pain within dermatomes is summarised in Table 5.3 (see previous 
page). The degree of rash and pain were similar in confirmed and 'probable' cases. Two of 
the probable cases had negative VZV-DNA results from scab samples - both cases were 
women in their eighties, with extensive dermatomal rashes and pain. Most (14/18) of the 
'possible' cases had only a small patch of rash with localised or no pain. The four 'possible' 
cases with negative VZV-DNA results were scab samples, each taken from a small patch of 
rash. 
Eighteen of the enrolled cases (4 confirmed, 11 'probable' and 3 'possible' cases) had a history 
of previous zoster. Of these, sixteen had a single previous episode 12-74 years previously. 
Two cases reported two previous episodes - one was a confirmed case with two episodes of 
'zoster' six months apart 19 years previously, and the other was a 'probable' case aged 81 
years with episodes in childhood and 30 years previously. In 16 of the 18 cases, the previous 
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episodes were at a different body site to the present episode. Two cases had previous episodes 
at the same site. One was a 'possible' case with a small patch of rash on his thorax. The other 
was a 70 year-old woman with 'probable' ophthalmic zoster, whose initial episode 15 years 
previously had resulted in significant pain and scarring, typical of zoster. 
Of the 248 cases with known treatment status, 131 (53%) were given oral antivirals, and 20 
(8%) were given topical antivirals. 
5.3 DEMOGRAPHIC CHARACTERISTICS OF CONFIRMED / PROBABLE CASES 
Demographic characteristics were determined for the 244 confirmed and 'probable' cases only, 
as their data were used in the risk factor analyses. The median age of these cases was 57.2 
(range: 16.5-91.2) years. The majority of cases occurred with approximately equal frequency 
in five age groups encompassing the ages 30-79 years (Table 5.4). Overall, 43.5% of cases 
were male - there was an excess of female cases in most age groups, but a marked excess of 
male cases (29 males vs. 13 females) aged between 30-39 years (Figure 5.1, overleaf). 
Table 5.4: Age distribution of confirmed/probable zoster cases 
A&e&rouu Re&istered uatients Confirmed/urobable cases 
(years) n(%)a n(%) 
16-19 N/A 5 
20-29 33029 (21.6) 17 (7.1) 
30-39 44467 (29.0) 42 (17.6) 
40-49 25971 (17.0) 30 (12.6) 
50-59 18423 (12.0) 37 (15.5) 
60-69 14164 (9.2) 41 (17.1) 
~ 
70-79 10906 (7.1) 43 (18.0) 
80-89 5166 (3.4) 26 (10.9) 
( 
90+ 1120 (0.7) 3 (1.2) 
NI A = data not available • No I % ofpennanently registered patients from all practices combined 
Ninety percent (220) of the confirmed and probable cases were white, 4% (10) were Afro-
Caribbean, 3% (7) were Asian, and 3% were of other ethnicities. 
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35 Figure 5.1: Age distribution of confll'llledlprobable zoster cases, by sex 
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5.4 ENROLMENT OF CONTROLS FOR CONFIRMED AND PROBABLE CASES 
A total of 488 matched controls were needed for the 244 confirmed and probable cases. 
Letters were sent to 895 individuals, of whom 162 were ineligible for the following reasons: 
118 had a history of zoster, 22 were immunosuppressed or had a recent history of cancer, 11 
were African, one was temporarily registered, and 10 were incapable of answering 
questions. A further 145 were unsuitable, because they no longer lived in London (106), 
were living away for extended periods (22), were dead (11) or had an incorrect date of birth 
on practice records (6). Of the remaining 588 potentially eligible individuals, 103 (17.5%) 
were not included in the study; 75 (12.8%) refused, 9 (1.5%) twice cancelled interviews, 3 
were in hospital, 1 had a non-existent address, and 15 could not be contacted after 4-13 
attempts. The remaining 485 control~ were enrolled after a median of two (range: 0-21) 
contacts; only one matched control was obtained for three of the enrolled cases. One 
control later became a case and was included as both a case and a control. The mean 
difference in age between cases and their matched controls was 4.7 days. 
5.5 DATA COLLECTION FROM CONFIRMED / PROBABLE CASES AND 
CONTROLS 
. The 244 confirmed and probable cases and their 485 matched controls were interviewed in 
their own homes, at their workplaces or elsewhere. Translators were used for seven 
individuals who did not speak English - six of the translators were family members, and one 
was a staff member at a Turkish community centre for the elderly. Four proxy interviewees 
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were used, two of whom were carers for cases with Down's syndrome, one was the wife of 
a case who was hospitalised, and one was the husband of a control with Alzheimer's 
disease. A further 91 interviewees (32 cases and 59 controls) were helped in answering 
questions by a spouse, other family members or (in one case) by a carer. The questionnaire 
took a median of 67 minutes (range: 30-166 minutes) to administer. One case terminated 
the interview before completion. Controls were interviewed a median of 35 days (range: 0-
141 days) after cases. A total of 22 (4.5%) controls were interviewed more than 90 days 
after cases. These were mostly the sixth or subsequent control who had been approached 
for a specific case, where delays were incurred in accessing previous controls who were 
eventually found to be ineligible, who refused to participate, or who agreed to take part but 
then failed to attend an interview on two occasions. 
Anthropometric measures were obtained for 96% (703/729) of interviewees. Measures were 
not taken from individuais who could not safely stand on the weighing scales, who refused 
to be weighed, or who were matched controls of cases with missing anthropometric data. 
5.6 DISCUSSION 
The target of 244 enrolled cases was attained more quickly than had been estimated, due to a 
higher than expected number of cases reported by practices, and low refusal rates. 
Nevertheless, there was underreporting by some practices. This was surmised from the 
following: 
1. Some practices reported fewer cases over time, until no cases were reported (see Table 
5.1). One practice (practice number 3) reported very few cases after moving premises mid-
way through the study. 
2. Some cases were not reported when initially seen by one GP, but were reported after a 
subsequent visit to a second GP in the practice. 
3. A high proportion of cases were reported by the two fully computerised practices that 
performed weekly searches of their computerised records. 
4. Searches of partially computerised records identified some cases that had not been reported 
by the practice. 
A recent study of infectious intestinal disease which utilized a GP research framework and 
dedicated research nurses estimated that practices actively reported only 64% of eligible 
cases.347 Reporting levels were significantly lower amongst practices with larger number of 
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partners and practices with limited research experience. In this study, practice size was not 
clearly associated with poor reporting (Table 5.1). General underreporting of cases by some 
practices was unlikely to have introduced bias, as controls were matched to cases by practice. 
However, incomplete reporting might introduce bias if general practitioners were more likely 
to report cases that fitted the study hypotheses. This was unlikely, as the overall study was 
investigating a wide variety of risk factors for zoster and these factors were discussed only 
briefly with GPs at the beginning of the study. In addition, analysis of patterns of practice 
reporting and of cases that were retrospectively ascertained or reported after second 
consultations indicated that incomplete reporting was due to overall underreporting by 
practices or by specific GPs, and not selective reporting of cases. 
The common occurrence of rash in thoracic dermatomes has been reported in many 
community-based studies,4,17-22,34,64,68 and the distribution of rashes at different body sites in 
this study was almost identical to that reported in the large Rochester study.4 The equal spread 
of cases occurring between the ages of 30 and 79 years reflects an underlying increasing 
incidence with age, as there were decreasing numbers of patients at risk in the older age groups 
(Table 5.4). Actual incidences were not calculated, as the degree of underreporting in the 
different age groups was unknown. Similarly, it is difficult to assess any seasonality in the 
occurrence of zoster - the low numbers of cases reported in August and January probably 
resulted from underreporting by locums in the months where many GPs were on holiday. 
The slight preponderance of female cases has been reported in other community-based zoster 
studies,4,22,23,53,62 and in older age groups this is at least partly explained by the higher 
proportion of females in the population at risk. The excess of male cases aged between 30-39 
years is more unusual, although in the Rochester study males aged 35-44 years had 
significantly higher incidence of zoster compared to females (as discussed in Chapter 2).4 
There are a number of possible reasons for the male excess in this age group. Firstly, males 
might be more likely than females to visit their GP after they developed zoster. This seems 
improbable, as the characteristic pain and rash of zoster is such that all individuals are likely to 
seek medical assistance. Secondly, males of this age may have higher levels of potential risk 
factors for zoster than females, such as poor nutrition or lack of contact with children. Thirdly, 
the higher numbers amongst males may reflect undiagnosed or undisclosed HN infection in 
. homosexual men, a group in London with relatively high prevalence of HIV infection.284 
Inclusion of men with HN infection may influence estimates of the effect of specific 
exposures such as contact with children, and this is explored in the analyses of these exposures 
(Chapter 6). 
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Samples were not obtained from all cases, due to delays between rash onset and reporting 
and interviewing cases, rapid healing of vesicles from the widespread use of oral antivirals, 
and difficulties in carrying out PCR on scabs. The clinical case definition for 'probable' 
cases was designed to reflect the characteristic presentation of zoster and to exclude cases 
of herpes simplex virus (HSV) infection. Nevertheless, a small number of atypical HSV 
cases may have been included amongst probable cases, and a few zoster cases with very 
limited rash and pain may have been excluded.36,44 In addition, laboratory error in the 
diagnosis of confirmed cases cannot be excluded. In the case of recent ultraviolet radiation 
(UVR) exposure, inclusion ofHSV cases may have led to an overestimate of effect, as UVR 
is a known precipitant of HSV.348 This is discussed in the section on UVR analyses in 
Chapter 6. The HSV-DNA negative test results from 'unlikely' cases who had typical 
clinical HSV infection may have resulted from the use of a single set of HSV -primers with 
limited sensitivity. 
Participation by controls was also high (82.5%). Some bias may have been introduced if 
the minority who refused to participate or who could not be contacted were eligible for 
inclusion and had different patterns of the exposures of interest compared to participating 
controls. A small minority of controls were interviewed more than 90 days after cases. 
This was not a problem for most exposures, as questions referred to 'usual' exposure in the 
year before interview. However, controls may have forgotten some specific events that 
occurred around the time of rash onset in the case, due to the greater time that had elapsed 
when they were interviewed. This could result in an underestimate of putative protective 
effects such as contacts with cases of varicella, and an overestimate of risk factors such as 
stressful events. These and other issues such as potential recall bias are considered in the 
relevant sections of the next Chapter, and in Chapter 7. 
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6. ANALYSIS OF EXPOSURES 
This Chapter reports on the analyses of the effects of exposures on risk of zoster. It is 
divided into eight sections. The first five sections describe the analyses for each ofthe main 
groups of risk factors - contacts with children and varicella, ethnicity and country of birth, 
micronutrient intake, ultraviolet radiation exposure, and stress and illness. Each section 
includes a list of specific hypotheses that were te.sted, additional data categorisation or 
modelling strategies that were not detailed in Chapter 3, and results of univariable and 
multivariable analyses. The sixth and seventh section describe the effects of mechanical 
trauma and potential confounders on risk of zoster. The final section reports the results of 
the combined model, which contained selected variables from earlier analyses. 
The Tables relating to these analyses can be found on pages 153-193. 
6.1 CONTACTS WITH CHILDREN AND WITH CASES OF VARICELLA OR 
ZOSTER 
6.1.1 Specific hypotheses 
Two main hypotheses were tested: 
1. Contacts in the last ten years with cases of varicella' or zoster decreases the risk of zoster 
2. Contacts in the last ten years with children aged 1-10 years decreases the risk of zoster, 
through increased access to cases of varicella 
The data were also examined to investigate whether recent exposure (in the last year) to 
cases ofVZV or children increased the risk of zoster, as has been suggested by some studies 
(outlined in Chapter 2). 
6.1.2 Data categorisation 
Contacts with cases of varicella or zoster in the last ten years were categorised simply into 
. number of contacts, grouping categories to ensure that there were at least thirty contacts 
amongst controls in each category. Social exposures to children in the last ten years were 
categorised in stages. First, exposures were divided into three types of contact: 
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1. Contact with specific children living in the household 
2. Contact with specific children not living in the household (e.g. grandchildren and 
neighbours) 
3. Contact with a range of different children in groups with changing membership (e.g. at 
school playgrounds or parties). 
Secondly, the number of social contacts in each group was calculated by multiplying 
average frequency of contact (per week or per month) by duration of contact (in years) for 
each child contacted, and summing the results. Thirdly, the total number of contacts was 
categorised as 'none' and into two, three or five quantiles of exposure, based on the number 
of exposed controls and the distribution of exposure amongst them. 
Occupational exposure to children was identified from the job calendar. These occupations 
were divided into a further three types of contact: 
4. Contact with a few specific children through childcare (e.g. childminding, full-time 
parenting) 
5. Contact with multiple well children, (e.g. teachers) 
6. Contact with multiple ill children, (e.g. doctors) 
It was not possible to calculate the total number of occupational child contacts from the job 
calendar, and so duration of occupational exposure in the last ten years was used. This was 
categorised as 'none', 'up to 5 years' and 'more than 5 years'. 
These data were used to create three levels of exposure for use in a hierarchical model: 
Exposure to varicella cases or zoster cases 
Exposure to multiple children (2, 3, 5 and 6, above) 
Exposure to a few children (1 and 4, above) 
6.1.3 Modelling strategy 
A conceptual framework was used to explore the interrelationship of child and VZV 
(varicella or zoster) exposures in the last ten years and in the last year.349 Variables were 
classified as distal, intermediate or proximal, according to their position in the proposed 
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chain of causation (see Figure 6.1, below). In this framework, contacts with cases of 
varicella or zoster were assumed to have a direct effect on the risk of zoster, and were 
categorised as proximal variables. Social or occupational contacts with multiple children 
likely to result in varicella exposures were categorised as intermediate variables. Contacts 
with a few children living in the household or via childcare work were categorised as distal 
variables, because some of their effect might be mediated through contacts with a wider 
range of children outside the household (the intermediate variables). Distal variables were 
added first to the multivariable model, and retained as long as they remained significantly 
associated with zoster (p5;O·l). Intermediate variables were added second, to demonstrate 
the extent to which they explained the effect of distal variables, then proximal variables 
were added to determine whether they explained distal and intermediate factors. Variables 
excluded at the univariable or distal stages of analysis were added again at the proximal 
stage, to assess whether they became significantly associated with zoster in the presence of 
other variables. Potential confounders were added to the model as outlined in Chapter 3, 
and effect modification of contact variables by age was investigated. 
Figure 6.1: Conceptual framework for modelling the effect of contacts with children or with 
cases of varicella or zoster on the risk of zoster 
Type of variable 
Distal 
(few children) 
Intermediate 
(multiple children) 
Proximal 
(VZV contacts) 
Social contacts with children 
living in the household 1 
Social contacts with children not 
living in the housel,told: 
- specific children 
- groups of children 
Occupational contacts with few 
children via childcare 1 
/ 
Occupational contacts with: 
- many well children 
- many ill children 
····--.. i--·-·-·····-········-·- .... -.. ---.----.... -.------.--.---............. --.. ---.-i-·-·--·----------···--
Contacts with cases of varicella or zoster 
··········---·····i·························-····---· 
Risk of zoster 
1 Parents who stayed at home to look after their children full-time appear in both distal groups 
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6.1.4 Univariable analyses 
Contact with one or more case of either varicella or zoster in the last ten years was strongly 
associated with protection against zoster (OR= 0.52, 95% CI = (0.37-0.72) p=O.OOOl). 
When contact with varicella cases was considered as an ordered categorical variable, there 
was strong evidence of a dose-response effect (Table 6.1.1). Contact with zoster cases also 
demonstrated graded protection, but this was less str~ngly significant. 
Exposure to children in the last ten years was also associated with protection against zoster. 
Protection increased with longer duration of occupational exposure to multiple ill children 
or to a few children via childcare, and with greater numbers of social contacts with children 
in various settings (Table 6.1.2). However, there was no significant association between 
duration of occupational exposure to multiple well children in the last ten years and risk of 
zoster, even after analyses were restricted to individuals working in primary school or 
nursery settings (OR=0'94; 95% CI=0'47-1'87, p=O.861). Similar effects were obtained 
when lifetime occupational exposures in various settings were examined (data not shown). 
6.1.5 Multivariable analyses 
Exposures in the last ten years: Neither distal child contact variable remained significantly 
associated with risk of zoster after adjusting for the effects of intermediate social child 
contacts (Table 6.1.3 and Figure 6.1). Childcare and household contact variables were 
therefore dropped from the model. Intermediate social and occupational child contact 
variables remained significantly associated with protection against zoster in the 
intermediate model after adjusting for each other, with little change to the effect estimates 
(data not shown). However, the strength of associations decreased after adjusting for 
contact with known cases of varicella, remaining most strongly significant for contacts with 
children in groups (Table 6.1.4, column 3). 
Contact with varicella cases remained strongly associated with protection against zoster 
after adjusting for occupational and social child contacts (Table 6.1.4, column 3, bottom 
half). In contrast, contact with zoster cases was not significantly associated with zoster in 
. the final model. Ethnicity slightly confounded the effect of occupational exposure to ill 
children, and was added to all models. After adding ethnicity, other potential confounders 
(childhood residence in the tropics and socioeconomic variables) made minimal difference 
to effect estimates for the variables of interest. The effect of the contact variables did not 
vary with participants' age (p for interaction> 0.3 for all). 
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Study participants were not tested for human immunodeficiency virus (HIV) infection, and 
the effect of child contacts might be confounded by undiagnosed HIV infection in cases. 
Homosexual men in London are a group at high risk of HIV infection (increasing their 
chance of developing zoster), and may have relatively few child contacts. 11S,284 
Multivariable analyses were therefore repeated in two subgroups of individuals at low risk 
of HIV infection, 1) women and 2) all individuals aged more than sixty years. Statistical 
power was reduced, but protective trends associated with social and occupational child 
contacts were similar to those demonstrated in the whole dataset (Table 6.1.5, columns 3 
and 4). The effect of imperfect specificity of the 'probable' zoster case definition was also 
investigated by repeating analyses in the subset of 'confirmed' cases and their matched 
controls. Similar protective patterns were again demonstrated (Table 6.1.5, column 5). 
Exposures in the last year: Similar protective effects were found when the analysis was 
repeated for child and VZV contacts in the year before interview (data not shown). 
Household child contacts and childcare work in the last year were no longer significantly 
associated with zoster in intermediate models. Contacts with specific children living 
outside the household, with children in groups and with ill children were protective in 
intermediate models, and effects decreased after adjustment for varicella contacts in the last 
year. Contacts with children in groups remained most significantly associated with zoster 
in the final model (p=0.039); individuals with ;:::313 contacts in the last year had less than 
two-fifths the risk of zoster compared to those with no contacts (OR=0.37; 95% CI=O.l6-
0.86). Adjustment in this model for the effect of past child contact exposures was limited, 
as some of these were correlated with recent child exposure variables and could not be 
added to the model. However, recent varicella contacts were weakly associated with risk of 
zoster in the final model after adjustment for past varicella contacts (p=0.041); compared to 
individuals with no known varicella contacts in the last year, those with one contact were at 
increased risk of zoster (OR=1.97; 95% CI=1.03-3.79), and those with two or more contacts 
tended towards a decreased risk of zoster (OR=0.57; 95% CI: 0.23-1.42). Similar results 
were obtained from analyses of social contacts with children or with cases of varicella in the 
month before rash onset in the case (data not shown). 
The effect of social contacts in the last year with specific children living outside the 
. household varied significantly with age (p for interaction=0.014), with protection against 
zoster restricted to individuals aged less than 60 years (Table 6.1.6). Older individuals 
were in contact with fewer children compared to younger individuals but saw these few 
children more frequently, resulting in repeated contacts with the same children. This may 
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have resulted in fewer opportunities to meet children with varicella. The joint importance 
of contacting a range of different children and the frequency of these contacts was 
investigated by comparing the effect of frequency of contact (mean number of contacts per 
child in the last year) amongst individuals contacting few (1-3) or many (4-27) specific 
children living outside the household (Table 6.1.7). Results of adjusted analyses indicated 
that increasing frequency of child contact was protective against zoster only amongst 
individuals contacting at least four different children in the last year (p for 
interaction=0.073). 
6.1.6 Discussion 
The findings suggest that continued exogenous exposure to varicella is protective against 
zoster in latently-infected adults. This is consistent with the report by Gershon et al that 
leukaemic children were -significantly less likely to develop zoster if they had household 
exposure to varicella, and that many of the protected children developed increased VZV-
specific immunity, demonstrating exogenous boosting.108 The present analyses have also 
received subsequent support from a recently published study by Brisson et al. 35o This 
comprised an analysis of the 4th MSGP study, which for the first time collected data on the 
household composition of patients?3 Brisson et al found that patients who lived with a 
child were at significantly lower risk of developing zoster in the year of the study 
(RR=0.75, 95% CI=0.63-0.89), and estimated that the duration of protection associated with 
this exposure lasted on average for 20 years (95% CI=7-41 years). 
In this study, analyses using a hierarchical model building strategy demonstrate that living 
with children appears to protect against zoster largely by increasing access to a range of 
other children outside the household,' and that the protection afforded by contacts with 
multiple children appears to be largely explained by contacts with varicella cases. The 
latter conclusion is supported by analyses showing that protection against zoster is strongest 
where contacts are with children in groups of changing membership in occupational or 
social settings (increasing the likelihood of contacting a case of varicella), and that 
protection depends on both the number of different children contacted and the frequency of 
contact with them. 
Some protective effect of child contacts remained after adjustment for known varicella 
contacts. This may represent unrecognised or forgotten contacts with children with 
varicella, especially likely for social contacts with children in groups of changing 
membership. If this is so, the total protective effect of (known and unknown) varicella 
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contacts will be greater than that estimated in the final model, which represents only the 
effect of known varicella contacts independent of the effect of unknown contacts. 
Interestingly, occupational contact with multiple well children (e.g. teaching) was not 
protective against zoster. Possible reasons for this include: 
1. The nature of the contact: perhaps varicella contacts are more distant in these settings 
compared to social settings, or are more limited in duration if children with varicella are 
absent from school whilst experiencing rash. 
2. Unmeasured differences in occupational contact between cases and controls: there was 
some evidence that amongst the 40 individuals who had worked in primary school or 
nursery settings in the last ten years, cases may have had less frequent contacts with 
children compared with controls. Ten of the 13 cases either did not work regularly in 
the classroom (for example, working as a handyman), or had relatively little time with 
children (for example, violin teachers working one day a week or Heads of Department 
with limited classroom teaching), compared to 10 of 27 controls. 
3. Negative confounding: any protective effect of occupational exposures with well 
children may have been masked by a strong confounder, such as recent stressful events. 
This is discussed further in Section 6.8, later in this Chapter. 
Contact with zoster cases was not associated with pr?tection against zoster. This is not 
surprising, as zoster is less infectious than varicella and most reported zoster contacts had rash 
on non-exposed areas ofthe body. 
The independent effect of recent varicella exposure on the risk of zoster is less clear. Child 
contacts in the last year were similarly' protective, but it was not possible to control for the 
effect of all past child contacts, so some recent protection may be due to past exposures. 
Interestingly, a single contact with a varicella case in the last year was weakly associated with 
an increased risk of zoster, although this was not seen with multiple contacts. It is likely that 
this is not a real effect, but was due to recall bias on the part of cases. Many individuals with 
zoster in the study believed that zoster resulted from contact with cases of varicella or zoster, 
and had spent time trying to remember any contacts that might have 'infected' them. 
Ethnicity is a potential confounder of the effect of child contacts on risk of zoster, as some 
ethnic groups may be at lower risk of zoster and have greater contacts with children via 
extended families. so However, neither ethnicity nor country of residence in childhood 
accounted for the protective effect of child contacts in this study. Secondly, subgroup analyses 
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indicated that the protective effect of child contacts was unlikely to result from undetermined 
HIV infection or misdiagnosis of zoster cases. 
Reverse causality is also unlikely to explain the findings. Firstly, the majority of cases were 
interviewed within two weeks of rash onset. Secondly, the number of child contacts was 
calculated using the average frequency before onset of rash, not the frequency in the last few 
days. For example, a case who saw her grandchild ~n average once a week in the last year 
would be assigned 52 child contacts, even if she had not seen the child since onset of rash. In 
contrast, recall bias (as outlined above) may have led to underestimation of the protective 
effects of child and varicella contacts, because cases may have been more likely to have 
remembered recent contacts compared with controls. Potential bias introduced by selective 
reporting of cases by practice or participation bias amongst controls is discussed in the next 
Chapter. 
These analyses were presented at the Conference of the International Epidemiological 
Association (Oxford, September 2001), and at the 7th Meeting of the European Working 
Group on Varicella (Warsaw, November 2002). The findings have subsequently been 
published in the LancerSl (see Appendix 8). 
6.2 ETHNICITY AND COUNTRY OF BIRTH 
6.2.1 Specific hypotheses 
The primary hypothesis was that ethnicity is related to risk of zoster, with individuals of Afro-
Caribbean or Asian ethnicity at lowe,r risk of zoster compared to individuals of other 
ethnicities. Secondary hypotheses comprised three possible explanations for any protection 
associated with ethnicity, namely that: 
1. Individuals of Afro-Caribbean or Asian ethnicity have reduced exposure to varicella in 
the first ten years oflife due to childhood residence in a 'late-varicella' country, and are 
more likely to acquire varicella in adolescence or adulthood. Therefore, they have a 
shorter duration of latent VZV infection compared to age-matched individuals who 
spent their childhood in 'early-varicella' countries. Shorter duration of latent infection 
may be associated with higher levels of VZV -specific immunity and thus lower risk of 
VZV reactivation as zoster. 
86 
2. Individuals of Afro-Caribbean or Asian ethnicity experience frequent exogenous 
boosting of VZV -specific immunity, due to multiple contacts with children in extended 
families. 
3. Any protection associated with ethnicity is due to confounding by other protective 
factors against zoster, such as micronutrient intake. 
6.2.2 Data categorisation 
Ethnicity was categorised into four main groups - White, Afro-Caribbean, Asian and Other 
(mostly individuals from the Middle East and of mixed-race). For all individuals, residence 
in childhood was derived from the residence calendars for the ages 1-10 years, which are 
the ages at maximum risk for acquiring varicella in temperate countries. Residence was 
categorised first as a binary variable, in two ways: 
1. 'Tropical' or 'non-tropical': a tropical residence was defined as lying at ~25° latitude 
North or South. 
2. Early-varicella (EV) or late-varicella (LV) residences: LV residences included those 
within the Caribbean region, South India, Sri Lanka or South East Asia (see Chapter 2, 
Section 2.3.3.1). 
Childhood residence in an LV country was hypothesised, to represent reduced risk of acquiring 
varicella in childhood. However, some participants spent only a small proportion of their early 
childhood in LV countries and then returned to EV countries to attend primary school. As 
heaviest exposure to cases of varicella was likely to occur at primary school, the duration and 
timing of childhood residence in LV countries had to be taken into account. Therefore, 
individuals were divided into three groups: 
1. Childhood residence solely in an EV or non-tropical country 
2. Childhood residence in an LV or tropical country - mostly before primary school age 
3. Childhood residence in an LV or tropical country - for most or all of primary schooling 
(with ~4 years between the ages of5-10 years) 
. Age at varicella was categorised into four age groups that reflected differing known or 
hypothesised risks of zoster - 1-10 years (baseline), less than one year old (identified in 
previous research as a risk factor for zoster),17,101 and 11-20 years and greater than 20 years 
(both hypothesised to be associated with lower risk of zoster). Duration of latent VZV 
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infection was derived from age at varicella and current age, and was expressed as number of 
years since varicella. When creating this variable, individuals who had a history of 
varicella at unknown age were assumed to have acquired varicella in childhood between I-
10 years of age. 
6.2.3 Modelling strategy 
A hierarchical approach was used to investigate the interrelationship of ethnicity, country of 
childhood residence and duration of latent VZV infection. This conceptual framework is 
outlined in Figure 6.2. Ethnicity was categorised as a distal variable, childhood country of 
residence as an intermediate variable, and duration of latent VZV infection as a proximal 
variable. Ethnicity was added first to the model. Country of residence in childhood was added 
second, to explore the extent to which it explained the effect of ethnicity. Duration of latency 
was added last, to estimate the extent to which this putative direct factor explained distal and 
intermediate factors. 
Figure 6.2: Conceptual framework for modelling the effects of ethnicity, country of 
childhood and age at varicella on risk of zoster 
Type of variable 
Distal 
Intermediate 
Proximal 
Ethnicity 
I Country of childhood 
No. of years since varicella 
(duration of latent VZV infection) 
Risk of zoster 
The hypothesised mediation of the effect of ethnicity through increased social child contacts 
and the confounding effects of other variables were examined later, in the combined model 
(described in Section 6.8, below). 
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6.2.4 Univariable analyses 
Results of univariable analyses are summarised in Table 6.2.1. There was no overall 
significant association between risk of zoster and ethnicity. However, individuals of Afro-
Caribbean ethnicity were at significantly lower risk of zoster compared to white participants 
(p=0.039). 
In all, 61 individuals spent at least part of their childhood in a tropical country, and 47 
individuals spent part or all of their childhood in an LV country - seven (1 %) White, 30 
(60%) Afro-Caribbean, six (38%) Asian and four (21 %) participants of 'Other' ethnicity. 
Of these 47 individuals, 38 spent their entire childhood in the LV country and two spent 
their primary school years there. The remaining seven individuals had shorter duration of 
childhood residence, five leaving before attending primary school (after 1.5-3.2 years of 
residence), one living in India from birth until aged 6.2 years, and one living in Singapore 
between the ages of 4.5 and 6 years. There was no significant association between risk of 
zoster and duration of residence in childhood either in a LV country or in a tropical country 
(Table 6.2.1). Similar results were obtained when residence in an LV or tropical country 
was recoded as a binary variable, with the intermediate category grouped either with the 
baseline or with the third category. Effect estimates were also similar when LV countries 
were restricted to those with strongest evidence of late-onset varicella (the Caribbean 
region, South India and Sri Lanka, data not shown). 
Sixty-five percent of participants remembered having varicella in the past. A history of 
varicella was significantly associated with protection against zoster (OR=0.68, 95% 
CI=0.48-0.98, p=0.037).. Age at varicella was weakly associated with risk of zoster -
individuals who acquired varicella before the age of one year were at a non-significantly 
increased risk of zoster, and those who acquired varicella after ten years of age were at non-
significantly lower risk (Table 6.2.1). After re-categorising individuals who had varicella 
at unknown age as having acquired varicella between the ages of 1-10 years, there was 
evidence that shorter duration of latent VZV infection (fewer years since varicella) was 
associated with protection against zoster. This graded protection was demonstrated more 
clearly after individuals with no history of varicella were excluded (Table 6.2.1, last 
. column). 
The associations between ethnicity, country of childhood, and age at varicella were also 
examined amongst controls, to see whether the hypothesised relationships between the 
variables existed in the population from which the cases arose. A history of varicella was 
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not significantly higher amongst White controls compared to Afro-Caribbean controls 
(68.4% vs. 57.5%, p=0.153). Similarly, there were no significant differences between 
White and Afro-Caribbean controls in age at varicella (p=0.751). However, 86.6% of 
controls (of any ethnicity) who attended primary school mostly or entirely in an EV country 
acquired varicella before the age of ten years, compared to 64.3% of controls who attended 
primary school in an LV country (p=0.02). 
6.2.5 Multivariable analyses 
After adding LV residence in childhood to the model, the effect of Afro-Caribbean ethnicity 
was slightly more protective and the effect of Asian ethnicity was reduced by about 10% 
(data not shown). However, childhood residence was not retained in the model, because it 
was not significantly associated with risk of zoster on univariable or multivariable analyses 
(p>0.2), was strongly correlated with ethnicity (r=0.439), and resulted in marked increase in 
standard errors of the effect estimates. Similar results were obtained when tropical 
residence in childhood was used instead of LV residence. The importance of country of 
childhood as a factor on the causal pathway between Afro-Caribbean ethnicity and zoster 
was further examined by restricting analyses to the 682 people who spent their childhood in 
the UK or another EV country. The effect of Afro-Caribbean ethnicity in this reduced 
dataset was very similar to the overall effect estimate (OR=0.40, 95%CI=0.13-1.29). 
Adding the duration of latent VZV infection as a proximal variable to the model increased 
the risk associated with Asian ethnicity, but had little effect on other estimates (Table 
6.2.2). Afro-Caribbean ethnicity and recent acquisition of varicella remained significantly 
associated with protection against zoster in the proximal model. Analyses were repeated 
after restricting data to cases and matched controls with a history of varicella (n=353); 
similar results were obtained (Table 6.2.3). Results were also similar when ethnicity was 
recoded as a binary variable (Afro-Caribbean and other, data not shown) 
There was no evidence that the effect of ethnicity or time since varicella varied with age 
(p>0.3 for both, data not shown) . 
. 6.2.6 Discussion 
In this study population, individuals of Afro-Caribbean ethnicity were at lower risk of zoster 
compared to individuals of White ethnicity, but Asian ethnicity was not significantly 
associated with risk of zoster. A higher proportion of Afro-Caribbean participants spent their 
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childhood in an LV country compared to Asian participants (60% vs. 38%), but childhood 
residence did not appear to explain the protection associated with Afro-Caribbean ethnicity. 
Categorisation of childhood residence as an LV location was imperfect, as data on average age 
at varicella is scarce for many regions, and might vary within countries due to factors such as 
rural or urban residence and social mixing patterns (as outlined in Chapter 2, Section 2.3.3.l) . 
However, the results of the proximal model suggest that the protective effect of Afro-
Caribbean ethnicity was not mediated through late acq~isition of varicella (see Table 6.2.2). 
Duration of latent VZV infection (number of years since varicella) remained significantly 
associated with zoster in the proximal model. This supports the hypothesis that waning of 
VZV -specific immunity with increasing time since varicella predisposes to zoster. The effect 
of duration of latent VZV infection might be expected to vary with current age, with a weaker 
effect seen amongst younger individuals. The lack of demonstrable effect modification may 
have been because there were only a few younger individuals with long latency and older 
individuals with short latency. The suggestion of an increased risk of zoster amongst 
individuals who acquired varicella in the first year of life is consistent with previous reports, 
although numbers were very small and the result did not reach statistical significance. 17,101 
Many participants (including a number of confirmed cases) had no recall of past varicella. As 
more than 80% of these individuals were over 50 years old, this may simply be due to the 
length of time since varicella occurred, as has been demonstrated elsewhere.352 One concern 
with this is that if some controls had not experienced varicella, they would not be at risk of 
zoster. However, a lack of varicella history was associated with an increased risk of zoster. 
Some cases may have unknowingly acquired varicella in utero or in infancy, increasing their 
risk of zoster. 17,101,102 Alternatively, some cases may have experienced very mild or subclinical 
varicella and so developed lower levels of protective immunity. The findings suggest that 
controls without a history of varicella probably acquired varicella in the past, and were at risk 
of developing zoster. Lack of varicella did not explain the effect of Afro-Caribbean ethnicity, 
which remained protective against zoster amongst individuals with a positive varicella history. 
Some individuals could not remember the age at which they developed varicella. The 
assumption that these individuals probably acquired varicella between the ages of 1-10 years is 
. reasonable, but may have led to some misclassification of age at varicella. If this occurred, the 
magnitude of protection associated with delayed varicella or the increased risk associated with 
very early varicella may have been underestimated. 
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The number of non-White participants was relatively small, and the estimates of the effect of 
ethnicity had wide 95% confidence intervals. Low numbers probably resulted partly from 
exclusion of individuals from sub-Saharan Africa, and from the fact that many individuals 
from ethnic minorities in South London are relatively young. This is unlikely to have 
introduced bias, as controls were matched to cases by age, but there were relatively few non-
White individuals in the predominantly older cases and controls. Bias could have been 
introduced if general practitioners were less likely t? report individuals of Afro-Caribbean 
ethnicity under the mistaken belief that they were African. However, general practitioners 
were not required to apply ethnic exclusion criteria, and were requested to report all cases. 
More African cases were reported than Afro-Caribbean cases (18 versus 10 adult cases). 
The analysis demonstrates that duration of latent VZV infection is a determinant of zoster, but 
it does not explain the protection associated with Afro-Caribbean ethnicity in this population. 
Other proximal determinants of the effect of Afro-Caribbean ethnicity were examined in the 
combined model. As discussed later in this Chapter, much of the protective effect was 
explained by increased social and occupational child contacts, and the remaining effect 
disappeared after controlling for other factors. 
6.3 FOOD INTAKE, MICRONUTRIENT INTAKE AND ANTHROPOMETRY 
6.3.1 Specific hypotheses 
The primary hypotheses were that: 
1. Low daily intakes of specific micronutrients in the year before interview or in the two 
months before rash onset increase'the risk of zoster. These micronutrients are vitamin 
A (as retinol equivalents), vitamins C, E and B6, folic acid, iron and zinc. 
2. Low intakes of foods rich in the micronutrients of interest increase the risk of zoster 
The secondary hypotheses were that: 
1, Individuals with illnesses associated with deficiency of any of the micronutrients of 
interest are at increased risk of zoster 
2. Low body mass index (or mindex or demiquet as alternative measures of body mass 
index) increases the risk of zoster 
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6.3.2 Data conversion and categorisation 
Individual micronutrient intake: food frequency data were first converted into energy-
adjusted daily intakes of each of the micronutrients of interest, as outlined in Chapter 4 
(Section 4.2). Daily intakes were calculated for two time periods: 
1. Daily intake in the last year 
2. Daily intake in the two months before rash onset in the case. 
In this way, the effects of longer-term and recent dietary intake were assessed. 
Micronutrient intake derived from a) foods and b) from foods and dietary supplements 
combined were considered separately, to examine both the effects of usual diet and of total 
micronutrient intake. Energy-adjusted intakes were categorised into quintiles of intake, 
based on the distribution amongst controls. 
Combined micronutrient intake: two new micronutrient variables were created to investigate 
the effects of combined micronutrient intake on the risk of zoster: 
1. Total micronutrient score: for each of the seven micronutrients, quintiles of intake were 
given a score from 1 (lowest level) to 5 (highest level). Individuals' total micronutrient 
scores (with values lying between 7 and 35) were obtained by summing their scores for 
each micronutrient. The total scores were then re:'categorised into quintiles of scores, 
with similar numbers of controls in each group. Individuals with high or low scores 
mostly had high or low intakes of all seven micronutrients of interest. However, 
relatively high scores were also found amongst individuals who had very high levels of 
one or two micronutrients but lower levels of others. Therefore, a second variable was 
created that reflected high micronutrient intakes over the range of micronutrients of 
interest, and not an unbalanced intake. 
2. Number of micronutrients at the highest intake level: for each micronutrient, intake was 
scored as '1' for the highest quintile of intake and '0' for lower intakes. An individual's 
score was the number of micro nutrients at the highest quintile of intake (with values of 0-
7). For this variable, all individuals with high scores had relatively high intakes of most 
of the micronutrients of interest. 
Intake of micronutrient-rich foods: fruit and vegetables were chosen to represent foods rich in 
the micronutrients of interest, as many of these contain relatively high quantities of vitamin 
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C, vitamin A (as carotenoids), folic acid and (for some vegetables) iron.336,338 Overall 
frequency of consumption of fruit or vegetables was calculated by summing frequencies of 
individual fruit and vegetable items reported in the food frequency questionnaire. The types 
of fruit or vegetables considered in these analyses were progressively restricted to those fruits 
or vegetables with higher levels of the micronutrients of interest; as follows: 
1. Fresh, frozen or tinned fruit or vegetables (of all colours) 
2. Fresh or frozen fruit or vegetables (of all colours) 
3. Green, yellow or orange/red vegetables - these often contain particularly high levels of 
vitamin C, folic acid and carotenoids.338 
For each fruit or vegetable variable, intake was categorised into five groups. The lowest 
intake was pre-defined as less than one portion a week for fruit intake, and less than one 
portion a day for vegetable intake or fruit and vegetable intake combined. Cut-off points for 
higher intakes were based where possible on approximately equal numbers of controls in 
each group. 
Underlying illnesses: a new variable was created, comprising individuals with illnesses or 
conditions resulting in decreased micronutrient availability and/or increased requirement, as 
these individuals might have a deficiency of one or more of the micronutrients of interest. In this 
population, such conditions included eating disorders, ,dysphagia with food regurgitation, 
ulcerative colitis, pregnancy, and epilepsy treated with phenytoin (which can result in folate 
deficiency).353 Individuals who had been diagnosed as having iron- or folate-deficiency anaemia 
were also included in this category. A second variable was generated, comprising individuals 
who had been prescribed one or more of the seven micronutrients. 
Anthropometric indices: body mass index was categorised into the same four groups that were 
used in the second National Diet and Nutritional Survey:342 1) 'Underweight' (20 or less), 2) 
'Average' (over 20 to 25), 3) 'Overweight' (over 25 to 30), and 4) 'Obese' (over 30). Other 
anthropometric measures were divided into quintiles of values, based on the distribution 
amongst controls, with the second lowest quintile taken as the baseline. 
6.3.3 Analytical and modelling strategy 
The effect of micronutrient intake from food was examined firstly in all individuals, and then 
restricted to individuals who were not taking micronutrient supplements. This was done to 
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ensure that any effect of food intake was not being overwhelmed by supplement intake. The 
effect of total micronutrient intake (from foods and supplements combined) was then 
examined. This was potentially confounded by illnesses or conditions associated with 
micronutrient deficiency, because 1) individuals with these conditions were potentially at 
higher risk of zoster and 2) some of these individuals had high micronutrient intakes from 
prescribed vitamins or minerals. Therefore, analyses of total micronutrient intake were carried 
out first on all individuals, and then repeated after excluding individuals who had underlying 
illnesses that could modify micronutrient availability or who had been prescribed one or more 
of the seven micronutrients under investigation. 
A hierarchical approach was used to explore the interrelationship of the effects of fruit or 
vegetable intake and food intake of the commonest micronutrients found in fruit and/or 
vegetables - vitamin C, vitamin A or folic acid (Figure 6.3, below). Fruit and vegetable intake 
were categorised as distal variables, and vitamin C, vitamin A and folic acid intake were 
categorised as proximal variables. Fruit or vegetable intake was added first to the model. 
Micronutrient intakes were then added to explore the extent to which the effect of fruit or 
vegetable intake was mediated via micronutrient intake. The effect of fruit and vegetable 
intake was also adjusted at this stage for potential confounders including ethnicity, smoking, 
alcohol and energy intake, house tenure, car ownership, illnesses associated with micronutrient 
deficiency and intake of non-prescribed supplements containing the micronutrients of interest. 
Combined micronutrient variables (described above) wer~ used in preference to exploring 
multiple interactions between pairs of micronutrients. Effect modification by age was 
considered for each micronutrient, for combined micronutrient scores and for fruit and 
vegetable intake. 
Figure 6.3: Conceptualframeworkfor modelling the effects offruit and vegetable intake 
and intake of vitamin C, vitamin A andfolic acid on risk of zoster 
Tvpe of variable 
Distal I Fruit intake Vegetable intake 
~ 
'-- "" -------------~~------------
Proximal I Vitamin A intake II Vitamin C intake r--F-ol-ic-a-cl-'d-in-ta-k-e' 
Risk of zoster 
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6.3.4 Univariable analyses 
Intakes in the last year: the effects of energy-adjusted daily intake from foods of each 
micronutrient on the risk of zoster are summarised in Table 6.3.1. No significant 
associations were found, except for a significant trend of increasing risk associated with 
decreasing vitamin C intake. 
A total of 283 individuals were taking non-prescribed s!lPplements containing one or more 
of the seven micronutrients of interest. These individuals were at similar risk of zoster 
compared to non-supplement takers (OR=O.93, 95% CI=O.67-1.30, p=O.671). Analyses of 
intake from foods were repeated in the smaller dataset (n=306) of matched sets of 
individuals who had not taken micronutrient supplements. The significant trend associated 
with vitamin C intake was not evident in this smaller group (p for trend=O.909), and no 
other significant associations were found (data not shown). 
When total intake from both foods and dietary supplements was examined, the effect of 
total vitamin C was weaker than that of intake from diet alone, with poor evidence of a dose 
response effect. (p for trend=O.160, data not shown). None of the other total micronutrient 
intakes was significantly associated with risk of zoster. This analysis included data from 24 
individuals (10 cases and 14 controls) with illnesses or conditions associated with 
micronutrient deficiency. These individuals were at approximately three times the risk of 
zoster compared to the rest ofthe study population (OR=3)8, 95% CI=1.32-7.65,p=O.008), 
and the majority (16/24) had been prescribed one or more of the micronutrients of interest. 
One other individual who did not report a history of iron-deficiency anaemia had also been 
prescribed maintenance doses of iron sulphate (200mg/day). The 17 individuals who had 
been prescribed micronutrients were at about four times the risk of zoster compared to 
individuals who were not taking prescribed supplements (OR=4.l3, 95%CI=1.43-11.98, 
p=O.006). The effect of intake from diet and supplements combined was reconsidered after 
excluding the 25 individuals with these illnesses andlor prescribed micronutrients. 
Amongst the remaining 227 matched sets with at least one case and one control (n=671), no 
significant associations were found (Table 6.3.2). Low vitamin E intake was weakly 
associated with risk of zoster (p=O.055), although there was no clear pattern of risk. 
Neither total micronutrient score nor the number of micronutrients at the highest intake 
level were associated with risk of zoster when scores were derived from a) foods or b) foods 
and supplements combined (Table 6.3.3). This lack of association persisted after excluding 
from analyses of food intakes those individuals taking supplements, and after excluding 
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from analyses of food and supplement intakes those individuals with illnesses associated 
with micronutrient deficiency (data not shown). 
The effects of intakes of fresh fruit and fresh or frozen vegetables on risk of zoster are 
summarised in Table 6.3.4. Low combined fruit and vegetable intake was associated with a 
strong graded increased risk of zoster; individuals taking one or less portion a day of fruit or 
vegetables were at nearly three times the risk of zoster compared to individuals taking at 
least eight portions a day. This increased risk remai~ed when fruit and vegetable intake 
were considered separately. The effect estimates were higher when intake of green, red or 
yellow vegetables (vegetables rich in the micronutrients of interest) was analysed, although 
the 95% confidence intervals were wide. Effects were similar when tinned fruit and 
vegetables were included in the analyses (data not shown). 
In order to clarify whether the lower frequency of fruit and vegetable intake amongst cases 
was specific for these foods·· or whether cases generally reported lower frequency of food 
consumption, analyses were repeated for other food groups. For example, there was no 
association between frequency of consumption of potatoes (which were not classified as 
vegetables in the FFQ) and risk of zoster (p=0.705, data not shown). 
Intake in the two months before rash onset: the effects on the risk of zoster of 1) daily 
energy-adjusted intake of each micronutrient from foods 2) intake from foods and 
supplements combined and 3) combined micronutrient int~ke were all similar to the effects 
of intakes in the last year (Table 6.3.5-6.3.7). The effects of fruit and vegetable intakes in 
the two months before rash onset were mostly slightly weaker compared to the effects of 
intakes in the last year (Table 6.3.8). 
Anthropometric indices: 17 individuals were not included in analyses because they could 
not stand safely on the weighing scales (12), refused to be weighed (2) or (for one case and 
two controls) because they were pregnant. Among the 240 matched sets with data for at 
least one case and one control (n=677 individuals), there was no evidence that being 
underweight (BMI:::;20) was associated with an increased risk of zoster (Table 6.3.9). 
Similarly, there was no increased risk of zoster amongst individuals with the lowest 
quintiles of mindex or demiquet measurements. 
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6.3.5 Multivariable analyses 
Table 6.3.10 summarises the results of the hierarchical models used to explore whether the 
effect of fruit and vegetable intake in the last year was explained by vitamin C intake in 
foods. Effect estimates for combined fruit and vegetable intake and for fruit intake alone 
were little altered after adjusting for vitamin C intake (Table 6.3.10, column 3). The effect 
estimates for vegetable intake were slightly diminished, but a significant dose-response 
effect remained. The effect estimates for the fruit ,and vegetable variables were also 
unaffected after adjusting for vitamin A intake or for folate intake (data not shown). In 
contrast, the increasing risk on univariable analysis associated with lower vitamin C intakes 
from food disappeared after controlling for fruit and/or vegetable intake, particularly after 
controlling for fruit intake (Table 6.3.11). 
Smoking negatively confounded the effect of fresh fruit intake but not the other variables 
(Table 6.3.10, final column). The effect of fruit and/or vegetable intake was not 
confounded by ethnicity, house tenure, car ownership, alcohol or total energy intake, body 
mass index, illnesses associated with micronutrient deficiency or intake of non-prescribed 
supplements containing the micronutrients of interest. Analysis of fruit, vegetable and 
vitamin C intake in the two months before rash showed similar results (data not shown). 
Effect modification by age: there was little evidence that age modified the effect of fruit or 
vegetable intake in the last year, or fruit intake in the two months before rash (p for 
interaction all >0.2, data not shown). However, there was some evidence that the protective 
effect of vegetable intake in the two months before rash was restricted to individuals aged 
60 years or older (Table 6.3.12). There was also evidence amongst older individuals of an 
effect associated with combined micronutrient intake in the last year - there was a 
significant trend towards increasing zoster risk with decreasing total micronutrient scores 
derived from food intakes (p for interaction=0.004), and a similar trend with decreasing 
number of micronutrients at the highest level of intake (p for interaction=0.0007, Table 
6.3.13). These effects in older individuals were not confounded by ethnicity, smoking, 
house tenure, car ownership, alcohol intake, micronutrient supplement intake or illnesses 
associated with micronutrient deficiency. Results were similar when analyses were 
restricted to individuals who were not taking micronutrient supplements, but were less 
strong when combined micronutrient variables were derived from both food and supplement 
intake (data not shown). Similar effect modification was seen for combined micronutrient 
intake in the two months before rash onset (data not shown). 
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6.3.6 Discussion 
In this population, low intakes of fruit and vegetables were associated with increased risk of 
zoster, with a strong dose response effect. Effect estimates were higher for intake of green, 
red or yellow vegetables than for intake of all vegetables, consistent with the hypothesis that 
high intakes of vitamin C, carotenoids and folic acid may protect against zoster by maintaining 
functional cell-mediated immunity. As discussed in Chapter 2, a number of studies have 
shown that supplementation with these nutrients can hav~ a beneficial effect on cell mediated 
immunity in the elderly. However, none of the individual micronutrient intakes in this study 
was associated with risk of zoster except dietary vitamin C. This micronutrient is mostly 
obtained from fruit and vegetables, and plasma vitamin C levels have been shown to be more 
strongly related to fruit and vegetable consumption compared to other antioxidants.354 Results 
of the hierarchical analysis suggest that the effect of vitamin C intake was simply a marker for 
fruit and vegetable intake, and not a step on the causal pathway. Nevertheless, low combined 
micronutrient intake was associated with increased risk of zoster in older individuals, and 
people with illnesses associated with micronutrient deficiency and/or taking prescribed 
micronutrients were at significantly higher risk of zoster. How can these findings be 
reconciled? 
Firstly, both frequency of fruit/vegetable intake and intake of individual micronutrients may 
have been estimated inaccurately, but to different degrees. Possible sources of inaccuracy 
include the following: 
Frequency of food consumption: non-differential misclassification of frequency of 
consumption could have led to underestimates of both fruit/vegetable consumption and 
micronutrient intake. Recall bias amongst cases in underreporting fruit/vegetable consumption 
but not other food items could have resulted in a stronger effect of fruit/vegetable consumption 
compared to overall micronutrient intake. However, there was no indication that cases 
believed that eating fruit and vegetables protected against zoster. 
Portion size: in the analysis it was assumed that individuals of the same age and sex ate similar 
portion sizes of each food. This was likely for most fruits and for a few other food items, 
where portions were easily defined as 'pieces'. However, 'medium portions' of vegetables and 
most other foods may have varied between individuals. This may have affected estimates in 
various ways. For example, if cases ate smaller portions of a range of foods compared to 
controls, this could have overestimated their dietary micronutrient intake (calculated using 
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falsely high portion sizes), leading to an underestimate of the effect of micronutrient intake on 
risk of zoster. 
Food item chosen/or each FFQ item: a single food item was chosen to represent each broadly 
characterised FFQ item in each age/sex group, as described in Chapter 4 (Section 4.2.3). The 
choice for fruit and most vegetables was narrow, as fruit and vegetable FFQ items mostly 
comprised a small number of specific foods. However, other FFQ items often contained a 
wide range of foods. For example, McCance and Widdo~son lists only one food for the FFQ 
item 'Fresh Bananas', but 91 food items that could be included under 'Beef.334,336 For FFQ 
items comprising a range of foods, the single food chosen to represent the item may have had a 
different micronutrient content to the foods actually consumed by some participants, resulting 
in inaccuracies in their estimated micronutrient intake. 
Nutrient database information: the nutrient content of specific foods is not constant, but may 
vary according to breed or tYPe, farming practices, changes made by manufacturers, storage, 
duration of cooking, etc. Nutrient databases provide average nutrient content of foods, which 
may differ from actual content in some cases. 
The FFQ was not used to obtain absolute values of micronutrients in the diet, but to rank 
individuals' intake. Nevertheless, the sources of variation described above may have led to 
some misclassification of ranking of micronutrient intake, and this may have been greater than 
misclassification of frequency of fruit and vegetable consumption. 
Secondly, fruit and vegetables contain a complex mixture of nutrients, which may act together 
to maintain immune health. In this study, many of the cases with low fruit and/or vegetable 
intake ate relatively large amounts of foods such as meats and potatoes, increasing their intake 
of single micronutrients from other food sources. It may be that these micronutrients acting 
alone have relatively weak effects on the risk of zoster. High combined intake of 
micronutrients was associated with lower risk of zoster, although this was only demonstrated 
amongst older individuals. It is plausible that combined micronutrients protect against the 
gradual decline in cell-mediated immunity that occurs with ageing, but have less impact 
amongst younger individuals with generally robust immune systems. However, no effect 
modification of fruit or vegetable intake by age was demonstrated, except for the effect of 
vegetable intake in the two months before rash onset. Perhaps the mixture of nutrients in fruit 
and vegetables is not fully represented by the combined micronutrient variables used in the 
analyses, and includes substances whose effects on the immune system (of both younger and 
older individuals) have not yet been appreciated. 
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Thirdly, the apparent protective effect of fruit and vegetable intake may be due to residual 
confounding by other variables that affect cell-mediated immunity. A number of confounders 
were taken into account in the analysis, including ethnicity, smoking, alcohol intake and 
underlying illness. The effects of fruit and vegetable intake also remained after adjustments for 
other factors in the final model, described later in this Chapter. However, misclassification of 
some of these confounders or the presence of other unidentified lifestyle or other risk factors for 
poor immune health may have contributed to some of the apparent effect of fruit and vegetables. 
In the UK Government's Health Survey for England (I;ISE) 2001, low fruit and vegetable 
consumption was strongly associated with low household income, but it is unclear what 
proximal determinants of zoster this could represent.355 Other determinants of low fruit and 
vegetable consumption in the HSE survey (cigarette smoking, age, sex, alcohol consumption, 
children living in the household, and body mass index) were either adjusted for in the present 
analysis or did not confound fruit consumption. One variable that might provide an alternative 
explanation for the effect of fruit intake is physical activity, as moderate exercise can be 
associated with both heightened immune functioning and with fruit intake. 356 
It is interesting that total micronutrient intake (including supplements) had less effect on 
risk of zoster than intake from diet alone, even after controlling for the effect of illnesses 
associated with micronutrient deficiencies. Perhaps some of the individuals taking 
micronutrients did so to compensate for poor diet or for feeling unwell, and had 
undiagnosed micronutrient deficiencies associated with poor immune function. The effect 
of fruit and vegetable intake in the two months before rash onset in the case was also less 
strong than intake in the year before interview. This suggests that longer-term dietary 
habits have a stronger effect on cell-mediated immunity compared to recent diet. 
Alternatively, the weaker effect may have been due to the delay between interviewing cases 
and controls in some matched sets. Individuals were asked about usual and seasonal diet 
without asking them about a specific time period, and intake in the two months before rash 
onset was calculated subsequently. Nevertheless, the period of interest was immediately 
before interview for cases, but was sometimes much earlier for controls. This could have 
led to differential misclassification of fruit and vegetable intake. 
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6.4 EXPOSURE TO ULTRAVIOLET RADIATION 
6.4.1 Specific hypotheses 
The analyses in this thesis focus on the effects of recent ultraviolet radiation (UVR) 
exposures, and UVR exposures in childhood (which might 'programme' the developing 
immune system). The primary hypotheses were that: 
1. Individuals with high cumulative UVR exposure from sunlight in childhood or in the last 
year are at increased risk of zoster. 
2. Individuals with high intensity of UVR exposure from sunlight in childhood or in the last 
year are at increased risk of zoster 
3. Individuals with high intermittency of UVR exposure from sunlight in childhood or in the 
last year are at increased risk of zoster. 
The three different patterns of UVR exposure (cumulative exposure, intensity of exposure 
and intermittency of exposure) are discussed in Section 6.4.2, below. 
The secondary hypotheses were that: 
1. The effects of UVR exposures on risk of zoster may be greater in individuals with a 
propensity to bum and/or an inability to tan compared to other individuals. 
2. Hats and protective clothing protect individuals from the effects ofUVR exposures. 
3. Use of sunbeds and/or medical UVR exposures in childhood or in the last year increase 
the risk of zoster 
6.4.2 Patterns of UVR exposure, data conversion and categorisation 
As outlined in Chapter 2, studies ofthe effects ofUVR exposure on the human immune system 
have mostly focused on the effects of short-term UVR exposure of varying dosage. Daily 
doses in these studies ranged from less than 1 MED to 4 MED, often administered as a short, 
intense exposure (see Table 2.2). Studies have established cumulative (total) UVR exposure 
as a risk factor for skin cancer, and this was therefore considered in this study as a potential 
risk factor for zoster. However, cumulative UVR dosage does not necessarily reflect intensity 
of UVR exposure, because individuals vary in the time they spend outdoors, both at their place 
of residence and on holiday. For example, a cumulative holiday UVR exposure of 14 MED 
102 
might include individuals with sub-erythemal doses of o.s MED per day during 28-day 
holidays, and individuals with exposures of 2 MED per day on 7 -day holidays. As the risk of 
immune suppression (and therefore risk of zoster) may increase with intensity of exposure, 
UVR intensity was also examined as a risk factor for zoster. Finally, it is unclear whether the 
immune system adapts to continuous high doses of UVR. If so, intermittency of UVR 
exposure may be a risk factor for zoster - acute exposure to high UVR dosage in individuals 
with habitually low UVR exposure may increase the risk of immunosuppression. Therefore, 
intermittency of exposure was also investigated. 
The three patterns ofUVR exposure from sunlight were generated as described below, and as 
summarised in Figure 6.4 (overleaf): 
Cumulative UVR exposure: for non-holiday periods, total weekly UVR exposure was 
estimated as outlined in Chapter 4 (Section 4.1), using data on ambient UVR levels and cloud 
cover for each residence, the -time spent outdoors between 9am and Spm on work (or school) 
days and non-workdays, and the number of work (or school) days per week. For holidays, 
UVR exposure was derived from the ambient UVR levels and cloud cover for each holiday 
destination, time spent outdoors and duration ofthe holiday. 
In childhood, UVR exposure mostly resulted from time spent outdoors in the warmer months 
(April-September). Most of this exposure occurred on school-days and non-school days at 
home, but some individuals also had briefer periods of (often intense) UVR exposure on 
summer holidays. However, individuals typically had very little UVR exposure during the 
cooler months (October to March) of childhood, either at home or on holiday. Therefore, 
cumulative UVR exposure in childhood was estimated only for the warmer months, as follows: 
a) Exposure. for the entire period of April-September, combining total non-holiday exposure 
(weekly non-holiday exposure x number of weeks not on holiday) with holiday exposure 
(Figure 6.4, /¥ij ) 
b) Weekly non-holiday exposure in the warmer months - exposure on schooldays and non-
schooldays combined (Figure 6.4, ~) 
c) Exposure during summer holidays away from home (Figure 6.4, ~) 
Adult UVR exposure in the last year was estimated as above, for a) the entire warmer months 
(non-holiday and holiday exposure combined), and for b) weekly non-holiday exposure in the 
warmer months (exposure on workdays and non-workdays). Although most adults had very 
little UVR exposure during winter months at home, some experienced sizeable UVR exposure 
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Figure 6.4: Generation of seven UVR exposure variables - cumulative UVR dose (1,2, 7), UVR intensity (3, 4) and UVR intermittency (5, 6) 
o 
Weekly UVR exposure in warmer months (Apr-Sept), excluding holidays: 
"' (weekly UVR exposure on work/school days) 
a) Daily UVR from 
work/school days 
in warmer months 
x No. of 
work/school days 
+ 
(weekly UVR exposure on non-work/school days) 
b) Daily UVR from 
non-work/school days 
in warmer months 
x No. of 
non-work/school days 
o 
Cumulative UVR exposure on holidays 
(UVR exposure on summer holidays) 
c) Daily UVR from 
summer holiday days 
x No. of 
summer holiday days 
(UVR exposure on winter holidays) 
d) DailyUVR from 
winter holiday days 
x No. of 
winter holiday days 
-.., 
-" 
CD o 
Higher daily value, a) or b) Intensity of UVR exposure within a non-holiday week c) or d) Intensity of UVR exposure on holidav 
Ratio of values, b : a Intermittency of UVR exposure within a non-holidav week 
o o 
Ratio of values, ~ : [2] = Intermittency of UVR exposure due to holidays 
§ [[2] X no. of non-holiday w.... + 2 (,umme< holiday') ~ = Cumulative UVR expo,u'e in wa<me' month" f,om non-holiday' & holidaY' combined ~ 
during winter holidays. Therefore, holiday UVR exposure in the last year was calculated 
separately for summer holidays and for winter holidays, and for summer and winter holidays 
combined. 
After UVR exposures had been estimated, individuals were categorised into quintiles of 
exposure, based on the distribution amongst controls. Holiday exposures included a sixth 
category of individuals who did not go on holiday. For UVR exposures in the last year, 
'holidays' included work trips that included periods of recreational sun exposure. 
Intensity of UVR exposure: maximum daily UVR intensity was examined for childhood and 
for the last year, as: 
a) The highest daily UVR dosage received in the warmer months within a non-holiday week 
(Figure 6.4, [Ij) 
b) The daily UVR dosage received on holiday (Figure 6.4, [!J) 
Individuals were then categorised into quintiles of exposure, as above. 
Intermittency of UVR exposure: this was examined as follows: 
a) Intermittency within a non-holiday week: individuals who worked mostly had few non-
workdays and experienced higher levels of UVR exposure on non-workdays compared to 
workdays. Therefore, internlittency of exposure within a non-holiday week in the warmer 
months was estimated as the ratio of daily UVR exposure on non-workdays to daily 
exposure on workdays (Figure 6.4,[I]). For individuals who worked for less than half the 
week, UVR exposure on workdays was taken as the 'intermittent' exposure, and 
intermittency was estimated as the ratio of daily UVR exposure on workdays to exposure 
on non-workdays. For individuals who ' did not work, intermittency within the week was 
categorised as '0'. For childhood UVR exposures, schooldays were substituted for 
workdays. 
b) Intermittency due to holidays: this was estimated as the ratio of daily UVR exposure on 
holidays to the highest daily exposure during a non-holiday week, and was calculated 
separately for holidays taken in the warmer and the cooler periods (Figure 6.4, ~. 
c) Sunburns: the effect of sunburns causing severe erythema or blistering in the last year 
was investigated as a marker of intermittent UVR exposure. The interview did not 
include a question on sunburns in childhood, and most individuals did not report the 
timing of sunburns in earlier life, so the effect of childhood sunburns was not examined. 
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In addition to these three patterns of UVR exposure in childhood and in the last year, two 
other aspects of exposure were considered: 
1. Sunbathing: individuals were asked at interview whether they sunbathed during non-
holiday periods. This provided a marker of regular sun-seeking behaviour in adulthood, 
and represented acute, usually intense UVR exposure. Therefore, the effect of UVR 
exposure from sunbathing in the last year was examined as a single variable, 
irrespective of other UVR exposures. 
2. Exposure in the month before rash onset: the possibility that high levels of UVR 
exposure might lead to immediate VZV reactivation were examined by analysing the 
effect of UVR exposure in the month before rash onset in the case, a) from non-holiday 
and holiday exposure combined, b) from holiday exposure alone and c) from 
sunbathing. 
6.4.3 Analytical strategy -
UVR dose-response: Kricker et al demonstrated that for skin cancer, the relationship 
between cumulative UVR exposure and risk of disease is not linear - the risk increases 
initially with increasing exposure, but decreases at highest exposure levels.287 In order to 
explore whether this departure from linearity was also applicable to zoster, models with a 
quadratic term for categorical variables were compared to models with simple linear terms, 
using likelihood ratio tests (LRT). 
Independent effects of UVR exposure variables: The independent effects of 'usual' (non-
holiday) and holiday UVR exposure were investigated by adding both variables to a 
multivariable model. Possible negative confounders of these effects included: 
a) Birth in a late varicella (LV) country: this might be associated with lower risk of zoster and 
high UVR exposure in childhood; 
b) Current illness: this might be associated with increased risk of zoster and lower recent 
UVR exposure; 
c) Susceptibility to burn/ability to tan - individuals with poor skin tolerance to UVR exposure 
often have low UVR exposure because they avoid the sun. However, they may be at 
higher risk of skin erythema (have a lower personal MED) at a given level of UVR 
exposure compared to individuals with good skin tolerance to UVR. Therefore, at any 
'standard MED' dosage they may be at increased risk of immune suppression. 
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The potential negative confounding effects of these variables were checked in all appropriate 
models. The confounding effect of ethnicity was also considered, as a composite of birth in a 
LV country and non-white skin colour. 
Effect of baseline UVR dosage on intermittency: the univariable effect of intermittency of 
UVR exposure takes no account of individuals' usual (baseline) level of exposure, which is 
used as the denominator in estimates of intermittency. Baseline UVR dosage could 
confound the effect of intermittency because individuals .with a very low baseline levels and 
modest 'intermittent' levels may have low total levels of UVR exposure but high 
intermittency of exposure. Therefore, the effect of intermittency independent of the 
baseline UVR dosage was examined by adding the baseline dosage to multivariable models. 
In addition, individuals with low UVR baseline dosage (who are least likely to have adapted 
to the immunosuppressive effect of UVR) might be more vulnerable to the effects of 
intermittency of UVR. This was investigated by subdividing individuals into two levels of 
baseline exposure, and examining the effect of intermittency separately in each group. The 
cut-offs for categories of baseline exposure and for intermittency variables were chosen to 
allow sufficient numbers for at least three intermittency categories in each of the two 
baseline groups. 
Effect of age: the effects of UVR exposures might be different in older individuals with 
declining cell-mediated immunity compared to younger individuals with more robust 
immune function. The effects of the UVR exposures, outlined above were therefore 
investigated separately in individuals aged less than 60 years and those aged 60 years and 
older. 
Protective effects of hats/clothing: hats and clothing may protect against the effect of UVR 
exposure on zoster by attenuating UVR d~sage. The confounding effects of wearing hats 
and protective clothes were first examined in multivariable models of UVR exposure. 
However, some individuals living or holidaying in cooler climates wore hats and clothes to 
shield themselves against the cold and rain, and not to protect against the sun. Therefore, 
the independent effects of hats and clothes were considered separately for low and high 
levels of UVR exposure. 
Effect modification by skin type: as discussed above, individuals' skin type may reflect their 
personal susceptibility to UVR-mediated immune suppression. The effects of UVR 
exposures were examined separately in individuals according to: 
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a) Their skin response to initial UVR exposure: individuals were divided into two groups -
those who tanned with/without mild burning, and those who developed a painful 
sunburn with peeling or blistering; 
b) Their skin response to repeated UVR exposure: individuals were also divided into two 
groups - those who obtained a moderate or deep tan, and those who obtained a slight or 
no tan (with or without freckling). 
6.4.4 Univariable analyses (Tables 6.4.1-6.4.6) 
Exposures in childhood: increasing total cumulative UVR exposure in the warmer months 
(holiday and non-holiday UVR exposures combined) was associated with a non-linear 
increasing risk of zoster, but this association was not significant (p=0.401, Table 6.4.1). 
However, both non-holiday UVR exposure in the warmer months and total summer holiday 
exposure were significantly associated with increased risk of zoster. The effect of non-
holiday UVR dosage appeared to have a quadratic pattern of risk (p=0.002, Table 6.4.1), 
with strong evidence of a departure from linearity (p=0.0006 for LRT of quadratic vs. linear 
model). The effect of childhood holiday exposure showed a weaker quadratic relationship, 
with less evidence of departure from linearity in the smaller dataset of holidaymakers 
(p=0.148 for LRT of quadratic vs. linear model). Individuals who did not go away on 
holiday in childhood were at more than twice the risk of zoster compared to individuals 
with the lowest holiday UVR exposures, but were not at increased risk of zoster compared 
to all holidaymakers (OR=0.94, 95%CI=0.66-1.32, p=O. 703). 
The effect of intensity (maximum daily dose) of UVR exposure in childhood within a non-
holiday week and on summer holidays showed a similar pattern to those for cumulative 
UVR exposures, but were less strongly statistically significant (Table 6.4.1). Intermittency 
of UVR exposure in the warmer months was not associated with increased risk of zoster on 
univariable analysis (Table 6.4.2) - neither high non-holiday intermittency (non-schoolday 
compared to schoolday exposure) nor holiday intermittency (holiday compared to non-
holiday exposure) was significantly associated with zoster risk. 
Few individuals (9% of cases and 11 % of controls, n=603) wore hats at least half the time 
in childhood to protect against the sun when not on holiday, and even fewer wore protective 
clothes at least half the time (3.7% of cases and 3.7% of controls, n=626). Neither variable 
was significantly associated with risk of zoster (hats: OR=0.83, 95%CI=0.48-1.45, p=0.517; 
clothes: OR=1.00, 95%CI=0.41-2.41, p=1.0). Amongst holidaymakers with available 
108 
information, 22 (15.6%) cases and 53 (19.7%) controls wore hats at least half the time 
(OR=0.67, 95%CI=0.34-1.32, p=0.241), and two (1.4%) cases and seven (2.6%) controls 
wore protective clothing at least half the time (OR=0.78, 95%CI=0.14-4.36, p=0.775) 
Twenty-two individuals (eight cases and 14 controls) reported medical UVR exposures in 
childhood, mostly in solaria set up for 'peaky' children in the 1930s. There was no 
association between these childhood UVR exposures and zoster risk (OR=1.16, 95% 
CI:0.46-2.89, p=0.753). 
Exposures in the last year: high cumulative total (holiday + non-holiday) UVR exposure in 
the warmer months was associated with a weakly significant, near-linear increasing risk of 
zoster (Table 6.4.3). However, there was no significant association between risk of zoster 
and other cumulative UVR exposures in the last year, including non-holiday UVR exposure 
in the warmer months, total UVR exposure during summer holidays (other than a weak 
quadratic association), winter holidays, or summer and winter holidays combined. 
Individuals who did not go on summer holidays were at a non-significantly increased risk of 
zoster compared to individuals with the lowest quintile of UVR holiday exposure, but were 
not at increased risk of zoster compared to all summer holiday goers (OR=1.20, 95% 
CI=0.87-1.66, p=0.273). In contrast, individuals who did not go on winter holidays were at 
a (weakly significant) lower risk of zoster compared with a) individuals with the lowest 
terti Ie of winter holiday exposure (Table 6.4.3) and b) all winter holiday goers (OR=0.73, 
95% CI=0.53-1.02,p=0.053). Overall, individuals who had no (summer or winter) holidays 
were at similar risk of zoster compared to holiday goers (Table 6.4.3). The risk of zoster 
associated with cumulative UVR exposure from sunbathing was also not significantly 
associated with zoster. 
Intensity ofUVR exposure in the last year during non-holiday periods and from (summer or 
winter) holiday exposures was not significantly associated with risk of zoster (Table 6.4.4), 
neither was intensity of exposure during summer holidays and winter holidays considered 
as separate exposures (data not shown). Intensity ofUVR exposure from sunbathing in the 
last year was also not significantly associated with zoster (p=0.481, data not shown). There 
was a weakly significant trend of increasing risk associated with increasing intermittency 
due to winter holidays, but no association with summer holiday intermittency. Thirty-three 
cases and 52 controls had experienced sunburns severe enough to cause severe erythema or 
blistering - sunburns were not associated with increased risk of zoster (OR=1.38; 
95%CI=0.81-2.28, p=0.234). Similarly, twenty-six individuals (11 cases and 15 controls) 
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had sunbed and/or medical UVR exposures in the last year, which was not significantly 
associated with zoster risk (OR=1.49, 95% CI=0.67-3.31, p=0.106). 
Wearing hats during the non-holiday warmer months was not associated with protection 
against zoster - 41 (16.8%) cases and 70 (14.4%) controls wore hats at least half the time 
(OR=1.22, 95%CI= 0.78-1.90, p=0.381). However, 37 (15.2%) cases and 102 (21.3%) 
controls wore protective clothing at least half the time during non-holiday periods, and this 
was associated with protection (OR=0.64, 95%CI~0.42-0.99, p=0.039). Amongst 
individuals who went on holiday, neither hat-wearing (OR=0.88, 95%CI=0.53-1.45, 
p=0.608) nor wearing protective clothing (OR=1.40, 95%CI=0.84-2.32, p=0.195) were 
significantly associated with risk of zoster. 
Exposures in the month before rash onset in the case: cumulative UVR exposures from 
holidays and non-holidays combined and from holidays alone were not significantly 
associated with zoster, and there was a weak protective trend associated with cumulative 
UVR exposure from sunbathing (Table 6.4.5). However, going on holiday or on a business 
trip that included recreational UVR exposure in the month before rash onset was weakly 
associated with increased risk of zoster (OR=1.49, 95% CI=0.97-2.27, p=0.067), and there 
was also a weakly significant trend of increasing risk with increasing intensity of UVR 
holiday exposure. Intermittency of exposure due to holidays had a significant, non-linear 
relationship with zoster risk. Severe sunburns were not associated with zoster risk (Table 
6.4.5), neither were medical or sunbed UVR exposures (OR=1.33, 95% CI=0.36-4.72, 
p=0.660). 
Effect of skin type: neither a) propensity to bum on initial UVR exposure nor b) ability to 
tan with continued exposure were associated with risk of zoster on univariable analysis 
(Table 6.4.6). However, those with least ability to tan (individuals who freckled without 
tanning) were at increased risk of zoster compared with individuals who obtained a deep tan 
(p=0.03). 
6.4.5 Multivariable analyses (Tables 6.4.7-6.4.15) 
Exposures in childhood: 616 individuals (214 matched sets) had data on cumulative UVR 
exposures for both non-holiday and holiday periods. Amongst controls who went on 
holiday in childhood, there was evidence that those with high non-holiday exposure also 
had high holiday exposure (p<0.00 1). The independent effects of non-holiday and holiday 
UVR exposure in childhood are summarised in Table 6.4.7. The effect of non-holiday 
exposure was slightly diminished after adjusting for holiday exposure, but remained 
significantly associated with risk of zoster. Other variables (LV childhood residence, skin 
response to UVR, current illness and wearing of hats and protective clothing) did not 
confound the adjusted effect estimates (data not shown), nor did ethnicity (Table 6.4.7, 
final column). In contrast to non-holiday exposure, cumulative summer holiday UVR 
exposure in childhood was not independently associated with zoster risk after controlling 
for non-holiday exposure (Table 6.4.7). Similar results were obtained when intensity of 
UVR exposure in childhood was examined, with the association with zoster remaining less 
strong than that of cumulative UVR dose (data not shown). 
Although cumulative holiday UVR exposure was not independently associated with risk of 
zoster in the complete dataset, there was evidence that the adjusted effect varied with age (p 
for interaction = 0.018). Increasing holiday exposure was significantly associated with 
increased risk of zoster amongst individuals aged less than 60 years, with a quadratic 
pattern of association (Table 6.4.8). The increased risk associated with not having a 
holiday was also restricted to younger individuals. None of the other UVR exposure 
variables showed effect modification by age (p for interaction >0.2 for all) 
The effect of total (non-holiday + holiday) cumulative UVR exposure in childhood could be 
masked by the possible increased risk associated with not going on holiday, because non-
holidaymakers were more likely to have lower total UVR exposure - the lowest two quintiles 
of total cumulative UVR exposure contained 57.2% of the individuals who did not go on 
summer holidays, but only 26.8% ofthe individuals who had holidays. Analyses of total UVR 
exposure were therefore repeated amongst the matched sets (278 individuals) ofholiday-goers. 
Effect estimates were increased for higher exposures levels in this small dataset compared to 
those estimated using all participants, with a weakly significant trend of increasing risk with 
increasing exposure (Table 6.4.9). 
The effect of childhood intermittency of UVR exposure remained non-significant after 
controlling for baseline UVR exposure (data not shown). However, there was evidence that 
the effect of UVR intermittency due to holidays varied with level of baseline exposure (p 
for interaction=0.02, Table 6.4.10). Increasing intermittency was associated with higher 
risk of zoster only amongst individuals who had high daily intensity of non-holiday 
exposure (at least four MED/day). Again, non-holidaymakers might mask the effect of 
intermittency, because they were at possibly increased risk of zoster but categorised in the 
lowest intermittency group (because they had no holiday exposure). However, effect 
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estimates were very similar in the smaller dataset of holidaymakers, except for a higher 
magnitude of risk amongst those with the highest quintile of intermittency (data not shown). 
The effect of hat-wearing in childhood did not vary according to level of either non-holiday 
or holiday UVR exposure (less than 5MED vs. more than 5MED, p for interaction>0.9 for 
both). There were not enough individuals wearing protective clothing in childhood to 
investigate whether the effect varied according to UVR exposure level. 
Exposure in the last year: the effects of non-holiday and holiday UVR exposures remained 
non-significant after controlling for each other and for potential negative confounders in a 
multivariable model (data not shown). The weakly significant trend in increasing risk of 
zoster with increasing total (holiday + non-holiday) cumulative summer UVR exposure was 
slightly strengthened after controlling for the confounding effects of current illness, 
ethnicity and ability to tan, but only individuals with the highest level of exposure were at 
significantly increased risk of zoster (Table 6.4.11). The effects of cumulative UVR 
exposures did not vary significantly by age. 
The effects of intermittency of UVR exposures in the last year remained non-significant 
after controlling for baseline UVR exposure and current illness, and there was no evidence 
that the effect of non-holiday or summer-holiday intermittency varied with baseline 
exposure (p for interaction >0.2 for both). Effect modification of intermittency due to 
winter holidays was not examined, as there was insufficient variation in winter non-holiday 
UVR exposure - only seven people were exposed to ~IMED/day. 
The weak protective effect associated with wearing protective clothing during non-holiday 
periods was not confounded by cumulative non-holiday UVR exposure, current illness, 
ethnicity or skin type (data not shown). The effect of wearing hats and protective clothes 
did not vary by level of either non-holiday or holiday UVR exposure (p for interaction>0.2 
for all). Individuals with the least ability to tan (who freckled without tanning) remained at 
increased risk of zoster compared with individuals who obtained a deep tan after adjusting 
for the confounding effects of ethnicity, current illness, and total UVR exposure in the 
warmer months (OR=2.33, 95% CI=1.07-5.08, p=0.033). However, there was little 
evidence that ability to tan or propensity to burn modified the effects of any of the UVR 
exposures of interest (p for interaction >0.15 for all). 
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Exposures in the month before rash onset: the effect of total (holiday + non-holiday) 
cumulative UVR exposure from sunlight in the month before rash onset was strengthened 
after controlling for the confounding effects of current illness, ethnicity and ability to tan 
(Table 6.4.11). The adjusted estimates were more strongly associated with risk of zoster 
than the equivalent estimates for exposures in the last year, with higher effect estimates for 
all exposure levels. The effect of intensity of holiday UVR exposure in the month 
preceding rash onset was not confounded by non-holiday UVR exposure, ethnicity, current 
illness or skin type (data not shown). 
There was evidence that age modified the effect of total UVR exposure in the month before 
rash onset (p for interaction=0.015), with a more strongly significant risk of zoster in 
individuals aged less than 60 years, although the pattern of risk was neither linear nor 
quadratic in either age group (Table 6.4.12). The effects of other UVR exposure variables 
did not vary with age. Numbers were insufficient to investigate whether the effect of 
wearing of hats and protective clothing varied according to level of holiday UVR exposure. 
There was also evidence that the effect of total holiday UVR exposure in the month before 
rash onset was modified by propensity to burn (p for interaction=0.046), although again the 
risks had no clear pattern (Table 6.4.13). Amongst individuals who tanned on initial UVR 
exposure, there was a trend towards increasing risk of zoster with increasing holiday UVR 
exposure compared to those who did not go on holiday, but effect estimates did not reach 
statistical significance. Amongst individuals who burned or peeled on initial exposure, the 
risk of zoster was significantly higher amongst individuals who had relatively low holiday 
exposures, but not amongst individuals with high holiday UVR exposures. However, only 
two cases and eight controls were in the top category of exposure. 
Exposure to UvR is known to increase the risk of immediate reactivation of latent herpes 
simplex virus (HSV) infection, the clinical presentation of which can occasionally be 
mistaken for zoster.44,234,348,357 The effect of using a 'probable' zoster case definition with 
imperfect specificity was examined by restricting analyses of UVR exposures in the month 
before rash onset to the small datasets of confirmed cases and their matched controls. 
Power was reduced due to the small numbers, but effect estimates for total (holiday + non-
holiday) UVR exposure amongst confirmed cases and matched controls were of greater 
magnitude than those for the whole dataset, and this effect persisted when data were further 
restricted to younger individuals (a group at higher risk of HSV reactivation compared to 
older individuals) (Table 6.4.14). 
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The effects of different UVR exposures for the three time periods are summarised in Table 
6.4.15. 
6.4.5 Discussion 
A strong effect of cumulative UVR exposure in the warmer months of childhood was 
identified, with a quadratic pattern of increased risk of zoster. This is similar to the pattern of 
association between early life UVR exposure and subsequent risk of basal cell carcinoma, 
reported by Kricker et al.287 Individuals' 'usual' (non-holiday) childhood UVR exposure was 
associated with increased risk of zoster amongst participants of all ages, but high holiday UVR 
exposure in childhood and a lack of childhood holidays were associated with increased risk 
only amongst younger individuals. Participants who had no childhood holidays also tended to 
have high non-holiday UVR exposure. However, increased zoster risk amongst those without 
holidays remained after controlling for non-holiday UVR, indicating that some of the risk 
resulted from other factors. - Total (non-holiday + holiday) cumulative childhood UVR 
exposure was not significantly associated with zoster risk, but this may be partly due to 
inclusion of the majority ofnon-holidaymakers (a group at possibly intermediate risk of zoster) 
in the lower quintiles of total exposure. 
Recent cumulative UVR exposure in adulthood was less strongly associated with risk of zoster. 
Unlike childhood exposure, there was some evidence that total (non-holiday + holiday) 
cumulative exposure in the last year was associated with increased zoster risk, but no 
association with either non-holiday or holiday exposure considered separately. In general, 
quintiles of childhood exposure for these variables had much higher values compared to the 
equivalent quintiles for recent exposure. Also, the effect of not taking summer holidays in the 
last year was less marked than the effect of no holidays in childhood, and so may have had less 
influence on the risk associated with the lowest quintiles of total UVR exposure. There was 
limited power to investigate the effects of cumulative UVR exposures in the month before rash 
onset, as the data included many individuals with similar exposure levels - for example, where 
zoster had occurred in the case during the winter months. Nevertheless, adjusted effect 
estimates of total cumulative exposure in the last month were slightly more strongly associated 
with risk of zoster compared with exposure in the last year, suggesting that recent exposure 
may affect zoster risk. 
In general, intensity ofUVR exposure at each time period had a weaker association with zoster 
compared to cumulative exposure, except for intensity of holiday UVR exposure shortly before 
rash onset. Estimates of exposure intensity used the maximum UVR dose received between 
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9am and 5pm on anyone day, without taking into account how long it took to receive this 
dose. There may have been considerable variation between individuals in the hourly intensity 
of exposure within a day - for example, a daily dose of 4 MED may have been experienced 
over eight hours by one individual but in a single hour by another, depending on their location 
of residence or holiday destination. This may explain some of the difference between younger 
and older individuals in the effect of cumulative holiday exposure in childhood. Younger 
individuals went to holiday destinations with significantly higher daily ambient UVR 
compared to older individuals, and spent fewer hours outdoors. So, younger individuals may 
have experienced the same daily UVR dose on holiday as older individuals but received a 
more intense dose within that time, and this may have increased their risk of 
immunosuppression. 
Other patterns of UVR exposure showed less strong associations with zoster. High 
intermittency of exposure in childhood was not associated with increased risk overall, and 
results of stratified analyses indicated that high childhood intermittency due to holidays was 
associated with increased zoster risk only amongst individuals who also had high non-holiday 
exposure. This suggests that it is total UVR dose that increases risk, and not simply a wide 
differential in exposure. Winter non-holiday exposure was low in almost all individuals, and 
the weak effect of recent winter holiday intermittency may simply have represented the effect 
of acute exposure amongst individuals who were not acclimatised to the sun. However, neither 
cumulative winter holiday exposure nor intensity of exposure were significantly associated 
with risk of zoster. 
There was some evidence that 'frecklers' (individuals with poor ability to tan) were at 
increased risk of zoster. Recent UVR exposure also had a greater effect amongst those with a 
propensity to bum, but there was limited power to examine this because few individuals who 
burned easily had high levels of UVR exposure. Effect modification by skin type is consistent 
with the hypothesis that individuals with poor skin tolerance to the sun might be particularly 
susceptible to UVR-mediated immune suppression. 
Hats were not found to be protective against the effect ofUVR on zoster risk, nor was clothing 
in most situations. The protection from hats may be limited as they only protect the head area 
from the sun, and the protective effect of clothing can be diminished by fabric colour, content, 
age and hydration.358,359 In addition, individuals who reported wearing protective clothing on 
holiday or during leisure activities may have subsequently increased their UVR exposure, 
believing themselves to be protected against the sun. Only individuals who wore protective 
clothing for most of the time during non-holiday periods were at possible lower risk of zoster. 
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These individuals may have been 'sun-avoiders', who wore appropriate protective clothing and 
actively limited their exposure to intense UVR. The lack of association of zoster risk with use 
of sunbeds, medical exposures and sunburns may have been due to small numbers of exposed 
individuals. 
Why might childhood UVR exposure increase the risk of zoster in adulthood? One 
possibility is that high UVR exposure in early childhood 'programmes' the immune system 
so that it responds less robustly to subsequent challenges. This might be particularly 
marked where exposures are intense (such as on holiday), leading to young age at zoster. 
Alternatively, variation in UVR exposures in childhood may represent a broad range of 
behavioural activity, some of which might be associated with immune programming - for 
example, childhood infections, vaccination status or endotoxin exposure.360-364 Infonnation 
was not collected on these childhood factors, or on proxy factors (such as childhood socio-
economic status), and it was not possible to assess their influence. Recent UVR exposure 
might affect the risk of zosfer by direct immunosuppression, facilitating reactivation of 
latent VZV infection. It was hypothesised that this effect might be more marked in older 
individuals, due to less robust functioning of the aging immune system. However, there 
was no evidence that recent UVR exposures had a greater effect in older individuals in this 
study. 
The quadratic pattern of childhood UVR exposure risk is intriguing. In the case of basal 
cell carcinoma, UVR-induced genetic mutations in skin cells increase with increasing UVR 
exposure.365,366 Kricker et al suggested that the cells may become non-viable at very high 
UVR exposure levels (due to accumulated mutations), and are destroyed before they can go 
on to become cancerous - therefore individuals with very high UVR exposure may be at 
lower risk of skin cancer compared to those with intennediate exposure.287 As outlined in 
Chapter 2, uVR may cause immunosuppression by damaging keratinocyte DNA, and the 
altered keratinocytes produce cytokines that preferentially activate TH2-type helper cells. 
Perhaps at very high UVR exposure levels the DNA damage is so great that the 
keratinocytes are destroyed, and so cytokine production causing the shift to TH2-type helper 
cells (which may result in immune programming) is switched off. 
One potential limitation of these analyses is the possible misclassification of HSV infection 
as zoster amongst 'probable' cases, resulting in an erroneous association with recent UVR 
exposure. Subgroup analyses of con finned cases indicates that misdiagnosis of zoster was 
unlikely to have contributed greatly to the weak effect associated with recent exposure. 
Other limitations to these data include: 
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1. Misclassification of ambient UVR levels at residences and holiday destinations: this 
was likely to be considerable. Average UVR levels and cloud cover were used for the 
half-year periods comprising the warmer and the cooler months. No account was taken 
of altitude or surface reflectance, which may have a pronounced effect on the amount of 
ambient UVR. 172 This non-differential misclassification may have led to 
underestimation of the effects ofUVR exposures. 
2. Misclassification of personal UVR exposure: in addition to misclassification of ambient 
UVR exposure, participants probably misreported how long they spent outdoors. Also, 
individuals were asked only about time spent outdoors between 9am-5pm, with no 
supplementary questions asked about exposure between llam-3pm (the time of 
maximum UVR dosage). Misreporting is likely to have been similar in cases and 
controls, and so may have contributed to underestimation of UVR effects. It is 
interesting that childhood UVR exposure was strongly associated with zoster risk 
despite possibly high levs:ls of misreporting by participants. Perhaps this reflects the 
advantage of using residence calendars, and prompting individuals with standardised 
questions to aid memory of childhood events. 
3. Health effects: this may have obscured the relationship between recent UVR exposure and 
zoster. Individuals who feel unwell may spend more time indoors, and may not go on 
holiday. If these individuals have lower functional immunity (resulting in increased 
susceptibility to zoster), associations between zoster and UVR may be negatively 
confounded. This may explain the weak protective effect of sunbathing in the month 
before rash onset. Controlling for current illness may have not have removed this problem 
if individuals with generalised malaise were not formally diagnosed as being ill. In 
addition, some cases may have felt unwell due to prodromal zoster, and reduced their UVR 
exposure shortly before rash onset. 
4. Effect of past UVR exposure on recent exposure: if long-term UVR exposure increases the 
risk of zoster, it may confound the effect of recent exposures under some circumstances. 
For example, individuals with high UVR exposure in the last twenty years may have 
developed UVR-related skin problems or have suffered severe sunburns, and then 
modified their sun-seeking behaviour. 
5. Other confounding: other risk factors for zoster may explain some of the associations 
found in these analyses. For example, stress may have confounded the weak effect of 
. recent winter holiday exposure. Potential confounders were explored in the combined 
model ( Section 6.8, below). 
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6. Delay between interviewing cases & controls: controls were interviewed after cases, but 
differences in recall of UVR exposure in the last year are likely to have been non-
systematic. For example, at interview controls had sometimes been on holiday more 
recently compared to their matched cases, and sometimes less recently. Answers may 
have been influenced by recent weather changes - time spent outdoors in the warmer 
months can vary considerably according to the weather, and reporting may have 
reflected most recent exposure rather than average exposure. Again, this may have lead 
to non-differential misclassification of exposure. The situation for UVR exposure in the 
month before rash onset in the case was somewhat different, where the period of interest 
was immediately before interview for cases but sometimes much earlier for controls. 
As with dietary intake (discussed earlier in this Chapter) individuals were asked about 
usual UVR exposure in the last year without asking them about a specific time period, 
and exposure in the month before rash onset was calculated subsequently. 
Nevertheless, delays in interviewing controls could have led to differential 
misclassification of UVR "exposure. 
The results of these analyses suggest that childhood (and possibly recent) UVR exposure may 
have an important effect on susceptibility to zoster. Extensive data were collected at interview 
on lifetime exposure to UVR. This will enable future analyses of the effects oflong-term UVR 
exposure on zoster risk, including potential confounding or effect modification of recent UVR 
exposure by past exposure. 
6.5 STRESS AND ILLNESS 
6.5.1 Specific hypotheses 
The primary hypotheses were that: 
1. Stressful events in the last 12 months and/or in the two months before rash onset 
increase the risk of zoster. 
2. Illnesses in the last 12 months and/or in the two months before rash onset that affect 
cell-mediated immunity increase the risk of zoster. 
Investigation of the two periods allowed assessment of the effects of both longer-term and 
acute stress and illness. Two months was chosen to investigate the effects of acute stress, 
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because (as outlined in Chapter 2) studies of bereaved spouses have shown that lymphocyte 
fu . .. . d· h fi h ft h fb t 136137 nctIOn IS Impalre III t e Irst two mont s a er t e acute stress 0 ereavemen. ' 
6.5.2 Data conversion and categorisation 
Individuals were prompted at interview about 12 types of stressful events (see Chapter 3, 
Section 3.9.1 and Appendix 7), and were also asked an open question about whether they 
had experienced any other stressful event in the last year. Responses to the open question 
included both stressful events (such as accidents or trouble with the police) and stressful 
feelings (such as feelings of isolation from the family or concerns about the participant's 
own health). Therefore, the data comprised a mixture of a) stressful events that were 
reported in response to the 12 standardised questions asked of all participants, and b) 
stressful events and feelings that were volunteered by some participants in response to the 
open question. The following three categories were generated: 
1. Prompted events: these were the 12 specific types of stressful event that were routinely 
asked of all participants. Multiple responses to each question (for example, if two close 
family members had been seriously ill in the last year) were counted as separate events. 
2. Unprompted events: these were events reported in response to the open-ended question 
3. Unprompted feelings: these were feelings reported in response to the open-ended 
question 
Individuals' positive responses were summed, to obtain the total number of stressful 
events/feelings overall, and the number in each of the three categories. For events that 
occurred over time (such as family illness), information was collected on when the event 
began and ended. This allowed categorisation of stressful events in the two months before 
rash onset into incident events (those starting less than two months before rash onset) and 
prevalent events (those starting earlier than two months before rash onset but extending into 
the two month period). 
Information was sought at interview about major medical conditions and treatments in the 
last year. Individuals were excluded from the study if they had an underlying condition that 
was associated with depressed cell-mediated immunity, as listed in Chapter 3 (Section 
3.7.3). However, remaining illnesses were considered relevant to the present analyses for 
two reasons. Firstly, individuals may experience being ill as a stressful event. Secondly, a 
few individuals had conditions that potentially could affect immune functioning (listed 
below). Subcategories of illness investigated as potential risk factors for zoster included: 
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1. Medical conditions or treatments possibly associated with impaired immune 
functioning - insulin-dependent diabetes mellitus, Down's syndrome, chronic fatigue 
syndrome, chronic renal failure, pregnancy and low-dose oral steroids (taken by one 
91-year old control for whom a replacement could not be found). 
2. Illnesses or treatments possibly associated with altered micronutrient availability or 
requirement (listed earlier in this Chapter, Section 6.3.2). 
3. Major infections 
4. Hospitalisations in the last six months 
5. Surgical procedures in the last six months, subdivided into minor invasive procedures 
and major procedures necessitating general anaesthetic. 
6. Psychiatric illness, and/or prescriptions for anxiolytic or antidepressant medication 
6.5.3 Analytical strategy 
Univariable analyses were undertaken of stressful events/feelings in the last 12 months and 
in the two months before rash onset. Analyses included: 
1. The effect of the total number of events/feelings (prompted and unprompted combined), 
and of each of the three stress variables (prompted events, unprompted events and 
unprompted feelings). 
2. The effect of each stressful factor (the effects of de~th of a spouse, death of a close 
relative, etc), considered singly or in groups of related factors (such as the three 'death' 
stress variables) where numbers were small. 
3. The effects of recent illnesses. 
Multivariable models were set up for each period - the last 12 months and the two months 
before rash. The models were built as follows: 
1. Stress events/feelings were added first to the model. Two alternative models were 
used, a) using the total number of (prompted+unprompted) events/feelings, and b) 
adding prompted stress events, unprompted events and unprompted feelings separately, 
as ordered categorical variables if there were sufficient numbers. The second model 
allowed investigation of the independent effects of prompted and unprompted 
events/feelings. 
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2. Illness variables were added to the model, and retained if they were independently 
associated with risk of zoster or if they confounded any of the stress variables. Again, 
two alternative models were used, a) using a variable encompassing any major medical 
or surgical condition, and b) using variables representing specific illnesses, listed 
above. In the second model, the variable representing illness in general was added 
after adding specific groups of illnesses, to estimate whether illnesses not included in 
the specific variables also had a confounding or independent effect on risk of zoster. 
3. Alcohol consumption and smoking may confound or lie on the causal pathway between 
stress and risk of zoster, because they are commonly associated with stress events and 
may also affect cell-mediated immune functioning. 311 -314 These two variables were 
therefore added to the model, and retained if they altered the effect estimates of any of 
the stress or illness variables. The potential confounding effects of socio-economic 
status variables (house tenure and car ownership) and ethnicity were also examined. 
4. Effect modification of -stress variables by a) age and b) illness was investigated. 
Interactions between incident and prevalent stress events in the two months before rash 
onset were also examined, to see whether the effect of acute stress was exacerbated by 
chronic stress. 
6.5.3 Univariable analyses 
The effects of stressful events or feelings in the 12 months before interview are summarised 
in Table 6.5.1. Increasing numbers of total (prompted+unprompted) events/feelings were 
associated with a graded increasing risk of zoster - individuals reporting five or more 
events/feelings were at more than three times the risk of zoster compared to individuals 
with no reported events. When individual stress variables were examined, unprompted 
events and unprompted feelings both had dose-response effects, although the latter was only 
weakly statistically significant. The effect of prompted stress events had a weaker, less 
graded association with risk of zoster. However, individuals reporting five or more 
prompted events were at more than double the risk of zoster compared to individuals 
reporting no events. Individual events/feelings that were most significantly associated with 
zoster included serious illness amongst family members, organising weddings or parties and 
a feeling of continuing bereavement. 
The univariable effects of incident stressful events or feelings in the two months before rash 
are summarised in Table 6.5.2. Again, there was a significant graded association between 
risk of zoster and total number of (promped+unprompted) events/feelings. Both incident 
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prompted events and unprompted events were significantly associated with zoster risk, with 
exposed individuals at more than twice and more than four times the risk of zoster 
respectively. Few individuals reported stressful feelings that started in the two months 
before rash, and these were not significantly associated with zoster risk. Individual 
events/feelings that were most significantly associated with zoster included death of a 
spouse, close relative or close friend, difficulties with work, accidents, robberies or assaults, 
and moving house. 
The effects of prevalent stressful events in the two months before rash onset were in general 
less strongly associated with risk of zoster compared to incident events (Table 6.5.3). 
Prevalent stressful feelings were weakly associated with increased risk of zoster, of which 
the strongest association was that of feelings of continuing bereavement. 
The univariable effects of recent illness on risk of zoster are summarised in Table 6.5.4. 
Individuals who reported any major medical or surgical condition in the last year were at 
nearly twice the risk of zoster compared to those who did not report major illness. Most of 
the specific conditions examined were not significantly associated with zoster risk. 
However, as shown earlier in this Chapter, illnesses or treatments leading to altered 
micronutrient availability or requirement were associated with more than a three-fold 
increased risk of zoster. Serious infections in the last six months were associated with more 
than twice the risk of zoster, and serious infections in the two months before rash onset 
were weakly associated with increased risk. Hospitalisations were associated with 
protection against zoster, but this did not reach statistical significance. 
6.5.4 Multivariable analyses 
Stress in the last 12 months: the effect estimates for the total number of stressful 
events/feelings in the last year were little changed after adjustment for either recent medical 
conditions or specific illnesses (Table 6.5.5). Similarly, the three individual stress variables 
were not confounded by each other or by illnesses. The effect of having any medical 
condition was slightly diminished after controlling for the effect of stress, but remained 
significantly associated with zoster risk, even after controlling for specific illnesses 
variables. Of these illnesses, the effects of serious infections and conditions associated with 
altered micronutrient availability were diminished in the multivariable model, but remained 
significantly or weakly significantly associated with zoster risk. The protective effect of 
hospitalisations increased, so that individuals experiencing hospitalisation in the last six 
months were at approximately two fifths the risk of zoster compared to non-hospitalised 
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individuals. None of the stress or illness variables were confounded by socio-economic 
status, ethnicity, alcohol consumption or smoking. 
There was evidence that the effects of a) all stress events/feelings and b) prompted stress 
events varied with age (p for interaction= 0.002 and 0.035 respectively). For each variable, 
stress was associated with a non-linear protective effect in individuals less than 60 years 
old, but with a non-linear increased risk amongst older individuals (Table 6.5.6). There 
was no evidence of interaction between stress variables~ or between stress and most illness 
variables. However, there was an interaction between stressful feelings and hospitalisations 
(p for interaction=0.009). Hospitalisation was associated with strong protection against 
zoster amongst those who did not report stressful feelings in the last year (OR=0.08, 
95%CI=0.01-0.61, p=0.015), but was not associated with risk of zoster amongst those who 
reported stressful feelings (OR=0.97, 95%CI=0.35-2.67, p=0.956). 
Stress in the two months bijore rash onset: the effect of the total number of incident 
stressful events/feelings in the two months before rash was little changed after adjusting for 
the effects of prevalent stress and any medical conditions (Table 6.5.7). However, the total 
number of prevalent stresses was only weakly associated with zoster risk in the 
multivariable model. Of the individual stress variables, incident prompted and unprompted 
stress events and prevalent unprompted stressful feelings remained significantly associated 
with risk of zoster after controlling for one another and for the effects of recent illness 
(Table 6.5.7). Individuals with medical conditions remai~ed at more than one and a half 
times the risk of zoster compared to individuals with no illness. When specific illnesses 
were considered, only conditions associated with altered micronutrient 
requirement/availability were independently associated with zoster after controlling for 
recent stress (OR=2.60, 95%CI=1.04-6.50, p=0.037). Other illness and stress variables did 
not confound the effect estimates for stress variables, nor did socio-economic status, 
ethnicity, alcohol intake or smoking. There was no evidence of interactions between the 
stress or illness variables in the model. Unlike stress in the last year, there was also no 
evidence of effect modification by age. 
6.5.5 Discussion 
Individuals who reported a high number of stressful events and/or feelings in the twelve 
months before interview were at increased risk of zoster. Of these, events or feelings that 
were unprompted (volunteered by the participant) were strongly related to increased risk, 
but prompted events (responses to standardised questions about major life events) were less 
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strongly associated with zoster risk. This is similar to the findings of Schmader et ai, where 
elderly cases of zoster and matched controls had a similar number of major life events in the 
year before zoster onset. 153 However, in the present study the effect of prompted events in 
the last year (and the effect of all events/feelings combined) varied with age, with some 
evidence of decreased risk amongst younger individuals but increased risk amongst older 
individuals. As mentioned in Chapter 2, the effect of stress on the immune system may 
depend on individuals' defence and coping mechanisms, and can result in heightened 
immune responses. 143-146 It is possible that stress affects the ageing immune system 
differently to the more robust immune system of younger individuals, or that older 
individuals are more likely to experience major life events as being stressful. 
In contrast to events in the last year, individuals reporting prompted stressful events that 
first occurred in the two months before rash onset in the case were at twice the risk of 
zoster, and this effect was not explained either by recent illness or by other stressful events. 
Schleifer et al and Bartrop et al showed that lymphocyte function was diminished in the 
first two months following acute stressful events. 136,137 Schmader et al found that although 
cases did not have significantly higher numbers of stressful events in the two months before 
rash, the number of self-rated 'negative' events were associated with zoster risk. 153 In 
general, recent prevalent stress was less strongly associated with risk of zoster compared to 
recent incident stress, and did not exacerbate the effects of acute stress. Schleiffer et al 
demonstrated that suppressed immune responses in the two months after bereavement were 
followed by intermediate levels of immune responsiven~ss in the next 4-14 months. 137 
Perhaps the lower magnitude of risk associated with prevalent stress reflects adaptation to 
the effects of stress over time. 
Conditions that affected micronutrient availability or requirement, and serious infections in 
the last six months were independently ass'ociated with risk of zoster. Both of these sets of 
conditions may affect cell-mediated immunity, and thus increase risk of zoster. However, 
individuals with other current medical conditions (for example cardiovascular disease) 
remained at increased risk of zoster after adjusting for specific illnesses that might affect 
immune function. This is consistent with the findings of Schmader et al that elderly 
individuals who self-rated their health as 'excellent' were at half the subsequent risk of 
zoster compared to other individuals.8o The increased risk associated with general ill-health 
may be mediated by unreported stress generated in response to being unwell, or other 
effects of poor health on immune functioning. Hospitalisations in the last six months were 
protective against zoster, but only amongst those who did not report stressful feelings. 
Eight of the nine (89%) cases that were hospitalised reported stressful feelings, mostly 
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relating to concerns about their own health. In contrast, only ten (34%) of the 29 
hospitalised controls reported stressful feelings, and many controls attended hospital for 
scheduled operations. Therefore, the apparent protective effect of hospitalisation may be 
due to differences in cases' and controls' underlying medical history and experience of 
hospitalisation. 
How should the three types of stress variable (prompted events, unprompted events, and 
unprompted feelings) be interpreted? Prompted events !epresent major life events likely to 
be associated with stress. Questions about these events were adapted from instruments used 
in previous studies.8o,ls3,3Is Unprompted events reported by interviewees included a number 
of major events such as being assaulted or court cases. This suggests that the variable 
representing the total number of (prompted and unprompted) stressful events/feelings may 
reflect differences in major stressful events experienced by the study population. 
However, use of an open question about stress increases the possibility of recall bias, 
particularly in the reporting of less major events and stressful feelings. Recall bias may 
explain much of the difference in magnitude of effect between unprompted and prompted 
stress events in the last year. Even some of the prompted events (for example, trouble with 
neighbours or difficulties at work) may be prone to recall bias. Differences in reporting ofless 
major stressful events in cases and controls in the two months before rash onset may also have 
been exacerbated by the delay in interviewing some of the controls relative to their matched 
cases. 
The results may also have been affected by participation bias. It is likely that individuals 
suffering acute stress or serious illness might be less willing to take part in the study, and 
this might be particularly true for controls. The reasons for non-participation were 
unknown for many individuals, but refusals included: severe depression (one case and one 
potential control), recent bereavement (two controls), ongoing bereavement (two cases and 
one control), spousal or family illness (six controls), hospitalisation (three controls), other 
ill health (one case and eight controls), and a recent accident (one control). Although 
overall levels of participation were high, participation bias may have contributed to some of 
the effects reported. 
Despite these limitations, there was evidence that stressful events increased the risk of 
zoster. The difference in the magnitude of effects associated with unprompted and 
prompted stress is an indicator of the strength of recall bias. However, the difference of the 
effect of prompted events amongst younger and older individuals suggests that there may be 
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a real effect of stress on risk of zoster. The confounding effect of stress on other risk factors 
for zoster is examined later in this Chapter. 
6.6 PHYSICAL TRAUMA 
6.6.1 Specific hypothesis 
The primary hypothesis was that mechanical trauma in the six months before interview 
and/or in the month before rash onset increases the risk of zoster. Trauma in the month 
before onset was chosen because there have been case reports of zoster occurring within a 
month of specific trauma.34,156,367,368 It was also hypothesised that the risk of zoster would 
be greater when the site of the trauma was the same as the site of subsequent rash. 
6.6.2 Data categorisation " 
Participants were asked about physical injuries (for example, falls or knocks that were 
severe enough to cause bruising) in the last six months, with details about the site of the 
injury and when it occurred. Information about trauma due to invasive surgery was 
acquired from the medical history. These data were combined to obtain a history of trauma 
at the same site as subsequent rash in the case, and a history of trauma at different sites. 
6.6.3 Analytical strategy 
Univariable analyses were undertaken of physical trauma in the last six months and in the 
month before rash onset in the case. Trauma to the same site as subsequent rash and trauma 
to different sites were both examined, to investigate the specific and general effects of 
trauma on risk of zoster. Multivariable analysis included adjustment for potential 
confounders of the effect of trauma, including current illness and alcohol consumption. 
Effect modification by age was also investigated. 
6.6.4 Univariable analyses 
The univariable effects of physical trauma on risk of zoster are summarised in Table 6.6.1. 
Trauma in the last six months to any site was not associated with risk of zoster, but 
individuals who experienced trauma in the month before rash onset were at more that twice 
the risk of zoster. Trauma at the same site as subsequent rash in the case in the last six 
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months was associated with a ten-fold increased risk of zoster, and trauma in the month 
before rash was associated with a nineteen-fold increased risk (although 95% confidence 
estimates for both estimates were wide). However, trauma at a different site to the rash was 
not associated with a significantly increased risk for either time period. 
6.6.5 Multivariable analyses 
The effect estimates of physical trauma to any site and trauma to the same site as 
subsequent rash were little affected after adjustment for current illness (Table 6.6.1, column 
5). Alcohol did not confound any of the effects of interest, and the two site-specific trauma 
variables (trauma to the same site and trauma to a different site) did not confound one 
another (data not shown). There was no evidence that age modified the effect of trauma in 
the last six months (p for interaction>0.2 for all three trauma variables). There were 
insufficient numbers to ascertain whether age modified the effect of trauma to the same site 
in the month before rash onset. However, there was evidence that the effect of trauma to 
any site and to a different site in the month before rash varied with age (p for 
interaction=O.Ol and 0.033 respectively). Amongst individuals aged less than 60 years, 
nether trauma variable was significantly associated with zoster after adjusting for current 
illness (Table 6.6.2). In contrast, older individuals who experienced trauma to any site 
were at more than six times the risk of zoster, and those who experienced trauma to a 
different site to subsequent rash were at more than four times the risk of zoster compared to 
individuals with no trauma. 
6.6.6 Discussion 
Physical trauma is associated with an increased risk of zoster, and this effect is stronger for 
trauma sustained shortly before rash onset." This is consistent with the findings amongst the 
case-series reported by Juel-Jenson and other case reports that could not estimate relative 
risk because controls were not employed to ascertain history of trauma in the 
population.34,156,367,368 In this study, only trauma at the site of subsequent rash was 
associated with zoster risk when all individuals were considered. This suggests that 
mechanical trauma may trigger reactivation of latent virus in the dorsal root ganglion of the 
nerve supplying the affected dermatome. However, the risk of zoster associated with 
trau,ma to other sites was also increased amongst older individuals. This might occur 
because the psychological stress following falls or accidents may affect Immune 
functioning, particularly amongst elderly individuals with ageing immune systems. 
Alternatively, physical trauma may not be associated with risk of zoster, but may appear to 
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be so because it is a consequence of general poor health not fully captured by reported 
current illness. 
The major limitation of these analyses is the possibility of recall bias, particularly for 
trauma to the site affected by zoster. This may have been exacerbated by the delay in 
interviewing some controls, who may have forgotten less serious trauma. As only a few 
individuals experienced trauma to the affected site and because there is a strong possibility 
of recall bias, only tentative inferences can be made froIl). these analyses. 
6.7 OTHER CONFOUNDERS 
Independent risk factors for zoster within each of the five main models (child/varicella 
contacts, ethnicity/country of birth, micronutrient intake, ultraviolet radiation exposure and 
stress/illness) also potentially confounded one another. This was examined in the final 
model, described next in this Chapter. However, a few variables were considered purely as 
confounders, and were not investigated as independent risk factors within the five models. 
These included: 
a) Smoking 
b) Alcohol intake 
c) Socio-economic status - housing tenure and car ownersh~p 
The potentially confounding effects of these variables in each ofthe main models have already 
been described. Their univariable effects on risk of zoster are reported here, for completeness. 
6.7.1 Data categorisation 
Individuals were categorised as non-smokers, ex-smokers and current smokers, and the 
number of cigarettes smoked per day in the last year or in the two months before rash onset 
were divided into 'none', 1-9, 10-19 and ~20. Daily alcohol intake in the last year and/or in 
the two months before rash onset was calculated in the same way as micronutrient intake 
(described in Chapter 4), using information on frequency of consumption, 'portion size' and 
the alcohol content of each alcoholic drink consumed. Intakes were then subdivided into 
'none' and into quartiles of exposure, based on the distribution amongst controls. 
Socioeconomic variables were categorised as on the questionnaire (see Appendix 7). 
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6.7.2 Univariable analyses 
The effects of the potential confounders on risk of zoster are summarised in Table 6.7.1. 
None of the variables were associated with zoster, either as categorical or as linear 
variables. The effects of alcohol and cigarette consumption in the two months before rash 
onset were very similar to those of consumption in the last year (data not shown). 
6.7.3 Discussion 
None of the potential confounders were significant risk factors for zoster on univariable 
analysis. This is consistent with their lack of confounding for most of the other variables in the 
five models. The effects of cigarette and alcohol consumption may have been underestimated, 
due to non-differential misclassification of exposure. However, smoking status slightly 
confounded the effect of fruit consumption, and was independently associated with risk of 
zoster in the final model (described below). 
6.8 COMBINED MODEL 
The multivariable sub-models described above were used to assess the independent effects 
of related variables. However, these analyses did not take into account that variables from 
different sub-models might also confound one another. T!Ierefore, a combined model was 
set up, to investigate the independent effects of all the variables of interest. 
6.8.1 Analytical strategy 
Variables from the five main multivariabi'e sub-models were combined to obtain a single 
model, using a dataset of 217 cases and 411 controls with no missing data. Variables were 
eligible for inclusion in the combined model if they were significantly associated with 
zoster to the level of p::50.1 in their sub-models, and/or if they were a confounder of any of 
the other significant variables. 
Sub-model analyses were repeated for the reduced (n=628) dataset, to re-establish baseline 
effe,ct estimates within the sub-model. The five sub-models were then combined. 
Confounding was assessed by comparing sub-model effect estimates with those obtained in 
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the combined model. Variables were dropped from the combined model if they were not 
significantly associated with zoster (p>O.I) and did not confound the other variables. 
Some sub-model analyses used more than one model or alternative variables - for example, 
the 'child contacts' analysis had one model for child contacts in the last 10 years and a 
second model for contacts in the last year, and the 'food model' used fruit intake and 
vegetable intake either as two separate variables or as a combined single variable. Where 
alternative variables or more than one version of the. sub-model existed, the following 
strategy was used: 
1. The variable or group of variables (sub-model) that were most strongly associated with 
zoster risk were first added to the combined model, to ascertain the independent and 
confounding effects of these variables. 
2. These variables were replaced by variables from the alternative sub-model, to determine 
the independent effects ofthe alternative variables in the combined model. 
Some variables were excluded after univariable or sub-model analysis, because they were 
not associated with risk of zoster (p>0.2 for univariable analyses, p>O.l for sub-model 
analyses). Some of these excluded variables were reassessed in the combined model, to 
check whether their effects had been masked by negative confounding. Variables were 
selected for reassessment by a) using a more generous cut-off for association on univariable 
analysis (p<0.4), and b) including variables with strong hypothesised links with risk of 
zoster. The latter variables included occupational contacts with well children, dietary 
micronutrient intake, holiday UVR exposure in childhood, skin type (ability to tan and 
propensity to bum), and serious infections in the last six months. 
The effect of some variables was restricted to either older or younger individuals in sub-model 
analysis. These age-specific effects were re-examined in the combined model, to see whether 
they persisted after controlling for a wider range of potential confounders. Due to small 
numbers, other variables were only retained in the age-specific models if they confounded the 
effect estimates of interest. 
6.8.2 Findings 
The variables with the most significant effects in sub-model reanalyses (using the reduced 
dataset) are listed in Table 6.8.1 (3rd column). In general, effect estimates were similar to 
the estimates obtained from the original (larger) datasets described earlier in this Chapter. 
130 
Further details of revised subgroup analyses and estimates obtained from the combined 
model are described below and summarised in Table 6.8.1 (main variables) and Table 6.8.2 
(alternative variables). 
Child contact variables: in revised sub-group analyses, the effects of the intermediate child 
contact variables (contacts with many children) were weakened after adding varicella contacts 
to the sub-model (data not shown). In the combined model, child and varicella contacts in the 
last 10 years remained significantly protective against .zoster (Table 6.8.1, final column). 
Occupational contact with multiple ill children was associated with increased protection after 
adjusting for the effects of variables from other sub-models - the major negative confounders 
were unprompted stress in the two months before rash onset and non-holiday UVR exposure in 
childhood. Occupational contact with many well children (e.g. teaching) remained 
unassociated with risk of zoster in the combined model (OR=1.31, 95%CI=O.65-2.63; 
p=0.452). 
Child and varicella contacts in the last year were considered in the combined model as 
alternative variables to contacts in the last ten years. Estimates for these variables were little 
altered in the combined model, except that the magnitude of increased risk associated with a 
single varicella contact was increased (Table 6.8.2). 
Food and micronutrient intake: individual micronutrient intakes were not significantly 
associated with risk of zoster in the combined model - p va}ues ranged from 0.14-0.94 (data 
not shown), consistent with original univariable analyses. In addition, (fresh or frozen) 
vegetable intake in the last year was not significantly associated with zoster in the final 
model and did not confound the effects of other variables (data not shown). Therefore, 
vegetable intake was dropped from analyses. Low fruit intake in the last year was 
associated with a higher risk of zoster in the combined model compared to the revised sub-
model (Table 6.8.1). This was mainly because many individuals with the lowest fruit 
intake had a high number of contacts with specific children outside the household, and had 
low non-holiday UVR in childhood. Combined fresh fruit and vegetable intake was 
assessed as an alternative variable to fresh fruit intake in the final model. This was 
associated with a graded increased risk of zoster in the revised sub-model, and effect 
estimates were little altered in the combined model (Table 6.8.2). 
In the original sub-model, combined micronutrient intake (measured as a micronutrient 
score) was not associated with risk of zoster amongst all individuals, but low micronutrient 
scores were associated with increased zoster risk amongst older individuals (Section 6.3.5, 
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above). In the combined model, micronutrient intake was again not significantly associated 
with risk of zoster overall (p=0. 981), but the increased risk amongst older individuals 
persisted after controlling for the confounding effects of social contacts with children (those 
not living in the household and children in groups), childhood non-holiday UVR exposure, 
current illness, and incident prompted and unprompted stress events (Table 6.8.3). Effect 
estimates were higher than those in the original sub-model, but confidence intervals for 
some of the effect estimates were very wide. 
Ultraviolet radiation (UVR) exposure: weekly non-holiday UVR exposure in the warmer 
months of childhood was more strongly associated with risk of zoster in the combined 
model compared to the sub-model, and retained a quadratic pattern of dose-response (Table 
6.8.1). Total holiday UVR in childhood was dropped from analyses, because it was not 
significantly associated with zoster in the combined model and did not confound any of the 
effect estimates of interest. However, in the original sub-model total childhood summer 
holiday UVR exposure was associated with increased risk of zoster amongst younger 
individuals (aged <60 years). In revised analyses, the effect of childhood holiday UVR 
exposure was confounded by non-holiday exposure, ethnicity, time since chickenpox and 
contacts with varicella cases in the last ten years. The adjusted effect estimates retained a 
quadratic pattern of increased risk amongst those who went on holiday (n=187), although 
this could not be tested formally due to small numbers (Table 6.8.3). 
Total UVR exposure in the month before rash onset in, the case was considered as an 
alternative variable to UVR exposure in childhood. As with the original analyses, 
increasing UVR exposure was associated with a non-linear increasing risk of zoster (Table 
6.8.2). The effect estimates for the highest levels of exposure were greater than estimates in 
the sub-model, due to negative confounding by a number of other variables. Ability to tan 
and propensity to bum were not associated with risk of zoster in the combined model 
(p=0.462 and 0.829, data not shown) 
Stress and illness: the effect estimates for incident prompted stress events and for prevalent 
stressful feelings in the two months before rash increased slightly in the combined model 
(Table 6.8.1). The effect estimate for incident unprompted stress events showed the greatest 
increase - the major negative confounders were occupational and social child contacts. 
Stress events in the last year were examined as an alternative to events in the two months 
before rash (Table 6.8.2). Individuals with five or more prompted stress events in the last 
12 months were at nearly seven times the risk of zoster compared to those with no events 
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after controlling for the effects of other risk factors for zoster. In contrast, unprompted 
stress events had a less graded association with risk of zoster in the combined model, and 
the effect of stressful feelings in the last year was little altered. 
In the original sub-model, there was evidence that the effect of prompted stress events in the 
last year varied with age - an increasing number of events was associated with non-linear 
decreased risk amongst younger individuals but increased risk amongst older individuals 
(Section 6.5.4, above). The direction of these effects persisted after controlling for a 
number of confounders from other sub-models (Table 6.8.3). The adjusted stress effect 
estimates were more strongly significantly associated with zoster risk in the final model, but 
the patterns of risk remained non-linear. 
The effect of current illness was little altered in the combined model (Table 6.8.1). When 
illnesses or treatments leading to altered micronutrient availability or requirement were 
substituted for current illness, they were associated with more than a three-fold increased 
risk of zoster (Table 6.8.2). However, serious infections in the last six months were not 
significantly associated with zoster in the combined model (OR=1.55, 95%CI=0.62-3.86; 
p=0.352). 
Ethnicity and time since varicella: individuals of Afro-Caribbean ethnicity were at half the 
risk of zoster on univariable analysis compared to individuals of White ethnicity. The 
protective effect disappeared after adjusting for other v~riables in the combined model 
(Table 6.8.1). This was investigated further by recoding ethnicity as a binary variable 
(Afro-Caribbean ethnicity vs. not), and carrying out analyses to identify proximal variables 
in the causal pathway between ethnicity and zoster risk. The results are summarised in 
Figure 6.S (overleaf). After adjusting for child & varicella contacts, the protective effect of 
Afro-Caribbean ethnicity was weakened from 0.49 (95% CI: 0.23-1.03) to 0.65 (0.28-1.48) 
- most of the confounding was due to contacts with specific children not living in the 
household (extended family and friends' children). The effect was further weakened to 
0.78 (0.32-1.89) after adjusting for childhood UVR exposure, and to 0.93 (0.37-2.32) after 
adding fresh fruit intake to the model. Addition of smoking marginally weakened the effect 
to 0.96 (0.38-2.47). Recent stress, current illness, and number of years since contracting 
varicella appeared to have no or slight negative confounding effect on ethnicity. After 
adding these variables, the final adjusted effect estimate for ethnicity was 0.81 (0.30-2.25). 
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Figure 6.5: UnivariabJe & adjusted estimates of the effect of ethnicity on risk of zoster 
Adiusted for contacts with + Adjusted for other child! 
Univariable OR specific children (last lOy) varicella contacts (last lOy) 
0.49 (0.23-1.03) ----+ 0.62 (0.29-1.34) --. 0.65 (0.28-1.48) 
p=fJ.05 p=O.215 p=O.291 
Adjusted for childhood non-
Dnivariable OR holiday UVR exposure 
0.49 (0.23-1.03) ~ 0.56 (0.25-125) 
p=O.OS p=fJ.I44 
Univariable OR 
0.49 (0.23-1.03) 
p=O.OS 
Univariable OR 
Adjusted for childJ varicella 
contacts and childhood UVR 
0.78 (0.32-1.89) 
p=O.577 
Adjusted for fresh fruit intake 
0.52 (0.24-1.11) 
p=0.08 
Adjusted for child! varicella! 
childhood UVR exposure 
& fruit intake 
, 0.93 (0.37-2.32) 
p=0.872 
Adjusted for smoking 
0.49 (0.23-1.03) .. 0.49 (0.23-1.03) 
p=O.OS p=fJ.OS 
Adjusted for child I varicella! 
childhood UVR exposure. 
fruit intake + smokin& 
0.96 (0.38-2.47) 
p=0.940 
Univariable OR .. 
0.49 (0.23-1.03) 
Adjusted for stress in 
last 2m + illness 
0.48 (0.23-1.04) 
p=O.053 p=O.OS 
Adjusted for no. of years 
since varicella 
Univariable OR .. 0.46 (0.21-0.98) 
0.49 (0.23-1.03) p=O.037 
p=O.OS 
Adjusted for 
all variables 
0.81 (0.30-2.25) 
p=0.691 
Recent acquisition of varicella remained strongly protective against zoster in the combined 
model (Table 6.S.1 ). The small number of individuals (one case and 11 controls) who had 
acquired varicella within the last ten years were at one twentieth the risk of zoster compared 
to those who had acquired infection at least 50 years ago, even after adjusting for other 
variables. 
Physical trauma: recent trauma to the site of subsequent rash remained significantly 
associated with risk of zoster in the combined mod~l (OR=20.l4, 95%CI=2.27-178.33). 
However, the variable was not retained in the model, because the findings were thought to be 
affected by recall bias, did not confound any of the other variables of interest, and numbers 
with recent trauma to the site of rash were very small. 
Smoking: smoking was considered only as a confounder in these analyses. However, it was 
noted that in the combined model current smokers were at approximately one third the risk of 
zoster compared to non-smokers (OR=0.35, 95%CI=0.19-0.65, p=0.0008) 
6.S.3 Discussion 
Most variables that were significantly associated with risk of zoster in sub-models had a 
similar pattern of risk in the combined model. A few variables (such as fresh fruit intake 
and childhood non-holiday UVR exposure) had greater magnitude of effect after adjusting 
for negative confounding by variables from other sub-m~dels. The presence of negative 
confounders in this dataset raises the question as to whether the effect of some variables that 
were not associated with zoster on univariable analysis were also negatively confounded. 
This was investigated by re-checking some of these variables in the combined model, none 
of which became significantly associated with risk of zoster. 
Of the major variables of interest, only Afro-Caribbean ethnicity was no longer significantly 
associated with zoster in the final analysis. This was protective in subgroup analyses, and 
previous researchers have suggested that this might be due to late age at varicella due to 
childhood residence in a late-onset varicella country.Sl In this population, childhood 
country of residence did not explain the protective effect, but collection of a wide variety of 
potential risk factors for zoster enabled analysis of proximal protective factors. Protection 
appeared to be largely mediated by increased social contacts with children, high intake of 
fresh fruits, and UVR exposure in childhood. The latter was slightly protective because 
many individuals of Afro-Caribbean ethnicity were exposed to the highest quintile of UVR 
exposure in childhood, whereas their matched controls mostly experienced the second, third 
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and fourth level of exposure. As childhood UVR exposure was associated with a quadratic 
pattern of zoster risk, individuals with the highest exposure levels were at lower risk of 
zoster compared with those at intermediate levels. 
Current smokers were at lower risk of zoster after adjusting for other confounders. This is 
consistent with the finding of Schmader et aI, who reported that elderly smokers were at 
half the risk of zoster compared to non-smokers after adjusting for the effects of age, sex, 
ethnicity, stress and current illness.8o It is not clear '\\;'hy smoking should decrease zoster 
risk, given that nicotine intake has been associated with depression of cell-mediated 
immunity.313·314 This might be partially explained if smokers were at similar risk of zoster 
compared to non-smokers, but had different recall of zoster risk factors. For example, 
smokers might under-report their fruit intake (a protective factor), or over-report stressful 
events (associated with increased risk). If this were so, smoking might appear to be 
protective after adjusting for these factors. 
The combined model contained a large number of variables. This was consistent with the 
aims of the study, which were to investigate the independent effects of a range of risk 
factors for zoster. However, when focusing on the effects of a sub-group of risk factors, 
other variables in the model could be restricted to those that confounded these factors. For 
example, when examining the effects of child and varicella contacts on risk of zoster, most 
confounding variables were dealt with in sub-model analyses - only one other major 
confounder (unprompted stress events) was identified in t~e combined model, and this only 
confounded one of the child contact variables (occupational contacts with ill children). By 
restricting the number of other variables in the model when testing hypotheses relating to 
specific risk factors for zoster, more precise effect estimates for these factors could be 
obtained. 
These analyses have identified a number of risk factors and protective factors for zoster, 
some of which were restricted to specific age groups. In the next Chapter, findings are 
summarised, potential limitations of the study are considered, and the research and public 
health implications of the findings are discussed. 
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7: DISCUSSION 
7.1 SUMMARY OF FINDINGS 
In this Section, the main findings of the study are considered in the context of what was 
already known about the topic before the study, and what the study has added. 
7.1.1 Contacts with children and cases of varicella 
What was already known: There were a lack of data to support or refute Hope-Simpson's 
hypothesis that exogenous boosting of cell-mediated immunity was important in maintaining 
VZV latency.34 Two studies provided limited evidence that individuals with occupational 
contact with ill children were at lower risk of zoster, 1 06, 107 and one study showed that 
immunosuppressed children were protected against zoster if there was a case of varicella in the 
household. 108 
What this study adds: contacts with children appear to protect individuals without underlying 
immunosuppression against zoster. A hierarchical analysis demonstrated that this protection is 
probably mediated by increasing exposure to cases of varicella. This supports Hope-
Simpson's hypothesis, extends the findings of Gershon et al to a general popUlation, and 
quantifies the degree of protection - the most heavily exposed individuals were at 
approximately one fifth the risk of zoster compared to unexposed individuals. These findings 
have since been supported by an analysis of the fourth Morbidity Statistics in General Practice 
study, which showed that individuals who had a child currently living in the household had a 
significantly lower incidence of zoster in one year of follow-up compared to individuals who 
did not live with children.35o 
7.1.2 Ethnic origin and country ofhirth 
What was already known: one study found that elderly Black Americans were at lower risk of 
zoster compared to White Americans.61 It was suggested that this might result from later age at 
varicella, due to childhood residence in a late-onset varicella (LV) country.81 This hypothesis 
had not been formally tested. 
What this study adds: consistent with previous research, this study showed that individuals of 
Afro-Caribbean origin were at less than half the risk of zoster compared to White individuals. 
However, neither childhood residence in a LV country nor late acquisition of varicella 
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explained the protection associated with Afro-Caribbean ethnicity, although late varicella was 
associated with protection against zoster. From the wide variety of information collected, it 
was possible to ascertain the proximal determinants of protection associated with ethnicity. 
These included multiple child contacts (leading to multiple varicella contacts), and high fresh 
fruit intake. 
7.1.3 Micronutrient and food intake 
What was already known: micronutrients are essential for cell-mediated immune functioning, 
and micronutrient deficiencies lead to immunosuppression. The elderly often have multiple 
micronutrient deficiencies, and so micronutrient status could be a determinant of both the loss 
of cell-mediated immunity with age and of zoster. Randomised controlled trials of 
micronutrient supplementation in the elderly have shown some evidence of improvement in 
cell-mediated immune functioning, but few studies have examined whether this results in 
increased protection against infections, and none have investigated zoster specifically. 
What this study adds: intakes of individual micronutrients were not associated with zoster risk, 
but older individuals with relatively low combined micronutrient intake were at higher risk of 
zoster. This suggests that multiple micronutrient deficiencies may be a risk factor for 
immunosenescence. There was a strong, graded association between low fresh fruit intake 
and increasing risk of zoster in individuals of all ages. Fruit contains a mix of nutrients that 
may act together to maintain immune health. 
7.1.4 Ultraviolet radiation (UVR) exposure 
What was already known: acute UVR exposure results in local and systemic 
immunosuppression. Acute exposure is a nsk factor for herpes simplex virus reactivation, but 
little else is known about risks of infection associated with either acute or long-term UVR 
exposure. A few studies have reported increased incidence of zoster in the warmer months, but 
no analytical studies of the effect of UVR exposure on risk of zoster have been reported. 
What this study adds: There was a strong increased risk of zoster associated with childhood 
non-holiday UVR exposure. Amongst younger individuals, there was some evidence that 
childhood holiday UVR exposure also increased the risk of zoster. These childhood exposures 
were associated with a quadratic pattern of risk of zoster, similar to the patterns seen in 
previous studies of basal cell carcinoma. One explanation of these findings is that early UVR 
exposure 'programmes' the immune system to respond less robustly to subsequent microbial 
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challenges. There was also some evidence that high total UVR exposure in the month before 
rash onset was associated with increased risk of zoster, but the risks associated with increasing 
exposure showed no clear pattern. 
7.1.5 Stress and illness 
What was already known: psychological stress can lead to depression of cell-mediated 
immunity, and may increase susceptibility to infections: A case-control and a cohort study 
investigating the effect of stress on zoster reported that 1) individuals with zoster experienced 
significantly more major life events in the six months before rash compared to individuals 
without zoster, and significantly more negatively-perceived major events in the two months 
before rash,153 and 2) there was some evidence that individuals who experienced negatively-
perceived life events were at increased risk of subsequent zoster. so Neither study had sufficient 
power to investigate thoroughly the risks associated with stress. In the cohort study, 
individuals who self-rated their health as 'excellent' were at one half the risk of zoster 
compared with other individuals.so Individuals with diminished cell-mediated immunity due to 
immunosuppressive conditions or therapies are at increased risk of zoster. However, the effect 
of other illnesses on risk of zoster is unknown. 
What this study adds: individuals who experienced incident major stress events in the two 
months before rash onset were at more than twice the risk of zoster compared to those who did 
not experience an event. Amongst older individuals, stre~sful events in the last 12 months 
were also associated with increased zoster risk. Other stressful events volunteered by 
participants in response to open questioning were associated with increased risk for both 
periods. These findings are consistent with previous studies, provide information on the 
importance of incident (as opposed to prevalent) events, and demonstrate that recent events 
may increase risk of zoster amongst younger as well as older individuals. Current medical 
conditions were associated with a 1.7-fold increased risk of zoster, and illnesses associated 
with altered micronutrient requirement or availability with a 3.6-fold increased risk, 
independent of reported stress. 
7.1.6 Physical trauma 
What was already known: previous case reports and case series suggested that mechanical 
trauma may result in reactivation of latent VZV. None of these studies employed controls to 
assess the frequency of trauma in the population from which the cases arose. 
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What this study adds: individuals who received trauma in the month before rash onset to the 
same site as subsequent rash were at eighteen times the risk of zoster compared to those 
without a history of trauma to the site, although the risk estimate had a wide 95% confidence 
interval. This suggests that trauma may increase the risk of zoster via direct stimulation of the 
peripheral nerve. 
7.2 STRENGTHS OF THE STUDY 
This study is the first to use robust epidemiological methods to investigate a wide range of risk 
factors for zoster. There were a number of advantages in using a population-based, matched 
case-control study design. These included: 
1. Advantages of the case-control design: although the lifetime risk of zoster is estimated at 
23-30%, annual incidences are relatively low. A cohort study would have been expensive 
and time-consuming, b~cause it would have involved recruiting, interviewing and 
following up a large number of individuals. In contrast, a case-control design was efficient 
in terms of both sample size and logistics. This increased efficiency was accentuated by 
the decision to include younger individuals, who are a group at lower risk of zoster. 
Inclusion of younger individuals allowed investigation of potential determinants of 
immunosenescence - risk factors for zoster that were found amongst older but not younger 
individuals. In addition, the study included examination of a wide range of exposures, for 
which a case-control study is particularly well-suited. 
2. Advantages of a population-based study: only a small proportion of zoster cases are seen 
in hospital settings. A hospital-based study would have enrolled cases that may have been 
atypical with respect to the exposures of interest, and would have raised difficulties in 
selecting an appropriate control group. Individuals with zoster are highly likely to consult 
their GP,and so use of a general-practice based study a) allowed recruitment of a more 
representative group of cases and b) identified a source of controls that represented the 
population from which the cases arose. 
3. Advantages of matching: matching further increased the efficiency of the study by dealing 
at the design stage with the major confounding effect of age. Individual matching resulted 
in selection of controls who were very similar to cases with respect to age (mean 
difference: 4.7 days). Matching for sex removed potential confounding by sex, and 
, facilitated some analyses - for example, comparing intake of foods within matched age-
sex triplets decreased unmeasured variation between cases and controls in the portion sizes 
consumed of specific foods. Matching by practice meant that a) cases and matched 
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controls were likely to have equal access to their GP, and b) any controls who developed 
zoster were as likely to be reported by GPs as previous cases had been. 
There were strengths associated with other aspects ofthe study methodology. Firstly, response 
rates were good for both cases (94%) and controls (at least 82.5%). High participation was 
attributed to a number of issues: 
a) The study was endorsed by the GPs, who made initial contact with cases in person. The 
initial letter sent to most controls was also signed by their GP; 
b) Attempts were made to actively involve all practice staff in the study; 
c) The PI followed up the initial invitation letter with a personal telephone call or visit before 
enrolling individuals, so that they could discuss concerns about participation; 
d) The PI made at least four follow-up attempts to contact individuals, by telephone and/or in 
person at different times. of day over a period of time. Additional strategies (such as 
seeking information from neighbours) were used to ascertain participants' whereabouts; 
e) The PI visited individuals mostly in their own homes, so as to minimise any inconvenience 
to them; 
f) It was stressed in all communications that participation comprised a single interview, with 
no need for follow-up. 
Secondly, there were advantages to the principal investigato{ (PI) undertaking all aspects of the 
fieldwork. This reduced the costs ofthe study considerably, eliminated inter-person variability 
in interviews, enabled the PI to assess participants' beliefs with respect to zoster that may have 
led to recall bias, and resulted in a very detailed understanding of the strengths and limitations 
of the questionnaire. 
7.3 POTENTIAL LIMITATIONS OF THE STUDY 
The study methodology enabled identification of many risk factors for zoster. However, 
aspects of the methodology might have influenced the study findings in other ways. Potential 
limitations of the study have already been discussed in the descriptive results (Chapter 5) and 
for specific analyses (Chapter 6). What follows is a summary of these discussions, considering 
the, study as a whole. 
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7.3.1 Selection bias 
Potential sources of selection bias included: 
1. Exclusion of cases who did not consult their GP: Zoster results in significant acute 
morbidity, and it is highly likely that cases consult their GPs about their symptoms. 
However, zoster occasionally presents with minimal rash and pain. Some very mild cases 
were seen in this study, but others may not have presented to their GP. As controls were 
not restricted to individuals who were known to seek treatment for minor symptoms, it is 
possible that cases and controls came from slightly different populations, but this is 
unlikely to have introduced significant bias. A second consideration is that severe cases 
may have presented initially elsewhere, such as at hospital. These cases were likely to 
have their care transferred to their general practice. In this study, two severe cases who 
initially consulted an out-of-hours deputising service and an Accident & Emergency 
Department were identifjed for inclusion when they made follow-up visits to their GP. 
Hand-searching of paper records of deputising service billings in two practices did not 
reveal any additional cases. 
2. Underreporting of cases by GPs: not all cases were reported by practices, despite a variety 
of ongoing reminders. General underreporting of cases increased the duration of fieldwork 
but was unlikely to have led to bias, because controls were matched to cases by practice. 
However, bias could have arisen if GPs were more likely to report cases that fitled the 
study hypotheses. As outlined in Chapter 5, this was considered unlikely, because a) the 
study objectives were only briefly discussed with GPs, and it was stressed that a wide 
variety of risk factors were being examined; b) some practices as a whole reported fewer 
cases over time (see Table 5.1); c) analysis of cases that were reported only after a second 
consultation and searches of partially computerised records in some practices revealed that 
underreporting was due to specific GPs failing to report any case, rather than selective 
reporting of cases. The drop in reporting over time by some practices could have 
introduced some bias if controls who developed zoster towards the end of the study were 
less likely to be reported compared to a case from the same practice who presented at the 
beginning of the study. However, controls who participated in the study were told that it 
was continuing for approximately 18 months, and they were mostly very interested in the 
study findings. It is therefore likely that any control who developed zoster would have 
either contacted the PI or mentioned the study to their GP, prompting the practice to report 
them as a case. One individual was interviewed as a control, and subsequently was 
reported and included as a case. 
3. Refusal by cases and controls to participate: participation rates were high, and the 
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eligibility of individuals who refused to take part was not ascertained. Nevertheless, some 
bias may have been introduced if those who refused (4% of potentially eligible cases and 
12.8% of potentially eligible controls) were different from those who participated with 
respect to the exposures of interest. This may have applied to stress events and illness, as 
four cases and 22 controls cited stressful events or ill-health as their reason for not 
participating. 
4. Other non-participation by cases and controls: four (1.4%) of potentially eligible cases 
and 28 (4.7%) of potentially eligible controls either 'Could not be contacted after multiple 
attempts, failed to attend the interview on two occasions, or were otherwise unavailable. 
It is likely that some of these individuals had moved away from the area. However, some 
may have been eligible for the study, and may have differed in exposure history from 
participants - for example, those who were unavailable because they were on extended 
holidays may have had higher UVR exposures. Again, any bias introduced is likely to 
have been minor, due to tpe small numbers involved. 
7.3.2 Information bias 
Recall bias: this is a potential problem in all case-control studies. In this study, attempts 
were made to minimise recall bias by not disclosing the exact study hypotheses and by 
asking standardised questions in a uniform way. As the PI administered all the 
questionnaires, much was learned about cases' beliefs with respect to risk factors for zoster. 
For example, many cases believed that zoster resulted from recent contact with cases of 
varicella. This may have resulted in cases remembering their child and varicella contacts 
better than controls, thus underestimating the strength of protection associated with these 
contacts (Chapter 6, Section 6.1.6). Another common belief was that zoster was due to 
'nerves'. This may have caused cases t? over-report recent stressful events compared to 
controls, causing an overestimate of the risk associated with stressful events. Such over-
reporting may particularly have applied to information gathered from the 'open' question 
about stress, categorised in the analyses as 'unprompted' events (Section 6.5.2). Effect 
estimates for recent trauma may also have been affected by recall bias. On the other hand, 
there was no evidence that cases considered UVR exposure or intake of specific foods to be 
risk factors for zoster, and the risk of zoster associated with low fruit intake did not appear 
to result from underreporting of food intake in general (Chapter 6, Section 6.3.4). 
Interviewer bias: the PI administered all the interviews, and so there was no masking of either 
the hypothesis or the case/control status of participants. If other interviewers had been used, it 
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would still have been very difficult to mask the case-control status of participants. Masking 
interviewers to the hypothesised direction of effect would have been possible for some of the 
exposures, but the underlying hypothesis for variables such as stress would probably have been 
obvious. Attempts were made to minimise information bias for exposure data by using a 
structured questionnaire with standard prompting questions, and it is very unlikely that the 
strong dose-response effects seen for a number of variables could have resulted from 
information bias. Data on the clinical presentation of zoster in cases were recorded at the 
beginning of the questionnaire, before ascertaining info11l)ation on exposures. 
Other differential misclassification of exposure: as outlined in Chapter 5 (Section 5.5), 22 
(4.5%) controls were interviewed more than 90 days after cases. Most questions (for example 
for food intake or child contacts) referred to 'usual' exposure in the last year, and this was 
unlikely to be systematically affected by delays in interviewing controls. However, events 
occurring in the month before rash onset may have been recalled differently by cases and 
.. 
controls, because cases were interviewed soon after they developed rash but controls were 
interviewed some time later. Individuals were not asked specifically about events occurring 
within this period - information was sought on all events (such as holidays) in the previous 
year, and these were subsequently categorised by the PI as falling within the one or two-month 
period before rash onset. The delay is unlikely to have introduced differential misc1assification 
for major events such as deaths or serious illness in the family, which controls would have 
remembered. However, it may have introduced greater misc1assification amongst controls of 
less major events or exposures that involved estimation ofttme spent outdoors or frequency of 
consumption. For example, a control interviewed 90 days after a case may have forgotten a 
varicella contact that occurred 3-4 months previously, whereas the case might remember a 
contact that occurred within the last month. Such differential misclassification would result in 
an underestimate of the protective effect of these contacts. Similarly, a control might 
remember less accurately the time slbe spent outdoors on a holiday four months ago compared 
to a case who went on holiday in the last month. The direction of bias introduced by this 
misclassification would depend on whether the delay caused controls to overestimate or 
underestimate their exposure. 
Classification of unconfirmed cases into 'probable' or 'possible' was carried out at the end of 
the study, without referring to individuals' exposure histories. Therefore, this is unlikely to 
have introduced major bias. 
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7.3.3 Non-differential misclassification 
Misclassijication of exposures - some misclassification of exposures such as micronutrient 
intake or UVR exposure was inevitable. For example, accurate measurement of micronutrient 
intake was limited by misclassification of frequency of food consumption, choice of a single 
food item to represent an entire food group, imperfect nutrient database information, and 
possible differences between cases and matched controls in portion sizes consumed (Chapter 6, 
Section 6.3.6). Both the FFQ and UVR data allQwed ranking of individuals within 
populations, rather than accurate estimates of absolute intake or exposure. Respondents were 
categorised into quintiles of exposure, and this may have reduced misclassification. 
Nevertheless, non-differential misclassification of exposure may have resulted in some cases 
and controls being categorised into the wrong quintile of exposure, resulting in under-
estimation of effects. 
" 
Misclassijication of cases: a specific case definition of zoster was used, in order to exclude 
cases ofHSV infection. As a result, a few of the 'possible' cases may have been very mild 
cases of zoster. Exclusion of these cases from analyses was unlikely to introduce bias, 
because they were not included as controls. However, this may have limited the 
generalisability of the study to cases of zoster with a given threshold of clinical severity. 
Despite the stringency of the zoster case definition, a few 'probable' zoster cases could have 
had atypical HSV infection. Inclusion of cases of HSV infection would result in an 
underestimate of the effect of exposures on risk of zoste,r, providing that these exposures 
were not associated with risk ofHSV infection. However, if the exposures were risk factors 
for HSV infection, there might be overestimation of the estimated association with zoster. 
For example, acute UVR exposure is known to increase the risk of immediate HSV 
reactivation.234-237 Therefore, if cases of HSV were mistakenly included as zoster, this 
might explain some of the apparent association seen between UVR exposure in the month 
before rash onset and increased risk of zoster. Any bias introduced in this way is likely to 
have been minor, as there were probably few cases of HSV infection included in analyses. 
Potential bias was investigated further by restricting analyses of recent UVR exposure and 
of child contacts to 'confirmed' cases and their matched controls. Results of these analyses 
suggested that the effects found were not attributable to undiagnosed HSV infection (Table 
6.4.14 and Table 6.1.5). 
Misclassijication of controls: controls were individuals with no self-reported history of 
zoster. If controls with past zoster were included, this might decrease the strength of 
association for historical exposures (such as UVR exposure in childhood), because controls 
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with past zoster may have developed zoster as a result of these exposures. Inclusion of these 
controls might also lead to an underestimate of the association with recent exposures (for 
example, usual diet), if their level of exposure had not changed in the years since they 
developed zoster. However, it is unlikely that controls had a history of zoster, as use of self-
reporting for zoster has been shown to be highly sensitive?83 
7.3.4 Residual confounding 
Individual matching dealt with major confounding effect of age, and potential confounding by 
sex. The extensive data collection for this study ensured that it was possible to control for a 
wide variety of potential confounders. Nevertheless, misclassification of exposures that acted 
as confounders may have resulted in a degree of residual confounding. In addition, other 
unidentified confounders may have existed for some exposures. For example, the apparent 
protective effect of fruit intake may have been partly due to the confounding effect of physical 
exercise.356 
Another potential confounder that needs consideration in this study is undiagnosed or 
undisclosed HIV infection. This might confound some associations because a) it was more 
likely to occur amongst cases compared to controls due to the increased risk of zoster amongst 
HIV-infected individuals, and b) it might be associated with some exposures - for example, 
homosexual men (who might be more likely to be HIV-positive) could have fewer child 
contacts. Practices were asked not to report cases with H~ infection by name, so that they 
would not be approached by the PI to take part in the study. Also, individuals of African 
ethnicity (a group at high risk of HIV infection in this population) were excluded from 
analyses. Therefore, it is likely that the proportion of individuals with undiagnosed HIV 
infection in this study was small. The effect of undiagnosed HIV infection on child contact 
estimates was also examined by restricting datasets to two subgroups at low risk of HIV 
infection in this population - women and older individuals. The results of these analyses 
suggest that HIV infection was not a major confounder of the protective effects of child 
contacts. 
7.3.5 Multiple comparisons 
The analysis of this study involved multiple comparisons. The concern with this is that some 
'statistically significant' associations could have occurred by chance. Although some 
researchers use stringent p values to represent 'significance' under these circumstances or 
inflate p values according to the number of comparisons made, this can result in a reduction of 
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type I errors at the expense of an increase in type II errors, and it has been argued that chance 
might not be the likeliest explanation for any of the associations observed?69 In this study, 
analyses were carried out to test stated hypotheses with plausible underlying biological 
mechanisms, and no corrections were undertaken for multiple comparisons. Chance is 
unlikely to explain the associations for those exposures where strong dose-response effects 
were seen or where highly statistically significant findings were obtained. Throughout the 
analyses, the number of comparisons that were made are clearly presented. 
7.3.6 Reverse causality 
A general concern in case-control studies is that individuals who develop disease 
subsequently change their exposure. However, reverse causality is unlikely to explain the 
findings in this study. Firstly, the majority of cases were interviewed within two weeks of 
rash onset. Secondly, participants were told throughout the interview that the exposures 
before rash onset were being sought. For example, the number of child contacts was 
calculated using the average frequency before onset of rash, not the frequency in the last 
few days (Chapter 6, Section 6.1.6). 
7.4 IMPLICATIONS FOR FUTURE RESEARCH 
This study identified new determinants for zoster. The findings will need to be replicated in 
other studies, which can focus on specific exposures in mor~ detail. Future studies will also be 
able to take into account a range of newly defined potential confounders or proximal 
determinants of zoster risk. For example, studies of the association between ethnicity and 
zoster will need to consider not only country of birth and age at varicella as factors on the 
causal pathway between ethnicity and zoster, but also exposures such as diet and child 
contacts. 
It is important to estimate the impact of varicella vaccination on incidence of zoster. This 
requires information on both the magnitude of protection afforded by a specified level of child 
or varicella contacts, and the prevalence of these exposures in the population of interest. If 
varicella contacts are to be used in impact calculations, further studies can be set up to 
determine the prevalence of exposure to varicella in the specified population. However, child 
co.ntact data might provide more useful information, because they represent both known and 
unknown varicella contacts. Frequency of social child contacts will also vary in different 
populations, due to differences in social mixing patterns with children. Therefore, the child 
contact odds ratios derived from this study could be combined with estimates of the number of • 
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individuals in the population of interest in each of the exposure strata used in this study. 
Alternatively, population-specific odds ratios could be re-estimated, using quintiles of 
exposure to children in that population. The PI has been recently approached by the National 
Centre for Immunisation Research in Australia, asking for assistance in planning a similar 
study on child and varicella contacts on the risk of zoster. 
Once effect- and prevalence estimates for child and varicella contacts have been obtained, 
these can be used in mathematical models to predict i~creases in zoster incidence resulting 
from loss of exogenous exposures after introduction of childhood varicella vaccination. These 
predictions can then inform evaluations of the cost-effectiveness of introducing varicella 
vaccination. In countries where vaccination has already been introduced, direct measurement 
of the potential impact of widespread childhood varicella vaccination on incidence of zoster 
has been hindered by limited surveillance of zoster. As a result of the recent debate about 
exogenous boosting, the US Centers for Disease Control and Prevention (CDC) have now set 
up sentinel sites in two areas; to monitor incidence of both varicella and zoster.370 Uptake of 
vaccination was initially slow, but any effect on zoster incidence should become apparent once 
levels of circulating wild-type virus have fallen sufficiently. 
Further epidemiological data are needed on the effects of UVR exposure on susceptibility to 
infections. The wealth of data collected in this study will be analysed at a future date to see 
whether long-term UVR exposure affects the risk of zoster, and whether it modifies the effects 
of childhood and recent exposure. Measurement of past UVR exposure needs better 
instruments, so that misc1assification of exposure is minimised and administration and coding 
of questionnaires is less labour intensive. Future studies of the effects of childhood UVR 
exposure on risk of zoster will also need to collect data on potential confounding variables, 
such as childhood vaccination and nutritional status. A cohort study of childhood exposure 
might allow a more accurate assessmen:t of UVR dosage (for example, using personal 
dosimeters), and could collect detailed information on potential confounders. However, this 
would necessitate a large study and very long duration of follow-up. It would be feasible to set 
up cross-sectional studies of adolescents to examine whether childhood UVR exposure 
programmes the immune system. This could involve use of questionnaires to determine past 
UVR exposure, history of infections and data on confounding variables, together with 
measurement of immune parameters. 
Future studies of the effect of diet on risk of zoster might collect more data on fruit and 
vegetable intake, including information on portion size and details of consumption of 
vegetables in different forms (for example, asking separately about cooked and raw carrot 
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consumption). This might clarify whether variability in these factors explained why there was 
only a relatively weak association between vegetable intake and risk of zoster in this study, but 
a strong association with fruit intake. Again, if there was scope to explore the effect of diet in 
existing large cohort studies, methodologies such as seven-day food diaries could be used. 
These methods might give a more useful assessment of actual (as opposed to relative) 
intake.304 The finding that elderly individuals with relatively low combined micronutrient 
intake were at increased risk of zoster suggests that these individuals might benefit from 
supplementation. Future randomised controlled trials cquld assess the effect of micronutrient 
supplementation separately in participants who are deficient in micronutrients, so see whether 
the effects differ according to baseline nutritional status. 
The immunological changes that characterise declining cell-mediated immunity in the elderly 
have been well described. 132 However, many studies investigating the ageing immune system 
have been cross-sectional, and relatively little is known about either the average age at onset of 
immunosenescence or its determinants. The present research split the study population into 
'younger' «60 years) and 'older' (~60 years) individuals, and identified two possible 
determinants of immunosenescence - low combined micronutrient intake and a high number 
of stressful events in the last 12 months. Future studies may wish to use more finely graded 
age groupings, and look for trends in risk with increasing age. 
Finally, it is widely assumed that zoster can be diagnosed on clinical grounds. Although 
atypical HSV and zoster presentations are probably rare jn immunocompetent individuals, 
there are a lack of good quality data with which to assess their frequency. Use of polymerase 
chain reaction in studies of individuals with zosteriform rashes and typical 'HSV' vesicular 
rashes will allow an accurate assessment of the sensitivity and specificity of clinical case 
definitions for zoster. 
7.S IMPLICATIONS FOR PRACTICE 
The findings on the effect of dietary intake on risk of zoster are of public health importance. 
Although the underlying mechanism by which high fruit intake may protect against zoster was 
not elucidated, the protective effects associated with fruit consumption provides further support 
for the recommendation from the World Health Organisation and from national governments 
to .eat five portions of fruit and/or vegetables per day.371-373 As outlined in Chapter 2, multiple 
micronutrient deficiencies are common amongst older individuals, particularly those who are 
institutionalised. There are insufficient data from randomised controlled trials to show that 
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micronutrient supplementation lowers susceptibility to infection, and so it is premature to 
suggest that supplements be provided routinely to the elderly to protect against zoster. 
Nevertheless, elderly individuals with relatively low micronutrient intake were at increased 
risk of zoster in this study, and selective supplementation of high-risk individuals may be 
considered as a cost-effective way to decrease morbidity. 
National and international organisations have expressed concerns that depletion of the ozone 
layer and the resulting increased exposure to UVR could result in a range of adverse health 
effects, including altered susceptibility to infectious diseases.2\4,374-376 Numerous national 
public health campaigns have been set up to advise individuals to protect themselves from the 
377-380 Th .. I d·fi d d· UVR sun. ese campaIgns mc u e speCI c programmes targete at re ucmg exposure 
in children, but they have all focussed on the need to prevent skin cancer. The findings from 
the present study indicate suggest that campaigns that encourage parents to protect their 
children against excessive UVR exposure may also help to reduce future zoster incidence. 
The study findings on the protective effect of exogenous VZV exposures against zoster are 
timely, because they were reported at a time when many European and non-European 
countries were considering the introduction of varicella vaccination. The findings were 
forwarded to the Department of Health's Joint Committee on Vaccines and Immunisation, 
where they informed the Committee's decision on whether to add varicella vaccine to the 
childhood schedule (A. Hall, personal communication). Since the study was published, a 
number of other European countries have decided against introducing routine varicella 
vaccination (data presented at the i h meeting of the VZV Research Foundation European 
Working Group on Varicella, November 2002). In countries such as the USA where 
childhood vaccination has already been introduced, there is now heightened interest in the 
results of the current multi-centre trial set up to ascertain whether varicella vaccination 
protects the elderly against zoster.381 If the results of the trial indicate that vaccination is 
effective, both existing and planned childhood varicella vaccination programmes will need 
to consider whether to add vaccination of older subjects to the vaccination schedule. 
In conclusion, this thesis has reported the design and results of the first population-based study 
set up to investigate multiple risk factors for zoster amongst individuals without underlying 
immunosuppression. The results confirmed previous findings on the effect of stress on risk of 
zoster, elucidated the mechanisms by which some ethnic groups may be at lower risk of zoster, 
and identified new determinants of zoster, including exogenous contacts with varicella cases, 
UVR exposure in childhood, and fruit intake. The inclusion of both older and younger 
individuals allowed investigation of potential determinants of Immunosenescence, and 
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identified two such risk factors - combined micronutrient intake and stressful events. The 
study findings have had a significant impact on international varicella vaccination policy, and 
are likely to inform both future research and public health practice. 
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9. Tables for analyses reported in Chapter 6 
(Table 6.6.1 - Table 6,:8.3) 
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Table 6.1.1: Univariable analyses of the effect of contacts with cases of varicella or zoster in the 
last 10 years on the risk of zoster (n=729) 
Contacts in last lOy 
No. of varicella contacts: 
None 
2 
3-4 
5+ 
No. of zoster contacts: 
None 
2+ 
CASES CONTROLS 
179 (73.4) 
34 (13.9) 
20 (8.2) 
6 (2.5) 
5 (2.0) 
189 (77.5) 
44 (18.0) 
11 (4.5) 
283 (58.4) 
74 (15.3) 
45 (9.3) 
44(9.1) 
39 (8.0) 
338 (69.7) 
110 (22.7) 
37 (7.6) 
Univariable OR (95% CI) 
1.00 
0.67 (0.41-1.08) p < 0.0001 
0.61 (0.34-1.09) p (trend) < 0.0001 
0.15 (0.06-0.39) 
0.14 (0.05-0.39) 
1.00 p = 0.052 
0.71 (0.48-1.05) p (trend) = 0.015 
0.51 (0.25-1.04) 
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Table 6.1.2: Univariable analyses of the effect of contacts with children in the last 10 years 
on the risk of zoster (n=729) 
Contacts in last lOy CASES Univariable OR (95% CI) 
Contacts with a few children 
Total no. of child-day contacts with 
children living in the household: 
None 202 (82·8) 355 (73,2) 1·00 
7-2550' 27(11·1) 65 (13,4) 0·62 (0·37-1'05) 
2551-14901 15 (6,1) 65 (1;,4) 0·34 (0·18-0'64) p=O'OOI 
p(t)=0'0002* 
Childcare work: 
None 233 (95'5) 436 (89'9) 1·00 
~ 5 years duration 10 (4'1) 28 (5'8) 0·37 (0'13-1'06) 
> 5 years duration 1 (0,4) 21 (4'3) 0·06 (0·01-0·50) p=O'OOI 
p(t)=O'OOOI* 
Contacts with multi(!le children 
Total no. of social contacts with specific 
children not living in the housenold: 
None 30 (12'3) 49(10,1) 1·00 
2-107' 60 (24'6) 87 (17·9) 1·02 (0'59-1·81) 
108-420 53 (21'7) 88 (18'1) 0·91 (0·51-1·62) 
421-1334 52 (21'3) 87 (18'9) 0·89 (0'49-1·63) 
1335-3457 30 (12'3) 87 (18'9) 0·53 (0'28-0·98) 
3458-32631 19(7'8) 87 (17'9) 0·30 (0'14-0·63) p=0'0003 
p(t) <0.0001'" 
Total no. of social contacts with 
children in groups: 
None 197 (80'7) 308 (63'5) 1·00 
6-550' 24 (9·8) 59 (12'2) 0·63 (0'38-1·06) 
551-3652 16 (6'6) 59 (12,1) 0·32 (0'17-0'62) 
3653-45023 7 (2·9) 59 (12,2) 0·12 (0'06-0·35) p<O'OOOI 
p(t) <0.0001'" 
Occupational contact with multiple 
ill children: 
None 241 (98'8) 460 (94·8) 1·00 
~ 5 years duration 2 (0'8) 14 (2'9) 0'26(0'06-1'17) 
> 5 years duration 1 (0,4) 11 (2·3) 0·17 (0·02-1·29) p=0'015 
p(t)=0.004* 
Occupational contact with multiple 
well children: 
None 209 (85.3) 419 (86.4) 1.00 
~ 5 years duration 20 (8.6) 36 (7.4) 1.11 (0.62-1.99) 
> 5 years duration 15 (6.1) 30 (6.2) 1.01 (0.52-1.96) p = 0.941 
p(t) = 0.859* 
, Quantiles of exposure - see Section 6.1.2. * p(t)= p value for trend 
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Table 6.1.3: Multivariable analysis - effects of contacts in the last ten year with a few children, 
before and after adjusting for multiple child contacts (n=729) 
Distal variables! 
Childcare work with a few 
specific children: 
None 
~ 5 years duration 
> 5 years duration 
Total no. of child-day contacts with 
children living in the household: 
None 
7-25502 
2551-14901 
Univariable OR 
(95% el) 
1·00 
0·37 (0'13-1'06) 
0·06 (0'01-0'50) 
p=0'OO04 
1·00 
0·62 (0'37-1'05) 
0·34 (0'18-0'64) 
p=O'OOl 
Adjusted for intermediate! 
social child contacts 
1·00 
0·94 (0,27-2'99) 
0·19 (0·02-1·79) 
1·00 
p=0'214 
p(t)=0'169* 
0·96 (0'54-1'69) 
0·71 (0'34-1'47) 
p=0'638 
t =0'403* 
1 See Figure 6.1 and text 2 Quantiles of exposure - see Section 6.1.2 ... p(t) = p value for trend 
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Table 6.1.4: Multivariable analyses of the effects of child contacts and contacts with varicella 
and zoster cases in the last 10 years on the risk of zoster (n=729) 
Intermediate variables! 
Total no. of social contacts with specific 
children not living in the household: 
None 
2-1072 
108-420 
421-1334 
1335-3457 
3458-32631 
Total no. of social contacts with 
children in groups: 
None 
6-5502 
551-3652 
3653-45023 
Occupational contact with multiple ill 
children: 
None 
:S 5 years duration 
> 5 years duration 
Proximal variables! 
No. of known contacts with varicella 
cases: 
None 
2 
3-4 
5+ 
No. of known contacts with zoster 
cases: 
None 
2+ 
Univariable OR 
(95% el) 
1·00 
1·02 (0'59-1·81) 
0·91 (0'51-1·62) 
0·89 (0·49-1'63, 
0·53 (0·28-0'98) 
0·30 (0,14-0·63) 
p=O'0003 
1·00 
0·63 (0'38-1·06) 
0·32 (0·17-0·62) 
0·12 (0'06-0·35) 
p<O'OOOI 
1·00 
0·26 (0·06-1·17) 
0·17 (0·02-1'29) 
p=O'OI? 
Univariable OR 
1·00 
Q'67 (0,42-1·08) 
0·61 (0'34-1'09) 
0·15 (0'06-0'39) 
0·14 (0·05-0·39) 
p<O'OOOI 
1·00 
0·71 (0'48-1·05) 
0·51 (0·25-1·04) 
p=O'052 
Adjusted for other intermediate 
variables+ varicella contacts3 
1·00 
1·03 (0·57-1·85) 
0·94 (0'52-1'73) 
0·90 (0·48-1'70) 
0·60 (0· 30-1·17) 
0·43 (0·19-0·94) 
p=O'079 
p(t)=O'007 
1·00 
0·72 (0·41-1·27) 
0·44 (0'22-0'89) 
0·19 (0'07-0·50) 
p=O'OOI 
p(t)=O'OOOI 
1·00 
0·25 (0'05-1'20) 
0·27 (0'03-2·51) 
p=O'062 
p (t)=O'025 
Adjusted for intermediate 
variables (abovd 
1·00 
0·90 (0'54-1'52) 
0·83 (0·45-1'56) 
0·26 (0'10-0'72) 
0·29 (0·10-0'84) 
p=O'OI6 
p (t)=O'003 
Adjusted for intermediate 
variables + varicella contacts3 
1·00 
0·79 (0'51-1·23) 
0·92 (0,42-2·03) 
p=O'581 
I See Figure I and text 2 Quantiles of exposure 3 Also adjusted for ethnicity *p(t) = P value for trend 
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Table 6.1.5: Effect of child contacts in the last lOy on the risk of zoster in study population subsets 
(not adjusted for contact with cases of varicella) 
Variable In total stud:y In women (!o(!ulation - all ages matched controls 
(n=729) (n=411) (n=275) 
Contacts with specific 
children not living 
in the household: 
None 1.00 1.00 1.00 1.00 
1-107 1.04 (0.58-1.86) 1.44 (0.65-3.17)- 1.13 (0.48-2.65) 1.27 (0.48-3.35) 
108-420 0.89 (0.49-1.61) 1.08 (0.49-2.40) 0.82 (0.34-1.99) 1.18 (0.44-3.17) 
421-1334 0.87 (0.46-1.63) 1.41 (0.61-3.25) 0.96 (0.41-2.26) 0.83 (0.29-2.35) 
1335-3457 0.52 (0.27-0.99) 0.75 (0.30-1.84) 0.76 (0.30-1.93) 0.24 (0.07-0.84) 
3458-32631 0.36 (0.17-0.77) 0.42 (0.12-1.39) 0.39 (0.12-1.09) 0.55 (0.15-2.02) 
Contacts with children 
in groups: 
None 1.00 1.00 1.00 1.00 
1-550 0.67 (0.39-1.15) 1.07 (0.43-2.63) 0.66 (0.31-1.40) 0.96 (0.42-2.17) 
551-3652 0.36 (0.18-0.71) 0.59 (0.18-1.90) 0.32 (0.12-0.80) 0.30 (0.10-0.92) 
3653-7492 0.14 (0.06-0.37) 0.15 (0.02-1.29) 0.22 (0.08-0.61) 0.09 (0.01-0.81) 
Occupational contact As binar:y As binar:y variable for 
with ill children: 
variable) lifetime contacts2 
None 1.00 1.00 1.00 1.00 
S; years 0.22 (0.05-1.05) 0.31 (0.03-2.90) 0.17 (0.02-1.46) 0.10 (0.01-0.84) 
>5 years 0.14 (0.02-1.27) ,0.21 (0.02-2.16) 
I No cases had exposure of more than 5 years 2 No cases had exposure in the last 20 years 
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Table 6.1.6. Effect! of social contacts in the last year with specific children not living in the 
household on the risk of zoster, by age of cases and controls. 
A&e < 60:1: (n=390) A&e ~ 60:1: (n=339) 
Contacts in last year with 
specific children not living in 
the household: 
None 1.00 1.00 
1-11 0.32 (0.14-0.72) 1.06 (0.48-2.33) 
12-52 0.55 (0.26-1.17) 2.12 (1.04-4.36) 
53-155 0.47 (0.21-1.08) 1.13 (0.54-2.38) 
156-381 0.28 (0.12-0.66) 0.56 (0.20-1.60) 
382-3650 0.12 (0.04-0.37) 1.14 (0.44-2.96) 
p=0.0007 p=O.139 
p(trend)=O .0003 
1 Adjusted for contacts with groups of children, occupational exposure to iII children in last 10 years, 
childcare I-lOy ago, ethnicity 
Table 6.1.7. Effece of number of contacts per child with specific children not living in the house on 
the risk of zoster among individuals with one or more contact in the last year, 
by number of specific children contacted (n=470) 
Number of specific children contacted in the last nar 
Contacts per child in last year 
with specific children not living 
in the household: 
1-6 
7 - 26 
27 -78 
79 - 365 
1 - 3 Children 
(n=242) 
1.00 
1.14 (0.54-2.41) 
1.40 (0.70-2.78) 
0.85 (0.39-1.91) 
p(trend)=0.925 
>3 Children 
(n=228) 
1.00 
0.66 (0.27-1.61) 
0.36 (0.14-0.88) 
0.27 (0.10-0.77) 
p(trend)=0.0004 
1 Adjusted for number of contacts with groups of children in the last year, occupational contact with ill children 
in the last year, duration of childcare 1-10 years ago, ethnicity 
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Table 6.2.2: Multivariable analysis - effect of ethnicity and number of years since varicella on 
risk of zoster (n=729) 
Variable 
Ethnicity: 
White 
Afro-Caribbean 
Asian 
Other 
No. o/years since varicella*: 
>50 years 
31 - 50 years 
11 - 30 years 
:::; 10 years 
No history of varicella 
Univariable OR 
1.00 
0.45 (0.20-0.96) 
1.46 (0.52-4.11) 
1.09 (0.42-2.86) 
p = 0.130 
1.00 
1.24 (0.63-2.45) 
0.70 (0.30-1.63) 
0.12 (0.01-1.07) 
1.42 (0.92-2.21) 
p = 0.026 
Adjusted for other variable 
in the Table 
1.00 
0.44 (0.21-0.92) 
2.03 (0.66-6.23) 
1.05 (0.38-2.91) 
p =0.057 
1.00 
1.27 (0.63-2.53) 
0.69 (0.29-1.63) 
0.10 (0.01-0.98) 
1.51 (0.97-2.35) 
p = 0.012 
* Those with a history of varicella at unknown age were re-categorised as acquiring varicella between l-lOyrs 
Table 6.2.3: Multivariable analysis - effect of ethnicity and number of years since varicella on 
risk of zoster, excluding those with no history of varicella (n=353) 
Variable 
Ethnicity: 
White 
Afro-Caribbean 
Asian 
Other 
No. o/years since varicella*: 
>50 years 
31 - 50 years 
11 - 30 years 
:::; 10 years 
No history of varicella 
Univariable OR 
1.00 
0.30 (0.10-0.93) 
0.86 (0.20-3.76) 
0.54 (0.14-2.07) 
P = 0.122 
1.00 
0.74 (0.21-2.63) 
0.12 (0.01-1.27) 
0.02 (0.00-0.56) 
(excluded) 
p = 0.037 
Adjusted for other variable 
in the Table 
1.00 
0.32 (0.10-1.00) 
1.12 (0.23-5.35) 
0.52 (0.13-2.08) 
P = 0.170 
1.00 
0.81 (0.22-2.95) 
0.14 (0.01-1.58) 
0.03 (0.00-0.67) 
p = 0.053 
p (trend) = 0.021 
* Those with a history of varicella at unknown age were re-categorised as acquiring varicella between l-lOyrs 
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Table 6.3.1: Univariable analyses of the effect of daily micronutrient intake from food in the 
previous year on the risk of zoster (n=726) 
Nutrient-adjusted' micronutrient intake CASES n(%) CONTROLS n(%) 
Iron (mg): 
13.1 - 23.8 50 (20.6) 96(19.9) 1.00 
11.7 - 13.0 49 (20.2) 97 (20.1) 0.98 (0.60-1.59) p =0.934 
10.7 - 11.6 42 (l7.3) 97 (20.1) 0.84 (0.51-1.39) p(t) = 0.865 
9.5-10.6 51 (21.0) 96 (19.9) 1.04 (0.64-1.70) 
5.8 - 9.4 51 (21.0) 97 (20.1) 1.02 (0.62-1.67) 
Zinc (mg): 
10.7-15.9 46 (18.9) 97 (20.1) 1.00 
9.8 - 10.6 50 (20.6) 97 (20.1) 1.08 (0.66-1.77) p = 0.456 
9.0 - 9.7 38 (15.6) 96 (19.9) 0.83 (0.49-1.39) pet) = 0.577 
7.9 - 8.9 62 (25.5) 97 (20.1) 1.31 (0.82-2.08) 
4.8 - 7.8 47 (19.3) 96 (19.9) 1.04 (0.62-1.73) 
Retinol-equivalents (J-lg): 
2211.9 - 10420.8 47 (19.3) 97 (20.1) 1.00 
1149.0 - 2211.8 53 (21.8) 97 (20.1) 1.11 (0.69-1.77) p = 0.898 
931.4 - 1148.9 50 (20.6) 96 (19.9) 1.08 (0.66-1.75) p(t) = 0.863 
740.0 - 931.3 42 (17.3) 97 (20.1) 0.88 (0.52-1.47) 
161.0 -739.9 51 (21.0) 96(19.9) 1.06 (0.64-1.74) 
Vitamin B6 (mg): 
2.6-4.2 45 (18.5) 96 (20.0) 1.00 
2.3 - 2.5 49 (20.2) 97 (20.0) 1.07 (0.65-1.76) p = 0.737 
2.1 - 2.2 43 (l7.7) 97 (20.0) 0.95 (0.57-1.58) p(t) = 0.585 
1.8 - 2.0 59 (24.3) 97 (20.0) 1.31 (0.81-2.13) 
0.8 - 1.7 47 (19.3) 96 (20.0) 1.05 (0.62-1.76) 
Folic acid (pg): 
365.7 - 615.2 40(16.5) 97 (20.1) 1.00 
324.4 - 365.6 48 (19.7) 97 (20.1) 1.22 (0.74-2.02) p = 0.763 
290.6 - 324.3 49 (20.2) 95(19.6) 1.26 (0.76-7.09) p(t) = 0.267 
250.1 - 290.5 55 (22.6) 97 (20.1) 1.39 (0.85-2.29) 
111.3 - 250.0 51 (2, 1.0) 97 (20.1) 1.29 (0.77-2.15) 
Vitamin C (mg): 
175.7 - 384.9 33 (13.6) 97 (20.1) 1.00 
130.1- 177.4 48 (19.7) 97 (20.1) 1.49 (0.88-2.53) p = 0.160 
97.3 - 130.0 50 (20.6) 97 (20.1) 1.56 (0.92-2.65) p(t) = 0.021 
68.5 - 97.2 50 (20.6) 95(19.6) 1.60 (0.95-2.70) 
5.2 - 68.4 62 (25.5) 97 (20.1) 1.95 (1.15-3.30) 
Vitamin E (mg): 
14.0 - 30.4 46(18.9) 97 (20.1) 1.00 
9.2 - 13.9 56(23.1) 97 (20.1) 1.23 (0.75-2.02) p = 0.775 
7.1-9.1 52 (21.4) 97 (20.1) 1.13 (0.69-1.86) p(t) = 0.502 
5.4 -7.0 47 (19.3) 96 (19.9) 0.99 (0.60-1.65) 
1.7 - 5.3 42 (17.3) 96 (19.9) 0.89 (0.53-1.51) 
I Derived from the residuals from the regression model of micronutrient intake and total energy intake, and the predicted 
micronutrient value for the mean energy intake (see Chapter 4) pet) = p value for trend 
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Table 6.3.2: Effect of daily micronutrient intake from food & supplements in the previous year on risk 
ofzoster in individuals without conditions associated with micronutrient deficiencyZ (n=671) 
Nutrient-adjusted l micronutrient intake CASES n(%) CONTROLS n(%) OR (95% CI) 
Iron (mg): 
14.1-241.8 43(18.9) 88 (19.8) 1.00 
12.0 - 14.0 46 (20.3) 91 (20.5) 1.05 (0.63-1.77) p= 0.964 
10.8 - 11.9 46 (20.3) 87 (19.6) 1.09 (0.66-1.82) p(t) = 0.639 
9.6 - 10.7 43 (18.9) 91 (20.5) 0.99 (0.59-1.67) 
5.6 - 9.5 49 (21.6) 87 (19.6) 1.18 (0.70-1.98) 
Zinc (mg): 
11.1 - 34.9 45 (19.8) 89 (20.1) 1.00 
10.1 - 11.0 45(19.8) 89(20.1) 1.00 (0.60-1.67) p =0.933 
9.1 - 10.0 40 (17.6) 89 (20.1) 0.90 (0.54-1.49) p(t) = 0.718 
7.9 - 9.0 51 (22.5) 88 (19.8) 1.13 (0.69-1.85) 
4.8 - 7.8 46 (20.3) 89 (20.1) 1.04 (0.62-1.75) 
Retinol-equivalents (fJg): 
2358.6 - 10465.0 42 (18.5) 88 (19.8) 1.00 
1519.0 - 2358.5 47 (20.7) 88 (19.8) 1.13 (0.67-1.89) p=0.986 
1018.2 - 1518.9 46 (20.3) 88 (19.8) 1.09 (0.65-1.84) p(t) = 0.873 
777.3 - 1018.1 44 (19.4) 90 (20.3) 1.02 (0.60-1.72) 
161.7 - 777.2 48 (21.1) 90 (20.3) 1.11 (0.66-1.89) 
Vitamin B6 (mg): 
3.2 - 309.2 40 (17.6) 87 (19.6) 1.00 
2.6 - 3.1 53 (23.4) 90 (20.3) 1.28 (0.77-2.13) p = 0.891 
2.2 - 2.5 47 (20.7) 90 (20.3) 1.16 (0.70-1.92) p(t) = 0.911 
1.9 - 2.1 45 (19.8) 93 (20.9) 1.05 (0.63-1.75) 
0.7 - 1.8 42 (18.5) 84 (18.9) 1.08 (0.62-1.87) 
Folic acid (fJg): 
411.8 - 1097.3 36(15.9) 84 (18.9) 1.00 
340.6 - 411.7 55 (24.2) 92 (20.7) 1.46 (0.86-2.47) p = 0.584 
299.0 - 340.5 44 (19.4) 91 (20.5) 1.17 (0.68-2.00) p(t) = 0.874 
254.8 - 298.9 50 (22.0) 87 (19.6) 1.40 (0.83-2.39) 
118.0 - 254.7 42 (1,8.5) 90 (20.3) 1.11 (0.64-1.94) 
Vitamin C (mg): 
209.4 - 1428.5 35 (15.4) 90 (20.3) 1.00 
146.1-209.3 53 (23.4) 87(19.6) 1.53 (0.93-2.52) p = 0.196 
105.0 - 146.0 51 (22.5) 89 (20.0) 1.48 (0.86-2.52) p(t) = 0.462 
72.7 - 104.9 36 (15.9) 92 (20.7) 1.01 (0.59-1.77) 
12.0 - 72.6 52 (22.9) 86(19.4) 1.57 (0.92-2.68) 
Vitamin E (mg): 
18.9 - 542.9 39 (17.2) 84 (18.9) 1.00 
11.9 - 18.8 63 (27.8) 89 (20.0) 1.54 (0.93-2.55) p = 0.055 
8.0 - 11.9 45 (19.8) 89 (20.0) 1.10(0.65-1.86) p(t) = 0.119 
5.7 - 7.9 50 (22.0) 90 (20.3) 1.16 (0.70-1.93) 
1.9 - 5.6 30 (13.2) 92 (20.7) 0.69 (0.39-1.23) 
I See footnote to Table 6.3.1 2 See text p(t) = p value for trend 
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Table 6.3.3: Univariable analyses of the effect of combined daily micronutrient intake in the 
previous year on risk of zoster (n=726) 
CASES CONTROLS OR (95% CI) 
a} Intakes from foods 
Total micronutrient score): 
27 -35 44 (18.1) 104 (21.5) 1.00 
23 -26 44 (18.1) 97 (20.1) 1.07 (0.65-1. 77) p = 0.655 
20-22 50 (20.6) 86 (17.8) 1.39 (0.84-2.31) p(t) = 0.289 
16 -19 54 (22.2) 96 (19.9) 1.33 (0.82-2.15) 
7 -15 51 (21.0) 100 (20.7) 1.23 (0.74-2.05) 
No. of micro nutrients at highest levef· 
3-7 40 (16.5) 99 (20.5) 1.00 
2 45 (18.5) 82 (17.0) 1.36 (0.82-2.25) p = 0.489 
68 (28.0) 142 (29.4) 1.19 (0.75-1.89) 
0 90 (37.0) 160 (33.1) 1.39 (0.89-2.17) 
b} Intakes from foods & su[![!lements: 
Total micronutrient score): 
27 -35 50 (20.6) 114 (23.6) 1.00 
23 -26 47 (19.3) 84 (17.4) 1.27 (0.78-2.06) p = 0.906 
20-22 36 (14.8) 72 (14.9) 1.15 (0.68-1.92) p(t) = 0.605 
16 - 19 57 (23.5) 106 (22.0) 1.15 (0.73-1.83) 
7 -15 53 (21.8) 107 (22.1) 1.19 (0.74-1.90) 
No. of micro nutrients at highest levef· 
3-7 41 (16.9) 98 (20.3) 1.00 
2 39 (16.1) 64 (13.2) 1.46 (0.85-2.51) p = 0.51 1 
1 57 (23.5) 122 (25.3) 1.12 (0.69-1.82) p(t) = 0.479 
0 106 (43.5) 199 (41.2) 1.29 (0.82-2.01) 
ISum of quintile scores of each micronutrient of interest (see text) 
2 At highest quintile of exposure (see text) 
p(t) = p value for trend ., 
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Table 6.3.4: Univariable analyses of the effect of dietary fruit and vegetable intake in the last year 
on risk of zoster (n=726) 
A vera&e intake in the last year OR (95% CI) 
Combined freshIJrozen fruit & 
vegetables: 
~ 8 portions per day 29 (11.9) 103 (21.3) 1.00 
6 - 7 portions per day 50 (20.6) 113 (23.4) 1.76 (1.02-3.04) p= 0.005 
4 - 5 portions per day 86 (35.4) 151 (31.3) 2.25 (1.34-3.79) p(t)=0.0004 
2 - 3 portions per day 61 (25.1) 91 (18.8) 2.63 (1.51-4.60) 
!> 1 portion per day 17 (7.0) 25 (5.2) 2.76 (1.23-6.00) 
Fresh fruit: 
> 3 portions per day 36 (14.8) 116 (24.0) 1.00 
2 - 3 portions per day 79 (32.5) 157 (32.5) 1.64 (1.03-2.60) p =0.025 
5 - 7 portions per week 68 (28.0) 122 (25.3) 1.77 (1.11-2.82) p(t)=0.002 
I - 4 portions per week 42 (17.3) 65 (13.5) 2.21 (1.26-3.87) 
< I portion per week 18 (7.4) 23 (4.8) 2.53 (1.22-5.22) 
Fresh or frozen (all colour) vegetables: 
~ 5 portions per day 39(16.1) 104 (21.5) 1.00 
4 portions per day 42(17.3) 104 (21.5) 1.10 (0.65-1.87) p = 0.094 
3 portions per day 62 (25.5) 117 (24.2) 1.45 (0.87-2.42) p(t)=0.005 
I - 2 portions per day 81 (33.3) 132 (27.3) 1.71 (1.06-2.76) 
< I portion per day 19(7.8) 26 (5.4) 2.09 (1.00-4.34) 
Fresh/frozen green, red or yellow 
vegetables: 
~ 5 portions per day 4 (1.6) 27 (5.6) 1.00 
4 portions per day 15(6.2) 39 (8.t) 2.64 (0.79-8.82) p= 0.055 
3 portions per day 51 (21.0) 101 (20.9) 3.51 (1.15-10.74) p(t)=O.OII 
I - 2 portions per day 135 (55.6) 258 (53.4) 3.66 (1.23-10.92) 
< I portion per day 38 (15.6) 58 (12.0) 4.39 (1.40-13.74) 
p(t) = p value for trend 
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Table 6.3.5: Univariable analyses of the effect of daily micronutrient intake from food 
in the two months before rash onset on risk of zoster (n=726) 
Nutrient-adjusted micronutrient intake CASES n(%) CONTROLS n(%) OR (95% CI) 
Iron (mg): 
13.1-23.9 51 (21.0) 97 (20.1) 1.00 
11.6 - 13.0 49 (20.2) 97 (20.1) 0.97 (0.60-1.58) p = 0.597 
10.7 - 11.5 37 (15.2) 97 (20.1) 0.73 (0.44-1.22) p(t) = 0.720 
9.4 - 10.6 54 (22.2) 97 (20.1) 1.08 (0.66-1.77) 
5.7 - 9.3 52 (21.4) 95(19.6) 1.05 (0.65-1.71) 
Zinc (mg): 
10.7 - 16.2 47 (19.3) 97 (20.1) 1.00 
9.7 - 10.6 47 (19.3) 97 (20.1) 1.00 (0.60-1.66) p= 0.975 
9.0 - 9.7 46 (18.9) 97 (20.1) 0.98 (0.59-1.62) p(t) = 0.566 
7.8 - 8.9 51 (21.0) 96(19.9) 1.09 (0.68-1.76) 
4.8 - 7.7 52 (21.4) 96 (19.9) 1.12 (0.68-1.85) 
Retinol-equivalents (jJg): 
2177.9 - 10364.4 50 (20.6) 97 (20.1) 1.00 
1148.4 - 2177.8 55 (22.6) 97 (20.1) 1.08 (0.68-1. 73) p =0.928 
921.6-1148.3 45 (18.5) 96(19.9) 0.91 (0.56-1.49) p(t) = 0.552 
725.0 - 921.5 45 (18.5) 97 (20.1) 0.89 (0.54-1.47) 
137.8 -725.0 48 (19.8) 96(19.9) 0.94 (0.57-1.54) 
Vitamin B6 (mg): 
2.6-4.2 44 (18.1) 97 (20.1) 1.00 
2.3 - 2.5 49 (20.2) 97 (20.1) 1.12 (0.69-1.84) p = 0.665 
2.1-2.2 41 (16.9) 97 (20.1) 0.95 (0.58-1.56) p(t) = 0.286 
1.8 - 2.0 55 (23.6) 96 (19.9) 1.31 (0.79-2.15) 
0.8 - 1.7 54 (22.2) 96 (19.9) 1.26 (0.76-2.10) 
Folic acid (J.lg): 
368.1 - 631.6 37 (15.2) 97 (20.1) 1.00 
326.4 - 368.0 45 (18.5) 97 (20.1) 1.24 (0.73-2.10) p = 0.447 
286.6 - 326.3 56(23.1) 96 (19.9) 1.54 (0.93-2.55) p(t) = 0.152 
246.7 - 286.5 55 (22.6) 97 (20.1) 1.51 (0.91-2.50) 
112.0 - 246.6 50 (2,0.6) 96 (19.9) 1.40 (0.83-2.36) 
Vitamin C (mg): 
176.9 - 461.9 34 (14.0) 97 (20.1) 1.00 
129.7- 176.8 45 (18.5) 97 (20.1) 1.38 (0.80-2.36) p = 0.194 
97.1 - 129.6 50 (20.6) 97 (20.1) 1.50 (0.90-2.50) p(t) = O.OlO 
67.0 - 97.0 54 (22.2) 96 (19.9) 1.65 (0.97-2.79) 
5.2 - 66.9 60 (24.7) 96(19.9) 1.82 (1.09-3.12) 
Vitamin E (mg): 
14.4 - 30.2 46 (18.9) 97 (20.1) 1.00 
9.2 - 14.3 55 (22.6) 97 (20.1) 1.20 (0.74-1.96) p = 0.667 
7.1-9.1 55 (22.6) 97 (20.1) 1.20 (0.73-1.96) p(t) = 0.440 
5.4 -7.0 46 (18.9) 95 (19.7) 0.98 (0.60-1.63) 
1.7 - 5.3 41 (16.9) 97 (20.1) 0.85 (0.50-1.47) 
I Derived from the residuals from the regression model of micronutrient intake and total energy intake, and the predicted 
micronutrient value for the mean energy intake (see Chapter 4) p(t) = p value for trend 
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Table 6.3.6: Effect of daily micronutrient intake from food/supplements in the 2m before rash onset on 
zoster risk in individuals without conditions associated with micronutrient deficiencyl (n=671) 
Nutrient-adjusted micronutrient intake CASES n (%) CONTROLS n (%) OR (95% CI) 
Iron (mg): 
13.8 - 240.5 53 (21.8) 97 (20.1) 1.00 
12.0 -13.7 52 (2104) 97 (20.1) 1.00 (0.61-1.64) p =0.366 
10.8 - 11.9 35 (1404) 97 (20.1) 0.66 (0.39-1.12) pet) = 0.903 
9.6 - 10.7 47 (19.3) 97 (20.1) 0.90 (0.54-1.47) 
5.6 - 9.5 56 (23.1) 95 (19.6) 1.09 (0.67-1.79) 
Zinc (mg): 
11.1 - 37.3 49 (20.2) 97 (20.1) 1.00 
10.0 - 11.0 48 (19.8) 97 (20.1) 0.98 (0.60-1.60) p = 0.982 
9.0-9.9 45 (18.5) 97 (20.1) 0.92 (0.56-1.50) pet) = 0.755 
7.9 - 8.9 49 (20.2) 96 (19.9) 1.01 (0.62-1.64) 
4.7 - 7.8 52 (2104) 96(19.9) 1.08 (0.66-1.76) 
Retinol-equivalents (f.lg): 
2382.7 - 1035804 52 (2104) 97 (20.1) 1.00 
1518.6 - 2382.6 46 (18.9) 97 (20.1) 0.86 (0.52-1043) p= 0.462 
1018.0 - 1518.5 54 (22.2) 97 (20.1) 1.01 (0.63-1.64) pet) = 0.864 
777.1-1017.9 36 (14.8) 96(19.9) 0.68 (0040-1.15) 
137.8 - 777.0 55 (22.6) 96 (19.9) 1.03 (0.63-1.68) 
Vitamin B6 (mg): 
3.0 - 30804 52 (2104) 97 (20.1) 1.00 
2.5 - 2.9 40 (16.5) 97 (20.1) 0.76 (0046-1.27) p =0.822 
2.1 - 204 50 (20.6) 97 (20.1) 0.96 (0.59-1.55) pet) = 0.703 
1.8 - 2.0 50 (20.6) 97 (20.1) 0.97 (0.60-1.56) 
0.7 - 1.8 51 (21.0) 95 (19.6) 1.00 (0.59-1.69) 
Folic acid (f.lg): 
406.1 - 1092.9 47 (19.3) 97 (20.1) 1.00 
335.8 - 406.0 54 (22.2) 97 (20.1) 1.18 (0.72-1.93) p=0.901 
297.8 - 335.7 48 (19.8) 96 (19.9) 1.03 (0.63-1.70) pet) = 0.700 
251.3 - 297.7 51 (21.0) 97 (20.1) 1.11 (0.67-1.83) 
118.7 - 251.2 4307.7) 96 (19.9) 0.92 (0.55-1.55) 
Vitamin C (mg): 
209.1 - 1426.0 42 (17.3) 97 (20.1) 1.00 
147.3 - 209.0 42 (17.3) 97 (20.1) 1.02 (0.61-1.68) p = 0.668 
105.9 - 147.2 52 (21.4) 97 (20.1) 1.29 (0.78-2.13) p(t) =0.160 
71.0 - 105.8 52 (2104) 96 (19.9) 1.28 (0.77-2.13) 
12.0-70.9 55 (22.6) 96(19.9) 1.35 (0.81-2.25) 
Vitamin E (mg): 
18.8 - 53104 51 (20.6) 97 (20.1) 1.00 
12.1 - 18.7 54 (22.2) 97 (20.1) 1.06 (0.66-1. 71) p = 0.454 
8.0 - 12.0 52 (2104) 97 (20.1) 1.03 (0.63-1.66) pet) = 0.221 
5.6 - 7.9 52 (21.4) 96 (19.9) 1.03 (0.63-1.65) 
1.9-5.5 35 (1404) 96 (19.9) 0.68 (0040-1.16) 
I See footnote to Table 6.3.1 2 See text pet) = p value for trend 
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Table 6.3.7: Univariable analyses ofthe effect of combined daily micronutrient intake in the 
two months before rash on risk of zoster (n=726) 
CASES CONTROLS OR (95% CI) 
a} Intakes from foods 
Total micronutrient score]: 
27 -35 45 (18.5) 102 (21.1) 1.00 
23 -26 49 (20.2) 101 (20.9) 1.09 (0.66-1.80) p = 0.856 
20-22 44 (18.1) 89 (18.4) 1.12 (0.68-1.84) 
16 -19 54 (22.2) 92 (19.0) 1.31 (0.81-2.12) 
7 -15 51 (21.0) 99 (20.5) 1.17 (0.71-1.94) 
No. of micronutrients at highest levef· 
3-7 44 (18.1) 98 (20.3) 1.00 
2 42 (17.3) 81 (16.8) 1.16 (0.69-1.92) p = 0.856 
68 (28.0) 140 (29.0) 1.09 (0.69-1.73) 
0 89 (36.6) 164 (33.9) 1.20 (0.78-1.86) 
b} Intakes from foods & sUlmlements: 
Total micronutrient score!: 
27-35 52 (21.4) 110 (22.8) 1.00 
23-26 42 (17.3) 92 (19.1) 0.97 (0.59-1.59) p= 0.846 
20-22 42 (17.3) 70 (14.5) 1.28 (0.77-2.13) 
16 - 19 55 (22.6) 104 (21.5) 1.11 (0.70-1.77) 
7-15 52 (21.4) 107 (22.1) 1.03 (0.63-1.67) 
No. of micro nutrients at highest levef: 
3-7 45 (18.5) 93 (19.2) 1.00 
2 43(17.7) 72 (14.9) 1.23 (0.73-2,07) p = 0.632 
1 57 (23.5) 131 (27.1) 0.90 (0.55-1.45) 
0 98 (40.3) 187 (38.7) 1.08 (0.69-1.68) 
'Sum ofquintile scores of each micronutrient of interest (see text) 
2 At highest quintile of exposure (see text) " 
pet) = p value for trend 
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Table 6.3.8: Univariable analyses of the effect of dietary fruit and vegetable intake in the 2m before 
rash onset on the risk of zoster (n=726) 
A vera~e intake in the last year OR (95% el) 
Combined freshlJrozen fruit & 
vegetables: 
~ 8 portions per day 33 (13.6) 105(21.7) 1.00 
6 - 7 portions per day 43 (17.7) 109 (22.6) 1.38 (0.81-2.35) p = 0.010 
4 - 5 portions per day 91 (37.5) 146 (30.2) 2.18 (1.32-3.60) p(t)=0.002 
2 - 3 portions per day 61 (25.1) 98420.3) 2.13 (1.26-3.61) 
:S; 1 portion per day 15 (6.2) 25 (5.2) 2.11 (0.97-4.57) 
Fresh fruit: 
> 3 portions per day 39 (16.1) 116 (24.0) 1.00 
2 - 3 portions per day 77 (31.7) 157 (32.5) 1.50 (0.95-2.37) p =0.069 
5 - 7 portions per week 67 (27.6) 117 (24.2) 1.70 (1.06-2.72) p(t)=0.006 
1 - 4 portions per week 42 (17.3) 70 (14.5) 1.88 (1.08-3.26) 
< 1 portion per week 18 (7.4) 23 (4.8) 2.36 (1.14-4.87) 
" 
Fresh or frozen (all colour) vegetables: 
~ 5 portions per day 37 (15.2) 104 (21.5) 1.00 
4 portions per day 45 (18.5) 96 (19.9) 1.35 (0.80-2.26) p = 0.173 
3 portions per day 60 (24.7) 118 (24.4) 1.49 (0.89-2.49) p(t)=0.015 
1 - 2 portions per day 86 (35.4) 140 (29.0) 1.80 (1.12-2.92) 
< 1 portion per day 15(6.2) 25 (5.2) 1.78 (0.81-23.89) 
Fresh/frozen green, red or yellow 
vegetables: 
~ 5 portions per day 4 (1.6) 28 (5.9) 1.00 
4 portions per day 17 (7.0) 38 (7.9.) 3.27 (0.98-10.86) p = 0.047 
3 portions per day 46 (18.9) 103 (21.3) 3.20 (1.05-9.75) p(t)=0.027 
1 - 2 portions per day 139 (57.2) 250 (51.8) 4.13 (1.39-12.30) 
< 1 portion per day 37 (15.2) 64 (12.2) 4.02 (1.30-12.46) 
p(t) = p value for trend 
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Table 6.3.9: Univariable analyses of the effect of anthropometric indices on the risk of zoster 
Ex~osure OR (9S% CI) 
Body mass index (n=677): 
'Underweight' (:$;20) 98 (42.4) 183(41.0) 0.77 (0.38-1.56) 
'Average' (>20 - 25) 88(38.1) 155 (34.8) 1.00 p =0.523 
'Overweight' (>25 - 30) 31 (13.4) 75 (16.8) 1.09 (0.75-1.57) 
'Obese' (>30) 14 (6.1) 33 (7.4) 0.77 (0.47-1.26) 
Mindex (women only: n=379/: 
54.03 - 76.91 26 (20.0) 47 (18.9) 0.98 (0.48-2.02) 
76.92 - 84.56 30 (23.1) 5 I (20.5) 1.00 p = 0.861 
84.57 - 92.55 27 (20.8) 51 (20.5) 0.94 (0.47- 1.86) 
92.56 - 106.48 27 (20.8) 50 (20.1) 0.95 (0.48-1.90) 
106.49 - 148.77 20(15.4) 50 (20.1) 0.70 (0.35- 1.40) 
Demiquet (men only: n=299): 
70.08 - 102.56 22 (21.6) 39 (19.8) 0.96 (0.46-2.01) 
102.57 - 113.72 23 (22.6) 38(19.3) 1.00 p = 0.807 
113.73 - 122.50 20(19.6) 41 (20.8) 0.82 (0.39-1.75) 
122.51 - 133.86 23 (20.8) 41 (20.8) 0.94 (0.45- 1.97) 
133.87 - 212.08 14 (13.7) 38(19.3) 0.63 (0.29-1.40) 
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Table 6.3.10: Effects of fresh/frozen fruit and vegetable intake in the last year on the risk of zoster, 
adjusted for dietary vitamin C intake (n=726) 
A veraKe intake in the last l:ear Univariable OR Adjusted for dietan: Adjusted for dietan: 
(95% cn vitamin C intake vit.C intake & smokinK 
Combined fresh/frozen fruit & 
vegetables: 
~ 8 portions per day 1.00 1.00 1.00 
6 - 7 portions per day 1.76 (1.02-3.04) 1.71 (0.96-3.05) 1.82 (1.01-3.28) 
4 - 5 portions per day 2.25 (1.34-3.79) 2.22 (1.23-4.00) 2.30 (1.26-4.18) 
2 - 3 portions per day 2.63 (1.51-4.60) 2.57 (1.31-5.04) 2.73 (1.38-5.41) 
:s; I portion per day 2.76 (1.23-6.00) 2.67 (1.07-6.69) 2.94 (1.16-7.46) 
p=0.005 p=0.06 p=0.005 
p(t)=0.0004 p(t)=0.007 p(t)=0.005 
Fresh fruit: 
> 3 portions per day 1.00 1.00 1.00 
2 - 3 portions per day 1.64 (1.03-2.60) 1.54 (0.94-2.54) 1.63 (0.98-2.71) 
5 - 7 portions per week 1.77 (1.11-2.82) 1.65 (0.97-2.83) 1.76 (1.02-3.03) 
I - 4 portions per week 2.21 (1.26-3.87) 2.06 (1.05-4.04) 2.27 (1.14-4.51) 
< I portion per week 2.53 (1.22-5.22) 2.33 (0.98-5.51) 2.84 (1.17-6.92) 
p=0.025 p=0.240 p=0.128 
p(t)=0.002 p(t)=0.035 p(t)=0.015 
Fresh/frozen (all colour) 
vegetables: 
~ 5 portions per day 1.00 1.00 1.00 
4 portions per day 1.10(0.65-1.87) 1.10 (0.58-1.73) 1.31 (0.89-2.64) 
3 portions per day 1.45 (0.87-2.42) 1.32 (0.77-2.25) 1.49 (0.86-2.59) 
I - 2 portions per day 1.71 (1.06-2.76) 1.49 (0.89-2.51) 1.82 (0.87-2.72) 
< I portion per day 2.09 (1.00-4.34) 1.74 (0.78-3.90) 1.69 (0.94-3.06) 
p=0.094 p=0.371 p=0.372 
p (t)=0.005 P (t)=0.049 P (t)=0.048 
Fresh or frozen red/yellow/green 
vegetables: 
~ 5 portions per day 1.00 1.00 1.00 
4 portions per day 2.64 (0.79-8.82) 2.36 (0.70-7.99) 2.35 (0.69-8.02) 
3 portions per day 3.51 (1.15-10.74) 2.98 (0.95-9.38) 2.96 (0.93-9.37) 
I - 2 portions per day 3.66 (1.23-10.92) 3.01 (0.97-9.32) 2.90 (0.93-9.04) 
< I portion per day 4.39 (1.40-13.74) 3.26 (0.97-9.32) 3.23 (0.96-10.89) 
p=0.055 p=0.291 p=0.320 
p (t)=O.OII P (t)=0.I06 P (t)=0.129 
Table 6.3.11: Effects of nutrient-adjusted vitamin C intake in the last year from foods on risk of zoster, 
adjusted for fresh/frozen fruit and vegetable intake (n=726) 
Nutrient-adjusted 
vi! C intake (mg): 
175.7 - 384.9 
·130.1- 177.4 
97.3 - 130.0 
68.5 - 97.2 
5.2 - 68.4 
Univariable OR 
(95% cn 
1.00 
1.49 (0.88-2.53) 
1.56 (0.92-2.65) 
1.60 (0.95-2.70) 
1.95 (1.15-3.30) 
p=0.160 
(t =0.002 
Adjusted for fruit Adjusted for fruit Adjusted for 
& vegetable intake intake vegetable intake 
1.00 1.00 1.00 
1.20 (0.68-2.09) 1.29 (0.75-2.24) 1.46 (0.85-2.50) 
1.09 (0.61-1.95) 1.21 (0.68-2.16) 1.47 (0.85-2.50) 
1.01 (0.55-1.84) 1.15 (0.64-2.09) 1.42 (0.81-2.47) 
1.11 (0.57-2.18) 1.22 (0.64-2.36) 1.56 (0.87-2.79) 
p=0.640 p=0.922 p=0.573 
t =0.986 (t =0.767 t =0.223 
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Table 6.3.12 Effect* of fresh/frozen vegetable intake in the last 2m on risk of zoster, by age 
FreshIJrozen vegetable intake: 
~ 5 portions per day 
4 portions per day 
3 portions per day 
I - 2 portions per day 
< I portion per day 
Age<60 
1.00 
0.94 (0.49-1.81) 
1.30 (0.67-2.55) 
0.87 (0.46-1.66) 
0.73 (0.21-2.58) 
"'Adjusted for smoking and fresh fruit intake 
p=0.036 
Age~60 
1.00 
2.45 (0.90-6.68) 
1.83 (0.69-4.84) 
3.56 (1.40-9.02) 
3.16 (0.93-10.73) 
Table 6.3.13: Effect of total micronutrient score and number of micro nutrients at highest 
intake level (from food) in the last year on risk of zoster, by age 
A&e < 60 years A&e ~ 60 years 
(n=390) (n=336) 
Micronutrient score: 
27 -35 1.00 1.00 
23 -26 0.71 (0.37-1.36) 2.03 (0.83-4.93) 
20-22 0.79 (0.41-1.55) 3.12 (1.35-7.20) 
16 - 19 0.87 (0.47-1.60) 2.80 (1.21-6.47) 
7 -15 0.45 (0.21-0.95) 3.73 (1.64-8.50) 
P = 0.281 P = 0.013 
P (trend) = 0.131 P (trend) = 0.002 
No. of micro nutrients at 
highest intake level: 
3-7 1.00 1.00 
2 1.66 (0.87-3.17) 1.06 (0.44-2.53) 
0.71 (0.39-1.31) 2.59 (l.l9-5.61) 
0 0.96 (0.54-1.71) 2.60 (1.23-5.50) 
'p=0.061 P = 0.007 
P (trend) = 0.002 
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Table 6.4.1: Univariable effects of cumulative UVR exposure and intensity of UVR exposure 
from sunlight in childhood on the risk of zoster 
UVR exposure (MED) OR (9S%CI) 
Cumulative UVR exl!.0sures in childhood 
Total UVR exposure in warmer months 
from non-holidays+ holidays combined (n=6J6): 
246.5 - 504.0 29 (13.5) 78 (19.4) 1.00 
504.1 - 630.2 49 (22.9) 81 (21.1) 1.59 (0.90-2.79) p = 0.401 
630.3 - 730.3 41 (19.2) 82 (20.4) 1.33 (0.75-2.35) p(t) =0.148 
730.4 - 936.9 47 (22.1) 81 (20.0) 1.62 (0.91-2.88) 
937.0 - 2448.1 48 (22.4) 80 (19.9) 1.66 (0.94-2.94) 
Total weekly UVR exposure in warmer months, 
excluding holidays (n=63J): 
3.03 - 16.20 22 (10.1) 82 (19.8) 1.00 
16.21 - 20.51 53 (24.3) 82 (19.8) 2.54 (1.39-4.64) p = 0.006 
20.52 - 23.92 59 (27.1) 86 (20.8) 2.58 (1.44-4.63) p(q) = 0.002 
23.93 - 27.35 47 (21.6) 80 (19.4) 2.31 (1.25-4.26) p(t) = 0.320 
27.35 - 84.21 37 (17.0) 83 (20.1) 1.63 (0.88-3.02) 
Total UVR exposure on summer holidays 
(n=689): 
No holidays 89 (38.2) 181 (39.7) 2.38 (1.16-4.87) 
2.80 - 39.2 10(4.3) 51 (11.2) 1.00 p=0.02 
39.3-61.1 33 (14.2) 57 (12.5) 2.86 (1.28-6.37) p(t) = 0.043 1 
61.2 - 84.6 26 (11.2) 54 (11.8) 2.33 (1.02- 5.32) 
84.7 - 160.2 41 (17.6) 58 (12.7) 3.72 (1.68-8.27) 
160.3 -1037.2 34 (14.6) 550.2.1) 3.17 (1.41-7.13) 
Intensi(!. o( UVR exl!.0sure in childhood 
Highest daily UVR exposure per week in warmer 
months, excluding holidays (n=63J): 
0.43 - 1.62 29 (13.3) 82 (19.9) 1.00 
1.63 - 2.16 50 (22.9) 77 (18.6) 1.83 (1.06-3.17) p= 0.098 
2.17-3.33 '42(19.3) 73(17.7) 1.68 (0.94-2.98) p(t) = 0.643 
3.34-4.32 55 (25.2) 85 (20.6) 1.84 (1.06-3.17) 
4.33 - 15.27 42 (19.3) 96 (23.2) 1.21 (0.69-2.12) 
Daily UVR exposure on holiday (n=689): 
No holidays/trips 87 (38.2) 178 (39.0) 1.43 (0.79-2.86) 
0.40 - 4.32 18 (7.6) 54 (12.0) 1.00 
4.32 - 5.19 28 (11.8) 58(12.7) 1.44 (0.72-2.86) p = 0.093 
5.19 - 6.05 23 (9.7) 49 (10.8) 1.35 (0.67-2.72) p(t) = 0.0491 
6.05 - 6.91 26 (21.4) 55 (12.1) 1.45 (0.71-3.00) 
6.91 - 15.27 51 (11.3) 62 (13.6) 2.53 (1.31-4.91) 
IUsing holidaymakers only (n=295) p(t) = p value for trend p(q) = p value for quadratic association 
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Table 6.4.2: Univariable effects of intermittent UVR exposure from sunlight in childhood on risk 
of zoster 
UVR exposure (MED) OR(95%CI) 
Intermittencr. in non-holidar.l!.eriods 
Ratio of non-schoolday to schoolday exposure 
in warmer months (n=631/: 
:s; 1.00 13 (6.0) 24 (5.8) 1.00 
1.1 - 1.8 45 (20.6) 97 (23.5) 0.89 (0.41-1.92) p= 0.741 
1.9 - 2.3 46 (21.1) 96 (23.2) 0.86 (0.39-1.87) p(t) = 0.266 
2.4 - 2.9 55 (25.2) 98 (23.7) 1.06 (0.49-2.30) 
3.0 - 9.0 59(27.1) 98 (23.7) 1.17 (0.54-2.52) 
Intermittencr. due to childhood holidar.s 
Ratio of holiday to non-holiday UVR exposure 
in warmer months (n=616/: 
:s; 1.00 (including no holidays) 106 (49.5) 229 (57.0) 1.00 
1.01 - 1.20 31 (14.5) 43 (10.7) 1.60 (0.93-2.75) p = 0.233 
1.11 - 1.42 33 (15.4) 44 (10.9) 1.68 (1.00-2.84) p(t) = 0.414 
1.43 - 1.85 24 (1 1.2) 44 (10.9) 1.17 (0.68-2.00) 
1.86 - 6.0 20 (9.4) 42 (10.5) 1.11 (0.61-2.20) 
I Highest daily exposure on schoolday: highest daily exposure on non-schoolday in summer months 
2Highest daily exposure on holiday: highest daily exposure on non-holiday in summer months 
p(t) = p value for trend p(q) = p value for quadratic association 
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Table 6.4.3: Univariable effects of cumulative UVR exposure from sunlight in the last year 
on risk of zoster (n=729) 
UVR exposure (MED) OR(9S%CI) 
Total UVR exposure in warmer months,from 
non-holidays & holidays combined: 
0- 157.7 37(15.2) 92 (19.0) 1.00 
157.8 - 245.7 54 (22.1) 102 (21.0) 1.35 (0.81-2.24) p=0.290 
245.8 - 363.6 42 (17.2) 96 (19.8) 1.15 (0.66-2.01) pet) = 0.073 
363.7 - 534.2 49 (20.1) 9& (20.2) 1.32 (0.77-2.27) 
534.3 - 1169.3 62 (25.4) 97 (20.0) 1.76 (1.02-3.02) 
Total weekly UVR exposure in warmer months, 
excluding holidays: 
0-4.7 43 (17.6) 96 (19.8) 1.00 
4.8 - 8.4 45(18.4) 97 (20.0) 1.04 (0.62-1.73) p=0.311 
8.5 - 12.1 54 (22.1) 104 (21.4) 1.20(0.72-1.99) p(t)=0.120 
12.2 - 18.1 41 (16.8) 95 (19.6) 1.00 (0.58-1.72) 
18.2 - 43.2 61 (25.0) 93 (19.2) 1.61 (0.95-2.74) 
Total UVR exposure on summer holidays/trips: 
No holidays 107 (43.9) 193 (39.8) 1.67 (0.93-2.99) 
0-22.9 20 (8.2) 58 (12.0) 1.00 P = 0.224 
23.0 - 41.0 24 (9.8) 59 (12.1) 1.19 (0.59-2.41) pet) = 0.9261 
41.1 - 70.1 34 (13.9) 58 (12.0) 1.72 (0.88-3.37) p(q)= 0.035 1 
70.2 - 132.7 37 (15.2) 59 (12.1) 1.88 (0.95-3.71) 
132.8 - 893.4 22 (9.0) 58 (12.0) 1.10 (0.53-2.29) 
Total UVR exposure on winter holidays/trips: 
No holidays 159 (65.2) 350 (12.1) 0.71 (0.43-1.16) 
0-4.9 30 (12.3) 45 (9.3) 1.00 P =0.289 
5.0 - 22.9 25(10.2) 45 (9.3) 0.87 (0.44-1.69) pet) = 0.45i 
23.0 - 1186.7 30 (12.3) 45 (9.3) 1.03 (0.54-2.00) 
Total UVR exposure during holidays/trips 
(summer & winter combined): 
No holidays 83 (34.0) 160 (33.0) 1.08 (0.65-1.81) 
0-22.8 32 (13.1) 66 (13.6) 1.00 P = 0.642 
22.9 - 42.6 23 (9.4) 64 (13.2) 0.73 (0.38-1.39) pet) = 0.8411 
42.7 - 70.7 37(15.2) 65 (13.4) 1.18 (0.66-2.12) 
70.8 - 140.8 38 (15.6) 65 (13.4) 1.24 (0.66-2.25) 
140.9 - 1186.8 31 (12.7) 65(13.4) 0.98 (0.52-1.81) 
Total UVR exposure from sunbathing during 
non-holiday periods: 
None 135 (55.3) 283 (58.4) 1.00 
0.75 - 450.2 36 (14.8) 67 (13.8) 1.14 (0.72-1.80) p=0.862 
450.3 - 1618.1 36 (14.8) 67 (13.6) 1.16 (0.73-1.84) 
1618.2 - 8640.6 37 (15.1) 69 (14.2) 1.15 (0.72-1.83) 
I Using holidaymakers only pet) = p value for trend p(q) = p value for quadratic association 
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Table 6.4.4: Univariable effects of intensity and intermittency of UVR exposure from sunlight 
last year on risk of zoster (n=729) 
UVR exposure (MED) OR (95% el) 
IntensitJ!. ol UVR exf!.osure 
Highest daily UVR exposure per week 
in warmer months. excluding holidays: 
0-1.0 50 (20.5) 97 (20.0) 1.00 
1.1 - 1.6 45 (18.4) 120 (24.7) 0.74 (0.45-1.22) p = 0.226 
1.7 - 2.9 44 (18.0) 87 (17.9) 1.02 (0.60-1.73) p(t) = 0.261 
3.0 - 3.8 70 (28.7) 109 (22.5) 1.29 (0.78-2.14) 
3.9 - 11.5 35 (14.3) 72 (14.9) 1.00 (0.56-1. 79) 
Daily UVR exposure on summer/winter 
holidays: 
No holidays/trips 83 (33.9) 161 (33.1) 1.03 (0.62-1.69) 
0-2.2 33 (13.5) 66 (13.6) 1.00 p = 0.152 
2.3 - 3.8 21 (8.6) 65 (13.4) 0.63 (0.33-1.20) p(t) = 0.7221 
3.9 - 5.5 47 (19.2) 65 (13.4) 1.49 (0.83-2.65) 
5.6 - 7.6 27 (11.2) 65 (13.4) 0.84 (0.45-1.59) 
7.7-15.2 34 (13.9) 65(13.4) 1.05 (0.58-1.92) 
Intermittenc[ olexf!.osure 
Ratio of non-work day:work day exposure 
in summer month/: 
:S; 1.00* 151 (61.9) 292 (60.2) 1.00 
1.1 - 3.0 32 (13.1) 50 (10.3) 1.22 (0.70-2.12) p = 0.410 
3.1- 8.0 29 (11.9) 65 (13.4) 0.79 (0.46-1.36) p(t) =0.131 
8.1 - 16.0 18 (7.4) 36 (7.2) 0.89 (0.46-1. 72) 
16.1 - 00 14 (5.7) 42 (8.7) 0.60 (0.31-1.19) 
Ratio of holiday to non-holiday UVR exposure 
in summer monthi: 
:S; 1.00 (including no holidays) 125 (51.2) 240 (49.5) 1.00 
0.75 - 1.64 24 (9.8) 60 (12.4) 0.75 (0.44-1.28) p= 0.559 
1.65 - 2.40 40 (16.4) 62 (12.8) 1.22 (0.77-1.92) p(t) = 0.661 
2.41-3.64 27 (11.1) 62 (12.8) 0.84 (0.50-1.39) 
3.65 - 26.64 28 (11.5) 61 (12.6) 0.90 (0.54-1.48) 
Ratio of holiday to non-holiday UVR exposure 
in winter monthi: 
:S; 1.00 (including no holidays) 169 (69.3) 366 (75.5) 1.00 
1.01 - 4.9 22 (9.0) 39 (8.0) 1.21 (0.70-2.09) p = 0.328 
5.0 - 15.1 26(10.7) 41 (8.1) 1.35 (0.80-2.27) p(t) = 0.065 
15.2 - 00 27(11.1) 39 (8.0) 1.54 (0.90-2.63) 
• In~ludes individuals who did not work or worked 7 days/week 
I Highest daily exposure on non-work day: highest daily exposure on workday in summer months. Ratios were reversed 
for individuals who worked for less than half the week (see text) 
2 Highest daily exposure on holiday: highest daily exposure on non-holiday (see text) 
p(t) = p value for trend p(q) = p value for quadratic association 
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Table 6.4.5: Univariable effects of cumulative, intermittency and intensity of UVR exposure from 
sunlight in the month before rash onset on the risk of zoster (n=729) 
UVR exposure MED) 
OR(95%CI) 
Cumulative UVR exf!.osures 
Total UVR exposure (non-holidays+ holidays): 
0-3.06 39 (16.0) 97 (20.0) 1.00 
3.06 - 11.40 56 (23.0) 98 (20.2) 1.59 (0.92-2.77) p =0.356 
11.40 - 33.33 44 (18.0) 97 (20.0) 1.44 (0.70-2.98) pet) = 0.102 
33.33 - 64.02 51 (20.9) 96 (19.8) 1.83 (0.85-3.92) 
64.02 - 293.46 54 (22.1) 97 (20.0) 1.99 (0.91-4.36) 
Total UVR exposure on holidays & trips: 
No holidays 199 (81.6) 421 (86.8) 1.00 
0-26.39 24 (10.2) 32 (6.6) 1.56 (0.90-2.72) p=0.181 
26.39 - 266.29 21 (8.6) 32 (6.6) 1.41 (0.80-2.51) pet) = 0.107 
Total non-holiday UVR exposure from 
sunbathing: 
None 203 (82.9) 378 (78.0) 1.00 
0.75 - 8.8 24 (9.8) 54 (11.1) 0.81 (0.47-1.39) p=0.146 
8.9 - 171.05 17(7.0) 53 (10.9) 0.57 (0.32-1.04) p(t)=0.051 
Intensi!J!. ot. UVR exf!.osure 
Highest daily non-holiday UVR exposure: 
0-0.16 37(15.2) 98 (20.2) 1.00 
0.17 - 0.80 57 (23.4) 96 (19.8) 1.80 (1.03-3.14) p=0.164 
0.81 - 1.81 57 (23.4) 105 (21.6) 1.92 (0.92-3.99) pet) = 0.165 
1.82 - 3.25 39 (16.0) 93 (19.2) 1.56 (0.68-3.53) 
3.26 - 8.15 54 (22.1) 93(19.2) 2.20 (0.98-4.96) 
Highest daily UVR exposure on holidays 
& trips: 
No holidays 199 (81.6) 421 (86.8) 1.00 P = 0.146 
0-3.4 20 (8.2) 32 (6.6) 1.29 (0.72-2.31) pet) = 0.05 
3.4 - 14.4 . 25 (10.2) 32 (6.6) 1.71 (0.97-3.00) 
Intermittencr. ot. UVR exf!.osure 
Ratio of holiday to non-holiday exposuri: 
::; 1.00 (including no holidays) 209 (85.7) 436 (89.9) 1.00 
1.01 - 2.50 24 (9.8) 24 (5.0) 2.17 (1.16-4.07) P =0.048 
2.51 - 578.1 11 (4.5) 25(5.1) 0.92 (0.44-1.90) pet) = 0.362 
Sunburns causing severe erythema/blistering: 
No 236 (96.7) 474 (97.7) 1.00 
Yes 8 (3.3) 11 (2.3) 1.43 (0.56-3.67) p = 0.461 
.' 1,2 See footnotes to Table 6.4.3 & Table 6.4.4 pet) = p value for trend 
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Table 6.4.6: Univariable analyses of effect of skin response to UVR exposure on the risk of zoster 
Skin response to UVR exposure OR (95% el) 
Response to initial exposure - propensity to 
burn (n=677): 
Tans only 86 (37.4) 175 (39.1) 1.00 
Tans + burns 68 (29.6) 157 (35.1) 0.89 (0.50-1.32) p= 0.252 
Burns + peels 69 (30.0) 104 (23.3) 1.37 (0.90-2.09) pet) = 0.175 
Blisters + peels 7 (3.0) 11-(2.5) 1.33 (0.60-1.32) 
Response to chronic exposure - ability to tan 
(n = 709): 
Deep tan 58 (24.4) 133 (28.2) 1.00 
Moderate tan 115 (48.3) 218 (46.3) 1.23 (0.84-1.81) p = 0.153 
Mild tan + peeling 43 (18.1) 95 (20.2) 1.04 (0.64-1.70) pet) = 0.162 
Freckling without tan 22 (9.2) 25 (5.3) 2.20 (1.08-4.50) 
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Table 6.4.7: Independent effects ofweeldy non-holiday UVR exposure in the warmer months 
and total summer holiday exposure in childhood on the risk of zoster (n=616)1 
UVR exposure (MED) Univariable OR Adjusted for other Adjusted for other 
variable in the Table variable + ethnid!! 
Weekly UVR exposure in warmer 
months. excluding holidays: 
78.8 - 421.3 1.00 1.00 1.00 
421.4 - 533.3 2.66 (1.44-4.92) 2.30 (1.22-4.33) 2.30 (1.22-4.34) 
533.4-622.1 2.59 (1.43-4.70) 2.40 (1.31-4.41) 2.37 (1.28-4.38) 
622.2 - 711.0 2.42 (1.30-4.53) 2.17 (1.14-4.11) 2.16 (1.13-4.11) 
711.1 - 2189.2 1.72 (0.92-3.21) 1.58 (0.83-2.99) 1.61 (0.83-3.15) 
p = 0.007 P = 0.029 P = 0.041 
p(q) = 0.002 p(q) = 0.008 p(q) = 0.012 
Total UVR exposure 
during summer holidays: 
No holidays 1.91 (0.95-3.88) 1.77 (0.86-3.64) 1.78 (0.87-3.66) 
2.80 - 39.2 1.00 1.00 1.00 
39.3 - 61.1 -2.75 (1.24-6.10) 2.48 (1.1 0-5.59) 2.45 (1.08-5.54) 
61.2 - 84.6 2.23 (0.98-5.07) 1.83 (0.79-4.26) 1.82 (0.78-4.25) 
84.7 -160.2 3.18 (1.44-7.04) 2.70 (1.20-6.10) 2.65 (1.17-5.98) 
160.3 - 1037.2 2.74 (1.24-6.08) 2.27 (1.01-5.11) 2.21 (0.98-4.98) 
p=0.043 p=0.157 p=0.188 
I Individuals with infonnation on all covariates of interest p(q) = p value for quadratic association 
Table 6.4.8: Effect of cumulative holiday UVR exposure in childhood on risk of zoster, 
by age 
UVR exposure (MED) 
Cumulative holiday UVR exposure 
in childhood (n=6J6): 
No holidays 
2.8 - 39.2 
39.3 - 61.1 
61.2 - 84.6 
84.7 - 160.2 
160.3 -1037.2 
Age < 60yrs· 
(n=344) 
4.07 (1.29-12.83) 
1'.00 
2.78 (0.80-9.70) 
4.62 (1.44-16.26) 
5.95 (1.79-19.72) 
4.00 (1.11-12.44) 
p = 0.038 
p(q) = 0.027 (2) 
Age> 60yrs· 
(n=272) 
0.76 (0.28-2.07) 
1.00 
1.66 (0.50-5.50) 
0.44 (0.11-1.85) 
0.82 (0.22-3.11) 
1.01 (0.30-3.48) 
p = 0.234 
I Adjusted for weekly non-holiday UVR 2 Using holidaymakers only (n= 187) 
p(q) = p value for quadratic association 
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Table 6.4.9: Comparison of effect of total (holiday + non-holiday) cumulative UVR exposure in 
childhood on risk of zoster amongst all individuals and amongst holidaymakers 
UVR exposure (MED) 
Total UVR exposure in warmer months 
of childhood: 
246.5 - 504.0 
504.1 - 630.2 
630.3 - 730.3 
730.4 - 936.9 
937.0 - 2448.1 
pet) - p value for trend 
Amongst holidaymakers and 
non-holidaymakers (n=616) 
1.00 
1.59 (0.90-2.79) 
1.33 (0.75-2.35) 
1.62 (0.91-2.88). 
1.66 (0.94-2.94) 
p = 0.401 
p(t) = 0.148 
Amongst holidaymakers only 
(n=278) 
1.00 
1.30 (0.40-4.26) 
1.33 (0.47-3.72) 
2.04 (0.71-5.88) 
1.98 (0.69-5.69) 
p = 0.498 
pet) = 0.093 
Table 6.4.10: Effect of intermittency of holiday UVR exposure in childhood, at different levels of 
intensity of baseline (non-holiday) UVR exposure (n=616) 
UVR exposure (MED) 
Ratio of holiday to non-holiday 
UVR exposure in summer monthsl : 
~ 1.00 
1.01 - 1.50 
1.50 - 6.00 
" Highest daily non-holiday UVR 
<4 MED (n=216) 
1.00 
1.35 (0.59-3.08) 
0.77 (0.40-1.46) 
Highest daily non-holiday UVR 
~4 MED (n=400) 
1.00 
1.55 (0.97-2.47) 
4.07 (1.46-11.30) 
p = 0.018 
2 Highest daily exposure on holiday: highest daily exposure on non-holiday in summer months 
, 
Table 6.4.11: Independent effects of total cumulative UVR exposure in the warmer months 
of last year and in month before rash onset on risk of zoster (n=7091) 
UVR exposure (MED) 
Total UVR exposure in warmer 
months of last year: 
0-157.7 
157.8 - 245.7 
245.8 - 363.6 
363.7 - 534.2 
534.3 - 1169.3 
Total UVR exposure in month 
before rash onset: 
0-3.06 
3.06 - 11.40 
11.40 - 33.33 
33.33 - 64.02 
64.02 - 293.46 
Univariable OR 
1.00 
1.35 (0.80-2.26) 
1.19 (0.67-2.11) 
1.26 (0.70-2.14) 
1.76 (1.02-3.06) 
p= 0.298 
pet) = 0.094 
1.00 
1.70 (0.96-3.00) 
1.56 (0.75-3.26) 
1.92 (0.88-4.18) 
2.09 (0.94-4.64) 
p = 0.311 
p (t) = 0.099 
Adjusted for ethnicity, ability to tan 
and current illness 
1.00 
1.49 (0.86-2.56) 
1.37 (0.75-2.50) 
1.47 (0.82-2.64) 
2.14 (1.19-3.83) 
p = 0.131 
pet) = 0.023 
1.00 
1.91 (1.06-3.45) 
1.89 (0.88-4.09) 
2.44 (1.08-5.51) 
2.82 (1.23-6.49) 
p = 0.112 
pet) = 0.024 
I Individuals with information on all covariates of interest pet) = p value for trend 
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Table 6.4.12: Effece of total (holiday & non-holiday) UVR exposure in the month before rash 
onset on risk of zoster, by age 
Total UVR exposure (ME D) 
Total (holiday+non holiday) UVR 
exposure: 
0-3.06 
3.06 - 11.40 
11.40 - 33.33 
33.33 - 64.02 
64.02 - 293.46 
Age < 60yrs 
(n=390) 
1.00 
2.40 (0.90-6.37) 
1.69 (0.46-6.16) 
4.88 (1.29-18.48) 
3.88 (0.99-15.14) 
P = 0.016 
pet) = 0.015 
Age> 60yrs 
(n=339) 
1.00 
1.68 (0.78-3.59) 
3.00 (1.08-8.33) 
1.07 (0 .. 34-3.37) 
1.86 (0.61-5.67) 
p=0.079 
I Adjusted for current illness, ethnicity and ability to tan pet) = p value for trend 
Table 6.4.13: Effect! of total holiday UVR exposure in the month before rash onset on risk 
of zoster, by propensity to burn on initial UVR exposure (n=677) 2 
UVR exposure (MED) 
Total holiday UVR exposure: 
No holidays 
0-26.39 
26.39 - 266.29 
Tans 
1.00 
1.09 (0.52-2.26) 
1.87 (0.97-3.63) 
p = 0.046 
Peels/Blisters 
1.00 
3.40 (1.11-10.41) 
0.49 (0.10-2.41) 
I Adjusted for ethnicity and current illness 2 Individuals with information on aU covariates of interest 
Table 6.4.14: Effect of total (holiday+non holiday) UVR exposure in the month before rash onset 
on risk of zoster in all individuals and in matched sets containing confirmed cases 
UVR exposure from holidays+non-holidays 
in month before rash onset (MED) 
a) Amongst individuals olal! ages: 
0-3.06 
3.06 - 11.40 
11.40 - 33.33 
33.33 - 64.02 
64.02 - 293.46 
b) Amongst individuals aged <6Oy: 
0-3.06 
3.06 - 11.40 
11.40 - 33.33 
33.33 - 64.02 
64.02 - 293.46 
Adjusted1 OR 
(total study population) 
(n=709) 
,1.00 
1.91 (1.06-3.45) 
1.89 (0.88-4.09) 
2.44 (1.08-5.51) 
2.82 (1.23-6.49) 
p=0.112 
pet) = 0.024 
(n=390) 
1.00 
2.40 (0.90-6.37) 
1.69 (0.46-6.16) 
4.88 (1.29-18.48) 
3.88 (0.99-15.14) 
p= 0.016 
pet) = 0.015 
I Adjusted for ethnicity, ability to tan and current illness pet) = p value for trend 
Adjusted1 OR (matched sets 
with confirmed cases) 
(n=266) 
1.00 
4.14 (1.14-15.03) 
3.48 (0.79-15.23) 
4.28 (0.95-19.34) 
6.52 (1.38-30.88) 
p = 0.096 
pet) = 0.033 
(n=140) 
1.00 
2.77 (0.22-33.84) 
1.46 (0.08-26.94) 
6.25 (0.33-117.97) 
5.14 (0.26-101.86) 
p = 0.155 
pet) = 0.059 
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Table 6.4.15: Summary of adjusted effects of UVR variables on risk of zoster 
Exposure Effect in childhood 
1. Cumulative UVR exposure: 
- Total exposure in warmer months No effect 
- Weekly non-holiday UVR in warmer months Strongly increased risk 
- Total holiday UVR Strongly increased risk if <6Oy 
2 .Intensity of UVR exposure: 
- Maximum daily non-holiday UVR Increased risk?1 
- Maximum daily holiday UVR No effect 
3 Intermitteney of UVR exposure: 
- During non-holiday periods No effect 
- Due to holidays Increased risk if non-holiday UVR >4MED 
- Effect of sunburns (No information) 
4. Effect of sunbathing (No information) 
5. Effect of hats and protective clothing No effect 
6. Effect of skin type on UVR exposures No effect 
7. Effect of medical UVR exposureslsunbeds No effect 
1 Weakly statistically significant association 
Effect in the last year 
Increased risk?1 
No effect 
No effect 
No effect 
No effect 
No effect 
Winter: increased risk?1 
No effect 
No effect 
Decreased risk with protective clothing 
for non-holiday exposure?1 
No effect 
No effect 
Effect in month before rash onset 
Increased risk?1 
Effect modified by age?1 
No effect 
No effect 
Increased risk?1 
Increased risk (pattern unclear)?1 
, No effect 
Protective effect?1 
Increased risk from total holiday exposure 
amongst those with propensity to burn? 
No effect 
Table 6.5.1: Univariable effects of stress in the last 12 months on the risk of zoster (n=726) 
Stressful events/feelings in last 12 m CASES CONTROLS OR (95% CI) 
All prompted+unprompted eventslfeelings: 
None 23 (9.5) 81 (16.8) 1.00 
53 (21.8) 122 (25.3) 1.62 (0.90-2.90) p = 0.012 
2 56(23.1) 107 (22.2) 1.92 (1.09-3.37) p(t) = 0.0003 
3 42 (17.3) 78 (16.1) 2.19 (1.17-4.08) 
4 30 (12.4) 46 (9.5) 2.50 (1.28-4.88) 
<!5 40 (16.0) 49 (10.1) 3.20 (1.64-6.24) 
No. of prompted events: 
None 50 (20.6) 114 (23.6) 1.00 
52 (21.4) 133 (27.5) 0.94 (0.59-1.49) p = 0.124 
2 63 (25.9) 108 (22.4) 1.46 (0.90-2.38) p(t) = 0.014 
3 36 (14.8) 68(14.1) 1.31 (0.75-2.28) 
4 19(7.8) 34 (7.0) 1.41 (0.71-2.79) 
<!5 23 (9.3) 26 (5.4) 2.26 (1.12-4.54) 
No of unprompted events: 
None 179 (73.7) 407 (84.3) 1.00 
52 (21.4) 64 (13.2) 1.91 (1.25-2.91) p = 0.003 
2 12 (4.9) 12 (2.5) 2.17 (0.95-5.00) p(t) = 0.0009 
No of unprompted feelings: 
None 178 (73.3) 389 (80.6) 1.00 
1 61 (25.1) 88 (18.2) 1.56 (1.07-2.27) p = 0.068 
2 4 (1.6) 6 (1.2) 1.60 (0.45-5.76) p(t) = 0.003 
Effece of I!roml!ted l events 
Death of spouse 1 (0.4) 4 (0.8) 0.50 (0.06-4.47) p= 0.509 
Death of close family 19 (7.8) 33 (6.8) 1.17 (0.65-2.10) p = 0.612 
Death of close friend 29 (11.9) 42 (8.7) 1.43 (0.87-2.35) p = 0.166 
Serious illness - spouse 14 (5.8) 25 (5.2) 1.13 (0.57-2.24) p = 0.725 
Serious illness - close family 46 (18.9) 63 (13.0) 1.55 (1.02-2.35) p = 0.040 
Serious illness - close friend 12 (4.9) 12 (2.5) 1.94 (0.87-4.34) p = 0.107 
Divorce/separation 15(6.2) 29 (6) 1.04 (0.54-2.00) p = 0.911 
Difficulties with family members 75 (30.9) 153 (31.7) 0.96 (0.69-1.34) p = 0.822 
Dbjiculties with neighbours 30 (12.4) 75(15.5) 0.75 (0.47-1.20) p= 0.230 
Serious financial worries 64 (26.3) 113 (23.4) 1.19 (0.82-1.72) p = 0.371 
Moving house 25 (10.3) 39 (8.1) 1.33 (0.76-2.33) p = 0.313 
Difficulties at work/unemployment 82 (33.7) 162 (33.5) 0.99 (0.67-1.48) p = 0.973 
Effece of unl!roml!ted1 events/feelinJ:;s 
Arguments with spouse/ex-spouse 12 (4.9) 20 (4.1) 1.21 (0.58-2.50) p = 0.615 
Accidents/robberies/assaults 12 (4.9) 17 (3.5) 1.43 (0.67-3.04) p = 0.357 
Problems with accommodation / builders 19 (7.8) 30 (6.2) 1.30 (0.71-2.34) P = D.400 
Court cases/trouble with the law 7 (2.9) 8 (1.7) 1.83 (0.63-5.29) p = 0.278 
Organising events (eg.weddings. parties) 5 (2.1) 1 (0.2) 10.0 (1.17-85.57) p = 0.012 
Moved away from family 4 (1.7) 9 (1.9) 0.89 (0.27-2.89) p = 0.844 
Continuing bereavement 14 (5.8) 8 (1.7) 3.81 (1.53-9.49) p = 0.003 
Concerns about own health 44(18.1) 77 (15.9) 1.18 (0.78-1.80) p = 0.430 
Feeling isolated from family/friends 9 (3.7) 8 (1.7) 2.39 (0.88-6.49) p= 0.086 
I Responses to prompted questions 2 Responses to open question 3 Compared to not experiencing the event 
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Table 6.5.2: Univariable effects of incident stress in the two months before rash onset on the risk 
of zoster (n=726) 
Incident stressful events/feelings OR (95% CI) 
All incident eventsljeelings combined: 
None 153 (63.0) 388 (80.3) 1.00 
70 (28.8) 80 (16.6) 2.36 (1.59-3.48) p<O.OOOI 
~2 20 (8.2) 15 (3.1) 3.50 (1.75-6.98) p(t)< 0.0001 
~ I incident prompted event (vs not) 70 (28.8) 80 (16.6) 2.16 (1.46-3.19) p = 0.0001 
~ I incident unprompted event (vs not) 27(11.1) 14 (2.9) 4.05 (2.09-7.87) p< 0.0001 
~ I incident unprompted feeling (vs not) 5 (2.1) 4 (0.8) 2.50 (0.67-9.31) p=O.I72 
No. of incident prompted events: 
None 173 (71.2) 403 (83.4) 1.00 p =0.0005 
60 (24.7) 68 (14.1) 2.16 (1.43-3.25) p(t) = 0.0003 
~2 10 (4.1) 12 (2.5) 2.15 (0.91-5.07) 
Effece of ~rom~tedl event 
Death spouse/close family/close friend 15 (6.2) 11 (2.3) 2.73 (1.25-5.94) p=O.OII 
Serious illness spouse/close family or frien 12 (4.9) 12 (2.5) 1.94 (0.87-4.34) p = 0.107 
Divorce/separation 5 (2.1) 6 (1.2) 1.77 (0.50-6.24) p = 0.381 
Difficulties with family members 9 (3.7) 20(4.1) 0.87 (0.41-2.06) p = 0.838 
Difficulty with neighbours 6 (2.5) II (2.3) 1.09 (0.39-1.95) p= 0.737 
Serious financial worries 8 (3.3) 6 (1.2) 2.67 (0.93-7.69) p = 0.068 
Moving house 8 (3.3) 4 (0.8) 4.00 (1.20-13.28) p = 0.019 
Difficulties at work/unemployment 21 (8.6) 22 (4.5) 2.39 (1.16-4.92) p = 0.017 
Effect3 of un~rom~tedZ events/feelinK;s 
Arguments with spouse/ex-spouse 3 (1.2) I (0.2) 6.00 (0.62-57.68) p = 0.088 
Accidents/robberies/assaults 7 (2.9) 4 (0.8) 3.50 (1.02-11.96) p = 0.040 
Problems with accommodation / builders 5 (2.1) 5 (1.0) 2.19 (0.58-8.36) p= 0.250 
Court cases/trouble with law 4 (1.6) 2 (0.4) 4.00 (0.73-21.84) p = 0.096 
Organising weddings, parties etc 2 (0.8) 0 
Concerns about own health 5 (1.0) 5 (2.1) 2.00 (0.58-6.91) p = 0.278 
Feeling isolatedfromfamily and/or friends 1 (0.4) 2 (0.4) 1.00 (0.09-11.03) p = 1.000 
I Responses to prompted questions 2 Responses to open question 3 Compared to not experiencing the event 
183 
Table 6.5.3: Univariable effects of prevalent stress in the two months before rash onset on risk of 
zoster (n=726) 
Prevalent stressful events/feelings OR (95% CI) 
All prevalent eventslfeelings combined: 
None 42(17.3) 149 (30.9) 1.00 
1 76 (31.3) 160 (33.1) 1.44 (0.99-2.10) p = 0.013 
2 62 (25.5) 99 (20.5) 2.05 (1.30-3.23) 
~3 63 (25.9) 75(15.5) 1.67 (0.98-2.85) 
~ 1 prevalent prompted event (vs not) 147 (60.5) 256 (53) 1.35 (0.99-1.85) p = 0.059 
~ 1 prevalent unprompted event (vs not) 25 (10.3) 31 (6.4) 1.72 (0.98-3.03) p= 0.062 
~ 1 prevalent unprompted feeling (vs not) 50 (20.6) 72 (14.9) 1.53 (1.01-2.31) p = 0.046 
No. of prevalent prompted events: 
None 96 (39.5) 227 (47.0) 1.00 
81 (33.5) 154 (31.9) 1.25 (0.88-1.78) p=0.171 
2 48(19.8) 69 (14.3) 1.64 (1.05-2.55) 
~3 18 (7.4) 33 (6.8) 1.33 (0.72-2.47) 
Effece of I!roml!ted l event 
Serious illness - spouse 8 (3.3) 16 (3.3) 1.00 (0.42-2.38) p = 1.00 
Serious illness - family 20 (8.2) 28 (5.8) 1.47 (0.81-2.66) p = 0.213 
Serious illness - close friend 7 (2.9) 3 (0.6) 4.67 (1.21-18.04) p = 0.018 
Divorce/separation 6 (2.5) 6 (1.2) 2.00 (0.65-6.20) p = 0.235 
, 
Difficulties with family members 55 (22.6) 100 (20.7) 1.11 (0,77-1.60) p = 0.572 
Difficulty with neighbours 19 (7.8) 41 (8.5) 0.92 (0.51-1.64) p = 0.768 
Serious financial worries 49 (20.2) 84(17.4) 1.19 (0.81-1.77) p = 0.380 
Moving house 4 (1.5) 7 (1.5) 1.14 (0.33-3.90) p = 0.832 
Difficulties at work/unemployment 52 (21.4) 103 (21.3) 0.98 (0.65-1.50) p = 0.943 
Effece of unl!roml!ted1 events/feelinl:s 
Arguments with spouse/ex-spouse 6 (2.5) 12 (2.5) 1.00 (0.38-2.66) p = 1.00 
Problems with accommodation / builders 13 (5.4) 14 (2.9) 1.91 (0.88-4.14) p= 0.105 
Court cases/trouble with the law 1 (0.4) 5 (1.0) 0.35 (0.04-3.36) p = 0.320 
Organising events (weddings, parties etc) 1 (0.14) 0 
Continuing bereavement 10(4.2) 6 (1.2) 3.33 (1.21-9.17) p=0.017 
Concerns about own health 32 (13.2) 54 (11.2) 1.24 (0.76-2.04) P = 0.395 
Feeling isolatedfromfamily or friends 8 (3.3) 11 (2.3) 1.49 (0.58-3.81) p = 0.413 
I Responses to prompted questions 2 Responses to open question J Compared to not experiencing the event 
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Table 6.5.4: Univariable effects of recent illnesses and therapies 00 the risk of zoster (0=729) 
Illness 
4!lJ!. major medical or surgical condition in 
last 6m: 
Hospitalisations in last 6m: 
Hospitalisations in 2m before rash: 
Surgery in the last 6m: 
None 
Minor/invasive diagnostic procedures 
Major (general anaesthetic) 
Surgical procedure in 2m before rash 
Psychiatric illness in last 6m: 
Current antidepressent/anxiolytic treatment 
Illness or treatment associated with altered 
micronutrient availability/requirement' 
Illness or treatment possibly associated with 
impaired immune functioning 2 
Serious infections in the last 6m 
Serious infections in 2m before rash 
Past history of cancer 
168 (69.1) 
9 (3.7) 
3 (1.2) 
229 (93.8) 
10(4.1) 
5 (2.1) 
6 (2.5) 
7 (2.9) 
19 (7.8) 
13 (5.3) 
6 (2.5) 
19 (7.8) 
12 (4.4) 
3 (1.2) 
279 (57.8) 
29 (6.0) 
11 (2.3) 
455 (93.8) 
16 (3.3) 
14 (2.9) 
7 (1.4) 
18 (3.7) 
28 (5.8) 
9 (1.9) 
9 (1.9) 
17 (3.5) 
12 (2.2) 
11 (2.3) 
OR(95%CI) 
1.74 (1.23-2.46) p = 0.001 
0.61 (0.28-1.30) p = 0.183 
0.52 (0.14-1.95) p = 0.310 
1.00 
1.26 (0.56-2.83) p = 0.679 
0.70 (0.25-2.00) 
1.80 (0.57-5.69) p = 0.318 
0.78 (0.32-1.86) p = 0.566 
1.40 (0.76-2.58) p = 0.287 
3.34 (1.31-8.74) p = 0.009 
1.33 (0.47-3.75) p = 0.589 
2.30 (1.18-4.48) p = 0.Q\5 
2.00 (0.90-4.45) p = 0.093 
0.55 (0.15-1.96) p = 0.326 
1 Ulcerative colitis, eating disorders, dysphagia resulting in food regurgitation, iron- or folate-deficient anaemia, 
pregnancy, anti epileptic medication (phenytoin) 
2 Insulin-dependent diabetes mellitus, Down's syndrome, chronic fatigue syndrome, chronic renal failure, pregnancy, 
oral steroids 
m=months 
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Table 6.5.5: Multivariable analyses - effects of stressful events or feelings in last 12 months (n=726) 
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Table 6.5.6: Effect of stressful events/feelings in the last year on the risk of zoster, by age 
dn.Y. stressful eventlfeeling: 
None 
2 
3 
4 
No o/prompted stressful events: 
None 
2 
3 
4 
I Adjusted for medical conditions 
Age < 60y (0=390)1 Age ~ 60y (0=336)1 
1.00 
0.40 (0.14-1.08) 
0.47 (0.18-1.21) 
0.34 (0.12-0.94) 
0.72 (0.12-0.94) 
0.82 (0.26-1.99) 
p=0.038 
Age < 60y (0=390)1 
1.00 
0.33 (0.14-0.80) 
0.51 (0.22-1.17) 
0.40 (0.16-1.00) 
0.53 (0.20-1.38) 
0.94 (0.47-3.64) 
p=0.058 
1.00 
2.68 (1.24-5.81) 
3.24 (1.49-7.01) 
6.51 (2.58-16.39) 
3.68 (1.27-10.69) 
1.77 (1.12-12.71) 
p=0.0009 
Age ~ 60y (0=336t 
1.00 
1.19 (0.66-2.16) 
2.23 (1.09-4.56) 
3.32 (1.31-8.41) 
2.07 (0.49-8.74) 
1.44 (0.22-9.35) 
p=0.069 
2 Adjusted for number of unprompted events, stressful feelings, medical conditions 
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Table 6.5.7: Multivariable analysis - effect of stressful events or feelings in the 2 months before 
rash onset (n=726) 
Events/feelings 
All incident eventslfeelings: 
None 
<!2 
All prevalent eventslfeelings: 
None 
I 
2 
<!3 
Individual stress categories 
<! I incident prompted event: 
No 
Yes 
<! I incident unprompted event: 
No 
Yes 
<! I prevalent stressful feeling: 
No 
Yes 
Illnesses 
Any medical/surgical 
condition in the last year: 
No 
Yes 
Conditions ~ altered 
micronutrient availability: 
No 
Yes 
Univariable OR Adjusted for other stress 
variable & medical conditions 
1.00 
2.36 (1.59-3.48) 
3.50 (1.75-6.98) 
1.00 
p<O.OOOI 
p(t)<O.OOOI 
1.44 (0.99-2.10) 
2.05 (1.30-3.23) 
1.67 (0.98-2.85) 
p = 0.013 
1.00 
2.34 (1.56-3.50) 
3.20 (1.57-6.49) 
1.00 
p<O.OOOI 
p(t)<O.OOOI 
1.25 (0.84-1.86) 
1.80 (1.11-2.88) 
1.49 (0.86-2.60) 
p=0.093 
Adjusted for other stress 
variables & medical conditions 
1.00 
2.16 (1.46-3.19) 
p=O.OOOI 
1.00 
4.05 (2.09-7.87) 
p<O.OOOI 
1.00 
1.53 (1.01-2.31) 
p= 0.046 
1.00 
2.17 (1.44-3.27) 
p=0.0002 
1.00 
3.76 (1.90-7.42) 
p=O.OOOI 
1.00 
1.48 (0.95-2.29) 
p=0.08 
Adjusted for stress 
variables 
+ adjusted for food-
related illnesses] 
1.00 
1.74 (1.23-2.46) 
p = 0.001 
1.00 
3.34 (1.31-8.74) 
p=0.009 
1.00 
1.64 (1.14-2.37) 
p = 0.007 
1.00 
2.60 (1.04-6.50) 
p=0.037 
1.00 
1.61 (1.11-2.32) 
p=O.OII 
I Conditions associated with altered micronutrient availability/requirement 
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Table 6.6.1.: Effect of physical trauma (including surgery) on the risk of zoster (n=726) 
Physical trauma CASES CONTROLS Adjusted for current 
n(%) n(%) illness 
Last 6 months 
At any site: 
No 182 (74.9) 370 (76.6) 1.00 1.00 
Yes 61 (25.2) 113 (23.4) 1.10 (0.77-1.58) 1.03 (0.72-1.49) 
P = 0.598 p=0.864 
At same site as rash: 
No 226 (93.0) 478 (99.0) 1.00 1.00 
Yes 17 (7.0) 5 (1.0) 10.38 (3.02-35.62) 9.61 (2.79-33.17) 
P < 0.0001 p < 0.0001 
At different site to rash: 
No 198 (81.5) 373 (77.2) 1.00 1.00 
Yes 45 (18.5) 110 (22.8) 0.77 (0.52-1.14) 0.72 (0.49-1.08) 
P = 0.182 P =0.105 
Month before rash onset 
At any site: 
No 217 (89.3) 457 (94.6) 1.00 1.00 
Yes 26 (10.7) 26 (5.4) 2.28 (1.25-4.18) 2.24 (1.22-4.11) 
p= 0.007 P = 0.009 
At same site as rash: 
No 233 (95.5) 480 (99.4) 1.00 1.00 
Yes 11(4.5) 3 (0.6) 19.08 (2.44-149.10) 18.15 (2.32-142.31) 
,p =0.0001 P =0.0001 
At different site to rash: 
No 228 (93.8) 459 (95.0) 1.00 1.00 
Yes 15 (6.2) 22 (5.0) 1.28 (0.65-2.55) 1.27 (0.64-2.52) 
p = 0.478 P = 0.499 
Table 6.6.2: Effecr of physical trauma in the last month on risk of zoster, by age 
Trauma in month before rash 
At any site: 
No 
Yes 
At different site to rash: 
No 
Yes 
I Adjusted for current illness 
Age < 60y 
(0=390) 
1.00 
1.09 (0.47-2.55) 
p=0.840 
(0=381)1 
1.00 
0.78 (0.30-2.03) 
p=0.601 
Age~60y 
(n=336) 
1.00 
6.22 (2.05-18.86) 
p=O.OOI 
(0=311)1 
1.00 
4.23 (1.11-16.09) 
p=0.022 
2 Excluding individuals with trauma to the same site as rash 
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Table 6.7.1: Effect of selected potential confounders on the risk of zoster 
Confounder OR (95% el) 
Smoking status (n=726): 
Non-smoker 90 (37.0) 181 (37.5) 1.00 
Ex-smoker 87 (35.8) 142 (29.4) 1.26 (0.86-1.85) p = 0.119 
Current smoker 66 (27.2) 160(33.1) 0.82 (0.55-1.22) pet) = 0.375 
Cigarettes/day in last yr (n=726): 
None 179 (73.7) 332 (68.7) 1.00 
1-9 23 (9.5) 60 (12.4) 0.71 (0.42-1.20) p = 0.460 
10-19 20 (8.2) 50 (10.4) 0.75 (0.43-1.29) pet) = 0.362 
~20 21 (8.6) 41 (8.5) 0.92 (0.53-1.61) 
Daily alcohol intake in the last yr(g) 
(n=726): 
None 64 (26.3) 130 (26.9) 1.00 
0.4 - 4.8 34 (14.0) 92 (19.1) 0.76 (0.46-1.24) p = 0.300 
4.9 - 12.1 56 (23.1) 85 (17.6) 1.34 (0.85-2.09) pet) = 0.516 
12.2 - 28.6 43 (17.7) 89(18.4) 0.99 (0.60-1.63) 
28.7 - 173.1 46 (18.9) 87 (18.0) 1.06 (0.62-1.82) 
Housing tenure (n=729): 
Owner occupier 140 (57.4) 266 (54.8) 1.00 
Rents - council 62 (25.4) 142 (29.3) 0.80 (0.53-1.20) p = 0.722 
Rents - housing association 17 (7.0) 28 (5.8) 1.15 (0.58-2.25) 
Rents - private 24 (9.8) 45 (9.3) 1.01 (0.58-1.75) 
Other 1 (0.4) 4 (0.8) 0.50 (0.06-4.47) 
Cars in the household (n=729): 
None 90 (36.9) 196 (40.4) 1.00 p = 0.543 
One 116 (47.5) 217 (44.7) 1.23 (0.84-1.80) pet) = 0.354 
Two or more 38 (15.6) 72 (14.9) 1.24 (0.73-2.11) 
pet) = p value for trend 
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Table 6.8.1: Independent effect of variables on risk of zoster (combined model) (n = 628) 
Variable Adjusted OR (revised sub-model) Adjusted OR (combined model)' 
Contacts with specific children not resident 
in household (last JOy): 
None 
1-107 
108-420 
421-1334 
1335-3457 
3458-32631 
Contacts with groups of children (last lOy): 
None 
1-550 
551-3652 
3653-7492 
Occupational contact - ill children (last lOy) 
None 
Up to 5 years 
More than 5 years 
Contacts with varicella (last lOy): 
Ethnicity: 
None 
1 
2 
3-4 
5+ 
White 
Afrocaribbean 
Asian 
Other 
Freshfruit intake( last year): 
> 3 portions per day 
2 - 3 portions per day 
5 - 7 portions per week 
1 - 4 portions per week 
< 1 portion per week 
Childhood weekly summer non-holiday UVR: 
3.0-16.2 
16.2-20.5 
20.5-23.9 
23.9-27.4 
27.4-84.2 
Years since varicella: 
>50 years 
31 - 50 years 
11 - 30 years 
~ 10 years 
No history of varicella 
Prompted incident stress event in last 2m 
Unprompted incident stress event in last 2m 
Prevalent stressful feeling in last 2m 
1.00 
1.09 (0.56-2.13) 
0.88 (0.45-1.73) 
0.92 (0.46-1.84) 
0.69 (0.33-1.45) 
0.38 (0.16-0.91) 
p ~ O.OSh, 0.01' 
1.00 
0.70 (0.38-1.30) 
0.48 (0.23-0.98) 
0.24 (0.09-0.66) 
p <O.OOlh+1 
1.00 
0.26 (0.05-1.24) 
0.26 (0.03-2.43) 
p =O.012h 
1.00 
0.93 (0.54-1.60) 
0.81 (0.43-1.56) 
0.22 (0.07-0.66) 
0.30 (0.10-0.90) 
p=O.014h, 0.003' 
1.00 
0.48 (0.23-1.04) 
2.27 (0.70-7.38) 
0.95 (0.31-2.93) 
1.00 
1.91 (1.14-3.21) 
2.18 (I.29-3.68) 
2.60 (I.38-4.90) 
3.80 (1.64-8.79) 
p=O:\Oh 
p = O.OOSh, 0.0003' 
1.00 
2.68 (1.45-4.96) 
2.73 (1.49-5.00) 
2.43 (1.30-4.54) 
1.82 (0.96-3.48) 
p = 0.006b, 0.0009Q 
1.00 
1.44 (0.68-3.10) 
0.72 (0.20-1.75) 
0.09 (0.01-0.97) 
1.45 (0.88-2.37) p = 0.022h 
2.12 (1.36-3.32) p=O.OOOS 
3.60 (1.70-7.61) p=O.0005 
1.77 (1.10-2.84) p=O.OIS 
1.00 
1.06 (0.48-2.34) 
0.73 (0.32-1.65) 
0.91 (0.39-2.10) 
0.61 (0.25-1.48) 
0.28 (0.10-0.76) 
p = 0.03h; 0.005' 
1.00 
0.84 (0.41-1.72) 
0.42 (0.18-0.97) 
0.25 (0.08-0.82) 
p = 0.032h; 0.0041 
1.00 
0.12 (0.02-0.77) 
0.16 (0.13-1.90) 
p = 0.014b; 0.006' 
1.00 
0.91 (0.49-1.69) 
0.75 (0.35-1.65) 
0.17 (0.06-0.64) 
0.24 (0.07-0.86) 
p = O.oI 7b, 0.003' 
1.00 
0.92 (0.33-2.59) 
2.41 (0.50-11.69) 
1.64 (0.37-7.23) 
p=O.64h 
1.00 
2.05 (1.06-3.97) 
2.61 (1.32-5.14) 
3.43 (1.51-7.76) 
6.66 (2.14-20.67) 
p = 0.003b, 0.0001' 
1.00 
3.79 (I. 78-8.07) 
4.51 (2.05-9.93) 
4.96 (2.25-10.95) 
2.42 (1.09-5.38) 
p = 0.0002b, <O.oooIQ 
1.00 
1.32 (0.51-3.39) 
0.45 (0.14-1.45) 
0.05 (0.00-0.92) 
1.33 (0,70-2.53) p = 0.053h 
2.31 (1.32-4.04) p=0.003 
5.65 (2.14-14.94) p=O.0002 
2.00 (1.10-3.63) p=O.021 
Current illness (vs not) 1.57 (1.08-2.30) p=O.OIS 1.71 (1.08-2.73) p=O.02 
I Adjusted for other variables in the model+smoking h p value (heterogeneity) 1 p value (trend) Q p value (quadratic) 
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Table 6.8.2: Combined model- independent effects of alternative variables (n=628) 
Variable 
Child/varicella contacts in last year 
Contacts with specific children not resident 
in household: 
None 
I-II 
12-52 
53-155 
156-381 
382-3650 
Contacts with groups of children: 
None 
1-312 
313-993 
Occupational contact with ill children: 
No 
Yes 
Contacts with varicella: 
None 
2+ 
Fresh/frozen fruit & vegetables in last yr 
~ 8 portions per day 
6 - 7 portions per day 
4 - 5 portions per day 
2 - 3 portions per day 
S; I portion per day 
Total UVR exposure (month before rash): 
0-3.06 
3.06 - 11.40 
11.40 - 33.33 
33.33 - 64.02 
64.02 - 293.46 
Stress/Illness in the last year: 
No. of prompted stress events: 
None 
2 
3 
4 
~5 
No. of unprompted stress events: 
None 
2 
Stressful feelings: 
Illnesses -+ altered micronutrient 
availability 
Adjusted OR (revised sub-model) Adjusted OR (combined model l ) 
1.00 
0.84 (0.45-1.56) 
1.37 (0.79-2.38) 
0.88 (0.48-1.59) 
0.65 (0.33-1.28) 
0.50 (0.23-1.09) 
p=O.09h;O.063' 
1.00 
0.83 (0.45-1.51) 
0.18 (0.07-0.42) 
p=O.023h;O.OI3' 
1.00 
0.42 (0.07-2.44) p=O.304 
1.00 
1.92 (0.96-3.84) 
0.38 (0.13-1.09) p=O.02h 
1.00 
1.66 (0.92-2.99) 
2.37 (1.36-4.13) 
2.84 (1.55-5.21) 
3.28 (1.43-7.53) 
p=O.OO3h;O~OOO I' 
1.00 
2.52 (1.32-4.80) 
1.94 (0.88-4.24) 
2.59 (1.12-5.99) 
2.92 (1.24-6.90) p=O.03~ 
1.00 
0.96 (0.58-1.57) 
1.62 (0.96-2.76) 
1.40 (0.77-2.54) 
1.68 (0.82-3.42) 
2.41 (1.1 0-5 .28) 
p=O.IOlh;O.OIl' 
1.00 
1.77 (1.13-2.77) 
2.10(0.88-5.03) 
p=O.OI6h;O.OO5' 
1.80 (1.20-2.69) p=O.0005 
2.36 (0.83-6.70) p=O.098 
1.00 
0.94 (0.43-2.06) 
1.25 (0.62-2.52) 
0.79 (0.38-1.64) 
0.55 (0.24-1.26) 
0.40 (0.15-1.04) 
p=O.123\O.022' 
1.00 
0.73 (0.36-1.48) 
0.26 (0.08-0.83) 
p=O.04h;O.OI6' 
1.00 
0.21 (0.02-1.86) p=O.128 
1.00 
3.61 (1.50-8.68) 
0.41 (0.13-1.28) p=O.005h 
1.00 
1.74 (0.84-3.61) 
2.53 (1.27-5.05) 
3.08 (1.42-6.65) 
3.75 (1.23-11.43) 
p=O.024h;O.OOI' 
1.00 
2.55 (1.20-5.42) 
1.79 (0.69-4.63) 
3.66 (1.33-10.07) 
3.59 (1.30-9.90) p=O.022h 
1.00 
0.83 (0.45-1.54) 
1.80 (0.90-3.62) 
1.63 (0.78-3.44) 
1.61 (0.61-4.24) 
6.96 (2.35-20.56) 
p=o.003h;O.0008' 
1.00 
2.08 (1.14-3.82) 
1.73 (0.55-5.41) 
p=O.042h;O.024' 
1.76 (1.02-3.06) p=O.022 
3.67 (1.05-12.82) p=O.039 
I Adjusted for variables from other sub-models, as listed in Table 6.8.1 
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Table 6.8.3: Independent effects of selected variables, by age - controlling for confounders from 
other sub-models 
Exposure 
Micronutrient score},' 
27 -35 
23 -26 
20-22 
16 - 19 
7- 15 
Summer holiday UVR exposure (childhood/ 
No holidays 
2.80 - 39.2 
39.3 - 61.1 
61.2 - 84.6 
84.7 -160.2 
160.3 - 1037.2 
Prompted stress events (last yr)3.4,' 
None 
2 
3 
~4 
Age < 60 years 
(N/S) 
2.83 (0.83-9.62) 
1.00 
1.92 (0.49-7.45) 
3.87 (1.08-13.90) 
4.11 (1.14-14.87) 
3.06 (0.79-11.86) 
p= O.203h 
1.00 
0.27 (0.08-0.83) 
0.46 (0.16-1.37) 
0.28 (0.09-0.95) 
1.10 (0.36-3.38) , 
p= O.003h 
Age ~ 60 years 
1.00 
3.67 (0.81-16.55) 
9.65 (2.51-37.09) 
7.44 (1.97-28.03) 
20.31 (4.64-88.84) 
p<O.OOO I h+t 
(N/S) 
1.00 
1.18 (0.56-2.49) 
2.74 (1.08-6.96) 
6.00 (1.86-19.40) 
3.39 (0.71-16.16) 
p=O.006h 
I Adjusted for contacts in last lOy with groups of children + specific children not living in the household, total weekly non-
holiday UVR exposure in warmer months of childhood, current illness, incident prompted + unprompted stress events in 
the 2 months before rash (n=278) 
2 Adjusted for weekly non-holiday UVR exposure in warmer months of childhood, ethnicity, years since varicella and 
contacts with varicella cases in last lOy (n=344). 
3Individuals aged <60yrs: adjusted for unprompted stress events & feelings in last 12m, current illness, contacts with 
varicella cases and no of years since varicella (n=350) 
4Individuals aged ~ 60yrs: adjusted for unprompted stress events & feelings in last 12m, current illness, fiuit intake, contacts 
with children not living in the household (n=278) 
h p value (heterogeneity) t p value (trend) qp value (quadratic) 
N/S: variable not significantly associated with risk of zoster in this age group 
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(GP reporting form) 
FAX TRANSMISSION 
FROM: 
TO: Dr Sara Thomas 
Infectious Disease Epidemiology Unit 
London School of Hygiene & Tropical Medicine 
Tel: 0171 9272496 
Fax: 0171 6374314 
DETAILS OF PATIENT WITH ZOSTER 
Date of consultation: / / GP's initials 
Patient's Name: 
Address: 
Tel: ..................................... . 
Sex: Male D Female D Date of birth: / / 
If patient refuses even to be contacted, please notify sex and date of birth ONLY 
221 
Have vou just seen a case 01 ... 
SHINGLES ;J 
Please remember to report all cases for the 
london School 01 Hvgiene & Tropical Medicine 
SHINGLES STUDY 
11991-19991 
I liAISE WITH SUSAN WEllS I 
222 
South london General Practices IlSHTM Shingles Study n991-1999) 
PARTICIPANTS' UPDATE - MONTH 9 [MAY 1998) 
****** Health Centre: shingles cases to date 
Cases reported in May: 5 
Total cases reported Sept 97-May 98: 36 
List of cases ascertained in May 
1. ***** 12 yrs 
2. ****** 67 yrs 
3. ******** - 50 yrs 
4. ********* 42 yrs 
5. ********* 29 yrs 
Missing cases from May? 
Please let us know about any other new cases of shingles seen in May which are not 
listed above. These cases can still be added to the study. 
A summary of all cases reported to date from the 19 participating practices is provided 
overleaf. 
Please continue to report all shingles cases - liaise with Maureen Holder 
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LSHTM/South London Practices Shingles Study: reported cases, Sept 1997-May 1998 
Practice Registered patients' Cases reported Total cases 
May 98 Sept 97-May 98 
****** Street Health Centre 8532 9 
********* Partnership (3 sites) 22393 21 
********** Road Group Practice 7500 0 17 
The Surgery, ** ********* Hill 7388 0 6 
********* Health Centre 5656 4 
********** Hill Group Practice 10465 (8)b 15 
The Surgery, ** ******** Green 9934 3 12 
******** Medical Centre 9510 0 9 
The Surgery, *** ******* Way 5922 0 10 
***** Hill Group Practice 15088 3 20 
******* Health Centre 15449 5 36 
The Surgery, ** ***** Road 9405 2 18 
The *** Surgery, ***** Road 9199 5 
*********** Health Centre 7350 4 13 
********* Group Practice 16314 2 26 
***** ****** Partnership (2 sites) 11899 0 11 
The Smgery, ** ********* Lane 6945 5 
************* Health Centre 11884 (2)b 17 
The Smgery, ** ********* Road 9788 0 12 
TOTAL 200621 34 266 
a Sept 1997, excluding temporary patients b Including one or more case reported retrospectively 
The South London General Practices / LSHTM Shingles Study has been set up to 
estimate the incidence of and risk factors for shingles in an urban population. All 
new cases of shingles are ascertained from J 9 general practices, and eligible cases 
and controls (individuals without shingles) are also enrolled in the riskfactor study. 
For further information, contact your practice liaison person (listed overleaf) or Dr 
Sara Thomas, Infectious Disease Epidelf/iology Unit, London School of Hygiene & 
Tropical Medicine (Tel/Fax: 0171 927 2496) 
London School of Hygiene and Tropical Medicine 
(University of London) 
Infectious Disease Epidemiology Unit 
Keppel Street, London WC1 E 7HT 
Direct tel: 0171 9272496 (ansaphone) 
Fax: 0171 6374314 
E-MAIL ECDESTHO@LSHTM.AC.UK 
Dear *** 
(Letter to cases) 
The *** Surgery is working with the London School of Hygiene & Tropical Medicine 
on a study to find out the reasons why some people get shingles. In order to do this, we 
need to talk to every patient from the Practice who develops shingles. I enclose a leaflet 
which gives details about the London School and about the study. 
The Surgery has informed me that you recently developed shingles. I am therefore 
writing to see whether you would be able to help us with this work. As the leaflet 
explains, this would involve answering some questions about the places you have lived 
and worked, your usual diet, and recent contacts with people with chickenpox, and 
checking your height and weight. I would only need to visit you once, and the whole 
interview usually takes less than an hour and a half. 
I will contact you within the next couple of days, to answer any questions you have 
about the study. If you decide to take part, I will then arrange to visit you at a time 
which is convenient to you. I hope that your shingles are not causing you too much 
discomfort, and I look forward to speakjng with you shortly. 
Yours sincerely 
Dr Sara Thomas 
Enc. 
224 
Infectious Disease Epidemiology Unit 
London School of Hygiene & Tropical Medicine 
tv Keppel Street, London WClE 7HT 
N 
VI 
RISK FACTORS FOR SHINGLES 
(HERPES ZOSTER) IN AN URBAN 
POPULATION 
Dr Sara Thomas 
Dr Andrew Hall 
INFORMATION ABOUT THE STUDY 
(for people without shingles) 
What is the London School? 
The London School of Hygiene and 
Tropical Medicine is part of the University 
of London, and is an internationally 
renowned centre for teaching and research 
in public health. Research is carried out on 
a wide variety of diseases, and the findings 
can be used to develop ways to prevent or 
limit ill-health. 
What is the shingles study? 
Shingles (known medically as herpes 
zoster) is a relatively common skin 
condition which results in a painful, 
blistering skin rash. We know that it is due 
to the chickenpox virus which remains in 
our bodies following the first infection, and 
then for some reason becomes active again. 
It is not known why this happens in some 
people but not in others, and we are 
therefore carrying out a study (with the co-
operation of your GP) to try to find out. 
We are particularly interested in whether 
the risk of developing shingles has 
anything to do with diet or sunlight 
exposure. We also need to know if it has 
anything to do with recent contact with 
people suffering from chickenpox. The 
results of this study may give us important 
information which will help discussions 
about whether to introduce chickenpox 
vaccination in the United Kingdom, and 
may also help with advice given to people 
about their diet and exposure to sunlight. , 
We have a group of people who have 
suffered shingles recently, but we also need 
to talk to people who have never had 
shingles as a comparison. Weare therefore 
inviting people who have never had 
shingles to take part in this study. 
What does the study involve? 
If you have never had shingles and you 
decide to help us with this study, Sara 
Thomas (one of the study researcherS!) will 
arrange to visit you at a convenient time, to 
ask you some questions about the places 
you have lived, worked or visited (so we 
can estimate your exposure to sunlight 
during your life), your usual diet (including 
smoking and alcohol consumption), and 
any recent contacts you may have had with 
people with chickenpox. The interview 
will be completed at a single visit, and will 
probably take about an hour and a half. We 
would also like to measure your height and 
weight, but no other tests are needed. 
You are of course not obliged to take part 
in this study, and you may withdraw at any 
time during the interview without giving us 
a reason. This will not affect the medical 
care you receive from your GP in any way. 
However, your participation would be 
. greatly appreciated, as the success of the 
study depends on as many people taking 
part as possible. 
Confidentiality 
All information you give us remains 
completely confidential. Any information 
which we store on computer (so that we 
can analyse the information we collect) will 
be coded with a number, and not with your 
name. The interview forms will only be 
seen by the study researchers and will not 
be made available to anybody else. 
What happens next? 
We may contact you within the next few 
days, to talk further with you about whether 
you would like to help us with this 
research. If you have any further questions 
about the study, we will be happy to answer 
them at this time. 
Thankyouforyourhep. 
SYDENHAM GREEN GROUP PRACTICE 
00 
SYDENHAM GREEN HEALTH CENTRE 
26 Holmshaw Close, London SE26 4TH Tel No. 01816768836 Fax No. 01717714710 
(GP letter to controls) . 
Dear 
Sydenham Green Health Centre is helping the London School of Hygiene and Tropical 
Medicine with a study to find out the reasons why some people get shingles. In order to do 
this, one of their researchers would like to talk to people who have shingles, and to some 
people of the same age who have never had shingles. Enclosed is an information leaflet, which 
gives details about the London School and about their study. 
Since a person your age has developed shingles, we would like to give your name to the 
London School as someone they might approach, to see whether you would consider helping 
with this work. Sara Thomas (one of the study researchers) may then contact you and discuss 
the study with you. If after talking to her you decide you would like to take part, she wi]] 
arrange to come and see you to ask you some questions, as outlined in the information leaflet. 
Unless I hear from you, I will assume that you do not mind your name being given to Dr 
Thomas. This does not mean that you have to take part in the study, but just that you do not 
mind talking with her. She wi]] answer any questions you have about the study, so that you 
can then make a decision about whether you would like to part,icipate. 
If you do not wish to be contacted, please return the reply slip to Mrs Jo Bate at the Surgery. 
With many thanks for your help. 
Dear Mrs Bate 
I do not wish to be contacted about the shingles study. 
Name: Date: 
------------------~----------------~-----------------------------£22~6~--­
Dr. B. Essex • Dr. A. Platmal'1 • Dr. J.Sikorski • Dr. S. Thomas • Dr. J. Campbell 
CONFIDENTIAL 
ZOSTER RISK FACTOR STUDY 
Interview Date: / IDNumber: 0000 
Zoster status: Case: 0 (1) => a) below Control: 0 (0) => b) below 
May I begin by checking a few details about yourself? 
Date of Birth: / / Age: 00 Sex: Male 0 (1) Female D (2) 
And the general practice you attend is _______________ GPID: 0 0 
And can I check a few details about your health - starting with shingles: 
a) If Case: when did the rash fir:.st appear? _ / _ / _ Duration of rash 00 days 
And which side is the rash?: RightD (1) 
(note extent of rash) 
Left D (2) cranial D (1) 
thoracic 0 (3) 
cervical D (2) 
lumbar 0 (4) 
sacral 0 (5) disseminated 0 (6) 
no details 0 (9) 
Was there any pain? Where was this? When did it start? 
(note extent of pain) 
Did your doctor give you any treatment for the shingles? 
(note Rx) 
Have you had shingles before? Yes 0 (1) __ yrs ago No 0 (0) Don't know 0 (9) 
b) If Control: can I check that you have never-had shingles? No, neverO (0) YesO (1) 
Don't knowO (9) 
Illnesses: and ifI can check your general health: do you currently have any serious medical 
conditions or any serious infections? (Also: Check if any other serious conditions in the last 5 
years) 
(9) 
Yes 0 (1) => c) below No 0(0) Don't know 0(9) Decline to answer 0 
c) if Yes: do you mind telling me what these are? 
Details: ______________ _ Decline to answer 0 (9) 
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Current drugs: can I check with you any tablets or other treatments you are taking at the moment? 
Rx (Name/dose) How long for? 
Are there any other tablets or treatments you have had in the last 12 months? 
Yes D (1) => What were they for, and when did you take them? ___________ _ 
No D (0) 
Residence: I would now like to check the different places you have lived during your life and the 
different jobs you have had, so that we can work out how much sunlight you have been exposed to 
at various times in your life. Do you have the residence and job calendars we sent you? Did you 
fill them in? (if NO, complete now) 
Ethnic group What do you consider your ethnic origin to be? 
(If necessary: ethnicity is not necessarily the same as nationality; it is how you see yourself, the origins 
of yourself and your family, a mixture of culture, skin colour, religion) 
Eligible: YesD (1) => Immunosuppressed /declined questions 
=> African origin 
=> Control with previous shingles 
=> 'Unlikely' zoster 
D 
D 
D 
D 
=>Other(state) ____________ _ 
Chickenpox history: can I now ask whether you remember having chickenpox? 
Yes 0(1) => d) No D (0) 
d) If Yes: How old were you? Age ____ yrs Don't know D (9) 
Did anyone in your household have chickenpox at the same time as you? 
Yes 0 (1) => (e) No 0(0) Don't know 0 (9) 
e) If Yes: how many other people got chickenpox at the same time? D 
when did you get chickenpox 1 st D (1) 2nd D (2) 3rd+ 0 (3) Don't know D (9) 
in relation to the others? 
Chickenpox Do you remember being in contact with anyone who had chickenpox or shingles in the 
Contacts: last ten years (since 198*)? 
(Prompts: let's start with people;. in the household. Has anyone in the household had chickenpox or 
shingles since 198*? How about other family members? Friends? Anyone at work? Anyone else in the 
last 10 years?) 
Chickenpox: Yes 0 (1) => (e) No D (0) Shingles: Yes 0 (2) => (e) No 0(0) 
e) If 'Yes': who, and how long ago was that? (Complete below) 
C.pox TYPE OF CHICKENPOX/SHINGLES CONTACT(llive details) 
How long or Household Family/Friend Workplace Other 
ago? shingles? member (non-household) 
I 
2 
3 
4 
5 
6 
7 
-
Child contacts: Have any of the jobs you have had in your life involved (mark on job calendar) 
Regular contact with young children? Yes 0(1) 
Regular contact with people ill in hospital? Yes 0 (1) 
No 0 (2) Don't know 0 (9) 
No 0 (2) Don't know 0(9) 
Other than at work, have you been in regular contact with any young children (under 10 years old) in the 
last ten years? These could be members of your family, or other children. 
(Prompts: lets start with any children who have lived in the household in the last 10 years. How about 
other children? Any family members? Friends' children? Neighbours? Anyone else? To clarify about 
relevant children: so this is anyone who is under 20 years old now) 
Yes, household contact D (1) => (Table) Yes, non-household contactD(2) => (Table) 
No D (0) Don't know 0 (9) 
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CIDLD CONTACTS IN LAST 10 YEARS 
Household child contacts Non-household child contacts 
Who / age? Dates (from - to) Who/ age? Dates (from-to) How often? 
I 
2 
3 
4 
5 
6 
7 
8 
Total no. of children in household 0 Total no of specific children outside hlhold 0 
Skin reaction: The next questions are about your how your skin reacts to sunlight. Firstly, how does 
your skin react when exposed to bright sunlight for the first time in summer. For example, if you were 
exposed to bright sunlight in the UK for the first time for one hour in the middle of the day, without any 
protection, would you: 
- Get a severe sunburn with blistering? 
- Get painful sunburn for a few days followed by peeling? 
- Get mildly burnt followed by some degree of tanning? 
- Get darker without any burning? 
- None of the above (.specify) ___________ _ 
- Don't know 
0(1) 
0(2) 
0(3) 
0(4) 
0(5) 
0(9) 
What would happen if your skin was repeatedly exposed to bright sunlight in summer without protection? 
Would it become: 
- Deeply tanned? 
- Moderately tanned? 
- Only mildly tanned because of a tendency to peel? 
- Only freckled, with no suntan at all? 
- None of the above (specify) __________ . __ _ 
- Don't know 
0(1) 
0(2) 
0(3) 
0(4) 
0(5) 
0(9) 
PAST UV EXPOSURE: I would now like to find out how much time you have spent outside at various 
times in your life, both as part of your work and in your leisure time. So I am going to ask you about 
your working days and non-working days separately, and for each of these I would like you to estimate 
how many hours on average you spent outside between 9am and 5pm in direct light. I will ask you 
separately about holidays. When I say 'outside in direct light', I mean completely outside, so do not 
include time spent in a car or under any shade. 
If we begin by considering the time when you were a child, say about 6 or 7 years old, living in 
*** and going to school. 
In the warmer months (April to September): 
- on school days, how much time did you usually spend outdoors in direct light between 9-5? __ hrs/day 
- at weekends, how much time did you usually spend outdoors in direct light between 9-5? ___ hrs/day 
- during school holidays, how much time did you usually spend outdoors between 9-5? ___ hrslday 
(Prompts: did you walk to school? How long did that take? And did you go out during the day at 
school? How longfor? What time did schoolfinish? When you got home, did you go out to play? Was 
that straight away, or did you eq,t something first (how long did that take)? Until what time did you stay 
out?) 
And if we think about the cooler months (October to March) when you were 6-7: 
- on school days, how much time did you usually spend outdoors in direct light between 9-5? __ hrs/day 
- at weekends, how much time did you usually spend outdoors in direct light between 9-5? __ hrs/day 
- during school holidays, how much time did you usually spend outdoors between 9-5? __ hrs/day 
When you were a young child about this age, did you go on holiday at all? 
Yes 0(1) => (a-d) below No DO) Don't know 0 
a) If YES, how often did you go on holiday during this period? More than 1 holiday/year 0(1) 
Every year 0(2) 
One every 2-3 years 0(3) 
Every 4-5 years 0(4) 
Less frequently 0(5) 
Don't know 0(9) 
b) In which country or area did you most commonly take your holiday? 
c)- How many days did you spend on holiday on average, during this period? ______ _ 
d) On a typical holiday, when you were a child how many hours between 9 & 5 would you usually spend 
outdoors in the direct light (not in the shade)?: 
_______ hours 
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When you were outdoors, how often did you wear a hat that shaded your face from the sun? 
- and how often did you wear clothes that protected you from the sun, which covered your arms and legs? 
Non-holidays Holidays 
Hat Clothes Hat Clothes 
Always or almost always (1) 
Not always but more than half the time (2) 
About half the time (3) 
Less than half the time (4) 
Never or hardly ever (5) 
Don't know (9) 
Last 20 yrs: if we now consider your exposure to sunlight later in your life (Complete table, last page): 
(For 20 yrs ago): if we start with 20 years ago (so around 1977(8», when you were ** years old 
working as a *** and living in *** , if we consider just the warmer months (April to September): 
- On days you worked, how much time did you usually spend outdoors in direct light between 9-5? 
- and at weekends or days off, how much time did you usually spend outdoors in direct light between 9-5? 
And if we think about the cooler months (October to March) during this time in your life: 
- On days you worked, how much time did you usually spend outdoors in direct light between 9-5? 
- and between 9-5 at weekends or days off? 
And during this period of your life did you go on holiday or take any trips during the warmer months? 
(Apr-Sept)? 
Yes 0(1) ~ (Table) No 0 (0) Don't know 0 (9) 
a) If YES, how often did you go on holiday during this period? (More than 1 holiday/year =(1), Every 
year=(2); one every 2-3 years=(3); every 4-5 years=(4); less frequently=(5); don't know = (9) ) 
b) In which country or area did you most commonly take your holiday? 
c) And on average, how long would you go on holiday for? 
d) On a typical holiday, how many hours between 9 & 5 would you usually spend outdoors in the direct 
light (not in the shade)? 
And during this period of your life, did you take any holidays during the cooler months (October to 
March)? 
Yes 0(1) ~ (a-d) below No 0 (0) Don't know 0(9) 
a) If YES, how often did you go on holiday during this period? [>1 holiday/year = (1), Every year = (2); 
one every 2-3 years = (3); every 3-4 years; = (4) less frequently = (5); don't know = (9)] 
b) In which country or area did you most commonly take your holiday? 
c) How many days did you spend on holiday on average, during this period? 
d) On a typical holiday, how many hours between 9 & 5 would you usually spend outdoors in the direct 
light not in the shade)?: 
And if we consider any protection against the sun during this time: when you were outdoors at work, or 
on non-working days (but not holidays), how often did you wear a hat that protected your face from the 
sun? And how about clothes that protected your arms and legs from the sun (Always/almost always (1); 
not always, but more than 112 the time (2); about half the time (3); less than half the time (4); never, or 
almost never (5)) 
And during holidays? 
REPEAT FOR J 0 YEARS A GO-AND DURING THE LAST YEAR - ALSO FOR OTHER RESIDENCES 
OUTSIDE THE UK IN THE LAST 20 YRS. 
Previous jobs: Are there any other jobs where for six months or more in which you usually worked 
outdoors for more than one hour a day between 9-5 (Job includes periods of unemployment, unpaid 
jobs, and looking after the home or children) 
Yes 0 (1) No 0 (0) Don't know 0 (9) 
IjYes: complete columns on amount o/time outdoors & use o/hat/protective clothing 
Outdoor leisure activities: I'd like to ask about outdoor leisure activities that you may have taken part in 
the last 20 years. 
Since you were *** years old have you done any of the following between 9-5 on at least 10 days in one 
year: 
• Sports, such as tennis, cricket, football? Yes 0(1) No 0(0) Don't know 0(9) 
• Golf Yes 0(1) No 0(0) Don't know 0(9) 
• Lawn bowls Yes 0(1) No 0(0) Don't know 0 (9) 
• Fishing Yes 0(1) No 0(0) Don't know 0 (9) 
• Swimming in an outdoor swimming pool Yes 0(1) No 
0 
(0) Don't know 0 (9) 
• Walking or jogging Yes 0(1) No 
0 
(0) Don't know 0 (9) 
• Gardening Yes 0(1) No 0 (0) Don't know 0 (9) 
• Watching outdoor sports Yes 0(1) No 0 (0) Don't know 0 (9) 
• Other (specify) 
For every activity answered as YES, fill in the table below 
TYPE OF ACTIVITY 
In what year did you start this 
activity? 
When did you last do this activity? 
fifthis year, give date) 
So overall you you have done this 
for about ** years? 
On average, how often did you do it 
- during the warmer months 
- during the cooler months 
On average, how many hours a day 
between 9-5 were you outdoors (not 
in the shade) doing this activity each 
time you did it? 
In the warmer months, do you sunbathe or sit out to catch the sun (other than during holidays)? 
Yes 0 (1) No 0 (0) Don't know 0(9) 
If Yes: for how many years have you done this? 
how often on average do you do it? ________ _ 
and when you do sunbathe, how many hours do you usually do it for? 0 0 
and when was the last time you sunbathed? ____ _ 
SUNBURN: In general, during your life have you ever been sunburned so badly so as to cause blistering? 
Yes 0 (1) ~ below No 0(0) Don't know 0(9) 
If YES, how long ago did this happen? (Document each occasion) 
1) _____ _ 4) _____ _ 
2) _____ _ 5) ____ _ 
3) _____ _ 6) _____ _ 
Are there any other times when you have been sunburned badly enough so as to cause discomfort for 2 
days or more? 
Yes 0(1) ~ below No 0(0) Don't know 0(9) 
If YES, how long ago did this happen? (Document each occasion) 
1) _____ _ 4) ____ _ 
2) _____ _ 5) _____ _ 
3) ____ _ 6) _____ _ 
SUNSCREEN: have you ever used a sunscreen lotion to prevent sunburn when out in the sun? 
Yes 0 (1) => a-d No 0(0) Don't know 0(9) 
a) If YES, when did you first start using sunscreen? ____________ _ 
b) And how often do you use it? On Holiday? 
- Always or almost always 
- Not always, but more than half the time 
0(1) 
0(2) 
0(3) 
0(4) 
0(5) 
- More or less half the time 
- Less than half the time 
- Never or hardly never 
c) Is the sunscreen you usually use high protection (ie SPF of 10 or more)? 
Yes 0(1) No 0(0) Don't know 0 (9) 
Otherwise? 
0(1) 
0(2) 
0(3) 
0(4) 
0(5) 
d) Has your sunscreen usage changed over time, and if so, how? _____________ _ 
SUNBEDS: Have you ever used a sunlamp or gone to a tanning salon or solarium to get a suntan? 
Yes 0 (1) => a-d No 0(0) Don't know 0 (9) 
a) If YES, when did you first start using a sunlamp/sunbed ____________ _ 
b) When was the last time you used a sunlamp/sunbed _______________ _ 
c) And how often do you use it, on average? __________________ _ 
d) Has your sunlamp/sunbed usage changed over time, and if so, how? _________ _ 
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UV TREATMENTS: Have you ever had special UV lamp treatment prescribed by your doctor for any 
medical condition, for example for psoriasis or for vitiligo? 
Yes 0 (1) => a) 
a) If YES: 
Don't know 0 (9) 
How old were you when you first had this treatment? (Column 3) 
How often did you receive the treatment? (Column 5) 
How old were you when you stopped the treatment? (Column 4) 
Did you have any further course ofUV treatment after this first course? (Complete additional rows) 
CONDITION Age started Age stopped Frequency of Rx 
1 
2 
3 
4 
5 
6 
DIETARY QUESTIONNAI)U:: the next series of questions related to the types of food you have eaten 
in the last year. 
Special Diets: firstly, can I just check - are you on a special diet for any reason; I mean by that are there 
types 
offood which you don't eat or types offood which you must eat? 
Yes 0 (1) => a) No 0(0) Don't know 0 (9) 
a) If YES: Diabetic 0(1) Low salt 0(5) 
No meat 0(2) No fish 0(6) 
Low fat 0(3) High protein 0(7) 
Gluten free 0(4) No dairy produce/low lactose 0(8) 
Other (specify) 
Changes: During the last year have there been any major changes in what you eat or in your food habits? 
Yes 0 (1) =:> a) No 0(0) =:> Food questionnaire, overleaf 
a) If YES, what has changed? ________________________ _ 
FOOD LIST: I am now going to ask you how often you eat various kinds of foods. We need to do this 
in quite a lot of detail, so that we can find out the variety of vitamins, proteins etc you have and the main 
sources of energy in your diet. 
All the questions refer to your diet during the last year (so the last 12 months). I will give you lists of 
foods and for each food type I want you to tell me how often you have eaten it, on average. The choice of 
responses is on this card (SHOW CARD). I will start with meat and meat products. Please estimate your 
food use as best you can. 
(Food Tables; for shaded items, quantity per occasion is asked as well as frequency, and then the number 
per portions per week or per day is calculated) 
!FOOD AND AMOUNTS AVERAGE USE IN THE LAST YEAR 
Never, I-3x a Once a 2-4x a 5-6x a Once a 2-3x a 4-5x a 6+xa 
IMEAT (medium serving) <Ix a month week week week day day day day 
month 
lBeef: roast, steak, mince, stew or 1 2 3 4 5 6 7 8 9 
~asserole 
lBeefburgers 1 2 3 4 5 6 7 8 9 
Pork: roast, chops, stew or slices 1 2 3 4 5 6 7 8 9 
Lamb: roast, chops or stew 1 2 3 4 5 6 7 8 9 
Chicken / other poultry (eg turkey) 1 2 3 4 5 6 7 8 9 
Bacon 1 2 3 4 5 6 7 8 9 
Ham 1 2 3 4 5 6 7 8 9 
Corned beef, Spam, luncheon 1 2 3 4 5 6 7 8 9 
meats 
Sausages 1 2 3 4 5 6 7 8 9 
Savoury pies eg meat pies, pork 1 2 3 4 5 6 7 8 9 
pie, pasties, steak & kidney pie, 
sausage rolls 
lLiver pate, liver sausage 1 2 3 4 5 6 7 8 9 
IAny other meat product? 
~f yes, specify and give frequency 
----------------------------------------- 1 2 3 4 5 6 7 8 9 
----------------------------------------- 1 2 3 4 5 6 7 8 9 
------------------------------------------ 1 2 3 4 5 6 7 8 9 
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FOOD AND AMOUNTS AVERAGE USE IN THE LAST YEAR 
Never, 1-3x a Once 2-4x a 5-6x a Once 2-3x a 4-5x a 6+ x a 
FISH (medium serving) < lxa month a week week a day day day day 
month week 
Fried fish in batter, eg fish & chips 1 2 3 4 5 6 7 8 9 
Fish fmgers, fish cakes I 2 3 4 5 6 7 8 9 
Other white fish, fresh or frozen; 1 2 3 4 5 6 7 8 9 
eg cod, haddock, plaice, sole, 
halibut 
Oily fish, fresh or canned; eg I 2 3 4 5 6 7 8 9 
mackerel, kippers, tuna, salmon, 
sardines, herring 
Shellfish; eg crab, prawns, mussels 1 2 3 4 5 6 7 8 9 
Fish roe, taramasalata 1 2 3 4 5 6 7 8 9 
Any other fish product? 
If yes, specify and give frequency 
------------------------------------------- I 2 3 4 5 6 7 8 9 
------------------------------------------- 1 2 3 4 5 6 7 8 9 
------------------------------------------- 1 2 3 4 5 6 7 8 9 
FOOD AND AMOUNTS A VERAGE USE IN THE LAST YEAR 
Never, 1-3x a Once 2-4x a 5-6x a Once a 2-3x a 4-5x a 6+ x a 
BREAD & SAVOURY BISCUITS < Ix a month a week week day day day day 
.(one slice or biscuit) month week 
White bread and rolls I 2 3 4 5 6 7 8 9 
Brown bread and rolls 1 2 3 4 5 6 7 8 9 
Wholemeal bread and rolls I 2 3 4 5 6 7 8 9 
Speciality bread; eg ciabatta, rye I 2 3 4 5 6 7 8 9 
bread, pitta bread 
I (specify ) 
Cream crackers, cheese biscuits 1 2 3 4 5 6 7 8 9 
Crispbread eg Ryvita I 2 3 4 5 6 7 8 9 
FOOD AND AMOUNTS A VERAGE USE IN THE LAST YEAR 
Never, 1-3x a Once ~ 2-4x a 5-6x a Once a 2-3x a 4-5x a 6+ x a 
CEREALS (one bowl) < Ix a month week week week day day day day 
month 
Porridge, Readybrek S Y 1 2 3 4 5 6 7 8 9 
Breakfast cereal eg cornflakes, 1 2 . 3 4 5 6 7 8 9 
muesli S Y 
FOOD AND AMOUNTS A VERAGE USE IN THE LAST YEAR 
Never, 1-3x a Once 2-4x a 5-6x a Once 2-3x a 4-5x a 6+xa 
POTATOES, RICE, PASTA < Ixa month a week week week a day day day day 
medium serving) month 
Potatoes - boiled, mashed, 
instant, jacket 1 2 3 4 5 6 7 8 9 
Potatoes - chips I 2 3 4 5 6 7 8 9 
Potatoes - roast 1 2 3 4 5 6 7 8 9 
[potato salad 1 2 3 4 5 6 7 8 9 
twhite Rice 1 2 3 4 5 6 7 8 9 
IBrown rice 1 2 3 4 5 6 7 8 9 
Lasagne, moussaka: made-up dish 1 2 3 4 5 6 7 8 9 
White or green pasta - dried/fresh 
I 2 3 4 5 6 7 8 9 ~g spaghetti, macaroni, noodles 
WholemealI)asta - dried/fresh 1 2 3 4 5 6 7 8 9 
Tinned pasta 1 2 3 4 5 6 7 8 9 
Pizza 1 2 3 4 5 6 7 8 9 
FOOD AND AMOUNTS AVERAGE USE IN THE LAST YEAR 
Never, 1-3x a Once 2-4x a 5-6x a Once 2-3x a 4-5x a 6+ x a 
DAIRY PRODUCTS < Ix a month a week week week a day day day day 
month 
Single or sour cream (tblspn) 1 2 3 4 5 6 7 8 9 
Double or clotted cream (tblspn) 1 2 3 4 5 6 7 8 9 
Low fat yoghurt, fromage frais 
l0 25K carton) 1 2 3 4 5 6 7 8 9 
Fu ll fat or Greek yoghurt (125g 
1 2 3 4 5 6 7 8 9 carton) 
Dairy desserts (125g carton) 1 2 3 4 5 6 7 8 9 
Cheese eg Cheddar, Brie, Edam 
1 2 3 4 5 6 7 8 9 I(medium serving) 
Cottage cheese, low fat soft 1 2 3 4 5 6 7 8 9 
cheese (medium serving) 
Eggs: boiled/fried/scrambled etc 
1 2 3 4 5 6 7 8 9 (one) 
Quiche (medium serving) 1 2 3 4 5 6 7 8 9 
Low ca lorie, low fat salad cream 
1 2 3 4 5 6 7 8 9 (tblspn) 
Salad cream, mayonnaise 
1 2 3 4 5 6 7 8 9 I(tblspn) 
French dressing (tblspn) 1 2 3 4 5 6 7 8 9 
Other salad dressing (tblspn) 1 2 3 4 5 6 7 8 9 
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FOOD AND AMOUNTS A VERAGE USE IN THE LAST YEAR 
Never, 1-3x a Once 2-4x a 5-6x a Once 2-3x a 4-5x a 6+ x a 
FAT ON BREAD OR < Ix a month a week week a day day day day 
VEGETABLES month week 
100% butter 1 2 3 4 5 6 7 8 9 
Block margarine (hard) 1 2 3 4 5 6 7 8 9 
Soft margarine (not low fat) 1 2 3 4 5 6 7 8 9 
Low fat spread 1 2 3 4 5 6 7 8 9 
FOOD AND AMOUNTS AVERAGE USE IN THE LAST YEAR 
Never, 1-3x a Once 2-4x a 5-6x a Once 2-3x a 4-5x a 6+ x a 
SWEETS AND SNACKS < Ix a month a week week a day day day day 
(medium serving) month week 
Sweet biscuits, chocolate eg 
digestive (one) 1 2 3 4 5 6 7 8 9 
Sweet biscuits, plain eg Nice, 
ginger (one) 1 2 3 4 5 6 7 8 9 
Cakes eg fruit, sponge - home 
baked 1 2 3 4 5 6 7 8 9 
Cakes eg fruit, sponge - ready 
1 2 3 4 5 6 7 8 9 made 
Buns, pastries: eg scones, 
flaI'iacks - home-baked 1 2 3 4 5 6 7 8 9 
Buns, pastries: eg croissants, 
doughnuts- ready-made 1 2 3 4 5 6 7 8 9 
Fruit pies, tarts, crumbles: home-
baked 1 2 3 4 5 6 7 8 9 
Fruit pies, tarts, crumbles -
ready-made 1 2 3 4 5 6 7 8 9 
Sponge puddings - home-baked 1 2 3 4 5 6 7 8 9 
Sponge puddings - packed mixes 1 2 3 4 5 6 7 8 9 
Sponge puddings - ready-made 1 2 3 4 5 6 7 8 9 
Rice pudding, semolina, tapioca 1 2 3 4 5 6 7 8 9 
Blancmange, mousse, trifle, 
other milkQuddings 1 2 3 4 5 6 7 8 9 
Ice cream, choc ices 1 2 3 4 5 6 7 8 9 
Chocolates, single or square 1 2 3 4 5 6 7 8 9 
Chocolate snack bars eg Mars, 
1 2 3 4 5 6 7 8 9 Crunchie 
Sweets, toffees, mints 1 2 3 4 5 6 7 8 9 
Sugar added to tea, coffee, cereal 
I (tspn) 1 2 3 4 5 6 7 8 9 
Crisps or other packet snacks eg 
Wotsits 1 2 3 4 5 6 7 8 9 
Peanuts or other nuts (50g) 1 2 3 4 5 6 7 8 9 
FOOD AND AMOUNTS AVERAGE USE IN THE LAST YEAR 
Never, 1-3x a Once 2-4x a 5-6x a Once 2-3x a 4-5x a 6+ x a 
SOUPS. SAUCES & SPREADS < Ix a month a week week week a day day day day 
month 
Vegetable soups (bowl) - home-
made S Y 1 2 3 4 5 6 7 8 9 
Vegetable soups (bowl) - packet 
S Y 1 2 3 4 5 6 7 8 9 
Vegetable soups (bowl) - tinned 
S Y 1 2 3 4 5 6 7 8 9 
Meat soups (bowl) - home-made 
S Y 1 2 3 4 5 6 7 8 9 
Meat soups (bowl) - packet S Y 1 2 3 4 5 6 7 8 9 
Meat soups (bowl) - tinned S Y 1 2 3 4 5 6 7 8 9 
Sauces: eg white sauce, cheese 
sauce, gravy (tblspn) 1 2 3 4 5 6 7 8 9 
Tomato ketchup (tablespoon) I 2 3 4 5 6 7 8 9 
Pickles, chutney (tablespoon) 1 2 3 4 5 6 7 8 9 
Marmite, Bovril (tablespoon) I 2 3 4 5 6 7 8 9 
Jam, marmalade, honey (teaspn) 1 2 3 4 5 6 7 8 9 
Peanut butter (teaspoon) I 2 3 4 5 6 7 8 9 
FOOD AND AMOUNTS AVERAGE USE IN THE LAST YEAR 
Never, 1-3x a Once 2-4x a 5-6x a Once 2-3x a 4-5x a 6+ x a 
DRINKS <Ix a month a week week a day day day day 
month week 
Tea (cup) I 2 3 4 5 6 7 8 9 
Coffee, instant or ground (cup) 1 2 3 4 5 6 7 8 9 
Coffee, decaffeinated (cup) 1 2 3 4 5 6 7 8 9 
Coffee whitener eg Coffee-mate 
teaspo) 1 
-
2 3 4 5 6 7 8 9 
Cocoa, hot chocolate (cup) S Y 1 2 3 4 5 6 7 8 9 
Horlicks, Ovaltine, malt drink (cup) 
S Y 1 2 3 4 5 6 7 8 9 
Wine (glass) I 2 3 4 5 6 7 8 9 
Beer, lager or cider (half pint) 1 2 3 4 5 6 7 8 9 
Port, sherry, vermouth, liqueurs 
I (glass) 1 2 3 4 5 6 7 8 9 
Spirits eg gin, brandy, whisky, 
vodka (single) 1 2 3 4 5 6 7 8 9 
Low calorie or diet fizzy drinks 
I(glass) I 2 3 4 5 6 7 8 9 
Fizzy soft drinks; eg Coca Cola, 
lemonade I 2 3 4 5 6 7 8 9 
Pure (100%) fruit juice eg orange, 
app]eiuice I 2 3 4 5 6 7 8 9 
Fruit squash or cordial (glass) I 2 3 4 5 6 7 8 9 
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FOOD AND AMOUNTS AVERAGE USE IN THE LAST YEAR 
Never, I-3x a Once 2-4x a 5-6x a Once 2-3x a 4-5x a 6+xa 
FRUIT (1 fruit or medium <Ix a month a week week a day day day day 
servine) month week 
Apples, fresh 1 2 3 4 5 6 7 8 9 
Oranges, satsurnas, mandarins, 
8 clementines, fresh S Y 1 2 3 4 5 6 7 9 
Grapefruit, fresh 1 2 3 4 5 6 7 8 9 
Bananas, fresh 1 2 3 4 5 6 7 8 9 
Grapes, fresh S Y 1 2 3 4 5 6 7 8 9 
Melon, fresh S Y 1 2 3 4 5 6 7 8 9 
Kiwi fruit, fresh 1 2 3 4 5 6 7 8 9 
Pears, fresh S Y 1 2 3 4 5 6 7 8 9 
Peaches, plums, apricots S Y 1 2 3 4 5 6 7 8 9 
Strawberries/raspberries, fresh S Y 1 2 3 4 5 6 7 8 9 
Any other fresh fruit? (specify) 
------------------------------------ S Y 1 2 3 4 5 6 7 8 9 
----------------------------------- S Y 1 2 3 4 5 6 7 8 9 
Tinned fruit 1 2 3 4 5 6 7 8 9 
Dried fruit eg raisins, prunes, dates 1 2 3 4 5 6 7 8 9 
FOOD AND AMOUNTS AVERAGE USE IN THE LAST YEAR 
Never, I-3x a Once 2-4x a 5-6x a Once 2-3x a 4-5x a 6+ xa 
VEGETABLES (Fresh or frozen) <Ixa month a week week a day day day day 
medium servin2 "- month week 
Carrots 1 2 3 4 5 6 7 8 9 
Broccoli 1 2 3 4 5 6 7 8 9 
Spring greens, kale 1 2 3 4 5 6 7 8 9 
Cabbage 1 2 3 4 5 6 7 8 9 
Peas 1 2 3 4 5 6 7 8 9 
Cauliflower 1 2 3 4 5 6 7 8 9 
Leeks 1 2 3 4 5 6 7 8 9 
Onions 1 2 3 4 5 6 7 8 9 
Garlic 1 2 3 4 5 6 7 8 9 
Mushrooms 1 2 3 4 5 6 7 8 9 
Sweet peppers 1 2 3 4 5 6 7 8 9 
Beansprouts 1 2 3 4 5 6 7 8 9 
CONTINUED ........................ 
FOOD AND AMOUNTS AVERAGE USE IN THE LAST YEAR 
Never, 1-3x a Once 2-4x a 5-6x a Once 2-3x a 4-5x a 6+xa 
VETET ABLES (contd) <Ix a month a week week a day day day day 
month week 
Tomatoes 1 2 3 4 5 6 7 8 9 
Beetroot I 2 3 4 5 6 7 8 9 
Coleslaw 1 2 3 4 5 6 7 8 9 
Avocado 1 2 3 4 5 6 7 8 9 
Spinach S Y I 2 3 4 5 6 7 8 9 
Brussels sprouts S Y 1 2 3 4 5 6 7 8 9 
Green beans, broad beans, runner 
beans S Y 1 2 3 4 5 6 7 8 9 
Marrow, courgettes S Y .. 1 2 3 4 5 6 7 8 9 
Parsnips, turnips, swedes S Y 1 2 3 4 5 6 7 8 9 
Green salad, lettuce, cucumber 1 2 3 4 5 6 7 8 9 
celery S Y 
Watercress S Y 1 2 3 4 5 6 7 8 9 
Sweetcom S Y 1 2 3 4 5 6 7 8 9 
Any other vegetables? (specify) 
------------------------------ S Y 1 2 3 4 5 6 7 8 9 
------------------------------ S Y 1 2 3 4 5 6 7 8 9 
Tinned vegetables 1 2 3 4 5 6 7 8 9 
Baked beans 1 2 3 4 5 6 7 8 9 
Dried lentils, beans, peas 1 2 3 4 5 6 7 8 9 
Tofu, soya meat, TVP, vegeburger 1 2 3 4 5 6 7 8 9 
Are there any OTHER foods which you ate regularly? Yes D No D 
If YES, list below: 
Usual Serving Size Frequency eaten 
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What type of milk do you most often use (select one)? 
Full cream D (1) Soya 
Semi-skimmed D (2) Dried milk 
Skimmed D (3) Other 
Channel Islands D (4) None 
How much milk do you drink each day, including milk with tea, coffee, cereals etc: 
None D (0) Three quarters of a pint 
Quarter of pint D (1) One pint 
HaIfa pint D (2) More than one pint 
Did you usually eat breakfast cereal (other than porridge and Ready Brek mentioned earlier)? 
Yes D (1) No D (0) 
If YES, which brand and type of breakfast cereal, including muesli did you usual eat? 
List the one or two types most often used 
D (5) 
D (6) 
D (7) 
D (0) 
D (3) 
D (4) 
D (5) 
What kind offat, if any, did you most often use for frying, roasting, grilling etc (Select one only)? 
None D (0) Vegetable oil D (3) 
Butter D (1) Solid vegetable fat D (4) 
Lard / dripping D (2) Margarine D (5) 
If you used vegetable oil, please give type (eg com, sunflower) 
What kind of fat, if any, did you most often use for baking cakes etc? 
None D (0) Vegetable oil D (3) 
Butter D (1) Solid vegetable fat D (4) 
Lard / dripping D (2) Margarine D (5) 
What kind of fat, if any, did you most often use for spreading on bread or adding to vegetables? Specify 
precise brand, eg Anchor Half Fat Spread, Delight Extra Low, Flora, Flora Extra Light etc 
Have you taken any vitamins, minerals, fish oils, fibre or other food supplements during the past year? 
Yes D (1) No D (0) Don't know D (9) 
If YES, complete the table below. If more than five types of supplement have been taken, put the most 
frequently consumed brands first 
Vitamin Average frequency 
Supplements Tick one box per line to show how often on average supplements are consumed 
Dose: no of pills Never, 1-3x a Once 2-4xa 5-6x a Once 2-3x a 4-5x a 6+a 
Name and brand capsules,teaspns <Ix a month a week week a day day day day 
consumed month week List full name, 
brand and strength 
-
. 
Smoking: Can I now ask about smoking - which best describes your smoking habits (including cigar or 
pipe smoking?): 
Current smoker (either regular or occasional) D (1) 
Never at any time been a regular smoker D (0) 
Ex-smoker: smoked regularly in the past D (2) Gave up ___ yrs ago 
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Have you smoked any cigarettes at all in the last 12 months? 
Yes, one or more 0 (1):::::> f), below 
No, none 
f) If Yes, number of cigarettes smoked on average over the last year: 
Can be given as either Cigarettes per day 
Cigarettes per week 
Total cigarettes during the year __ _ 
or 
or 
or 
Stress: can I now ask about any stressful events that you may have experienced in the last year? 
• Firstly can I ask about whether anyone close to you has died in the last year? 
A husband/wife or partner? Yes 0(1):::::> when was this? months ago No 0(0) 
Another close family member? Yes 0 (1):::::> months ago No 0 (0) 
A close friend? Yes 0 (1):::::> months ago NoO (0) 
• Can I ask about whether anyone close to you have been seriously ill? 
A husband/wife or partner? ? Yes 0(1):::::> when was this? months ago No 0(0) 
Another close family member? Yes 0(1):::::> months ago No 0(0) 
A close friend? Yes 0(1):::::> months ago No 0(0) 
• Or any other other events you found stressful? 
Divorce / separation Yes o (1):::::> when was this? months ago No 0(0) 
Difficulties with other Yes 0(1):::::> months ago No 0(0) 
family members 
Difficulties with neighbours Yes 0(1):::::> months ago No 0(0) 
Serious fmancial worries Yes 0(1):::::> months ago No 0(0) 
Moving house Yes 0(1):::::> months ago No 0(0) 
Problems at work Yes 0(1):::::> months ago No 0(0) 
• Are there any other events which stand out as having caused you stress in the last year? 
Yes 0(1) (specify) months ago No 0(0) 
Trauma: have you had any physical injuries in the last six months, for example any falls, or knocks 
which resulted in bruising, or any other injuries? 
Yes 0(1) :::::> (a) No 0(0) Don't know 0(9) 
a) If Yes, how long ago was this, and what sort of injury was it? (Table, below) 
When? Site of Injury Details 
1 
2 
3 
. 
4 
Finally, if I could ask a couple of general questions: 
Housing Tenure: regarding your current accommodation, do you (and/or your spouse/partner): 
Own your present home D (1) 
Rent your home from the local council 0 (2) 
Rent your home from a housing association 0 (3) 
Rent your home privately or are rent free D (4) 
Other 0 (5) Specify __________ _ 
Car access: is there a car or van available for use by you or other members of your household? 
Yes, one 
Yes, two or more 
No, none 
0(1) 
0(2) 
0(0) 
END OF INTERVIEW - Thank subject for help 
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INTERVIEW DETAILS 
Length of interview: 0 0 minutes 
Interview completed: Yes 0(1) No 0(0) ~(a) 
a) If interview curtailed, please give reasons ___________________ _ 
Did anyone help with the interview? 
Yes (proxy for subject) 0 (1) ~ (b) Yes (subject completed, 0 (2) ~ (b) 
with help) 
No 0(0) 
b) If 'Yes', relationship to subject of others helping with interview: 
Lives with subject: Yes 0(1) No 0 (0) 
Relationship: Spouse 0(1) Other relative 0(2) Other (please specify) _______ (3) 
SUBJECT'S MEMORY OF PAST HISTORY: 
Poor Fair Good Declined to Comments 
I (some problems) answer 
Sun exposure 
Diet 
Personal/work history 
Contacts with children 
.. 
/ chickenpox 
Anthropometry: 
Weight ___ Kg Height ____ cm Dernispan _____ cm 
_____ cm 
Sample taken? 
Yes 0(1) ~ Specimen No. ___ _ No 0(0) ~ Reason? _____ _ 
RESIDENCE CALENDAR 
Start by writing in the left-hand column the name of the village/town and country where you were born, 
and in the right-hand column the dates (period of time) you lived there 
Start a new row for each time you moved to a different area - please include in the list any places you 
visited for more than six months 
You do not need to include moves within the same town or city 
If you lived in a village or a small town, please write down the county as well, to help us identify where 
the village was. 
If you lived outside the UK, please write down the name of the country as well. 
Please see the example of a completed residence calendar overleaf (provided in original letter) 
-
TOWN PERIOD COVERED 
(& country if outside the UK) month/year - month/year 
, 
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JOB CALENDAR 
Start with the time when you were 14 years old. In the left-hand column of the fIrst row, write down your 
job title or (if appropriate) school pupil. In the middle column, write down the dates (the period of time) 
that you were in that job. In the right-hand column, write down how many days a week you did this job 
(for example, 5 days/week). 
Start a new row for each time your job or main activity changed - for example, if you worked for the 
same company for 20 years, fIrst working in the offIce and then working as a sales rep, this would count 
as two different jobs (two different lines in the job calendar) . 
Please include voluntary work, times when you were at college or university, and times when you were 
not employed or were looking after the home and children. 
Please leave out any jobs you did for less than 6 months. 
Please see the example of a completed job calendar overleaf (provided in original letter) 
JOB PERIOD COVERED Number of days 
(including student, house-wife, unemployed, retired) month/year - month/year worked per week 
, 
-
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UV EXPOSURE IN LAST 20 YEARS 
Working days 20 yrS ago 10 yrs ago Last year (Other) (Other) (Other) 
Job title 
Wanner (brs/day) 
Cooler (brs/day) 
Non-working days 
Wanner (hrs/day) 
Cooler (brs/day) , 
Holidays - A~r/Se~t (include dates) N/A N/A N/A 
How often? (code) 
Which country? 
\ 
How many days? 
Exposure 9-5 
Holidays - OctIMar (include dates) N/A N/A N/A 
How often? (code) , 
, 
Which country? 
How many days? 
Exposure 9-5 
Job/non-work days 
Freq hat 
Freq prot clothes 
Holidays 
Freq hat 
Freq prot clothes 
-_._- ~-
- -
~ 
::> 
ARTICLES 
@ Contacts with varicella or with children and protection 
against herpes zoster in adults: a case-control study 
Sara L Thomas, Jeremy G Wheeler, Andrew J Hall 
Summary 
Background Whether exogenous exposure to varicella-
zoster-virus protects individuals with latent varicella-zoster 
virus infection against herpes loster by boosting immunity 
is not known. To test the hypothesis that contacts with 
children increase exposure to varicella-loster virus and 
protect latently infected adults against loster, we did a 
case-control study in south London, UK. 
Methods From 22 general practices, we identified patients 
with recently diagnosed loster, and control individuals with 
no history of loster, matched to patients by age, sex, and 
practice. Participants were asked about contacts with 
people with varicella or loster in the past 10 years, and 
social and occupational contacts with children as proxies 
for varicella contacts. Odds ratios were estimated with 
conditional logistic regression. 
Findings Data from 244 patients and 485 controls were 
analysed. On multivariable analysis, protection associated 
with contacts with a few children in the household or via 
childcare seemed to be largely mediated by increased 
access to children outside the household. Social contacts 
with many children outside the household and occupational 
contacts with ill children were associated with graded 
protection against loster, with less than a fifth the risk in 
the most heavily exposed groups compared with the least 
exposed. The strength of protection diminished after 
controlling for known varicella contacts; the latter remained 
significantly protective (odds ratio 0·29 [95% CI 
0'10-0·84] for those with five contacts or more). 
Interpretation Re-exposure to varicella-loster virus via 
contact with children seems to protect latently infected 
individuals against loster. Reduction of childhood varicella 
by vaccination might lead to increased incidence of adult 
zoster. Vaccination of the elderly (if effective) should be 
considered in countries with childhood varicella vaccination 
programmes. 
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Introduction 
Primary infection with varicella-zoster virus causes 
varicella, after which the virus establishes latency in 
dorsal root ganglia. '-3 Reactivation of latent infection is 
thought to result from declining specific cell-mediated 
immunity, and leads to herpes zoster."" Zoster occurs 
frequently in ageing populations and causes substantial 
acute and chronic morbidity, the commonest long-term 
complication being persistent pain (post-herpetic 
neuralgia),' 
Hope-Simpson postulated that exogenous exposure to 
people with varicella or zoster might boost specific 
immunity and therefore decrease the risk of zoster 
in latently infected individuals. 8 Mothers of children 
with varicella have cell-mediated immune boosting, 
and children with leukaemia seem to be protected 
against zoster by household exposure to varicella. 9.10 
However, whether exogenous exposure protects 
against zoster in immunocompetent adults is unclear. In 
one study, paediatricians had more contacts with 
patients infected with varicella-zoster virus than 
dermatologists or psychiatrists, and were significantly 
less likely to have developed zoster, but the results could 
have been influenced by very low response rates to the 
survey." 
The role of immune boosting is an important issue for 
varicella vaccination programmes, since a reduction in 
childhood varicella will result in fewer exogenous 
exposures to varicella-zoster virus, which could lead to 
increased incidence of zoster among unvaccinated 
adults." Varicella vaccination has already been 
introduced in countries such as the USA and Japan, and 
is being considered by many European countries. We 
therefore set up a study to test the hypothesis that 
exogenous exposure to varicella-zoster virus protects 
against zoster. 
Methods 
Patients and controls 
This investigation was one objective of a community-
based case-control study of risk factors for zoster in 
immunocompetent adults in south London, UK, 
between September, 1997, and December, 1998. A 
reporting system was set up among 22 general practices 
to identify individuals who had recently been diagnosed 
with zoster by their family physician. For each patient 
with zoster, two controls with no history of zoster were 
sought by searching practice registers for individuals 
who were nearest in age to the patient, and matched for 
sex and practice. Patients and potential controls were 
approached and invited to take part in the study. Those 
who agreed and were eligible were interviewed at home. 
Ethics approval was obtained from the London School 
of Hygiene and Tropical Medicine Ethics Committee, 
and from four local research ethics committees. All 
participants gave written informed consent. 
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Cases of zoster were confirmed where possible by use 
of PCR to detect varicella-zoster virus DNA in vesicular 
fluid or crust samples obtained at interview." 
Unconfirmed cases were divided into "probable" and 
"other" groups with standardised diagnostic criteria 
applied at interview. Probable cases had a unilateral 
vesicular or maculopapular rash with a dermatomal 
distribution where either rash or pain covered at least 
half the dermatome, or rash and pain were less 
extensive, but pain lasted at least 1 month after rash 
onset. Patients with a history of a similar dermatomal 
rash at any site within the past 10 years were excluded 
from the probable group. In this study, only data from 
confirmed and probable cases and their matched 
controls were analysed. 
Patients and controls were excluded if they were 
younger than 16 years; had a cell-mediated 
immunosuppressive disorder or therapy in the past 
6 months or a history of active cancer in the past 5 years; 
were of African ethnic origin (a group at higher risk of 
undiagnosed HIV infection in this population);'4 were 
temporarily registered with the practice; or were 
incapable of answering questions. Patients were also 
excluded if they were identified more than 8 weeks after 
rash onset. Controls were excluded if they had a history 
of zoster. 
Data collection 
Participants were asked about contacts with people with 
varicella or zoster in the past 10 years. Because varicella 
is mostly acquired before the age of 10 years in the 
UK," additional data were sought on contacts with 
children aged 1-10 years as surrogates for exogenous 
varicella exposures. We asked questions about social 
contacts with children in the past 10 years, including (1) 
specific children living in the household, (2) specific 
children not living in the household (such as 
grandchildren and neighbours), or (3) a range of 
different children in groups with changing membership 
(such as at school playgrounds or parties). For each 
child, we sought information on the average frequency 
(per week or per month) and duration (in years) of 
contact. We also asked about the duration of 
occupational exposure to children, either with (4) a few 
specific children through childcare (eg, through 
childminding, full-time parenting), (5) with many well 
children (eg, through teaching), or (6) with many iII 
children (eg, through being a doctor). These data were 
used to create three types of exposure: exposure to 
people with varicella or zoster, exposure to a few 
children (1 and 4, above), or exposure to many children 
(2, 3, 5, and 6). Information on potential confounders 
included ethnic origin, lifetime country of residence, 
and socioeconomic factors (household tenure and car 
ownership). 
We calculated the total number of social contacts with 
children in the past 10 years by multiplying the average 
frequency of contact by duration of contact for each 
child, and summing the results. Social contacts were 
then grouped into "none" and into two, three, or five 
"exposed" groups, each of which contained an equal 
number of controls (quantiles of exposure). Duration of 
occupational exposure was divided into "none", "up to 
5 years", and "more than 5 years" of exposure. 
Statistical analysis 
Sample-size calculations for the entire study were 
derived from standard equations for matched case-
control studies, adjusted for our choice of two controls 
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Type of variable 
Distal 
(few children) 
Intermediate 
(many 
children) 
Social contacts 
with children 
living in the 
household' 
Social contacts 
with children not 
living in the 
household: 
• specific children 
• groups of children 
ARTICLES 
Occupational 
contacts with 
few children 
via childcare' 
Occupational 
contacts with: 
• many well children 
• many ill children 
Proximal Contacts with cases of varicella or zoster (varicella-zoster L-_______________ ....I 
vi ru s contacts) 
Risk of zoster 
Conceptual framework for modelling effect of contacts with 
children or with patients with varicella or zoster on risk of 
zoster 
'Parents who stayed at home to look after children full-time appear in 
both distal groups. 
per case. 16 Taking an odds ratio of 2'0, a minimum 10% 
prevalence of exposure in controls, 90% power at 5% 
significance (two-sided), and a 20% increase to 
accommodate multivariable analyses, we needed to 
assess 244 confirmed and probable cases, and 
488 controls. 
We set out to test the hypothesis that contacts with 
children protected latently infected adults against zoster, 
and that this protection resulted from increased 
exposure to varicella-zoster virus. Analyses were done 
with Stata statistical software, version 6.0 (StataCorp, 
College Station, TX, USA). Odds ratios were estimated 
by conditional logistic regression, with zoster as the 
outcome variable. The significance of associations 
between exposure variables and risk of zoster was 
calculated with likelihood ratio tests of heterogeneity 
and of linear trend; 95% CIs were calculated with Wald-
based SEs. Univariable analyses identified variables 
associated with zoster to the significance level of p,,;;0·2 
for initial inclusion inmultivariable models. 
Variables were classified as distal, intermediate, or 
proximal, according to their position in the proposed 
chain of causation as outlined in the figure." In this 
conceptual framework, varicella or zoster exposures had 
a direct effect on the risk of zoster, and were categorised 
as proximal variables. Social or occupational contacts 
with many children that were likely to result in varicella 
exposures were categorised as intermediate variables. 
Contacts with a few children living in the household or 
via child care work were categorised as distal variables 
because some of their effect might be mediated through 
contacts with a wider range of children outside the 
household (the intermediate variables). Distal variables 
were added first to the multivariable model, and 
retained as long as they remained significantly 
associated with zoster (p";;O·I). Intermediate variables 
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Distal variables Patients (n=244) Controls (n=485) Unlvarlable odds p Adjusted for Intermediate p 
ratio (95% CI) social child contacts 
Chlldcare work with a few specific children 
None 233 (95·5%) 1·00 1·00 
.. 5 years' duration 10 (4·1%) 
436 (89,9%) 
28 (5·8%) 
21 (4·3%) 
0·37 (0·13-1·06) 0·94 (0·27-2·99) 
>5 years' duration 1 (0·4%) 0·06 (0·01-0·50) 0·0004 0·19 (0·02-1·79) 0·214 
0·169 (trend) 
Number of chlld-day contacts with children living In household 
None 202 (82·8%) 355 (73·2%) 1·00 1·00 
7-2550* 27 (11,1%) 65 (13·4%) 0·62 (0·37-1·05) 0·96 (0·54-1·69) 
2551-14 901 15 (6·1%) 65 (13·4%) 0·34 (0·18-0·64) 0·001 0·71 (0·34-1·47) 0·638 
0·403 (trend) 
'Quantiles of exposure, see methods. 
Table 1: Effects on risk of zoster of contacts with limited numbers of children living In household and via chlldcare work In past 
10 years 
were added second, to demonstrate the extent to which 
they explained the effect of distal variables, then 
proximal variables were added to determine whether 
they explained distal and intermediate factors. Variables 
excluded at the univariable or distal stages of analysis 
were added again at the proximal stage to assess whether 
they became significantly associated with zoster in the 
presence of other variables. Confounding vari1lbles were 
added to the model if they changed any of the effect 
estimates of interest by 10% or more." Interactions 
between contact variables and age were investigated in 
the final model. 
Role of the funding source 
Neither funder of this study was involved in the study 
design; the collection, analysis, and interpretation of 
data; the writing of the report; or the decision to submit 
the paper for publication. 
Results 
During the study period, 436 patients were identified, 
of whom 139 were ineligible (46 were younger than 
16 years, 37 had recent immunosuppression, 18 were 
African, 11 were temporarily registered, four were 
incapable of answering questions, and 23 were identified 
more than 8 weeks after rash onset). Of the remaining 
297 patients, 16 (5'4%) were not enrolled: 12 refused 
and four were away from London or repeatedly 
unavailable for more than 8 weeks. The eligibility of 
these patients was not ascertained. The remaining 281 
patients were categorised as confirmed (92), probable 
(152), or other (37) cases. Of the confirmed and 
probable cases, 107 (43'9%) were men, and the median 
age was 57·2 years (range 16'5-91'2). 
488 controls were needed for the 244 confirmed and 
probable cases. Letters were sent to 895 individuals, of 
whom 162 were ineligible (118 had a history of zoster, 
22 had recent immunosuppression, 11 were African, one 
was temporarily registered, and 10 were incapable of 
answering questions). A further 145 were unsuitable 
(106 no longer lived in London, 22 were living away for 
extended periods, 11 were dead, and six had an 
incorrect date of birth on practice records). Of the 
remaining 588 potentially eligible individuals, 103 
(17'5%) were not included in the study (75 refused, 
nine twice cancelled interviews, three were in hospital, 
one had a non-existent address, and 15 could not be 
contacted after more than four attempts). The 
remaining 485 'controls were enrolled; for three of the 
enrolled patients only one matched control was 
obtained. The mean difference in age between patients 
and their matched controls was 4'7 days. Controls were 
interviewed a median of 35 days after patients. 
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Contact with a few children living in the household or 
via childcare work in the past 10 years was strongly 
associated with protection against zoster on univariable 
analysis, with evidence of a dose-response effect. 
However, neither distal variable remained significantly 
associated with risk of zoster after adjusting for the 
effects of social contacts with specific children not living 
in the household and children in groups (table 1). 
Childcare and household contact variables were 
therefore dropped from the model. 
Table 2 lists univariable effect estimates for the 
intermediate child contact variables, in the 10 years 
before interview, that were associated with zoster. 
Protection increased with longer duration of 
occupational exposure to many ill children, and with 
greater numbers of social contacts with specific children 
not living in the household or children in groups. There 
was no significant association between duration of 
occupational exposure to many well children in the past 
10 years and risk of zoster, even after analyses were 
restricted to individuals working in primary-school or 
nursery settings (odds ratio 0·94 [95% CI 0·47-1·87]). 
Intermediate child contact variables remained 
significantly associa'ted with protection against zoster 
after adjusting for each other and for ethnic origin, with 
little change to the effect estimates (data not shown). 
However, the strength of aSSOC18ttons between 
intermediate child contacts and zoster decreased 
after adjusting for contact with known cases of varicella 
(table 2), remaining most strongly significant for 
contacts with children in groups. 
Contact with people with varicella in the past 10 years 
was strongly associated with protection against zoster on 
univariable analysis (table 2), and this association 
remained after adjusting for occupational and social 
child contacts. Contact with people with zoster was 
weakly associated with protection against zoster on 
univariable analysis, but not significantly associated with 
zoster in the final model (table 2). Ethnic origin slightly 
confounded the effect of occupational exposure to ill 
children, and was added to all models. After adding 
ethnic origin, childhood residence in the tropics and 
socioeconomic variables made little difference to effect 
estimates for the variables of interest. The effect of the 
contact variables did not vary with participants' age (p 
for interaction >0·3 for all). 
We could not test study participants for HIV 
infection, and so could not confirm that all cases and 
controls were HIV-negative. The effect of child contacts 
might be confounded by undiagnosed HIV infection in 
patients. Homosexual men in London are a group at 
high risk of HIV infection (which increases their chance 
of developing zoster), and could have relatively few child 
THE LANCET· Vol 360' August 31,2002' www.thelancet.com 
Intermediate variables 
Number of social contacts with specific 
children not living in household 
None 
2-107t 
108-420 
421-1334 
1335-3457 
3458-32631 
Number of social contacts with children 
in groups 
None 
6-550t 
551-3652 
3653-45023 
Patients 
(n=244) 
30 (12-3%) 
60 (24-6%) 
53 (21-7%) 
52 (21-3%) 
30 (12-3%) 
19 (7-8%) 
197 (80-7%) 
24 (9-8%) 
16(6-6%) 
7 (2-9%) 
Occupational contact with many ill children 
None 241 (98-8%) 
.. 5 years' duration 2 (0-8%) 
Controls 
(n=485) 
49 (10-1%) 
87 (17-9%) 
88 (18-1%) 
87 (18-9%) 
87 (18-9%) 
87 (17-9%) 
308 (63-5%) 
59 (12-2%) 
59 (12-1%) 
59 (12-2%) 
460 (94-8%) 
14 (2-9%) 
Unlvarlable odds 
ratio (95% CI) 
1-00 
1-02 (0-59-1-81) 
0-91 (0-51-1-62) 
0-89 (0-49-1-63) 
0-53 (0-28-{)-98) 
0-30 (0-14-{)-63) 
1-00 
0-63 (0-38-1-06) 
0-32 (0-17-{)-62) 
0-12 (0-06-{)-35) 
1-00 
0-26 (0-06-1-17) 
p 
----
0-0003 
<0-0001 
Adjusted for other 
Intermediate variables 
and varicella contacts' 
1-00 
1-03 (0-57-1-85) 
0-94 (0-52-1-73) 
0-90 (0-48-1-70) 
0-60 (0-30-1-17) 
0-43 (0-19-{)-94) 
1-00 
0-72 (0-41-1-27) 
0-44 (0-22-{)-89) 
0-19 (0-07-{)-50) 
1-00 
0-25 (0-05-1-20) 
ARTICLES 
p 
0-079 
0-007 (trend) 
0-001 
0-0001 (trend) 
11 (2-3%) 0-17 (0-02-1-29) 0-015 0-27 (0-03-2-51) >5 years' duration 1 (0-4%) 0-062 
___________________________________________ 0-025 (trend) 
Proximal variables 
Number of known varicella contacts 
None 179 (73-4%) 283 (58-4%) 1-00 1-00* 
1 34(13-9%) 74 (15-3%) 0-67 (0-42-1-08) 0-90 (0-54-1-52) :j: 
2 20 (8-2%) 45 (9-3%) 0-61 (0-34-1-09) 0-83 (0-45-1-56) :j: 
3-4 6(2-5%) 44(9-1%) 0-15 (0-06-{)-39) 0-26 (0-10-{)-72) * 
;;.5 5(2-0%) 39(8-0%) 0-14 (0-05-{)-39) 0-0001 0-29 (0-10-{)-84) * 0-016 
0-003 (trend) 
Number of known zoster contacts 
None 189 (77-5%) 338 (69-7%) 1-00 1-00§ 
1 44 (18-0%) 110 (22-7%) 0-71 (0-48-1-05) 0-79 (0-51-1-23)§ 
;;.2 11 (4-5%) 37 (7-6%) 0-51 (0-25-1-04) 0-052 0-92 (0-42-2-03)§ 0-581 
'Also adjusted for ethnic origin_ tQuantiles of exposure. see methods_ :j:Adjusted for intennediate variables and ethnic origin_ §Adjusted for intennediate variables. 
varicella contacts. and ethnic origin_ 
Table 2: Effects on risk of zoster of contacts with many children and exgenous exposure to varlcella·zoster virus In the past 10 years 
contacts_"'" Multivariable analyses were therefore 
repeated in two subgroups of individuals at low risk of 
HIV infection: first women and then all individuals older 
than 60 years. Statistical power was reduced, but 
protective trends associated with social and occupational 
child contacts were similar to those shown in the whole 
dataset (data available on request). The effect of 
imperfect specificity of the probable zoster case definition 
was also investigated by repeating analyses in the subset 
of confirmed cases and their matched controls. Similar 
protective patterns were shown. 
changing membership in occupational or social settings 
(increasing the likelihood of contacting a case of 
varicella) . 
Some protective effect of child contacts remained after 
adjustment for known varicella contacts. This effect 
might represent unrecognised or forgotten contacts with 
children with varicella, since varicella is infectious before 
rash onset, and this is especially likely for social contacts 
with children in groups of changing membership.20 If this 
explanation is correct, the total protective effect of 
(known and unknown) varicella contacts will be greater 
than that estimated in the final model, which represents 
only the effect of known varicella contacts independent of 
the effect of unknown contacts. Interestingly, 
occupational contact with many well children (eg, 
through teaching) was not protective against zoster. 
Perhaps varicella contacts are more distant in these 
settings than in social settings, and are more limited in 
duration if children with varicella are absent from school 
while experiencing rash. Contact with zoster cases was 
not associated with protection against zoster. This 
finding is less surprising, since zoster is less infectious 
than varicella and most zoster contacts had rash on non-
exposed areas of the body. 
Discussion 
The findings from this study suggest that continued 
exogenous exposure to varicella is protective against 
zoster in latently infected adults. This result is consistent 
with those of Gershon and colleagues,'o who found that 
vaccinated children with leukaemia were at significantly 
lower risk of zoster if they had household exposure to 
varicella, and that many of these children had evidence of 
immunological boosting. In our study, there were dose-
response effects associated with a range of occupational 
and social exposures to children and with varicella 
contacts. Results of analyses using a hierarchical model-
building strategy (figure) show that living with children 
seems to protect against zoster largely by increasing 
access to a range of other children outside the household, 
and that the protection afforded by contacts with many 
children seems to be largely explained by exposure to 
varicella-zoster virus. The latter conclusion is supported 
by analyses showing that protection against zoster is 
strongest when contacts are with children in groups of 
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Other explanations for the protective effect of child 
contacts should be considered. First, ethnic origin is a 
potential confounder of the effect of child contacts on 
risk of zoster, since some ethnic groups could be at lower 
risk of zoster than others and have greater contacts with 
children via extended families." However, neither ethnic 
origin nor country of residence in childhood accounted 
for the protective effect of child contacts in this study. 
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Second, subgroup analyses indicated that the protective 
effect of child contacts was unlikely to result from 
undetermined HIV infection or misdiagnosis of zoster 
cases. Incomplete reporting of cases by practices might 
introduce bias if general practitioners were more likely to 
report cases with fewer child contacts. This situation is 
unlikely, since the overall study was investigating various 
risk factors for zoster, and investigation of a limited 
number of unreported cases showed that failure to be 
reported was due to general under-reporting by some 
practices or by specific practitioners, rather than selective 
reporting of cases. Participation by controls was high 
(82'5%), but some bias might have been introduced if 
those who refused or could not be contacted were eligible 
for inclusion and had fewer contacts with children. 
Recall bias occurs in case-control studies if patients 
remember past exposures differently from controls. In 
this study, recall bias might have led to underestimation 
of the protective effects of child and varicella contacts. 
Many patients believed that zoster resulted from contact 
with cases of varicella or zoster, and had spent time trying 
to remember any contacts that might have infected them. 
Another concern in case-control studies is that having the 
disease affects exposure-in this situation, cOntact with 
children. However, reverse causality is unlikely to explain 
the fmdings. First, most patients were interviewed within 
2 weeks of rash onset. Second, the number of child 
contacts was calculated from the average frequency 
before onset of rash, not the frequency in the past few 
days. For example, a patient who saw her grandchild on 
average once a week in the past year would be assigned 
52 child contacts, even if she had not seen the child since 
onset of rash. 
Children who are vaccinated against varicella might be 
at lower risk of later developing zoster.22 Therefore, 
widespread varicella vaccination programmes might 
eventually decrease the incidence of zoster. However, the 
results of this study suggest that vaccination of children 
against varicella could lead to a prolonged period of 
increased incidence of zoster among unvaccinated adults, 
as a result of fewer exogenous exposures to varicella-
Zoster virus. This increase in incidence might have 
started already in countries such as the USA, but could 
be unrecognised due to limited surveillance of zoster. In 
view of this possibility, we should consider whether 
childhood varicella vaccination programmes should be 
expanded to include vaccination of older adults, to 
protect them against zoster. The results of the current US 
multicentre trial of varicella vaccination in elderly 
individuals will indicate whether this is a feasible 
approach.2l 
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